<!DOCTYPE  html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8"/><title>NASDAQ_CNXR_2016</title><meta name="author" content="Morningstar Document Research / Morningstar, Inc."/><style type="text/css"> * {margin:0; padding:0; text-indent:0; }
 h2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 14.5pt; }
 .h3, h3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 9.5pt; }
 .s1 { color: black; font-family:Menlo, sans-serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 9.5pt; }
 .s2 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 7.5pt; }
 h1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 19.5pt; }
 .s3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 7pt; }
 .s4 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 7pt; }
 .s5 { color: black; font-family:"Arial Unicode MS", sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 7pt; }
 .s6 { color: black; font-family:Menlo, sans-serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 7pt; }
 .s7 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 8pt; }
 .s8 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 7pt; }
 .s9 { color: #0000ED; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: underline; font-size: 8pt; }
 .s10 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 .s11 { color: #0000ED; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt; }
 .s12 { color: #0000ED; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt; }
 .s13 { color: #0000ED; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: underline; font-size: 8pt; }
 .s14 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 8pt; }
 .s15 { color: black; font-family:"Times New Roman", serif; font-style: italic; font-weight: normal; text-decoration: none; font-size: 8pt; }
 .s16 { color: black; font-family:"Times New Roman", serif; font-style: italic; font-weight: normal; text-decoration: none; font-size: 8pt; }
 .p, p { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; margin:0pt; }
 h4 { color: black; font-family:TimesNewRomanPS-BoldItalicMT, serif; font-style: italic; font-weight: bold; text-decoration: none; font-size: 8pt; }
 .s17 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 6pt; vertical-align: 2pt; }
 .s18 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 .s19 { color: black; font-family:Arial-BoldItalicMT, sans-serif; font-style: italic; font-weight: bold; text-decoration: none; font-size: 8pt; }
 .s21 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt; }
 .s23 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 5.5pt; }
 .s24 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 7pt; vertical-align: 1pt; }
 .s25 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 1.5pt; }
 .s26 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 1pt; }
 .s27 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 8pt; }
 .s28 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10pt; vertical-align: -2pt; }
 .s29 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 1pt; }
 .s30 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt; }
 .s31 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 1.5pt; }
 .s32 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 .a { color: #0000ED; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt; }
 .s33 { color: #0000ED; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 .s34 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 0.5pt; }
 .s35 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: underline; font-size: 8pt; }
 .s36 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 .s37 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 .s38 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: underline; font-size: 7pt; }
 .s39 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 5.5pt; }
 .s40 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 7.5pt; }
 .s41 { color: #333; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 .s42 { color: #7F7F7F; font-family:Arial, sans-serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9.5pt; }
 li {display: block; }
 #l1 {padding-left: 0pt; }
 #l1> li:before {content: "☐ "; color: black; font-family:Menlo, sans-serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 9.5pt; }
 #l2 {padding-left: 0pt; }
 #l2> li:before {content: "• "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 li {display: block; }
 #l3 {padding-left: 0pt;counter-reset: d1 2; }
 #l3> li:before {counter-increment: d1; content: "("counter(d1, lower-roman)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l3> li:first-child:before {counter-increment: d1 0;  }
 #l4 {padding-left: 0pt; }
 #l4> li:before {content: "• "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 li {display: block; }
 #l5 {padding-left: 0pt;counter-reset: e1 1; }
 #l5> li:before {counter-increment: e1; content: "("counter(e1, decimal)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l5> li:first-child:before {counter-increment: e1 0;  }
 #l6 {padding-left: 0pt;counter-reset: e2 1; }
 #l6> li:before {counter-increment: e2; content: "("counter(e2, decimal)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l6> li:first-child:before {counter-increment: e2 0;  }
 #l7 {padding-left: 0pt; }
 #l7> li:before {content: "• "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 li {display: block; }
 #l8 {padding-left: 0pt; }
 #l8> li:before {content: "* "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l9 {padding-left: 0pt;counter-reset: g1 2; }
 #l9> li:before {counter-increment: g1; content: "("counter(g1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l9> li:first-child:before {counter-increment: g1 0;  }
 #l10 {padding-left: 0pt; }
 #l10> li:before {content: "• "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l11 {padding-left: 0pt;counter-reset: h1 1; }
 #l11> li:before {counter-increment: h1; content: "("counter(h1, decimal)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l11> li:first-child:before {counter-increment: h1 0;  }
 #l12 {padding-left: 0pt; }
 #l12> li:before {content: "• "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10pt; vertical-align: -2pt; }
 #l13 {padding-left: 0pt;counter-reset: i1 1; }
 #l13> li:before {counter-increment: i1; content: "("counter(i1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l13> li:first-child:before {counter-increment: i1 0;  }
 #l14 {padding-left: 0pt;counter-reset: i2 1; }
 #l14> li:before {counter-increment: i2; content: "("counter(i2, decimal)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 8pt; }
 #l14> li:first-child:before {counter-increment: i2 0;  }
 #l15 {padding-left: 0pt;counter-reset: j1 1; }
 #l15> li:before {counter-increment: j1; content: counter(j1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 8pt; }
 #l15> li:first-child:before {counter-increment: j1 0;  }
 #l16 {padding-left: 0pt;counter-reset: j2 1; }
 #l16> li:before {counter-increment: j2; content: counter(j2, lower-latin)") "; color: black; font-family:TimesNewRomanPS-BoldItalicMT, serif; font-style: italic; font-weight: bold; text-decoration: none; font-size: 8pt; }
 #l16> li:first-child:before {counter-increment: j2 0;  }
 #l17 {padding-left: 0pt; }
 #l17> li:before {content: "• "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l18 {padding-left: 0pt;counter-reset: k1 7; }
 #l18> li:before {counter-increment: k1; content: counter(k1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 8pt; }
 #l18> li:first-child:before {counter-increment: k1 0;  }
 #l19 {padding-left: 0pt;counter-reset: l1 10; }
 #l19> li:before {counter-increment: l1; content: counter(l1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 8pt; }
 #l19> li:first-child:before {counter-increment: l1 0;  }
 #l20 {padding-left: 0pt;counter-reset: m1 1; }
 #l20> li:before {counter-increment: m1; content: "("counter(m1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l20> li:first-child:before {counter-increment: m1 0;  }
 #l21 {padding-left: 0pt;counter-reset: n1 1; }
 #l21> li:before {counter-increment: n1; content: "("counter(n1, decimal)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l21> li:first-child:before {counter-increment: n1 0;  }
 li {display: block; }
 #l22 {padding-left: 0pt;counter-reset: l1 10; }
 #l22> li:before {counter-increment: l1; content: counter(l1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 8pt; }
 #l22> li:first-child:before {counter-increment: l1 0;  }
 #l23 {padding-left: 0pt;counter-reset: l2 1; }
 #l23> li:before {counter-increment: l2; content: counter(l2, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l23> li:first-child:before {counter-increment: l2 0;  }
 #l24 {padding-left: 0pt;counter-reset: l3 1; }
 #l24> li:before {counter-increment: l3; content: counter(l3, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l24> li:first-child:before {counter-increment: l3 0;  }
 #l25 {padding-left: 0pt;counter-reset: l3 1; }
 #l25> li:before {counter-increment: l3; content: counter(l3, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l25> li:first-child:before {counter-increment: l3 0;  }
 li {display: block; }
 #l26 {padding-left: 0pt;counter-reset: o1 1; }
 #l26> li:before {counter-increment: o1; content: counter(o1, decimal)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l26> li:first-child:before {counter-increment: o1 0;  }
 #l27 {padding-left: 0pt;counter-reset: o2 1; }
 #l27> li:before {counter-increment: o2; content: counter(o2, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l27> li:first-child:before {counter-increment: o2 0;  }
 #l28 {padding-left: 0pt;counter-reset: o2 1; }
 #l28> li:before {counter-increment: o2; content: counter(o2, lower-latin)". "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 8pt; }
 #l28> li:first-child:before {counter-increment: o2 0;  }
</style></head><body><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="721" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_001.png"/></span></p><h2 style="padding-left: 19pt;text-indent: 0pt;line-height: 16pt;text-align: center;"><a name="bookmark0">UNITED STATES</a><a name="bookmark1">&zwnj;</a></h2><h2 style="padding-left: 19pt;text-indent: 0pt;line-height: 17pt;text-align: center;">SECURITIES AND EXCHANGE COMMISSION</h2><h3 style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">Washington, D.C. 20549</h3><p style="padding-left: 223pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="143" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_002.png"/></span></p><h2 style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">FORM 10-K</h2><p style="padding-left: 223pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="143" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_003.png"/></span></p><p class="s1" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">☒ <span class="h3">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></p><p class="s2" style="padding-top: 1pt;padding-left: 206pt;text-indent: 0pt;line-height: 117%;text-align: center;">For the fiscal year ended December 31, 2016 OR</p><ul id="l1"><li style="padding-left: 32pt;text-indent: -24pt;text-align: left;"><h3 style="display: inline;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</h3><p class="s2" style="padding-top: 1pt;padding-bottom: 2pt;padding-left: 218pt;text-indent: -32pt;line-height: 117%;text-align: left;">For the Transition Period from to Commission File Number 001-36778</p><p style="padding-left: 223pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="143" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_004.png"/></span></p><h1 style="padding-left: 19pt;text-indent: 0pt;text-align: center;">CONNECTURE, INC.</h1><p class="s3" style="padding-left: 19pt;text-indent: 0pt;text-align: center;">(Exact name of registrant as specified in its charter)</p><p style="text-indent: 0pt;text-align: left;"><span><img width="144" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_005.png"/></span></p><p class="s2" style="padding-top: 6pt;padding-left: 22pt;text-indent: 0pt;text-align: center;">Delaware                                                                                                                                                          58-2488736</p><p class="s2" style="padding-top: 3pt;padding-left: 66pt;text-indent: 1pt;text-align: left;">(State or other jurisdiction of incorporation or organization)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s2" style="padding-left: 35pt;text-indent: 0pt;text-align: center;">18500 West Corporate Drive, Suite 250</p><p class="s2" style="padding-left: 35pt;text-indent: 0pt;text-align: center;">Brookfield, WI 53045</p><p class="s3" style="padding-left: 35pt;text-indent: 0pt;text-align: center;">(Address of principal executive offices and zip code)</p><p class="s2" style="padding-top: 1pt;padding-left: 35pt;text-indent: 0pt;text-align: center;">(262) 432-8282</p><p class="s3" style="padding-left: 35pt;text-indent: 0pt;text-align: center;">(Registrant’s telephone number, including area code)</p><p class="s2" style="padding-top: 1pt;padding-left: 35pt;text-indent: 0pt;text-align: center;">Securities registered pursuant to Section 12(b) of the Act:</p><p class="s2" style="padding-top: 3pt;padding-left: 29pt;text-indent: 10pt;text-align: left;">(I.R.S. Employer Identification Number)</p><p class="s2" style="padding-top: 2pt;padding-left: 184pt;text-indent: -141pt;line-height: 117%;text-align: left;">Common Stock, par value $0.001 per share The NASDAQ Global Market LLC Securities registered pursuant to Section 12(g) of the Act:</p><p class="s2" style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">None</p><p style="padding-left: 223pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="143" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_006.png"/></span></p><p class="s4" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes <span class="s5">☐ </span>No <span class="s5">☒</span></p><p class="s4" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes <span class="s5">☐ </span>No <span class="s5">☒</span></p><p class="s4" style="padding-top: 1pt;padding-left: 8pt;text-indent: 0pt;line-height: 92%;text-align: left;">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes <span class="s5">☒ </span>No <span class="s5">☐</span></p><p class="s4" style="padding-top: 1pt;padding-left: 8pt;text-indent: 0pt;text-align: justify;">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes <span class="s5">☒ </span>No <span class="s5">☐</span></p><p class="s4" style="padding-top: 1pt;padding-left: 8pt;text-indent: 0pt;line-height: 92%;text-align: left;">Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§ 229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. <span class="s5">☒</span></p><p class="s4" style="padding-top: 1pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.</p><p class="s4" style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Large accelerated filer <span class="s6">☐ </span>Accelerated filer <span class="s6">☐</span></p><p class="s4" style="padding-top: 4pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Non-accelerated filer <span class="s6">☐ </span>(Do not check if a smaller reporting company) Smaller reporting company <span class="s6">☒</span></p><p class="s4" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes <span class="s5">☐ </span>No <span class="s6">☒</span></p><p class="s4" style="padding-top: 1pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">As of June 30, 2016, the date of the registrant’s most recently completed second quarter, the aggregate fair market value of the registrant’s common stock held by non-affiliates was approximately $37.1 million based on the closing sales price as reported on the NASDAQ Global Market.</p><p class="s4" style="padding-top: 1pt;padding-bottom: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">As of March 10, 2017, there were 22,584,540 shares of the registrant’s common stock, par value $0.001, issued and outstanding.</p><p style="padding-left: 223pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="143" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_007.png"/></span></p><p class="s2" style="padding-left: 17pt;text-indent: 0pt;text-align: center;">DOCUMENTS INCORPORATED BY REFERENCE:</p><p class="s4" style="padding-top: 1pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">The information required by Part III of this Report, to the extent not set forth herein, is incorporated herein by reference from the Proxy Statement relating to the registrant’s 2017 annual meeting of stockholders, which shall be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year to which this Report relates.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="721" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_008.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_009.png"/></span></p><table style="border-collapse:collapse;margin-left:5.5pt" cellspacing="0"><tr style="height:43pt"><td style="width:52pt" rowspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:462pt"><p class="s7" style="padding-left: 147pt;padding-right: 170pt;text-indent: 0pt;line-height: 9pt;text-align: center;">CONNECTURE, INC.</p><p class="s7" style="padding-left: 147pt;padding-right: 170pt;text-indent: 0pt;text-align: center;">Form 10-K</p><p class="s7" style="padding-left: 147pt;padding-right: 171pt;text-indent: 0pt;text-align: center;">For the Year Ended December 31, 2016 TABLE OF CONTENTS</p></td><td style="width:27pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:13pt"><td style="width:462pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:27pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-top: 4pt;padding-left: 5pt;text-indent: 0pt;line-height: 7pt;text-align: left;"><a name="bookmark2">Page</a><a name="bookmark3">&zwnj;</a><a name="bookmark37">&zwnj;</a></p></td></tr><tr style="height:26pt"><td style="width:52pt"><p style="padding-top: 6pt;padding-left: 2pt;text-indent: 0pt;text-align: left;"><a href="#bookmark38" class="s9">PART I</a></p><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 1.</p></td><td style="width:462pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s12" style="padding-top: 5pt;padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Business</p></td><td style="width:27pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-top: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1</p></td></tr><tr style="height:10pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 1A.</p></td><td style="width:462pt"><p class="s12" style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Risk Factors</p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">13</p></td></tr><tr style="height:10pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 1B.</p></td><td style="width:462pt"><p class="s12" style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Unresolved Staff Comments</p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">32</p></td></tr><tr style="height:10pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 2.</p></td><td style="width:462pt"><p class="s12" style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Properties</p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">32</p></td></tr><tr style="height:10pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 3.</p></td><td style="width:462pt"><p class="s12" style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Legal Proceedings</p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">32</p></td></tr><tr style="height:13pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;text-align: left;">Item 4.</p></td><td style="width:462pt"><p class="s12" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">Mine Safety Disclosures</p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;text-align: right;">33</p></td></tr><tr style="height:23pt"><td style="width:52pt"><p style="padding-top: 3pt;padding-left: 2pt;text-indent: 0pt;text-align: left;"><a href="#bookmark51" class="s9">PART II</a></p><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 5.</p></td><td style="width:462pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s12" style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</p></td><td style="width:27pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">34</p></td></tr><tr style="height:10pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 6.</p></td><td style="width:462pt"><p class="s12" style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Selected Financial Data</p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">36</p></td></tr><tr style="height:10pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 7.</p></td><td style="width:462pt"><p class="s12" style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Management’s Discussion and Analysis of Financial Condition and Results of Operations</p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">40</p></td></tr><tr style="height:10pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 7A.</p></td><td style="width:462pt"><p class="s12" style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Quantitative and Qualitative Disclosures About Market Risk</p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">60</p></td></tr><tr style="height:10pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 8.</p></td><td style="width:462pt"><p class="s12" style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Financial Statements and Supplementary Data</p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">60</p></td></tr><tr style="height:10pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 9.</p></td><td style="width:462pt"><p class="s12" style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">60</p></td></tr><tr style="height:10pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 9A.</p></td><td style="width:462pt"><p class="s12" style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Controls and Procedures</p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">60</p></td></tr><tr style="height:13pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;text-align: left;">Item 9B.</p></td><td style="width:462pt"><p class="s12" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">Other Information</p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;text-align: right;">61</p></td></tr><tr style="height:23pt"><td style="width:52pt"><p class="s13" style="padding-top: 3pt;padding-left: 2pt;text-indent: 0pt;text-align: left;">PART III</p><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 10.</p></td><td style="width:462pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s12" style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Directors, Executive Officers and Corporate Governance</p></td><td style="width:27pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">62</p></td></tr><tr style="height:10pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 11.</p></td><td style="width:462pt"><p style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;"><a href="#bookmark71" class="s11">Executive Compensation</a></p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">62</p></td></tr><tr style="height:10pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 12.</p></td><td style="width:462pt"><p class="s12" style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">62</p></td></tr><tr style="height:10pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 13.</p></td><td style="width:462pt"><p class="s12" style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Certain Relationships and Related Transactions and Director Independence</p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">62</p></td></tr><tr style="height:13pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;text-align: left;">Item 14.</p></td><td style="width:462pt"><p class="s12" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">Principal Accounting Fees and Services</p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;text-align: right;">62</p></td></tr><tr style="height:23pt"><td style="width:52pt"><p style="padding-top: 3pt;padding-left: 2pt;text-indent: 0pt;text-align: left;"><a href="#bookmark78" class="s9">PART IV</a></p><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 15.</p></td><td style="width:462pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s12" style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Exhibits and Financial Statement Schedules</p></td><td style="width:27pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">63</p></td></tr><tr style="height:10pt"><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Item 16.</p></td><td style="width:462pt"><p class="s12" style="padding-left: 13pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Form 10-K Summary</p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">63</p></td></tr><tr style="height:10pt"><td style="width:52pt"><p style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;"><a href="#bookmark82" class="s11">Signatures</a></p></td><td style="width:462pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:27pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">64</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 223pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="143" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_010.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_011.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;"><a name="bookmark38">PART 1</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Forward Looking Statements</p><p class="s15" style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Except for the historical financial information contained herein, the matters discussed in this Annual Report on Form 10-K (as well as documents incorporated herein by reference) may be considered “forward-looking” statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including, but not limited to, statements regarding our future financial position, business strategy and plans and objectives of management for future operations. When used in this Annual Report, the words “believe,” “may,” “could,” “will,” “estimate,” “continue,” “intend,” “expect,” “anticipate,” “plan,” “project” and similar expressions are intended to identify forward-looking statements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from those reflected in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in this report, and in particular, the risks discussed under Part 1, Item 1A: “Risk Factors” and those discussed in other documents we file with the Securities and Exchange Commission. Except as required by law, we do not intend to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 8pt;text-indent: 24pt;text-align: left;">In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this report and in the documents incorporated in this report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Accordingly, readers are cautioned not to place undue reliance on such forward-looking statements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 8pt;text-indent: 24pt;text-align: left;"><a href="#bookmark39" class="s16" name="bookmark4">Unless otherwise indicated, references to “Connecture,” “the Company,” “we,” “our” and “us” in this Annual Report on Form 10-K refer to</a> Connecture, Inc. and its consolidated subsidiaries.<a name="bookmark5">&zwnj;</a><a name="bookmark39">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;line-height: 158%;text-align: left;"><a name="bookmark40">Item 1. Business. Overview</a></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We are a leading web-based consumer shopping, enrollment and retention platform for health insurance distribution. Our solutions offer a personalized health insurance shopping experience that recommends the best fit insurance plan based on an individual’s preferences, health status, preferred providers, medications and expected out-of-pocket costs. Our customers are payers, brokers, government agencies, and web-based insurance marketplace operators, who distribute health and ancillary insurance. Our solutions automate key functions in the insurance distribution process, allowing our customers to price and present plan options accurately to consumers and efficiently enroll, renew and manage plan members.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The United States health insurance marketplace continues to experience structural changes that alter how health insurance is purchased and distributed. Consumer access to and plan choices for health insurance continues to grow. As a result, consumers need effective decision-support tools to help them optimize their health insurance choices. Concurrently, the traditional distribution approaches for health plans and brokers have had to evolve from offering a more limited set of plans to employers through group coverage to cost-effectively selling insurance in the more fragmented individual market and in public and private exchanges. These exchanges are essentially online marketplaces sponsored either by a non-government entity, such as an employer, insurance broker or other distributor (in the case of private exchanges) or by a federal or state government entity (in the case of public exchanges.) This evolution calls for technology solutions that allow individuals and businesses to compare products and make purchases directly from health plans in a way that is cost-effective for health plan distributors.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">In 1999 we incorporated in Delaware, and since then, we have provided technology-enabled health plan sales automation solutions. As of December 31, 2016, our customer base included more than 75 health plans, including 20 of the top 25 health plans (based on total enrollment). As of December 31, 2016, our technology powered more than 35 private, state and federal exchanges. Our personalized health insurance shopping experience is available to the approximately 52 million Medicare beneficiaries through our provision of shopping, price comparison, plan ranking and enrollment software for Medicare.gov and 1-800-Medicare call center agents. We estimate that approximately 3.5 million Medicare beneficiaries used our software in the 2016 enrollment period.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;text-indent: 0pt;text-align: center;">1</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_012.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Industry Background</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The United States health insurance industry is responsible for the administration of healthcare benefits to over 175 million individuals covered by employer-based health insurance and is experiencing a structural transformation in which shopping for and enrollment in health insurance products is transitioning from a wholesale or group-based distribution model to an individual or retail-oriented consumer marketplace. This transformation, in conjunction with regulatory and competitive pressure on distribution and overhead costs, places substantial new business and technology requirements on health plans, brokers and aggregators and has created an attractive opportunity in the markets we serve.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Consumer-Centric Marketplace</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">With a new president and administration in the White House, we expect there may be changes in the Federal regulations brought about as part of the Patient Protection and Affordable Care Act (PPACA). However, we anticipate the role of the consumer will only continue to be more important.</p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Responsibility for health insurance purchasing will largely fall to individuals and will place a continued importance on better, more informed decision- making. This trend is evident in several key health insurance membership market segments:</p><ul id="l2"><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s15" style="display: inline;">Individual Insurance Market: <span class="p">Mandated insurance coverage has driven significant growth in the under-65 individual market. Anecdotal information from health plans indicates that more small group employers (defined as employers having less than 100 employees) are looking to exit the market and associated provision of health insurance and as such we believe that these previously insured employees will be seeking coverage in the individual market.</span></p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s15" style="display: inline;">Employer-sponsored Insurance Market: <span class="p">For individuals who currently receive insurance through their employers, there has been a trend toward employees bearing a greater share of the cost of these benefits. This trend creates an increased need for employees to engage in the shopping experience, purchase the right levels of coverage and better understand the overall financial implications of their benefit selection decisions.</span></p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s15" style="display: inline;">Exchange-based Insurance Market: <span class="p">According to a study by Accenture, employers in 2016 moved approximately 8 million lives to private exchanges, up 35% from 2015. These efforts include mechanisms to make health insurance a defined contribution benefit and decouple benefit expenses from medical cost inflation trends. As part of this shift, large employers are also moving retirees from group Medicare Advantage plans to retail Medicare Advantage plans that are distributed through retiree exchanges.</span></p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s15" style="display: inline;">Medicare Market: <span class="p">We believe that the number of participants in Medicare Advantage and Medicare Supplement plans will increase from approximately 30 million individuals in 2015 to approximately 34 million individuals in 2018 based on data from the Congressional Budget Office and other industry analysts, and that there will be increased movement from group Medicare Advantage plans to retail Medicare Advantage plans.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">As a whole, these trends are directing an evolution of health insurance technology toward supporting more effective and consumer-friendly solutions that help consumers to better compare and enroll in plans based on their actual healthcare needs and to optimize their increased health insurance responsibility and spend.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Pressure to Manage Distribution Costs and Operating Expenses</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">While health plans and brokers need to support a more individualized and fragmented health insurance shopping and enrollment process, they are under increasing pressure to lower distribution costs. Federal regulations brought about as part of the PPACA had a material effect on health plan profitability and increased the competition for gaining and retaining members. This forced health plans to find better ways to manage areas of non-medical cost structure, such as sales commissions and internal information technology development. As a result, health plans have undertaken efforts to lower brokerage commissions and to implement innovative third-party technologies to reduce investment in internally-developed software. Similarly, brokers who now face depressed commissions from health plans need to leverage technology-based, automated processes to sell more cost-effectively and to identify product cross- selling opportunities, such as with ancillary products, as part of the plan selection process.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Increasing Opportunity for Technology</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">As shopping and enrollment in health insurance transitions to an individual, retail-oriented consumer marketplace, we believe there is opportunity for intuitive, web-based technologies to automate and lower the cost of health insurance distribution, as well as increase enrollment opportunities and member retention.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;text-indent: 0pt;text-align: center;">2</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_013.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">The Connecture Sales Automation Solution</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our leading web-based consumer shopping, quoting, enrollment and engagement solutions support a range of health insurance products and services, including Group, Individual and Medicare coverage, with a focus on providing a consumer-centric experience. We simplify the health plan and prescription drug shopping experience with data-driven tools that empower consumers to make smarter, more personalized coverage choices. For health plan, broker and exchange operator customers, we deliver powerful and unified distribution solutions that we believe help them increase their revenue opportunity as they serve a growing, but fragmented population, while also reducing the costs associated with acquiring new and retaining current members.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 78pt;text-indent: 0pt;text-align: left;"><span><img width="530" height="144" alt="image" src="NASDAQ_CNXR_2016/Image_014.jpg"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">We automate the following key functions of the health and ancillary insurance distribution process for our customers:</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s14" style="display: inline;">Rate Setting and Modeling: <span class="p">prices and presents plan options accurately to consumers;</span></p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s14" style="display: inline;">Shopping and Quoting: <span class="p">allows consumers to view and compare plans, including estimated premiums, out-of-pocket costs and plan benefits;</span></p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s14" style="display: inline;">Application and Enrollment: <span class="p">streamlines application and enrollment operations, eliminating manual processes and paper processing;</span></p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s14" style="display: inline;">Renewal Management: <span class="p">streamlines the renewal process, eliminating manual processes and paper processing;</span></p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s14" style="display: inline;">Member Management: <span class="p">updates plan offering details based on members’ work or life changes; and</span></p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s14" style="display: inline;">Exchange Integration: <span class="p">connects to state and federal exchanges to determine subsidy eligibility.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We believe the breadth, depth and scale of our solutions across key functional areas are critical to our success in the complex and changing health insurance marketplace. In particular, our personalized and data-driven shopping experience helps customers make better health insurance purchasing decisions. Our web-based solutions are designed to maximize enrollment and member retention opportunities, and our technology enables rapid deployment of benefits and engagement technology to help our customers adapt to evolving market needs and build stronger relationships with their members.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Our Competitive Strengths</p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">We believe we have the following key competitive strengths:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Health plan shopping and enrollment leadership</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">While the health insurance industry is in the midst of adapting to rapidly changing requirements, and many start-up competitors are struggling to adapt to the uncertain future direction of the PPACA, we have built our flexible platform infrastructure to be relevant over the long-haul, no matter the political environment. We have a more than 15-year history in the technology-enabled health plan shopping and enrollment serving individuals both under and over-65, including the following:</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Leadership in the commercial under-65 health insurance market;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Over ten years as the web-based technology solution for Medicare.gov;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Relationships with a broad range of health plans and brokers, including 20 of the top 25 health plans (based on total enrollment).</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;text-indent: 0pt;text-align: center;">3</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_015.png"/></span></p><h4 style="padding-top: 3pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Domain and technology development expertise</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The health insurance market is characterized by high levels of regulation and complexity. There are many plan types and configurations available to individuals and ensuring that the options are presented and marketed effectively is key. Further, our technology assists our customers to compete more effectively by allowing them to introduce new products and change pricing and benefit designs dynamically. We also believe that our solutions allow our customers to more effectively enter new markets and distribute new products faster and more efficiently. We believe our depth of knowledge and our proven ability to innovate positions us to be a leader in our industry.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Configurable and scalable solutions to meet customer needs</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Many of our solutions are designed to handle both high degrees of configurability and significant growth in users without requiring major software re- engineering or capital expenditures by our customers. Our solutions are cost-effective for our customers because we offer a platform that is comprehensive across key sales automation functions, but also has individual software applications that can integrate with common existing customer software applications. We deliver quick deployment solutions in the cloud as well as large scale enterprise solutions. Today, our technology is used by many of the largest health plans and brokers to power their critical shopping and enrollment functions. We also power the country’s largest multi-payer exchange, Medicare.gov, and successfully handle more than two million Medicare Advantage and Medicare Part D enrollments annually.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Large and valuable database of health plan and drug cost information and ancillary products</h4><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">We believe that our large database of health plan and drug cost information enables us to deliver higher value to our customers and consumers alike.</p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">We are a primary source of health plan and pharmacy data for Medicare products available on Medicare.gov and the broad range of our health plan relationships makes us a valuable and extensive source of permission-based health plan information. These data are critical for consumers to make difficult decisions about trade-offs between plan premiums vs. out-of-pocket costs, physician networks and pharmaceutical formularies. Our large dataset of health plan and drug cost information powers our empirically-driven recommendations engine that we believe provides consumers with more precise decision- support tools. In addition, our platform also supports many ancillary products such as dental, life insurance, critical illness and wellness which allows health plans and brokers to sell a more customized package of insurance products, thereby helping to differentiate the consumer shopping experience and maximize our customers’ revenue opportunity.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Reportable Segments</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: justify;">Our reportable segments, Enterprise/Commercial, Enterprise/State, Medicare and Private Exchanges are based on software and service offerings. Financial information for our reportable segments is included in Note 14 of the Notes to Consolidated Financial Statements included in Part II, Item 8: “Financial Statements and Supplementary Data” of this Annual Report on Form 10-K.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: justify;">Our portfolio of web-based software solutions allows customers to offer solutions for Group, Individual and Medicare markets. Each application is modular and functions independently, yet can integrate together to create a comprehensive and robust solution. Our portfolio of solutions is summarized below by reportable segment.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Enterprise Commercial Solution for Health Plans</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Connecture’s primary Enterprise Commercial solution automates sales and enrollment processing in order to allow health plans to operate more cost- effectively, extend reach and provide a better consumer and/or employer/broker experience. The full consumer lifecycle for sales automation is managed, from business acquisition through renewals. Our platform allows a broad range of consumers (individual plan sales, group sales, or single health plan private exchanges) to make better health insurance decisions. Consumers, brokers and other agents can more easily shop for, purchase and renew insurance. The software solution can be configured for any size of health plan and streamlines workflow for health insurance distribution and automates multiple lines of business, including health, dental, group life, vision, accidental death and dismemberment, short-term disability and long-term disability. The solution is web-based, secure and scalable.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">The business functions automated for the individual consumer market include:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Shopping</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The Shopping application allows for the capture of consumer information, the comparison of plans and viewing of rates. In addition, users can retrieve previously saved quotes, copy and create new quotes and indicate acceptance of plans online. The functionality supports all the applicable rules related to open enrollment, metal tier plan information and member-level rate display.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;text-indent: 0pt;text-align: center;">4</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_016.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The solution also offers a Plan Advisor Tool which allows the consumer, broker or sales representative to shop and compare plans, products and key benefit features via an interactive “guided shopping” experience based on questions around the consumer’s individual risk tolerance, ability to pay more up- front/higher deductible, personal health factors, desired add-on plans or riders. These questions are then rated and scored and plans are presented based on how the consumer answered each question. There are also subsidy and cost calculators to help the prospective member gauge financial risk. Each implementation is designed to match the health plan’s current website and brand.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Enrollment</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">An Online Application steps the user through an easy to navigate electronic application. Questions (or fields) can be standard or dynamic. Enrollment enables the health plan to combine enrollment forms for multiple products into one online application. Once an electronic application has been started, the user can save and return at a later time to complete it. A consumer can also receive assistance with completing the application from the broker or sales representative. The broker or sales representative may aid in determining the best coverage fit for his or her customer, based on presented plan details and prices. The broker or sales representative can start the online application process for his or her customer and then forward the application to the customer for completion. eSignature is also supported.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Administrative Review</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Applications that do not meet the health plan’s established rules will be routed to an internal user where they can review and approve, withdraw or indicate that an applicant is not eligible for the coverage requested. To expedite the approval process, administrative reviewers can also edit individual new business enrollments. For example, enrollments held for approval due to circumstances such as home address checks, health plan specific configuration checks or attachment uploads can be edited to allow the process to continue moving forward.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Renewals</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The renewal application is comprised of a series of workflow steps which will allow for the automatic initiation of the renewal process without manual intervention; health plans, however, can also configure business rules to denote renewal groups and subject such groups to the manual renewal process.</p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Functionality includes renewal import, renewal quoting and acceptance, renewal export, package generation and distribution, recommended and alternate plan mapping and agent/broker PDF generation.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Member Management</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The member management application allows members the ability to update their profiles with work and life event changes at any point throughout the year through an online portal. The system will track the requested change of coverage through a defined approval process.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">The member is able to perform the following functions within the system:</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">View and modify subscriber and dependent information (e.g., name, address, phone numbers, e-mail, student status, date of birth, gender, social security number);</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Add and remove dependents from coverage;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">View current benefits and rates;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">View address information; and</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">View and modify payment information.</p></li></ul></li></ul><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">Health plans can also determine unique business rules to determine if administrative review is necessary for specific policy changes.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The solution utilizes common capabilities for both the individual consumer and the employer group’s needs. The business functions automated for employer groups include:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Quoting</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">New Business Quoting provides a guided workflow to capture basic employer demographic information and employee census details in order to view available plans and corresponding rates. Within each new business quote, the user can view the composite/age rates, estimated premiums, plan benefits and benefit comparisons.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;text-indent: 0pt;text-align: center;">5</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_017.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">It also provides a guided workflow designed specifically for defined contribution in addition to traditional defined benefit plans. Users can initiate a defined contribution quote by selecting an array of plans options. These options are defined by the health plan and configured within the product server and rate repository. The collection of employer demographics and census information can serve both defined contribution and defined benefit quoting.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Employer and Employee Shopping</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The Shopping application allows for the capture of basic consumer information, the comparison of plans and viewing of rates. In addition, users can retrieve previously saved quotes, copy and create new quotes and indicate acceptance of plans online. The functionality supports any of the mandated rules related to open enrollment, metal tier plan information and member-level rate display.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The solution for groups also offers a Plan Advisor Tool, which allows employee-consumers, or the human resources administrator at the employer or the broker or sales representative working with them, to shop and compare plans, products and key benefit features via an interactive “guided shopping” experience based on questions around their own individual risk tolerance, ability to pay more up-front/higher deductible, personal health factors, desired add-on plans or riders, etc. These questions are rated and scored. Plans are presented based on how the consumer answers each question. Each implementation is designed to match the health plan’s current website and brand. There is both a subsidy calculator and a cost calculator to help the prospective member gauge financial risk.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Enrollment and Renewals</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Developed specifically for the group market, the solution leverages common capabilities from the Individual applications and delivers necessary functionality tailored for employer group and employee enrollment. Comprehensive functionality also supports the group renewal process.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Group Policy Administration</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: justify;">The Group Policy Administration application allows human resources administrators and members the ability to update profiles with work and life event changes at any point throughout the year through an online portal. The system tracks the requested change of coverage through a defined approval process.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We also offer single-health plan private exchanges as an extension to the solution. These private exchanges enable insurance health plans to offer more choices to their employer customers. They facilitate an array of defined contribution and defined benefit plans, promote flexibility and consumer personalization and include medical and ancillary products in the consumer offering. We enable a one-stop shopping and enrollment experience that allows employers to make available to their employees a list of plans and benefits for consideration, pricing, selection and enrollment, including recommendation of best fit plans.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We also offer integration of a health plan’s consumer enrollment website to the Federal exchange through a Direct Enrollment capability currently supported by the Federal exchange, which provides the health plans the opportunity to maximize member retention by presenting only their Qualified Health Plans.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Medicare Solution</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We provide innovative, web-based Medicare plan comparison and enrollment tools for health plans, PBMs, pharmacies, field marketing organizations, or FMOs, and call centers. These products are used by the Medicare population through commercial health plans, retiree transition exchanges (group to individual, group to group) provided by benefits consulting firms and Medicare.gov.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">Key capabilities offered for our Medicare solution include:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Consumer Plan Comparison and Shopping</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The plan comparison and shopping solution is deployable in multiple portal website configurations including consumer, agent/broker and call center representative. The application supports the most common Medicare plan options including Medicare Advantage, or MA, Medicare Advantage Prescription Drug, or MAPD, Prescription Drug, or PDP, and Medicare Supplement plans. In addition to operating as a stand-alone website, the offering can also be made available as an Application Programming Interface or API. This allows the customer to embed the functionality within their existing internet assets without the need for a separate website.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;text-indent: 0pt;text-align: center;">6</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_018.png"/></span></p><p class="s15" style="padding-top: 3pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Plan Comparison and Retention</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our Medicare solution utilizes features from the shopping application to improve the efficiency of the policy renewal process. Medicare beneficiaries can receive their forms pre-populated with their personal information from the new business enrollment process, seeing plan options and cost estimates built on known information, such as age and pharmaceutical drug utilization. These pre-filled forms minimize potential errors and can expedite the enrollment process. Beneficiaries are also offered a Short Enrollment Request Form to facilitate enrolling in a different plan offered by the same health plan (when allowed by Centers for Medicare and Medicaid Services, or CMS).</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">On-line Enrollment</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The On-line Enrollment application can be fully integrated with the solution. The application unifies multiple distribution channels (e.g., brokers, field marketing organizations, call centers, etc.) into a single automated application submission to the health plan. Reporting is also available on an integrated basis. Common Medicare plan options including MA, MAPD, PDP and Medicare Supplement plans are supported with dynamic form generation coupled with extensive customization options.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Mobile Field Enrollment</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">In many cases brokers and agents are in the field and do not have access to the internet at the time of meeting with prospective beneficiaries. Our Mobile Field Enrollment application allows the user to store the enrollment data locally on their tablet and sync with the health plan once they are online. Customer information can also be loaded from the agent/broker’s contact address book located on their tablet. In addition to enrollment forms, other sales information, including presentations and scope of appointment forms are available electronically on the tablet as well.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Private Exchange Solutions</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our Private Exchange reportable segment provides benefit consultants, brokers, exchange operators and aggregators with a group defined- contribution benefit exchange solution. The solution enables users to provide their employer and individual customers with a compliant benefit shopping, enrollment and post-enrollment benefits management experience. Brokers are empowered with a custom-branded private exchange environment that provides analytics and decision support. Our Private Exchange solution expands upon our single-plan shopping and enrollment tools by allowing users to compare plans, premiums and products from among multiple health plans within a specific geography. Our solution also allows customers to sell commercial and Medicare products.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Through our RxHealth Insurance Agency, Inc. and ConnectedHealth, LLC subsidiaries, we are a CMS-approved Web-broker Entity, which allows us to assist customers online with (i) completing enrollment in Qualified Health Plans offered in the individual market through the Federal Exchange;</p><ol id="l3"><li style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><p style="display: inline;">applying for tax credits and cost sharing reductions for Qualified Health Plans; and (iii) other customer service assistance related to health insurance coverage and enrollment processes through the Federal Exchange. Using Web-broker Entity services allows brokers, agencies and aggregators to provide a CMS-approved technology platform to consumers shopping for Qualified Health Plans.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Under 65 Plan Comparison and Enrollment</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Building upon our shopping and enrollment applications, our Private Exchange applications delivers individual consumer and group quoting in a multi-payer configuration. The ability to intake an employer’s employee roster is supported to pre-fill demographic information and decrease process time. Brokers can monitor in-progress activity of the employees and analyze their sold group business, as well as create customized proposals for their customers.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Consumers and employees are provided medical plan decision support, including demographic and health condition analysis, provider network lookup, financial/out-of-pocket decision modeling, out-of-pocket cost calculator and drug comparison services as described below. In addition to medical products, ancillary and supplemental products (e.g., dental, vision, disability, etc.) are also supported in a single user shopping experience. Once the end-user has made plan selections, electronic enrollment during both annual open enrollment and special enrollment periods is available.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The solution includes integration with third-party benefits administration, consumer-directed health account management (FSA/HSA), call center services and population health and wellness management vendors.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Retiree Group Plan Comparison and Enrollment</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Developed for the employer seeking to transition its retirees from its current group coverage to individual Medicare plans, the retiree group plan comparison application allows for the creation of customized employer websites. The roster of eligible retirees can</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;text-indent: 0pt;text-align: center;">7</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_019.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">be pre-populated prior to making the site available for the retiree to select a new coverage plan. Health plans that have been selected by the employer are displayed to the retiree. Our Private Exchange solutions not only include technology, but also a repository of participating health plan and ancillary health plan data and integration connectivity. This repository enables the broker and exchange operator to deploy an offering quickly by avoiding an independent sourcing effort.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Enterprise State Solution for State Exchanges</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We have offered to state governments a solution that enabled states the ability to create public health insurance exchanges under PPACA. The state solution was customized for the government exchange market and includes three major functional components that facilitate plan selection:</p><ul id="l4"><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Individual or AHBE Shopping and Enrollment Applications—Intuitive tools that help consumers examine, compare and enroll in the best insurance options available for them and their families. Our individual shopping solution for state exchanges includes a range of plan comparison, consumer decision support and provider search tools.</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Small Group or SHOP Exchanges—For employer and employee shopping, quoting and enrollment.</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 26pt;text-align: left;">Due to limited market opportunities, we have continued to reduce our focus and dependency on this segment. As of December 31, 2016, we support one remaining state exchange, which we anticipate supporting through the duration of our contract ending in 2017.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Engagement Tools</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-top: 5pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Drug Compare</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We offer our customers, including PBMs, private exchanges and the federal government’s Medicare.gov website, a member engagement tool for drug pricing comparison called DrugCompare. We believe DrugCompare is the most widely-used and comprehensive drug pricing comparison database in the industry. The DrugCompare application presents dose equivalent therapeutic alternatives that are priced according to the shopper’s or member’s benefit and formulary. Lower cost formulary options are suggested, including direct generics, generic alternatives, brands, over the counter drugs, pill-splitting and alternative dosing schedules. Side-by-side pricing and safety comparisons are provided, as well as alerts regarding potential medication management interactions for a member. Our data network includes the ability to comparison shop across the country in retail and mail-order pharmacy locations.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Professional Services and Customer Support</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We deliver and support the Connecture platforms and solutions utilizing teams of highly qualified business and technical personnel. We have implementation teams in place to ensure seamless deployment and effective utilization of our solutions. Once deployed, our production support team is able to help customers with the option of maintaining various business rules, rates, plans and products on their own utilizing our proprietary tools, or having us maintain the platform on their behalf. And through working with our software application maintenance teams, customers are able to complete regular upgrades to the licensed applications, including updates for common regulatory items and new functionality.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Customers</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: justify;">Our customers include many of the nation’s leading commercial and Medicare health plans, public and private exchanges and PBMs. Our state and federal government contracts contain provisions allowing the government counterparty to terminate the contract for convenience, or for a lack of adequate funding, generally with 30 days’ written notice, which we believe to be customary for government contracts.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Sales and Marketing</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: justify;">We sell substantially all of our software solutions through our direct sales organization, comprised of health plan-focused and exchange-focused field sales professionals. These sales efforts are supported by multi-channel marketing tactics including modern digital outreach, websites, email, hosted webinars, print media, event marketing and public relations.</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We generate prospect leads, accelerate sales opportunities and build brand awareness through our marketing programs and strategic relationships. Our marketing programs target insurance and benefits executives, technology professionals and government department leaders as well as pharmaceutical benefits managers as direct outreach, but also address other influencers through nurturing programs and public relations.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;text-indent: 0pt;text-align: center;">8</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_020.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">For a discussion of our contracted backlog, see the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” including the subsections titled “Overview” and “Key Financial and Operating Performance Metrics.”</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Competition</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">While we do not believe any single competitor provides the breadth or the depth of the comprehensive Connecture solution set, we do face non- traditional competition from various sources.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">Our competition includes:</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">insurance health plans and national brokers that have invested in internally developed customer acquisition and retention solutions;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">various niche software vendors;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">systems integrators and large consulting firms;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">third party administrators and call centers that may look to add technology capabilities; and</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">general enterprise resource planning or CRM software vendors.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">We believe that we are differentiated primarily on the following factors:</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">user experience and personalization;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">breadth and depth of application functionality;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">15 years of longevity as a company in this market and domain expertise in health insurance, benefits and healthcare consumerism, as well as in commercial and government sectors;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">capability for customization through configuration, integration, security, scalability and reliability of applications;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">size and variety of customer base;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">extensive health plan and API data network;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">cloud-based and on-premise delivery model options;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">ability to integrate with legacy enterprise infrastructures and third-party applications such as CRM, and rapidly innovate and respond to customer needs and regulatory requirements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We believe that we compete effectively based upon these criteria. Nonetheless, the increasing acceptance of automated solutions in the health insurance marketplace and the adoption of more sophisticated technology and legislative reform will likely result in increased competition.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">Within the business segments that we serve, examples of our competitive positions include:</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Enterprise/Commercial:</p><p style="padding-top: 5pt;padding-left: 80pt;text-indent: 0pt;text-align: justify;">We do not believe that any single or small number of competitors is dominant in this segment, although we believe that we are a leader in this space. We have had historic strength in the individual consumer and small group markets. If we were to grow our position in the larger group market, we may face increased competition from more established firms based in either the enrollment management or core heath plan administration sectors.</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Medicare:</p><p style="padding-top: 5pt;padding-left: 80pt;text-indent: 0pt;text-align: left;">We believe that we are a leading technology solution vendor in this segment. This position is reflected in our role as the shopping technology for Medicare.gov, as well as the number of Medicare health plans we support, which as of December 31, 2016, was over 50 health plans. Additionally, we believe that we currently have a strong competitive position relative to other Medicare shopping and enrollment solutions, although some large health plans may possess the capability to develop their own solution that would compete with us, rather than procuring a solution externally.</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Private Exchange:</p><p style="padding-top: 5pt;padding-left: 80pt;text-indent: 0pt;text-align: left;">We believe this segment is relatively immature and the competitive environment is still evolving. As such, no competitor, or small group of competitors is dominant in the segment. A range of technology, benefits</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;text-indent: 0pt;text-align: center;">9</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_021.png"/></span></p><p style="padding-top: 3pt;padding-left: 80pt;text-indent: 0pt;text-align: left;">administration and call center vendors support private exchanges to varying degrees and these vendors differ as to the scope of software and services provided. We believe that our technology capabilities are robust and that our history of working with health plans in single and multi-plan solutions provide us an advantage, as well as our experience in the retiree exchange business. In addition, our flexible and scalable technology allows us to meet the unique needs of customers ranging from large national brokers to smaller regional customers.</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Enterprise/State:</p><p style="padding-top: 5pt;padding-left: 80pt;text-indent: 0pt;text-align: left;">We do not believe that any single or small number of competitors is dominant in this segment. Our competitors have included niche software vendors that address a specific functional need of a state’s overall exchange solution requirements, call center vendors that leverage internally developed software to also provide an internet portal and systems integrators and large consulting firms, which have long-standing relationships with state governments delivering customized solutions, primarily within the Medicaid market.</p><p style="padding-top: 5pt;padding-left: 80pt;text-indent: 0pt;text-align: left;">Due to limited market opportunities, we have continued to reduce our focus and dependency on this segment. As of December 31, 2016, we support one remaining state exchange, which we anticipate supporting through the duration of our contract ending in 2017.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Technology Infrastructure and Operations</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We have primarily deployed our software solutions using hosted and software-as-a-service, or SaaS, models. Our customers typically access our software via the web or mobile devices, rather than by installing software on their premises. Through both our single-tenant and multi-tenant platforms, our customers have options as to the configuration that best meets their needs. The multi-tenant approach provides significant operating leverage and improved efficiency as it helps us to reduce our fixed cost base and minimize unused capacity on our hardware. In addition, we believe our software architecture gives us an advantage over vendors of legacy systems, who may be using a less flexible architecture that would require significant time and expense to update. Our enterprise customers utilize a single-tenant software application which allows improved configurability and support for a variety of unique integrations.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We host our applications and serve our hosted customers from several data centers and hosting providers in different locations. We rely on third-party vendors to operate these data centers and provide services, which are designed to host mission-critical computer systems and have industry-standard measures in place to minimize service interruptions. Our technical operations staff manages the technology stacks supporting our platforms and uses automated monitoring tools throughout our system to detect unusual events or malfunctions that could interfere with our customers’ use of the Connecture solutions.</p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">We monitor application health by verifying that the applications, interfaces and supporting middleware are operational. If our monitoring tools detect a problem, they notify our technical operations staff, who respond immediately to diagnose and resolve the problem. We take the security of our data and our systems very seriously, and we focus on minimizing the risk of vulnerabilities in our system at the levels of software design and system and network administration.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Research and Development</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We believe that successfully developing and selling innovation is key to our long-term growth. Research and development expenses were $22.3 million, $22.7 million, and $18.1 million for the years ended December 31, 2016, 2015 and 2014, respectively.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Compliance and Certifications</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We voluntarily obtain third-party security examinations relating to security and data privacy. In addition, on an annual basis, we have a qualified security assessor complete an audit of compliance against the Payment Card Industry Data Security Standards, or PCI-DSS, applicable to Level 2 service providers. These standards focus on application and network security controls for companies that process, transmit or store credit card data on behalf of customers. As of December 31, 2016, we have demonstrated compliance with PCI-DSS 3.2 as determined by a qualified security assessor. During the year ended December 31, 2016, we also obtained our most recent independent SSAE16 SOC2<span class="s17">® </span>Report—Report on Controls at a Service Organization Relevant to Security, Availability, Process Integrity, Confidentiality or Privacy with no exceptions noted. We meet the requirements for a Business Associate as required by the Health Insurance Portability and Accountability Act, or HIPAA.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Intellectual Property</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We rely on a combination of trade secret, copyright and trademark laws, license agreements, confidentiality procedures, confidentiality and nondisclosure agreements and technical measures to protect the intellectual property used in our business. We generally enter into confidentiality and nondisclosure agreements with our employees, consultants, vendors and customers. We also seek to control access to and distribution of our software, documentation and other proprietary information.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 4pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">10</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_022.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We use several registered trademarks for our products and services, such as “Connecture,” “DRX,” “DestinationRX” “InsureAdvantage,” and “ConnectedHealth,” which are registered marks of Connecture in the United States. Through claimed common law trademark protection, we also protect other marks which identify our services, such as RxHealth, and we have reserved numerous domain names, including “connecture.com.”</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">We also rely on certain intellectual property rights that we license from third parties.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Government Regulation</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The healthcare and health insurance industries are highly regulated and entities are required to comply with extensive and complex United States laws and regulations at the federal and state levels. Although many regulatory and governmental requirements do not directly apply to our business, our customers are required to comply with a variety of United States laws, and we may be impacted by these laws as a result of our contractual obligations. We have attempted to structure our operations to comply with applicable legal requirements, but there can be no assurance that our operations will not be challenged or impacted by enforcement initiatives.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Requirements of PPACA</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: justify;">In March 2010, then-President Obama signed into law the Patient Protection and Affordable Care Act, or PPACA. As enacted, PPACA has impacted how healthcare services are covered, delivered and reimbursed through expanded coverage of uninsured individuals, reduced Medicare program spending and insurance market reforms.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">While many of the provisions of PPACA have not been directly applicable to us, PPACA, as enacted, has affected the business of many of our customers. Health plans and large employers have experienced changes in the numbers of individuals they insure as a result of Medicaid expansion and the creation of state and national exchanges. Although we are unable to predict with any reasonable certainty or otherwise quantify any future likely impact of PPACA on our business model, financial condition or results of operations, changes in the business of our customers and the number of individuals they insure may negatively impact our business. While in 2016 the PPACA remained in force, recent developments in the federal elections have indicated that efforts may be underway over the next several months to modify, substantially change, or possibly repeal the PPACA in its entirety. The specific changes and associated timing of any such efforts are presently unknown.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Requirements Regarding the Confidentiality, Privacy and Security of Personal Information</h4><p class="s15" style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">HIPAA and Other Privacy and Security Requirements.</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">There are numerous federal and state laws and regulations related to the privacy and security of personal health and other sensitive information. In particular, regulations promulgated pursuant to HIPAA established privacy and security standards that limit the use and disclosure of individually identifiable health information and require the implementation of administrative, physical and technological safeguards to ensure the confidentiality, integrity and availability of individually identifiable health information in electronic form. Health plans, healthcare clearinghouses and most providers are considered by the HIPAA regulations to be “Covered Entities.” With respect to our operations, we are a Business Associate of our health plan customers and we are directly subject to the privacy and security regulations and oversight established under HIPAA. We enter into written Business Associate Agreements with our customers, under which we are required to safeguard individually identifiable health information and comply with restrictions on how we may use and disclose such information.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Violations of the Privacy Standards and Security Standards might result in civil and criminal penalties, and ARRA increased the penalties for HIPAA violations and strengthened the enforcement provisions of HIPAA. For example, ARRA authorizes state attorneys general to bring civil actions seeking either injunctions or damages in response to violations of Privacy Standards and Security Standards that threaten the privacy of state residents. Additionally, some health plans interpret HIPAA requirements differently than we do, and as our customers are the Covered Entity under HIPAA we may be required to comply with their interpretations.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We might not be able to adequately address the business risks created by HIPAA implementation. Furthermore, we are unable to predict what changes to HIPAA or other laws or regulations might be made in the future or how those changes could affect our business or the costs of compliance.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">In addition to the Privacy Standards and Security Standards, most states have enacted patient confidentiality laws that protect against the disclosure of confidential medical and/or health information, and many states have adopted or are considering further legislation in this area, including privacy safeguards, security standards and data security breach notification requirements. Such state laws, if more stringent than HIPAA requirements, are not preempted by the federal requirements and we are required to comply with</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">11</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_023.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">them. Additionally, other laws or standards may apply to our operations, including requirements related to handling certain financial information, federal tax information, or FTI, and payment card association operating rules with respect to credit card data.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Failure by us to comply with any state standards regarding patient privacy may subject us to penalties, including civil monetary penalties and, in some circumstances, criminal penalties. Such failure may injure our reputation and adversely affect our ability to retain customers and attract new customers.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Medicare and Medicaid Regulatory Requirements</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We have contracts with insurance health plans who offer Medicare Managed Care (also known as Medicare Advantage or Medicare Part C) and Medicaid managed care plans. We also have contracts with insurance health plans who offer Medicare prescription drug benefits (also known as Medicare Part D) plans. The activities of the Medicare plans are regulated by CMS, and Medicaid is regulated at both the state and federal level. Though our health plan customers remain responsible to comply with CMS and other regulatory requirements, we operate as a First Tier, Downstream &amp; Related Entity, or FDR, in support of our Medicare customers. Some of the activities that we might perform, such as the enrollment of beneficiaries, may be subject to CMS and/or state regulation, and such regulations may force us to change the way we do business or otherwise restrict our ability to provide services to such plans.</p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Moreover, the regulatory environment with respect to these programs has become, and will likely continue to become, increasingly complex.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-top: 5pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Financial Services-Related Laws and Rules</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Financial services and electronic payment processing services are subject to numerous laws, regulations and industry standards, some of which might impact our operations and subject us, our vendors and our customers to liability as a result of the solutions we offer. In addition, our solutions might be impacted by payment card association operating rules, certification requirements and rules governing electronic funds transfers. If we fail to comply with applicable payment processing rules or requirements, we might be subject to fines and changes in transaction fees and may lose our ability to process credit and debit card transactions or facilitate other types of billing and payment solutions. Moreover, payment transactions processed using the Automated Clearing House Network, or ACH, are subject to network operating rules promulgated by the National Automated Clearing House Association and to various federal laws regarding such operations, including laws pertaining to electronic funds transfers, and these rules and laws might impact our billing and payment solutions.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Insurance Broker Laws</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Insurance laws in the United States are often complex, and states have broad authority to adopt regulations regarding brokerage activities. These regulations typically include the licensing of insurance brokers and agents and govern the handling and investment of customer funds held in a fiduciary capacity. We and our broker/agency customers may be subject to some of these regulations, and may not be able to fully comply.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">ERISA and Third-Party Administrator Laws</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The Employee Retirement Income Security Act of 1974, as amended, or ERISA, regulates how employee benefits are provided to or through certain types of employer-sponsored health benefits plans. ERISA is a set of laws and regulations that is subject to periodic interpretation by the United States Department of Labor as well as the federal courts.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Numerous states in which we do business have adopted regulations governing entities engaged in third-party administrator, or TPA, activities. TPA regulations typically impose requirements regarding enrollment into benefits plans, claims processing and payments and the handling of customer funds. Although we do not believe we are currently acting as a TPA, changes in state regulations could result in us being obligated to comply with such regulations, which might require us to obtain licenses to provide TPA services in such states.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Employees</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">As of December 31, 2016, we had 370 employees, all of whom are based in the United States. We consider our current relationship with our employees to be good. None of our employees is represented by a labor union or is a party to a collective bargaining agreement.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Quarterly Trends and Seasonality</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our overall operating results, including cash flow from operations, fluctuate from quarter to quarter as a result of a variety of factors, some of which are out of our control. These fluctuations are primarily driven by an increase in the third and fourth quarters in</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 4pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">12</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_024.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">activity at our customers in preparation for and during the annual insurance enrollment cycle, which occurs annually during our fourth quarter. Our historical results should not be considered a reliable indicator of our future results of operations.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Available Information</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;"><a href="http://www.connecture.com/" class="s18" target="_blank" name="bookmark6">Our Internet address is </a><a href="http://investors.connecture.com/" class="s18" target="_blank">www.connecture.com and our investor relations website is located at </a><a href="#bookmark41" class="s18">http://investors.connecture.com. We make available free of charge on our investor relations website under the headings “Financials” and “SEC Filings” our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports as soon as reasonably practicable after such materials are electronically filed with (or furnished to) the SEC. Information contained on our websites is not incorporated by reference into this Annual Report on Form 10-K. In addition, the public may read and copy materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains an Internet site, </a><a href="http://www.sec.gov/" class="s18" target="_blank">w</a>ww.sec.gov, that includes filings of and information about issuers that file electronically with the SEC.<a name="bookmark41">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark42">Item 1A. Risk Factors.</a></p><p class="s15" style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our business, prospects, financial condition or operating results could be materially adversely affected by any of these risks. The trading price of our common stock could decline due to any of the risks and uncertainties described below, and you may lose all or part of your investment. In assessing these risks, you should also refer to the other information contained in this Annual Report on Form 10-K, including our consolidated financial statements and related notes.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Risks Related to Our Business</p><h4 style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">We have a history of losses and we may be unable to achieve or sustain profitability.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We experienced a net loss of $26.5 million, $7.3 million and $10.2 million in 2016, 2015 and 2014, respectively. We cannot predict if we will achieve profitability in the near future or at all. We expect to make significant future expenditures to develop and expand our business. Our prior growth in revenue may not return or be sustainable, and we might not achieve sufficient revenue to achieve or maintain profitability. We may incur significant losses in the future for a number of reasons, including the other risks described in this Annual Report on Form 10-K, and we may encounter unforeseen expenses, difficulties, complications and delays and other unknown events. Accordingly, we may not be able to achieve or maintain profitability, and we may incur significant losses for the foreseeable future. Information on our going concern and management’s plan to continue to support its operations and meet its obligations is included in Note 3 of the Notes to Consolidated Financial Statements included in Part II, Item 8: “Financial Statements and Supplementary Data” of this Annual Report on Form 10-K.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The market for health insurance exchanges in the United States is relatively undeveloped, rapidly evolving and volatile, which makes it difficult to forecast adoption rates and demand for our solutions. If the market does not develop or develops more slowly than we expect, or if individuals, brokers or health plans select more traditional or alternative channels for the purchase and sale of health insurance, it could have a material adverse effect on our business and results of operations.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The market for health insurance exchanges in the United States is relatively undeveloped, rapidly evolving and volatile. Accordingly, our future financial performance will depend in part on growth in this market and on our ability to adapt to emerging demands and trends in this market. Demand for our exchange solutions has been driven in large part by recent regulatory changes, broader use of the Internet, shifts from group plans to the purchase of individual plans and advances in technology. It is difficult to predict, with any precision, adoption rates or the future growth rate and size of our target market. The market for health insurance sales automation software is relatively new and unproven, and it is uncertain whether it will achieve and sustain high levels of demand and market acceptance. The volatility and rapidly evolving nature of the market in which we operate, as well as other factors that are beyond our control, reduces our ability to accurately evaluate our long-term outlook and forecast annual performance.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Additionally, our success depends in part upon widespread individual and health plan acceptance of the Internet as a shopping platform and marketplace for the purchase and sale of health insurance. Individuals, employers, employees and health plans may choose to depend on more traditional sources, such as individual agents, or alternative sources may develop, including as a result of significant reforms to healthcare legislation through the Patient Protection and Affordable Care Act, or PPACA, and the Healthcare and Education Reconciliation Act of 2010, or HCERA, which we refer to collectively as Healthcare Reform.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: justify;">A reduction or slowdown in demand for health insurance exchanges caused by shifts in the marketplace, lack of acceptance, technological challenges, and competing solutions, or as a result of individuals, brokers, or health plans determining that other distribution channels for health insurance are superior to ours, would have a material adverse effect on our business, future growth, results of operations and financial condition.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">13</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_025.png"/></span></p><h4 style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Our history of incurring substantial levels of indebtedness could adversely affect our ability to raise additional capital to fund our operations, limit our ability to react to changes in the economy or our industry, expose us to interest rate risk to the extent of our variable rate debt and prevent us from meeting obligations on our indebtedness.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We have a history of incurring substantial amounts of indebtedness. As of December 31, 2016, our total indebtedness was $32.5 million. Our indebtedness, combined with our other existing and any future financial obligations and contractual commitments, including the requirement that the holders of our outstanding Series B Convertible Preferred Stock (the “Series B Preferred Stock”) consent before we incur any additional indebtedness outside of the ordinary course of business, could have important adverse consequences. For example, it could:</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">make it more difficult for us to satisfy our obligations with respect to our indebtedness, including making interest payments on our debt obligations, and any failure to comply with the obligations under any of our debt instruments, including restrictive covenants, could result in an event of default under the agreements governing such indebtedness;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">require us to dedicate a substantial portion of our cash flow from operations to payments on our indebtedness, thereby reducing funds available for working capital, capital expenditures, selling and marketing efforts, research and development and other purposes;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">cause us to incur substantial fees from time to time in connection with debt amendments or refinancing;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">increase our exposure to rising interest rates because a portion of our borrowings is at variable interest rates;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">place us at a disadvantage compared to our competitors that have less debt;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">limit our ability to pursue acquisitions;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">limit our flexibility in planning for, or reacting to, changes in our business and the health insurance industry;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">limit our ability to borrow additional funds, or to dispose of assets to raise funds, if needed, for working capital, capital expenditures, acquisitions, selling and marketing efforts, research and development and other corporate purposes; and</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">increase our vulnerability to adverse economic and industry conditions, which could place us at a competitive disadvantage compared to our competitors that have relatively less indebtedness.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">See the section titled “Liquidity and Capital Resources—Senior Credit Facility” for a description of our bank credit facility.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">We may need additional capital in the future, which may not be available to us on favorable terms, or at all, and may dilute the ownership of our common stock.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We intend to continue to make investments to support our business growth strategy and might require additional funds to respond to business challenges or opportunities, including the need to develop new products and services or enhance our existing services, enhance our operating infrastructure, and acquire complementary businesses and technologies. Accordingly, we might need to engage in equity or debt financings to secure additional funds. Our ability to raise additional capital may be impaired by the requirement that the holders of our Series A Convertible Preferred Stock (the “Series A Preferred Stock”) and the holders of our Series B Preferred Stock consent to the issuance of senior equity and that the holders of our Series B Preferred Stock consent to the incurrence of additional indebtedness outside of the ordinary course of business. If we raise additional funds through new issuances of equity or convertible debt securities, our existing stockholders could suffer significant dilution, and any new equity securities we issue could have rights, preferences and privileges superior to those of holders of our common stock. Any debt financing secured by us in the future could involve restrictive covenants relating to our capital-raising activities and other financial and operational matters, which might make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. In addition, we might not be able to obtain additional financing on terms favorable to us, if at all. Similarly, upon the occurrence of certain fundamental events, the holders of our Series A Preferred Stock and our Series B Preferred Stock (which we refer to collectively as our “Preferred Stock”) will have the right to require us to repurchase any or all of our outstanding Series A Preferred Stock and Series B Preferred Stock, respectively. It is possible that we would not have sufficient funds at the time that we are required to make any such purchase of Preferred Stock. We cannot assure the holders of our Preferred Stock that we will have sufficient financial resources, or will be able to arrange financing, to pay the repurchase price in cash with respect to any such Preferred Stock that holders have requested to be repurchased upon the occurrence of such an event. If we are unable to obtain adequate financing or financing on terms satisfactory to us when we require it, our ability to continue to support our business and to respond to business challenges could be significantly limited.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">14</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_026.png"/></span></p><h4 style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">If our existing customers do not continue or renew their agreements with us, renew at lower fee levels, decline to license additional software or purchase additional applications and services from us, or if customers with variable usage fees are unable to effectively increase their transaction volumes, it could have a material adverse effect on our business and operating results, including cash flows from operations.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We derive a significant portion of our revenue from renewal of existing customer agreements and sales of additional software and services to existing customers and expect to continue to do so. As a result, achieving a high renewal rate of our customer agreements and selling additional software and services is critical to our future operating results and cash flow.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We generally sell our software and services pursuant to agreements for terms of multiple years. Our customers may choose not to renew these contracts after the initial contract period expires. Additionally, some of our customers are able to terminate their respective contracts without cause or for convenience at any time. We may not be able to accurately predict future trends in customer renewals, and our customers’ renewal rates may decline or fluctuate. Without the continuance or renewal of our customer contracts our business and operating results may suffer.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">Factors that may affect the renewal rate for our existing contracts, and our ability to sell additional applications and services, include:</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the price, performance and functionality of our offering;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the availability, price, performance and functionality of competing solutions;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">our ability to develop complementary applications and services;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">our continued ability to access the pricing and other data necessary to enable us to deliver reliable offerings to customers;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the stability, performance and security of our hosting infrastructure and hosting services;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">changes in healthcare laws, regulations or trends; and</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the business environment of our customers.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">If any of our customers terminate or do not renew their contracts for our services, renew on less favorable terms, or do not purchase additional functionality or software, our revenue may grow more slowly than expected or decline, and our profitability and gross margins may be harmed.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We derive a portion of our revenue from arrangements having variable usage and commission revenue dependent on actual customer usage and consumer enrollments in health and ancillary insurance policies. Our customers may not be successful at maintaining or increasing transaction volumes processed through our web-based software solutions. As a result, we may not be able to achieve desired business and operating results from such variable usage and commission transaction arrangements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">A significant amount of our revenue is derived from a limited number of customers, and any reduction in revenue from any of these customers could have a material adverse effect on our business.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our ten largest customers by revenue accounted for 52.2% of our consolidated revenue in 2016. If any of our key customers decides not to renew its contracts with us, or to renew on less favorable terms, our business, revenue, reputation, and our ability to obtain new customers could be materially and adversely affected. Except for one customer, none of our customers accounted for 10% or more of our revenue in 2016.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Failure to manage our anticipated long-term growth effectively could increase our expenses, decrease our revenue and prevent us from implementing our business strategy.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">To manage our anticipated future growth effectively, we must continue to maintain and enhance our information technology infrastructure, financial and accounting systems and controls. We also must attract, train and retain qualified software engineers, technical and management personnel, sales and marketing personnel, customer support personnel and professional services personnel. Failure to effectively manage our growth could lead us to over-invest or under-invest in development and operations, result in weaknesses in our infrastructure, systems or controls, give rise to operational mistakes, losses, loss of productivity or business opportunities and result in loss of employees and reduced productivity of remaining employees. Our anticipated growth could require significant capital expenditures and might divert financial resources from other projects such as the development of new products and services. If our management is unable to effectively manage our anticipated growth, our expenses might increase more than expected, our revenue could decline or might grow more slowly than expected, and we might be unable to implement our business strategy. The quality of our products and services might suffer, which could negatively affect our reputation and harm our ability to retain and attract customers.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">15</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_027.png"/></span></p><h4 style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">We have experienced quarterly fluctuations, and expect to continue to experience quarterly fluctuations, in our operating results, including cash flows from operations, due to a number of factors, including the seasonality of our revenue, the sales and implementation cycles for our products and services, dependence on variable customer usage and marketplace transaction volumes, and other factors, that make our future results difficult to predict and could cause our operating results to fall below expectations.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our business is subject to seasonal fluctuations and our operating results are traditionally strongest in the fourth quarter of each year as a result of the open enrollment period established by PPACA and other requirements and regulations with respect to the sales and marketing of Medicare plans. Therefore, our stock price might be based on expectations of future performance that we might not meet and, if our revenue or operating results fall below the expectations of investors or securities analysts, the price of our common stock could decline substantially.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The sales cycle for our products and services can vary from, on average, two to 12 or more months, from initial contact to contract execution, depending on the client and complexity of the solution. After a customer contract is signed, we provide an implementation process for the customer which typically ranges from two to four months for our cloud-based implementations and from three to 15 months for complex enterprise implementations, each from contract execution to completion of implementation. As a result, the period of time between contract signing and recognition of associated revenue may be lengthy, and we are not able to predict with certainty the period in which implementation will be completed.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">During the sales and implementation cycles for our enterprise segments, we expend substantial time and effort, and incur significant additional operating expenses, but accounting principles do not allow us to recognize the resulting revenue until implementation is complete and the services are available for use by our customers, at which time we begin recognition of implementation revenue over the life of the contract or the estimated period of customer benefit, whichever is longer. Unanticipated difficulties and delays in implementation might arise as a result of failure by us or our customers to complete one or more of our or their respective responsibilities and, if implementation periods are extended or implementations are cancelled, revenue recognition could be delayed or fail to occur.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Our operating results have varied in the past. In addition to the other risk factors listed in this section, some of the important factors that may cause fluctuations in our quarterly operating results include:</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the timing and amount of cash payments received from the delivery of our software solutions;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">our increasing dependency on marketplace transaction volumes to generate variable usage and commission revenue;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the extent to which our products and services achieve or maintain market acceptance;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">our ability to introduce new products and services and enhancements to our existing products and services on a timely basis;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">new competitors and the introduction of enhanced products and services from competitors;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the financial condition of our current and potential customers;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">changes in customer budgets and procurement policies;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the amount and timing of our investment in research and development activities;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">technical difficulties with our products or interruptions in our services;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">our ability to hire and retain qualified personnel, including our sales force;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">changes in the regulatory environment related to benefits and healthcare;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">regulatory compliance costs;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the timing, size and ability to successfully integrate potential future acquisitions; and</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">unforeseen legal expenses, including litigation and settlement costs.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">In addition, a significant portion of our operating expense is relatively fixed in nature, and planned expenditures are based in part on expectations regarding future revenue. Accordingly, unexpected revenue shortfalls might decrease our gross margins and could cause significant changes in our operating results from quarter to quarter. If this occurs, the trading price of our common stock could fall substantially, either suddenly or over time.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">16</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_028.png"/></span></p><h4 style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">We operate in the highly competitive software industry. If we are not able to compete effectively, our business and operating results will be harmed.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The software market is highly competitive and is likely to attract increased competition, which could make it hard for us to succeed. Small, specialized providers continue to become more sophisticated and effective. In addition, large, well-financed, and technologically sophisticated software companies might focus more on our market. The size and financial strength of these entities is increasing as a result of continued consolidation in both the IT and health insurance industries. We expect large integrated software companies to become more active in our market, both through acquisitions and internal investment. As costs fall and technology improves, increased market saturation might change the competitive landscape in favor of our competitors.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Some of our current competitors have greater name recognition, longer operating histories, and significantly greater resources than we do. As a result, our competitors might be able to respond more quickly and effectively than we can to new or changing opportunities, technologies, standards, or customer requirements. In addition, current and potential competitors have established, and might in the future establish, cooperative relationships with vendors of complementary products, technologies, or services to increase the availability of their products in the marketplace. Accordingly, new competitors or alliances might emerge that have greater market share, a larger customer base, more widely adopted proprietary technologies, greater marketing expertise, greater financial resources and larger sales forces than we have, which could put us at a competitive disadvantage. Further, in light of these advantages, even if our products and services are more effective than those of our competitors, current or potential customers might accept competitive offerings in lieu of purchasing our offerings. Increased competition is likely to result in pricing pressures, which could negatively impact our sales, profitability or market share. In addition to new niche vendors, who offer stand-alone products and services, we face competition from existing enterprise vendors, including those currently focused on software solutions that have information systems in place with potential customers in our target market. These existing enterprise vendors might promise products or services that offer ease of integration with existing systems and which leverage existing vendor relationships. In addition, large health plans often have internal technology staffs and proprietary software for benefits and distribution management, making them less likely to buy our solutions.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">If our transition from our current technology platforms to new platforms does not occur rapidly or as efficiently as anticipated, it could have a material adverse effect on our business and results of operations.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We are expanding our software-as-a-service, or SaaS, and other cloud based and hosted offerings, including building new shared capabilities such as consumer shopping and personalization. Our ability to (i) complete that development and (ii) efficiently transition existing enterprise-platform customers to updated components is important to our future operating results. We are also investing in platform delivery improvements that will lower our cost of implementation and configuration and improve competitiveness. Our SaaS business model depends heavily on achieving economies of scale because the initial upfront investment is costly and the associated revenue is recognized on a ratable basis. If we fail to achieve efficient transitions, improvements to our capabilities, appropriate economies of scale or if we fail to manage or anticipate the evolution and demand of the SaaS pricing model, then our business and operating results could be adversely affected.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">In the event that our proprietary software does not operate properly, our reputation would suffer, claims would likely be asserted against us, and we would likely be required to divert our resources from other purposes, any of which could have a material adverse effect on our business.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Proprietary software development is time-consuming, expensive and complex. We may experience difficulties with software development, industry standards, design or marketing that could delay or prevent the development, introduction, or implementation of new solutions and enhancements. If our solutions do not function reliably or fail to achieve customer expectations in terms of performance, customers could assert liability claims against us and/or attempt to cancel their contracts with us. This could damage our reputation and impair our ability to attract or maintain customers.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Moreover, software as complex as ours has in the past contained, and may in the future contain, or develop, undetected defects or errors. Material performance problems or defects in our products and services might arise in the future. Errors might result from the interface of our services with legacy systems and data, which we did not develop and the function of which is outside of our control. Defects or errors might arise in our existing or new software or service processes. Because changes in health plan and legal requirements and practices relating to health insurance are frequent, we are continuously discovering defects and errors in our software and service processes compared against these requirements and practices. These defects and errors and any failure by us to identify and address them could result in loss of enrollment by our customers, loss of revenue or market share, liability to customers or others, failure to achieve market acceptance or expansion, diversion of development and other resources, injury to our reputation, and increased service and maintenance costs. Defects or errors in our product or service processes might discourage existing or potential customers from purchasing services from us.</p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Correcting defects or errors could prove to be impossible or impracticable. The costs incurred in correcting any defects or errors or in responding to resulting claims or liability might be substantial and could adversely affect our operating results.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">17</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_029.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our customers might assert claims against us in the future alleging that they suffered damages due to a defect, error, or other failure of our product or service processes. A claim could subject us to significant legal defense costs and adverse publicity regardless of the merits or eventual outcome of such claim.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">If we do not continue to provide innovative products and services, along with high quality support services, that are useful to our customers and consumers of insurance products, we might not remain competitive and our newer solutions may not be adopted by new and existing customers, which would have a material adverse effect on our business and results of operations.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our success depends in part on our ability to successfully develop and sell innovative products and services that health insurance plans and brokers and their customers will utilize. We must continue to invest significant resources in research and development in order to enhance our existing products and services and introduce new high quality products and services that customers will want. If we are unable to predict preferences of our customers or consumers or industry changes, or if we are unable to modify our products and services on a timely basis, we might lose customers. Our operating results would also suffer if our innovations are not responsive to the needs of our customers, are not appropriately timed with market opportunity, or are not effectively brought to market. As technology continues to develop, our competitors might be able to offer results that are, or that are perceived to be, substantially similar to or better than those generated by us. This would force us to compete on additional product and service attributes and to expend significant resources in order to remain competitive.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Our success also depends on providing high quality support services to resolve any issues related to our products and services. High quality education and customer support are important for the successful marketing and sale of our products and services and for the renewal of existing customers. If we do not help our customers quickly resolve issues and provide effective ongoing support, our ability to sell additional products and services to existing customers would suffer and our reputation with existing or potential customers would be harmed.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Failure to adequately develop and deploy our direct sales force could impede our growth.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We believe that our future growth will depend on the continued development of our direct sales force and its ability to obtain new customers and sell additional products and services to existing customers. Identifying and recruiting qualified personnel and training them in the use of our software requires significant time, expense, and attention. It can take up to nine months or longer before a new sales representative is fully trained and productive. Our business may be adversely affected if our efforts to retain, attract, and train our direct sales force do not generate a corresponding increase in revenue. In particular, if we are unable to hire and develop sufficient numbers of productive direct sales personnel or if new direct sales personnel are unable to achieve desired productivity levels in a reasonable period of time, sales of our products and services will suffer and our growth will be impeded.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">We rely on data center providers, Internet infrastructure, bandwidth providers, third-party computer hardware and software, other third parties, and our own systems for providing services to our customers, and any failure of or interruption in the services provided by these third parties or our own systems could expose us to litigation and may negatively impact our relationships with customers, adversely affecting our brand and our business.</h4><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">We currently serve our customers from two primary data centers, one located in Atlanta, Georgia and the other located in El Segundo, California.</p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">While we control and have access to our servers, we do not control the operation of these facilities. The owners of our data center facilities have no obligation to renew their agreements with us on commercially reasonable terms, or at all. With respect to the provision of core services, our two data center agreements provide for either automatic renewal or routine renewal unless terminated by one of the parties. If we are unable to renew these agreements on commercially reasonable terms, or if one of our data center operators is acquired, we may be required to transfer our servers and other infrastructure to new data center facilities, and we may incur significant costs and possible service interruption in connection with doing so. Problems faced by our third-party data center locations, with the telecommunications network providers with whom we or they contract, or with the systems by which our telecommunications providers allocate capacity among their customers, including us, could adversely affect the experience of our customers. Our third-party data centers operators could decide to close their facilities without adequate notice. In addition, any financial difficulties, such as bankruptcy faced by our third-party data centers operators or any of the service providers with whom we or they contract may have negative effects on our business, the nature and extent of which are difficult to predict.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">18</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_030.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">In addition, our ability to deliver our web-based services depends on the development and maintenance of the infrastructure of the Internet by third parties. This includes maintenance of a reliable network backbone with the necessary speed, data capacity, bandwidth capacity and security. Our services are designed to operate without interruption in accordance with our service level commitments. However, we have experienced and expect that we will experience future interruptions and delays in services and availability from time to time. In the event of a catastrophic event with respect to one or more of our systems, we may experience an extended period of system unavailability, which could negatively impact our relationship with customers. To operate without interruption, both we and our service providers must guard against:</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">damage from fire, power loss, natural disasters and other force majeure events outside our control;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">communications failures;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">software and hardware errors, failures and crashes;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">security breaches, computer viruses, hacking, denial-of-service attacks and similar disruptive problems; and</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">other potential interruptions.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We also rely on purchased or leased computer hardware and software licensed from third parties in order to offer our services. These licenses are generally commercially available on varying terms. However, it is possible that this hardware and software might not continue to be available on commercially reasonable terms, or at all. Any loss of the right to use any of this hardware or software could result in delays in the provisioning of our services until equivalent technology is either developed by us, or, if available, is identified, obtained and integrated.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We exercise limited control over third-party vendors, which increases our vulnerability to problems with technology and information services they provide. Interruptions in our network access and services might in connection with third-party technology and information services reduce our revenue, cause us to issue refunds to customers for prepaid and unused subscription services, subject us to potential liability, or adversely affect our renewal rates. Although we maintain insurance for our business, the coverage under our policies might not be adequate to compensate us for all losses that may occur. In addition, we might not be able to continue to obtain adequate insurance coverage at an acceptable cost, if at all.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">If our security measures are breached or fail, and unauthorized persons gain access to customers’ and consumers’ data, our products and services might be perceived as being unsecure, customers and consumers might curtail or stop using our products and services, and we might incur significant liabilities.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our products and services involve the collection, processing, storage and transmission of customers’ and consumers’ confidential information, which may include sensitive individually identifiable information that is subject to stringent statutory and regulatory obligations. Because of the sensitivity of this information, security features of our software and applications are very important. From time to time we may detect vulnerabilities in our systems, which, even if they do not result in a security breach, may reduce customer confidence and require substantial resources to address. If our security measures or those of our third-party service providers are breached or fail and/or are bypassed as a result of third-party action, employee error, malfeasance, or otherwise, someone might be able to obtain unauthorized access to our customers’ confidential information and/or patient data. As a result, our reputation could be damaged, our business might suffer, and we could face damages for contract breach, penalties for violation of applicable laws or regulations, and significant costs for remediation efforts to prevent future occurrences.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">In addition, we rely on various third parties, including health plans, brokers and other third-party service providers and consumers themselves, as users of our system, for key activities to protect and promote the security of our systems and the data and information accessible within them, such as enrollment information, consumer status changes and payment. On occasion, certain individuals have failed to perform these activities. For example, authorized users have failed to administer and use the login/password appropriately, which may allow the system to be accessed by unauthorized third parties. When we become aware of such breaches or incidents, we work with our customers to remedy the issue, terminate inappropriate access as necessary, and provide additional instruction in order to avoid the reoccurrence of such problems. Although to date these breaches have not resulted in claims against us or in material harm to our business, failures to perform these activities might result in claims against us, which could expose us to significant expense, legal liability, and harm to our reputation, which might result in loss of business.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Our security measures, and those of our third-party service providers, may not detect or prevent all attempts to hack our systems, denial-of-service attacks, viruses, malicious software, security breaches or other attacks and similar disruptions that may jeopardize the security of information stored in or transmitted by our sites, networks and systems or that we or our third-party service providers otherwise maintain, including payment card systems which may subject us to fines or higher transaction fees or limit or terminate our access to certain payment methods. Because techniques used to obtain unauthorized access or to sabotage systems change frequently and generally are not recognized until launched against a target, we and our hosting service providers might not be able to detect or prevent these techniques or to implement adequate preventive measures until after the techniques or other attacks</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">19</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_031.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">have already been launched. If an actual or perceived breach of our security or that of our hosting service providers occurs, the market perception of the effectiveness of our security measures could be harmed and we could lose sales and customers. In addition, our customers might authorize or enable third parties to access their information and data that is stored on our systems. Because we do not control such access, we cannot ensure the complete integrity or security of such data in our systems.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">For a more detailed discussion of the risks associated with a failure by us to comply with any of the federal and state standards regarding patient privacy, identity theft prevention and detection and data security, see the risk factor below under “—Risks Related to Regulation—The healthcare and health insurance industries are heavily regulated. Our failure to comply with regulatory requirements could create liability for us, result in adverse publicity and negatively affect our business.”</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Various events could interrupt customers’ access to our platform, exposing us to significant costs.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The ability to access our platform is critical to our customers. Our operations and facilities are vulnerable to interruption and/or damage from a number of sources, many of which are beyond our control, including, without limitation: (i) power loss and telecommunications failures, (ii) fire, flood, hurricane, and other natural disasters, (iii) software and hardware errors, failures or crashes in our own systems or in other systems, (iv) computer viruses, denial-of-service attacks, hacking and similar disruptive problems in our own systems and in other systems, and (v) civil unrest, war, and/or terrorism. We have implemented various measures to protect against interruptions of customers’ access to our platform. If customers’ access is interrupted because of problems in the operation of our facilities, we could be exposed to significant claims by customers. Our plans for disaster recovery and business continuity rely on third-party providers of related services. If those vendors fail us at a time when our systems are not operating correctly, we could incur a loss of revenue and liability for failure to fulfill our obligations. Any significant instances of system downtime could negatively affect our reputation and ability to retain customers and sell our services, which would adversely impact our revenue.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Because we recognize revenue and expense relating to delivery of software, transaction fees and professional services over varying periods, downturns or upturns in sales are not immediately reflected in full in our operating results.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We recognize recurring revenue monthly over the term of our contracts and recognize the majority of our professional services revenue ratably over the contract term or the estimated period of customer benefit, whichever is longer. As a result, a portion of the revenue we report each quarter is the recognition of deferred revenue from contracts we entered into during previous quarters. Consequently, a shortfall in demand for our software solutions and professional services or a decline in new or renewed contracts in any one quarter might not significantly reduce our revenue for that quarter, but could negatively affect our revenue in future quarters. Accordingly, the effect of significant downturns in new or renewed sales of our products and services is not reflected in full in our results of operations until future periods. Our revenue recognition model also makes it difficult for us to rapidly increase our revenue through additional sales in any period, because revenue from new customers must be recognized over the applicable term of the contracts or the estimated period of customer benefit, whichever is longer. An increasing number of our client arrangements include variable transaction based fees that are dependent on market conditions and our customers’ success in using our software services to transact annual insurance enrollments. The amount of revenue from such arrangements largely occurs in the fourth quarter of each calendar year in conjunction with the traditional annual health insurance renewal cycles of our customers. In addition, we recognize professional services expenses as incurred, which could cause professional services gross margin to be negative.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">We have recorded a significant amount of goodwill, intangible assets and deferred implementation costs. We may need to record write-downs from future impairments of these assets, which could adversely affect our costs and business operations.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our consolidated balance sheet includes significant goodwill, intangible assets and deferred implementation costs, including $31.1 million in goodwill, $9.2 million in other intangible assets and $23.3 million of deferred implementation costs, together representing approximately 77.0% of our total assets as of December 31, 2016. The determination of related estimated useful lives and whether these assets are impaired involves significant judgments and our ability to accurately predict future cash flows related to these intangible assets may not be accurate. We test our goodwill for impairment each fiscal year, but we also test goodwill, other intangible assets and deferred implementation costs for impairment at any time when there is a change in circumstances that indicates that the carrying value of these assets may be impaired. Any future determination that these assets are carried at greater than their fair value could result in substantial non-cash impairment charges, which could significantly impact our reported operating results.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Our estimate of the market size for our solutions may prove to be inaccurate, and even if the market size is accurate, we cannot assure you that our business will serve a significant portion of the market.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our estimate of the market size for our solutions is subject to significant uncertainty and is based on assumptions and estimates, including our internal analysis and industry experience, which may not prove to be accurate. Our ability to serve a significant portion of this estimated market is subject to many factors, including our success in implementing our business strategy, which is subject to</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 4pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">20</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_032.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">many risks and uncertainties. Accordingly, even if our estimate of the market size is accurate, we cannot assure you that our business will serve a significant portion of this estimated market for our solutions.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">We might not be able to utilize a significant portion of our net operating loss or other tax credit carryforwards, which could adversely affect our future operating cash flows.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">As of December 31, 2016, we had federal and state net operating loss carryforwards due to prior period losses, which if not utilized, will begin to expire in 2020. These carryforwards could expire unused and be unavailable to offset future income tax liabilities, which could adversely affect our future operating cash flows.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">In addition, under Section 382 of the Internal Revenue Code of 1986, as amended, our ability to utilize net operating loss carryforwards or other tax attributes in any taxable year may be limited if we experience an “ownership change.” A Section 382 “ownership change” generally occurs if one or more stockholders or groups of stockholders who own at least 5% of our stock increase their collective ownership by more than 50 percentage points over their lowest ownership percentage within a rolling three-year period. Similar rules might apply under state tax laws. As a result of prior equity issuances and other transactions in our stock, we have experienced “ownership changes” under Section 382 which limit the amount of net operating losses available to us. Future issuances and other transactions in our stock may cause an additional “ownership change.” Accordingly, the application of Section 382 could have a material effect on the use of our net operating loss carryforwards or other tax attributes, which could adversely affect our future operating cash flows.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">As of December 31, 2016 and 2015, we have recorded a full valuation allowance against net operating loss carryforwards, because we believe it is more likely than not that some portion or all of these deferred tax assets will not be realized.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Our government business relies on working effectively with the prime contractors that hold the contract with the government customers and those contracts being renewed or extended, as applicable. To the extent those relationships are not positively maintained or such contracts, such as our subcontract in connection with the Centers for Medicare and Medicaid Services, or CMS, contract, are not renewed or extended, it could have a material adverse effect on our business.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">In our government business to date, we have primarily worked as a subcontractor to prime contractors that contract directly with the federal or state government customer. In the scope of these relationships, we have provided specified components of the applicable government entity’s overall request. Based on our risk analysis of multiple factors, including the scope of the government entity’s request, the total potential contract value and the terms and conditions of the applicable contract, we have determined that operating in a subcontractor role has been most appropriate for our government business. It may or may not be more beneficial for us to contract directly with the government due to various factors including insurance, risk and liability issues. In order to secure government business, it is important that we identify and market our capabilities to the prime contractor community, participate on joint requests for proposals, and maintain effective working relationships throughout the term of the contract.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">In many cases, payment for our products and services is dependent upon the prime contractor getting paid by the government customer. As such, we may not be paid on a timely basis or at all if the prime contractor or other subcontractors have not completed their work.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">We use staff contracting firms located internationally or that source their resources from outside the United States to augment our employee base and assist in the development, distribution and delivery of our solutions. Future work with these firms might expose us to risks that could have a material adverse effect on our business.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We use staff contracting firms (both onshore and offshore) to scale up or down based on customer needs, work across various time zones to meet speed to market requirements, and lower our total cost of delivery. For over ten years, we have used staff contracting firms with employees located internationally. Associated risks include:</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">operating in international markets requires significant resources and management attention and might subject us to regulatory, economic, and political risks that are different from those in the United States, including data privacy and security considerations;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">ability of our vendor firms to continue to identify and staff local talent that meets our quality and turnaround requirements;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">currency fluctuations which raises the price of offshore labor and does not allow us to obtain cost efficiencies;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">difficulties in working with firms that staff and manage foreign operations;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">weaker protection for intellectual property and other legal rights than in the United States and practical difficulties in enforcing intellectual property and other rights outside of the United States;</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">21</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_033.png"/></span></p></li><li style="padding-top: 3pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">adverse tax consequences; and</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">unstable regional economic and political conditions.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">In addition, our customers may require us to staff projects with only employed or domestically-based staff. That requirement could increase our cost of delivery, which in turn could decrease our competiveness and lower our overall profitability.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Any future litigation against us could be costly and time-consuming to defend and could have a material adverse effect on our business, financial condition and results of operations.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We may become subject, from time to time, to legal proceedings and claims that arise in the ordinary course of business such as claims brought by our customers in connection with commercial disputes or employment claims made by our current or former employees. Litigation might result in substantial costs and may divert management’s attention and resources, which might seriously harm our business, overall financial condition, and operating results. We generally intend to defend ourselves vigorously; however, we cannot be certain of the ultimate outcomes of any claims that may arise in the future. Insurance might not cover such claims, might not provide sufficient payments to cover all the costs to resolve one or more such claims, and might not continue to be available on terms acceptable to us. A claim brought against us that is uninsured or underinsured could result in unanticipated costs, thereby reducing our operating results and leading analysts or potential investors to reduce their expectations of our performance, which could reduce the trading price of our stock. Additionally, certain litigation or the resolution of certain litigation may affect the availability or cost of some of our insurance coverage, which could adversely impact our results of operations and cash flows, expose us to increased risks that would be uninsured and adversely impact our ability to attract officers and directors.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">We might be unable to adequately protect our intellectual property, and intellectual property claims against us could result in the loss of significant rights. Even if we are successful in enforcing our intellectual property rights, we may incur significant costs in doing so, which could have a material adverse effect on our business.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our success depends in part upon our ability to protect our core technology and intellectual property. To accomplish this, we rely on a combination of intellectual property rights, including trademark, copyright, trade secret and other intellectual property rights, as well as customary contractual protections. Our intellectual property rights extend to our technologies and software applications. We also rely on intellectual property licensed from third parties. Our attempts to protect our intellectual property might be challenged by others or invalidated through administrative process or litigation. To the extent that our intellectual property and other proprietary rights are not adequately protected, third parties might gain access to our proprietary information, develop and market products or services similar to ours, or use trademarks similar to ours, each of which could materially harm our business.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">From time to time, third parties have alleged, and may allege in the future that we have violated their intellectual property rights. If we are forced to defend ourselves against intellectual property infringement claims, regardless of the merit or ultimate result of such claims, we may face costly litigation, diversion of technical and management personnel, limitations on our ability to market or provide our products and services. As a result of any such dispute, we may have to:</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">develop non-infringing technology;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">pay damages or refund fees;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">enter into or modify royalty or licensing agreements;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">cease providing certain products or services; or</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">take other actions to resolve the claims.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Moreover, if we are unable to implement one or more of the remedial actions described above, we may be prevented from continuing to offer, and our customers may be prevented from continuing to use, any of our affected products or services.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The use of open source software in our products and solutions may expose us to additional risks and harm our intellectual property rights.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Some of our products and solutions use or incorporate software that is subject to one or more open source licenses. Open source software is typically freely accessible, usable, and modifiable. Certain open source software licenses require a user who intends to distribute the open source software as a component of the user’s software to disclose publicly part or all of the source code to the user’s software. In addition, certain open source software licenses require the user of such software to make any derivative works of the open source code available to others on potentially unfavorable terms or at no cost.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">22</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_034.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The terms of many open source licenses to which we are subject have not been interpreted by United States or foreign courts. Accordingly, there is a risk that those licenses could be construed in a manner that imposes unanticipated conditions or restrictions on our ability to commercialize our solutions. In that event, we could be required to seek licenses from third parties in order to continue offering our products or solutions, to re-develop our products or solutions, to discontinue sales of our products or solutions, or to release our proprietary software code under the terms of an open source license, any of which could harm our business. Further, given the nature of open source software, it may be more likely that third parties might assert copyright and other intellectual property infringement claims against us based on our use of these open source software programs.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">While we monitor the use of all open source software in our products, solutions, processes, and technology and try to ensure that no open source software is used in such a way as to require us to disclose the source code to the related product or solution when we do not wish to do so, it is possible that such use may have inadvertently occurred in deploying our proprietary solutions. In addition, if a third-party software provider has incorporated certain types of open source software into software we license from such third party for our products and solutions without our knowledge, we could, under certain circumstances, be required to disclose the source code to our products and solutions. This could harm our intellectual property position and our business, results of operations, and financial condition.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Our confidentiality arrangements with employees and others may not adequately prevent disclosure of trade secrets and other proprietary information, and any such disclosure could have a material adverse effect on our business.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We have devoted substantial resources to the development of our technology, business operations and business plans. In order to protect our trade secrets and proprietary information, we rely in significant part on confidentiality arrangements with our employees, independent contractors, advisers and customers. These arrangements may not be effective to prevent disclosure of confidential information, including trade secrets, and may not provide an adequate remedy in the event of unauthorized disclosure of confidential information. In addition, others may independently discover trade secrets and proprietary information, and in such cases we would not be able to assert trade secret rights against such parties. The loss of trade secret protection could make it easier for third parties to compete with our products and services by copying functionality. In addition, any changes in, or unexpected interpretations of, the trade secret and other intellectual property laws may compromise our ability to enforce our trade secret and intellectual property rights. Costly and time-consuming litigation could be necessary to enforce and determine the scope of our proprietary rights, and failure to obtain or maintain trade secret protection could have a material adverse effect on our business.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">If we acquire companies or technologies in the future, they could prove difficult to integrate, disrupt our business, dilute stockholder value, and adversely affect our operating results and the value of our common stock.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">As part of our business strategy, we might acquire, enter into joint ventures with, or make investments in complementary companies, services, and technologies in the future. For example, in 2016, we acquired ConnectedHealth, LLC. Acquisitions and investments involve numerous risks, including:</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">difficulties in identifying and acquiring products, technologies or businesses that will help our business;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">difficulties in integrating operations, technologies, services and personnel;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">diversion of financial and managerial resources from existing operations;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">risk of entering new markets in which we have little to no experience; and</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">delays in customer purchases due to uncertainty and the inability to maintain relationships with customers of the acquired businesses.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">If we fail to properly evaluate acquisitions or investments, we might not achieve the anticipated benefits of any such acquisitions, we might incur costs in excess of what we anticipate, and management resources and attention might be diverted from other necessary or valuable activities, which would have a material adverse effect on our business and results of operations.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Consolidation in the health insurance industry in which our customers operate could cause us to lose customers or could reduce the volume of services purchased by consolidated customers following an acquisition or merger, which could have a material adverse effect on our business.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Consolidation in the health insurance industry has accelerated in recent years, and this trend could continue. We may lose customers due to industry consolidation, and we may not be able to expand sales of our solutions and services to new customers to replace lost customers. In addition, new companies or organizations that result from such consolidation may decide that our solutions are no longer needed because of their own internal processes or the use of alternative solutions. As these entities consolidate, competition to provide solutions and services to industry participants will become more intense and the importance of establishing relationships with large industry participants will become greater. These industry participants may try to use their market power to</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">23</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_035.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">negotiate price reductions for our solutions. Also, if consolidation of larger current customers occurs, the combined company may represent a larger percentage of business for us and, as a result, we are likely to rely more significantly on the combined company’s revenue to achieve growth. As a result, industry consolidation or consolidation among current customers or potential customers could adversely affect our business.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">We depend on our senior management team and other key employees, and the loss of one or more key personnel or an inability to attract hire, integrate and retain highly skilled personnel could adversely affect our business.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our success depends largely upon the continued services of key personnel. We also rely on our leadership team in the areas of research and development, marketing, services, and general and administrative functions, and on mission-critical individual contributors in research and development. From time to time, there may be changes in our executive management team resulting from the hiring or departure of executives, which could disrupt our business. The loss of one or more of our executive officers or other key employees could have a serious adverse effect on our business. The replacement of one or more of our executive officers or other key employees would involve significant time and expense and may significantly delay or prevent the achievement of our business objectives.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">To continue to execute our strategy, we also must identify, hire and retain highly skilled personnel. Competition is intense for engineers with high levels of experience in designing and developing software and Internet-related services. We might not be successful in maintaining our unique culture and continuing to attract and retain qualified personnel. We have from time to time in the past experienced, and we expect to continue to experience in the future, difficulty in hiring and retaining highly skilled personnel with appropriate qualifications. The pool of qualified personnel is limited overall and specifically in the geographic regions in which our principal offices are located. Failure to identify, hire and retain necessary key personnel could have a material adverse effect on our business, financial condition and results of operations.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Consumers of health insurance are increasingly relying on mobile devices as part of their decision-making process. If we are unsuccessful in expanding the capabilities of our shopping tools for mobile platforms, it could adversely affect our business.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We believe that consumers of health insurance are increasingly relying on mobile devices, such as smartphones and tablets, in connection with their health insurance purchasing decisions. Traditionally, our solutions have been designed for desktop platforms, and we must develop new capabilities to deliver compelling user experiences via mobile devices. To deliver high quality mobile offerings, it is important that our solutions integrate with a wide range of other mobile technologies, systems, networks and standards that we do not control. We may not be successful in developing products that operate effectively with these technologies, systems, networks or standards. Further, our success on mobile platforms will be dependent on our interoperability with popular mobile operating systems that we do not control, such as Android, iOS and Windows Mobile, and any change in such systems that degrade our functionality or give preferential treatment to competitive products could adversely affect usage of our solutions through mobile devices. If we fail to achieve success with our mobile offerings, our ability to deliver compelling user experiences to consumers as they increasingly rely on mobile devices in connection with their health insurance purchasing decisions will be constrained and our business could be adversely affected.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">If we cannot maintain or enhance our corporate culture, we could lose the innovation, teamwork, passion and focus on execution that we believe contribute to our success, which could have a material adverse effect on our business.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We believe that a critical component to our success has been our corporate culture. We have invested substantial time and resources in building our team. We may find it difficult to maintain the innovation, teamwork, passion and focus on execution that we believe are important aspects of our corporate culture. Failure to enhance or preserve our culture could negatively affect our future success, including our ability to retain and recruit personnel and to effectively focus on and pursue our corporate objectives.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Failure by our customers to obtain proper permissions and waivers might result in claims against us or may limit or prevent our use of data, which could have a material adverse effect on our business.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We require our customers to provide necessary notices and to obtain necessary permissions and waivers for use and disclosure of information on our platform, and we require contractual assurances from them that they have done so and will do so. If, however, despite these requirements and contractual obligations, our customers do not obtain necessary permissions and waivers, then our use and disclosure of information that we receive from them or on their behalf might be limited or prohibited by state or federal privacy laws or other laws. This could impair our functions, processes and databases that reflect, contain, or are based upon such data and might prevent use of such data. In addition, this could interfere with, or prevent creation or use of, rules, analyses, or other data-driven activities that benefit us and our business. Moreover, we might be subject to claims or liability for use or disclosure of information by reason of lack of valid notices, agreements, permissions or waivers. These claims or liabilities could subject us to unexpected costs and adversely affect our operating results.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">24</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_036.png"/></span></p><h4 style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">If we are required to collect sales and use taxes in additional jurisdictions, we might be subject to liability for additional sales and use taxes and our future sales may decrease.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We might incur significant expenses, and, as a result, lose sales, if states successfully impose broader guidelines on state sales and use taxes or successfully argue that current guidelines apply to us. We currently collect sales and use tax in a limited number of states. A successful assertion by one or more states requiring us to collect sales or other taxes on the licensing of our software or sale of our services could result in substantial tax liabilities for past transactions and otherwise harm our business. Each state has different rules and regulations governing sales and use taxes, and these rules and regulations are subject to varying interpretations that change over time. We review these rules and regulations periodically and, when we believe we are subject to sales and use taxes in a particular state, voluntarily engage with state tax authorities in order to determine how to comply with their rules and regulations. We cannot assure you that we will not be subject to sales and use taxes or related interest and penalties for past sales or use taxes in states where we currently believe no such taxes are required.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Vendors of services, like us, are typically held responsible by taxing authorities for the collection and payment of any applicable sales and similar taxes. If one or more taxing authorities determines that taxes should have, but have not, been paid with respect to our services, we might be liable for past taxes in addition to taxes going forward. Liability for past taxes might also include substantial interest and penalty charges. Our customer contracts typically provide that our customers must pay all applicable sales and similar taxes. Nevertheless, our customers might be reluctant to pay back taxes and might refuse responsibility for interest or penalties associated with those taxes. If we are required to collect and pay back taxes and the associated interest and penalties, and if our customers fail or refuse to reimburse us for all or a portion of these amounts (or if we decline to seek reimbursement from our clients), we will incur unplanned expenses that may be substantial. Moreover, imposition of such taxes on us going forward will effectively increase the cost of our software and services to our customers and might adversely affect our ability to retain existing customers or to gain new customers in the areas in which such taxes are imposed.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Risks Related to Regulation</p><h4 style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">The healthcare and health insurance industries are heavily regulated. Our failure to comply with regulatory requirements could create liability for us, result in adverse publicity and negatively affect our business.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The healthcare and health insurance industries are highly regulated and are subject to changing political, legislative, regulatory, and other influences. Existing and new laws and regulations could create unexpected liabilities for us, cause us to incur additional costs and restrict our operations. These laws and regulations are complex and their application to specific services and relationships are not clear. In particular, many existing laws and regulations affecting healthcare and health insurance and related benefits or products when enacted, did not anticipate the services that we provide, and these laws and regulations might be applied to our services in ways that we do not anticipate. Our failure to accurately anticipate the application of these laws and regulations, or our failure to comply, could require us to change our operations or cease using certain datasets, create liability for us, result in adverse publicity, and negatively affect our business. Some of the risks we face from the regulation of healthcare and health insurance are as follows:</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s15" style="display: inline;">Patient Protection and Affordable Care Act. <span class="p">Numerous lawsuits have challenged and continue to challenge the constitutionality and other aspects of PPACA, and regulations and regulatory guidance continue to be issued on various aspects of PPACA. Additionally, administrative changes as a result of the 2016 fall elections could impact aspects of PPACA, and in turn may affect our business. While many of the provisions of PPACA are not directly applicable to us, PPACA, as enacted, affects the business of many of our customers. Our customers might experience changes in the numbers of individuals they insure as a result of Medicaid expansion and the creation of state and national exchanges. Although we are unable to predict with any reasonable certainty or otherwise quantify the likely impact of PPACA on our business model, financial condition, or results of operations, changes in the business of our customers and the number of individuals they insure may negatively impact our business.</span></p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s15" style="display: inline;">HIPAA and Other Privacy and Security Requirements. <span class="p">There are numerous federal and state laws and regulations related to the privacy and security of personal health information. In particular, regulations promulgated pursuant to the Health Insurance Portability and Accountability Act of 1996, or HIPAA, established privacy and security standards, or Privacy Standards and Security Standards, that limit the use and disclosure of individually identifiable health information, and require the implementation of administrative, physical, and technological safeguards to ensure the confidentiality, integrity, and availability of individually identifiable health information in electronic form. Health plans, healthcare clearinghouses, and most providers are considered by the HIPAA regulations to be “Covered Entities.” With respect to our operations, we are a Business Associate of our health plan customers and we are directly subject to the privacy and security regulations established under HIPAA. We enter into written Business Associate Agreements with our health plan customers, under which we are required to safeguard individually identifiable health information and comply with restrictions how we may use and disclose such information. Effective February 2010, the American Recovery and Reinvestment Act of 2009, or ARRA, and effective March 2013, the HIPAA Omnibus Final Rules extended the direct application of certain provisions of the Privacy Standards and Security Standards to us when we are functioning as a</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">25</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_037.png"/></span></p><p style="padding-top: 3pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Business Associate of our health plan customers. ARRA and the HIPAA Omnibus Final Rule also subject Business Associates to direct oversight and audit by the HHS.</p><p style="padding-top: 5pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Violations of the Privacy Standards and Security Standards might result in civil and criminal penalties, and ARRA increased the penalties for HIPAA violations and strengthened the enforcement provisions of HIPAA. For example, ARRA authorizes state attorneys general to bring civil actions seeking either injunctions or damages in response to violations of Privacy Standards and Security Standards that threaten the privacy of state residents. Additionally, some health plans interpret HIPAA requirements differently than we do, and as our customers are the Covered Entity under HIPAA we may be required to comply with their interpretations.</p><p style="padding-top: 5pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">We might not be able to adequately address the business risks created by HIPAA implementation. Furthermore, we are unable to predict what changes to HIPAA or other laws or regulations might be made in the future or how those changes could affect our business or the costs of compliance.</p><p style="padding-top: 5pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">In addition to the Privacy Standards and Security Standards, most states have enacted patient confidentiality laws that protect against the disclosure of confidential medical and/or health information, and many states have adopted or are considering further legislation in this area, including privacy safeguards, security standards, and data security breach notification requirements. Such state laws, if more stringent than HIPAA requirements, are not preempted by the federal requirements and we are required to comply with them. Additionally, other laws or standards may apply to our operations, including requirements related to handling certain financial information, federal tax information, or FTI, and payment card association operating rules with respect to credit card data.</p><p style="padding-top: 5pt;padding-left: 56pt;text-indent: 0pt;text-align: justify;">Failure by us to comply with any state standards regarding patient privacy may subject us to penalties, including civil monetary penalties and, in some circumstances, criminal penalties. Such failure may injure our reputation and adversely affect our ability to retain customers and attract new customers.</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s15" style="display: inline;">Insurance Broker Laws. <span class="p">Insurance laws in the United States are often complex, and states have broad authority to adopt regulations regarding brokerage activities. These regulations typically include the licensing of insurance brokers and agents and govern the handling and investment of customer funds held in a fiduciary capacity. We and our broker/agency customers may be subject to some of these regulations, and may not be able to fully comply.</span></p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s15" style="display: inline;">Medicare and Medicaid Regulatory Requirements. <span class="p">We have contracts with health plans that offer Medicare Managed Care (also known as Medicare Advantage or Medicare Part C). We also have contracts with health plans that offer Medicare prescription drug benefits (also known as Medicare Part D) plans. The activities of the Medicare plans are regulated by CMS. Though our health plan customers remain responsible to comply with CMS requirements, we operate as a First Tier, Downstream &amp; Related Entity, or FDR, in support of our customers. Some of the activities that we might perform, such as the enrollment of beneficiaries, may be subject to CMS and/or state regulation, and such regulations may force us to change the way we do business or otherwise restrict our ability to provide services to such plans. Moreover, the regulatory environment with respect to these programs has become, and will likely continue to become, increasingly complex.</span></p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s15" style="display: inline;">Financial Services-Related Laws and Rules. <span class="p">Financial services and electronic payment processing services are subject to numerous laws, regulations and industry standards, some of which might impact our operations and subject us, our vendors, and our customers to liability as a result of the payment distribution and processing solutions we offer. In addition, payment distribution and processing solutions might be impacted by payment card association operating rules, certification requirements, and rules governing electronic funds transfers. If we fail to comply with applicable payment processing rules or requirements, we might be subject to fines and changes in transaction fees and may lose our ability to process credit and debit card transactions or facilitate other types of billing and payment solutions. Moreover, payment transactions processed using the Automated Clearing House Network, or ACH, are subject to network operating rules promulgated by the National Automated Clearing House Association and to various federal laws regarding such operations, including laws pertaining to electronic funds transfers, and these rules and laws might impact our billing and payment solutions. Further, our solutions might impact the ability of our payer customers to comply with state prompt payment laws. These laws require payers to pay healthcare claims meeting the statutory or regulatory definition of a “clean claim” within a specified time frame.</span></p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s15" style="display: inline;">False or Fraudulent Claim Laws. <span class="p">There are numerous federal and state laws that forbid submission of false information or the failure to disclose information in connection with submission and payment of claims for reimbursement from the government. In some cases, these laws also forbid abuse of existing systems for such submission and payment. Any contract we have with a government entity or in support of a government entity requires us to comply with these laws and regulations. Any failure of our services to comply with these laws and regulations could result in substantial liability, including but not limited to criminal liability, could adversely affect demand for our services, and could force us to expend significant capital, research and development, and other resources to address the failure. Any determination by a court or regulatory agency that our services with government customers violate these laws and regulations could subject us to civil or criminal penalties, invalidate all or portions of some of our government customer contracts, require us to</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">26</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_038.png"/></span></p><p style="padding-top: 3pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">change or terminate some portions of our business, require us to refund portions of our services fees, cause us to be disqualified from serving not only government customers but also all customers doing business with government payers, and have an adverse effect on our business.</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s15" style="display: inline;">ERISA. <span class="p">The Employee Retirement Income Security Act of 1974, as amended, or ERISA, regulates how employee benefits are provided to or through certain types of employer-sponsored health benefits plans. ERISA is a set of laws and regulations that is subject to periodic interpretation by the United States Department of Labor as well as the federal courts. In some circumstances, and under certain customer contracts, we might be deemed to have assumed duties that make us an ERISA fiduciary, and thus be required to carry out our operations in a manner that complies with ERISA in all material respects. Our current operations may render us subject to ERISA fiduciary obligations, and while we believe we are in compliance with ERISA and that any such compliance does not currently have a material adverse effect on our operations, there can be no assurance that continuing ERISA compliance efforts or any future changes to ERISA will not have a material adverse effect on us.</span></p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p class="s15" style="display: inline;">Third-Party Administrator Laws. <span class="p">Numerous states in which we do business have adopted regulations governing entities engaged in third-party administrator, or TPA, activities. TPA regulations typically impose requirements regarding enrollment into benefits plans, claims processing and payments, and the handling of customer funds. Additions to our service offerings and/or changes in state regulations could result in us being obligated to comply with such regulations, which might require us to obtain licenses to provide TPA services in such states.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The growth in the Medicare plan market is important to the overall growth rate of our business. The marketing and sale of Medicare plans are subject to numerous, complex and frequently changing laws and regulations, and the impact of changes in laws related to Medicare or any failure to comply with them could harm our business, results of operations and financial condition.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The number of people eligible for Medicare is one of the most significant drivers in the growth of Medicare plans. Any changes in the eligibility requirements for Medicare such as raising the age of eligibility would decrease the available pool of recipients and lower our growth expectations.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The marketing and sale of Medicare plans are subject to numerous laws, regulations and guidelines at both the Federal and state level. The marketing and sale of Medicare Advantage and Medicare Part D prescription drug plans are principally regulated by CMS, which is a division of the United States Department of Health and Human Services, and the marketing and sale of Medicare supplement plans is principally regulated on a state- by- state basis by state departments of insurance. The laws and regulations applicable to the marketing and sale of Medicare plans lack clarity, are numerous and complex, were not drafted to contemplate health insurance exchanges, and change frequently, particularly with respect to regulations and guidance issued by CMS for Medicare Advantage and Medicare Part D prescription drug plans and by the various state departments of insurance for Medicare supplement plans.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">As a result of these laws, regulations and guidelines, we have altered, and will need to continue to alter, our business operations and procedures, including without limitation, to comply with these changing requirements. Though our health plan customers remain responsible to comply with CMS requirements, we operate as an FDR, in support of our customers. Changes to the laws, regulations and guidelines relating to Medicare plans, the scope of their application to our business, their interpretation by regulators or our health plan customers, or the manner in which they are enforced could be incompatible with our business model. As a result, our business could be slowed or we could be prevented from operating portions of our business altogether, either of which would materially harm our results of operations and financial condition, particularly if this occurred during the Medicare annual enrollment period, which is when the vast majority of Medicare plans are sold.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Health plans may adjust their commission rates to comply with regulatory guidelines, such as those published by CMS with respect to the marketing of Medicare Advantage and Medicare Part D prescription drug plans. If these contractual changes result in reduced commissions, our revenue may decline. Because insurance rates may vary between health plans, plans and enrollment dates, changes in enrollment mix may impact our commission revenue. Future changes in health plan pricing practices could harm our business, results of operations and financial condition.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">In March 2010, the Federal government enacted significant reforms to healthcare legislation through the PPACA and the HCERA, which we refer to collectively as Healthcare Reform. In addition, one of the elements of the Budget Control Act of 2011 is the creation of a joint select committee on deficit reduction to develop recommendations, including changes to entitlement programs such as Medicare, to reduce the national debt by at least $1.5 trillion over 10 years. In connection with the United Sates Congress’s failure to agree on a proposal to lower the national deficit, the Budget Control Act mandates automatic cuts to domestic and defense spending, including a significant reduction in Medicare spending. The impact that Healthcare Reform and the Budget Control Act will have on the market for Medicare plans could change the demand for Medicare plans, the way these plans are delivered, or the commissions that health plans pay to us in connection with their sale or otherwise adversely impact us.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">27</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_039.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">In the event that these laws and regulations or changes in these laws and regulations, or other laws and regulations that impact the marketing and sale of Medicare plans, adversely impact our ability or our customers’ ability to market any type of Medicare plan on an exchange platform or the commissions that we receive for selling these plans, our business, results of operations and financial condition would be harmed.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Additional regulatory requirements placed on our software, services, and content could impose increased costs on us, delay or prevent our introduction of new service types, and impair the function or value of our existing service types.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our products and services are and are likely to continue to be subject to increasing regulatory requirements in a number of ways. As these requirements proliferate, we must change or adapt our products and services to comply. Changing regulatory requirements might render our services obsolete or might prevent us from pursuing our business objective or developing new services. This might in turn impose additional costs upon us to comply or to further develop our products and services. It might also make introduction of new product or service types more costly or more time-consuming than we currently anticipate. It might even prevent introduction by us of new products or services or cause the continuation of our existing products or services to become unprofitable or impossible.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Potential government subsidy of services similar to ours, or creation of a single-payer system, might reduce customer demand.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Recently, entities including brokers and United States federal and state governments have offered to subsidize adoption of online benefits platforms or clearinghouses. In addition, prior proposals regarding healthcare reform have included the concept of creation of a single payer for health insurance. This kind of consolidation of critical benefits activity could negatively impact the demand for our services.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Risks Related to Ownership of Our Common Stock</p><h4 style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Our stock price may be volatile.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The trading price of our common stock may be highly volatile and could be subject to wide fluctuations in response to various factors, including the risk factors described in this “Risk Factors” section and elsewhere in this Annual Report on Form 10-K and other factors which are beyond our control. These factors include:</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">our operating performance and the operating performance of similar companies;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the overall performance of the equity markets;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">announcements by us or our competitors of acquisitions, business plans, or commercial relationships;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">threatened or actual litigation;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">changes in laws or regulations relating to the sale of health insurance;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">any major change in our Board of Directors or management;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the significant ownership position controlled by a limited number of stockholders;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">publication of research reports or news stories about us, our competitors, or our industry, or positive or negative recommendations or withdrawal of research coverage by securities analysts;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">large volumes of sales of our shares of common stock by existing stockholders; and</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">general political and economic conditions.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">In addition, the stock market in general, and the market for technology companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of those companies. Securities class action litigation has often been instituted against companies following periods of volatility in the overall market and in the market price of a company’s securities. This litigation, if instituted against us, could result in substantial costs, divert our management’s attention and resources, and harm our business, operating results, and financial condition.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Francisco Partners controls a majority of our voting securities, which may limit the ability of our stockholders to influence corporate matters and may give rise to conflicts of interest.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 35pt;text-align: left;">On May 2, 2016, we completed the sale of 52,000 shares of our Series A Preferred Stock (the “Series A Financing”) pursuant to an Investment Agreement, dated March 11, 2016, as amended, by and among the Company, Francisco Partners IV, L.P. and Francisco Partners IV-A, L.P. (together, “Francisco Partners”) and Chrysalis Ventures II, L.P. (“Chrysalis”). As of December 31, 2016, Francisco Partners beneficially owned approximately 43% of our outstanding capital stock on an as-converted basis by virtue of</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">28</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_040.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">its ownership of shares of our Series A Preferred Stock and shares of our common stock it purchased in market transactions. On March 10, 2017, we completed the sale of 17,500 shares of our Series B Preferred Stock (the “Series B Financing”) pursuant to an Investment Agreement, dated March 10, 2017, by and among the Company, Francisco Partners and Chrysalis. As a result of that purchase, Francisco Partners owned, as of the closing of the Series B Financing, approximately 56% of our outstanding capital stock on an as-converted basis. Subject to certain protective provisions applicable to our Preferred Stock, shares of our outstanding common stock, Series A Preferred Stock and Series B Preferred Stock vote together on an as-converted basis, meaning that Francisco Partners controlled approximately 56% of our voting securities as of March 10, 2017. In addition, under the terms of the Investor Rights Agreement entered into with Francisco Partners in connection with the closing of the Series B Financing, for so long as Francisco Partners owns at least 10% of the aggregate shares of our Series B Preferred Stock, Series A Preferred Stock and common stock that it held as of March 10, 2017, it can: (i) for so long as it holds at least 5% of the aggregate outstanding securities of the Company (on an as-converted basis), designate a proportionate share of our Board of Directors based upon its percentage ownership of the Company’s outstanding securities on an as-converted basis, rounded up to the nearest whole director, which designees are entitled to serve on each committee of the Board, subject to applicable legal and NASDAQ requirements, and (ii) if no director designated by Francisco Partners is serving on the Board, designate one Board observer. As of the closing of the Series B Financing, Francisco Partners had one designee serving on our Board of Directors and one vacancy existed, which vacancy will be filled by Francisco Partners.</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 35pt;text-align: left;">In addition, Francisco Partners, as the controlling shareholder of both our Series A Preferred Stock and our Series B Preferred Stock, must consent before we take certain corporate actions, including:</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">amending our organizational documents in a manner that would have an adverse effect on the Series A Preferred Stock or Series B Preferred Stock;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">issuing securities that are senior to, or equal in priority with, the Series A Preferred Stock or Series B Preferred Stock; and</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">incurring indebtedness other than in the ordinary course of business or from our existing senior secured lender, Wells Fargo, up to the maximum amount authorized as of March 10, 2017.</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Accordingly, Francisco Partners may be able to exert significant influence over us and any action requiring the approval of the holders of our common stock, including the election of directors, the amendment of our amended and restated certificate of incorporation and amended and restated bylaws and the approval of mergers or other business combination transactions. Furthermore, the interests of Francisco Partners may not be aligned with our other stockholders, which could lead to actions that may not be in the best interests of our other stockholders. Francisco Partners and its affiliates are in the business of making or advising on investments in companies, including businesses that may directly or indirectly compete with certain portions of our business, and they may have interests that diverge from, or even conflict with, those of our other stockholders. They may also pursue acquisition opportunities that may be complementary to our business, and, as a result, those acquisition opportunities may not be available to us. In addition, Francisco Partner’s significant ownership in us may discourage, delay or prevent a third party from making a significant equity investment in us, or could discourage, delay or prevent transactions involving a change in control, including transactions in which our stockholders might otherwise receive a premium for their shares over the then-current market price. Likewise, Francisco Partners’ ability to prevent our acceptance of any senior equity or indebtedness other than in the ordinary course of business or from Wells Fargo under our existing credit facility, may make it more difficult for us to secure additional capital in the future if needed, which could significantly limit our ability to continue to support our business and to respond to business challenges.</p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">In addition, as of March 10, 2017, Chrysalis beneficially owned approximately 11% of our outstanding capital stock on an as-converted basis.</p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Chrysalis has a representative, David A. Jones, Jr., that serves on our Board of Directors as Chairman of the Board of Directors. Collectively, as of March 10, 2017, our directors, executive officers, and their affiliated entities beneficially owned approximately 68% of our outstanding capital stock on an as-converted basis. These stockholders, if they act together, could exert substantial influence over matters requiring approval by our stockholders, including the amendment of our amended and restated certificate of incorporation and amended and restated bylaws, and the approval of mergers or other business combination transactions, which may further discourage, delay or prevent a third party from making a significant equity investment in us, or could discourage, delay or prevent transactions involving a change in control, including transactions in which our stockholders might otherwise receive a premium for their shares over the then-current market price.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s19" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">We are a “controlled company” within the meaning of NASDAQ rules and, as a result, qualify for, and may rely on certain of the “controlled company” exemptions from certain NASDAQ corporate governance requirements, which could make our common stock less attractive to some investors or otherwise harm our stock price.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 35pt;text-align: left;">Under NASDAQ rules, a company of which more than 50% of the voting power is held by another person or group of persons acting together is a “controlled company” and may elect not to comply with certain NASDAQ corporate governance requirements. As a result of its purchase of Series B Preferred Stock, Francisco Partners holds approximately 56% of the voting power of our outstanding securities. As such we are eligible to take advantage of this “controlled company” exemption and intend to elect to</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 4pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">29</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_041.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">do so. A “controlled company” may elect not to comply with certain NASDAQ corporate governance requirements, including the requirements that (i) a majority of the board of directors consist of independent directors, (ii) compensation of officers be determined or recommended to the board of directors by a majority of its independent directors or by a compensation committee that is composed entirely of independent directors and (iii) director nominees be selected or recommended by a majority of the independent directors or by a nominating committee composed solely of independent directors. We intend to take advantage of certain of these “controlled company” exemptions, particularly with respect the compensation of our officers and the election of director nominees. Accordingly, our stockholders do not have the same protections afforded to stockholders of companies that are subject to all of the NASDAQ corporate governance requirements and as a result, our common stock may be less attractive to some investors or otherwise harmed. We cannot predict if investors will find our common stock less attractive because we will rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The issuance of shares of our Series A Preferred Stock and Series B Preferred Stock reduces the relative voting power of holders of our common stock, dilutes the ownership of such holders and may adversely affect the market price of our common stock.</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Holders of Series A Preferred Stock are entitled to a cumulative dividend at the rate of 7.5% per annum (subject to adjustment), payable quarterly in arrears. The dividends are to be paid in-kind, through an increase in the number of shares of common stock into which shares of Series A Preferred Stock are convertible, through at least May 2, 2018, and thereafter in cash or in-kind at our option. Upon the occurrence of certain events, the dividend rate will increase. Holders of Series B Preferred Stock are entitled to a cumulative dividend at the rate of 15% per annum (subject to adjustment), payable quarterly in arrears. The dividends are to be paid in-kind, through an increase in the number of shares of common stock into which shares of Series B Preferred Stock are convertible, through at least March 10, 2019, and thereafter in cash or in-kind at our option. Upon the occurrence of certain events, the dividend rate will increase.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">As of the closing of the Series B Financing, the outstanding shares of Series B Preferred Stock represented approximately 20% of our outstanding capital stock, on an as-converted basis and the outstanding shares of Series A Preferred Stock represented approximately 31% of our outstanding capital stock, on an as-converted basis (which includes the effect of an adjustment to the conversion ratio of the Series A Preferred Stock that occurred as a result of the Series B Financing and pursuant to the terms of the Series A Preferred Stock). Francisco Partners holds approximately 95% of such shares of Preferred Stock. As holders of our Preferred Stock are entitled to vote, on an as-converted basis, together with holders of our common stock on all matters submitted to a vote of the holders of our common stock, the issuance of the Preferred Stock, and the subsequent increase in the number of shares of common stock issuable upon conversion of the Preferred Stock through the payment of dividends, effectively reduces the relative voting power of the holders of our common stock.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">In addition, the conversion of the Preferred Stock to common stock would dilute the ownership interest of existing holders of our common stock, and any sales in the public market of the common stock issuable upon conversion of the Preferred Stock could adversely affect prevailing market prices of our common stock. We granted the holders of the Preferred Stock customary registration rights in respect of their shares of Preferred Stock, and any shares of common stock issued upon conversion of the Preferred Stock. We registered all outstanding shares of Series A Preferred Stock and the number of shares of common stock into which such shares of Series A Preferred Stock may be convertible as of May 3, 2018 on a Registration Statement on Form S-3 that was declared effective by the SEC on September 23, 2016. A registration statement with respect to the registration of the Series B Preferred Stock will be filed with the SEC within 120 days of the closing of the Series B Financing. The registration statements for the Preferred Stock will facilitate the resale of such securities into the public market, and any such resale would increase the number of shares of our common stock available for public trading. Sales by the holders of our Preferred Stock in the public market, or the perception that such sales might occur, could have a material adverse effect on the price of our common stock.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Our Preferred Stock has rights, preferences and privileges that are not held by, and are preferential to, the rights of our common stockholders, which could adversely affect our liquidity and financial condition, and may result in the interests of the holders of our Preferred Stock differing from those of our common stockholders.</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The holders of Preferred Stock have the right to receive a liquidation preference entitling them to be paid out of our assets available for distribution to stockholders before any payment may be made to holders of any other class or series of capital stock, an amount equal to the greater of the stated value of such holder’s shares of Preferred Stock or the amount that such holder would have been entitled to receive upon our liquidation, dissolution and winding up if all outstanding shares of such series of Preferred Stock had been converted into common stock immediately prior to such liquidation, dissolution or winding up, plus accrued but unpaid dividends.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: justify;">In addition, dividends on the Series A Preferred Stock accrue and are cumulative at the rate of 7.5% per annum, payable quarterly in arrears and on the Series B Preferred Stock at the rate of 15% per annum, payable quarterly in arrears. Upon the occurrence of certain events, the dividend rate for each series of Preferred Stock will increase. The dividends are to be paid in-kind,</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">30</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_042.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">through an increase in the number of shares of common stock into which shares of Preferred Stock are convertible, until May 2, 2018 with respect to the Series A Preferred Stock and March 10, 2019 with respect to the Series B Preferred Stock, and thereafter in cash or in-kind at our option. The holders of our Preferred Stock also have certain redemption rights, including the right to require us to repurchase all or any portion of the Preferred Stock upon the occurrence of certain events.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">These dividend and share repurchase obligations could impact our liquidity and reduce the amount of cash flows available for working capital, capital expenditures, growth opportunities, acquisitions, and other general corporate purposes. Our obligations to the holders of Preferred Stock, including the requirement that we obtain the consent of the holders of Series B Preferred Stock prior to incurring additional indebtedness other than in the ordinary course or pursuant to our current arrangements with Wells Fargo, could also limit our ability to obtain additional financing or increase our borrowing costs, which could have an adverse effect on our financial condition. The preferential rights could also result in divergent interests between the holders of shares of Preferred Stock and holders of our common stock. In addition to Ezra Perlman, who serves as a director at the designation of Francisco Partners, David A. Jones, Jr., the chairman of our Board of Directors, is affiliated with Chrysalis, which in addition to holding shares of our common stock, also holds shares of our Series A Preferred Stock and Series B Preferred Stock. Notwithstanding the fact that all directors are subject to fiduciary duties to us and to applicable law, the interests of the directors designated by Francisco Partners and of Mr. Jones may differ from the interests of our security holders as a whole or of our other directors.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">If securities or industry analysts do not continue to publish research or reports about our business, or publish inaccurate or unfavorable research or reports about our business, our stock price and trading volume could decline.</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The trading market for our common stock, to some extent, depends on the research and reports that securities or industry analysts publish about us and our business. We do not have any control over these analysts. If one or more of the analysts who cover us downgrade our common stock or change their opinion of our common stock, our stock price would likely decline. If one or more of these analysts cease coverage of our company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which could cause our stock price or trading volume to decline.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">We do not currently intend to pay dividends on our common stock and, consequently, your ability to achieve a return on your investment will depend on appreciation in the price of our common stock.</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We have never declared or paid any cash dividends on our common stock and do not currently intend to do so for the foreseeable future. We currently intend to invest our future earnings, if any, to fund our growth strategy. Therefore, you are not likely to receive any dividends on your common stock for the foreseeable future, and the success of an investment in shares of our common stock will depend upon future appreciation in its value, if any. There is no guarantee that shares of our common stock will appreciate in value or even maintain the price at which our stockholders purchased their shares.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Provisions in our amended and restated certificate of incorporation and amended and restated bylaws and Delaware law might discourage, delay, or prevent a change in control of our company or changes in our management and, therefore, depress the trading price of our common stock.</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Provisions of our amended and restated certificate of incorporation and amended and restated bylaws and Delaware law might discourage, delay, or prevent a merger, acquisition, or other change in control that stockholders consider favorable, including transactions in which you might otherwise receive a premium for your shares of our common stock. These provisions might also prevent or frustrate attempts by our stockholders to replace or remove our management. These provisions include:</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">limitations on the removal of directors;</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">advance notice requirements for stockholder proposals and nominations;</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">limitations on the ability of stockholders to call special meetings;</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the inability of stockholders to cumulate votes at any election of directors;</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the classification of our Board of Directors into three classes with only one class, representing approximately one-third of our directors, standing for election at each annual meeting; and</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the ability of our Board of Directors to make, alter or repeal our amended and restated bylaws.</p></li></ul></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: justify;">Our Board of Directors has the ability to designate the terms of and issue new series of preferred stock without stockholder approval. In addition, Section 203 of the Delaware General Corporation Law prohibits a publicly held Delaware corporation from engaging in a business combination with an interested stockholder, generally a person which together with its affiliates owns, or</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">31</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_043.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">within the last three years has owned, 15% of our voting stock, for a period of three years after the date of the transaction in which the person became an interested stockholder, unless the business combination is approved in a prescribed manner.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The existence of the foregoing provisions and anti-takeover measures could limit the price that investors are willing to pay in the future for shares of our common stock. They could also deter potential acquirers of our company, thereby reducing the likelihood that you could receive a premium for your common stock in an acquisition.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">We currently qualify as an emerging growth company under the JOBS Act and we cannot be certain if the reduced disclosure requirements applicable to emerging growth companies will make our common stock less attractive to investors.</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The JOBS Act permits “emerging growth companies” like us to take advantage of certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">In addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of the exemption from complying with new or revised accounting standards provided in Section 7(a)(2)(B) of the Securities Act as long as we are an emerging growth company. An emerging growth company can therefore delay the adoption of certain accounting standards until those standards would otherwise apply to private companies.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">For as long as we continue to be an emerging growth company, we intend to take advantage of certain other exemptions from various reporting requirements that are applicable to other public companies including, but not limited to, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements, exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved, and exemptions from the requirements of auditor attestation reports on the effectiveness of our internal control over financial reporting. We have elected to take advantage of the extended transition period for complying with new or revised accounting standards under Section 102(B)(1), which will allow us to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies. As a result of this election, our financial statements may not be comparable to companies that comply with public company effective dates.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We cannot predict if investors will find our common stock less attractive because we will rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our stock price may be more volatile.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;"><a href="#bookmark43" class="s18" name="bookmark7">We will remain an emerging growth company until the earlier of (1) the last day of the fiscal year (a) ending December 31, 2019, (b) in which we have total annual gross revenue of at least $1.0 billion, or (c) in which we become a large accelerated filer, which means that we have been public for at least 12 months, have filed at least one annual report and the market value of our common stock that is held by non-affiliates exceeds $700 million as of the last day of our then most recently completed second fiscal quarter, and (2) the date on which we have issued more than $1.0 billion in non-convertible debt during the</a> prior three-year period.<a name="bookmark43">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark44">Item 1B. Unresolved Staff Comments.</a></p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;"><a name="bookmark8">None.</a><a name="bookmark45">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark46">Item 2. Properties</a></p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We are headquartered in Brookfield, Wisconsin, where we lease approximately 32,000 square feet of office space under a lease expiring in August 2022. We also lease office space in Chicago, Illinois, Atlanta, Georgia, Los Angeles, California, Raleigh, North Carolina, Farmington, Connecticut, and Baltimore, Maryland. Our primary data centers are located in Atlanta, Georgia and El Segundo, California. We believe our current and planned office facilities and data center space will be adequate for our needs for the foreseeable future.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;"><a href="#bookmark47" class="s18" name="bookmark9">For additional information regarding obligations under operating leases, see Note 8 of the Notes to Consolidated Financial Statements included in</a> Part II, Item 8: “Financial Statements and Supplementary Data” of this Annual Report on Form 10-K.<a name="bookmark47">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark48">Item 3. Legal Proceedings</a></p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">From time to time, we may become involved in litigation related to claims arising from the ordinary course of our business. We believe that there are no claims or actions pending or threatened against us, the ultimate disposition of which would have a material adverse effect on us.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">32</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_044.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark10">Item 4. Mine Safety Disclosures</a><a name="bookmark49">&zwnj;</a><a name="bookmark50">&zwnj;</a></p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">Not applicable.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 4pt;padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">33</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_045.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark11">PART II</a><a name="bookmark12">&zwnj;</a><a name="bookmark51">&zwnj;</a><a name="bookmark52">&zwnj;</a></p><p class="s14" style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark53">Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></p><h4 style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">Market Information</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our common stock has been listed on the NASDAQ Global Market under the symbol “CNXR” since December 12, 2014. Prior to that date, there was no public trading market for our common stock. Our common stock priced at $8.00 per share in our initial public offering on December 11, 2014. The following table sets forth for the periods indicated the high and low intra-day sale prices per share of our common stock as reported on the NASDAQ Global Market:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:88.4214pt" cellspacing="0"><tr style="height:10pt"><td style="width:170pt"><p class="s7" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Year ended December 31, 2016</p></td><td style="width:132pt"><p class="s21" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">            <b>High             </b></p></td><td style="width:75pt"><p class="s21" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">             <b>Low             </b></p></td></tr><tr style="height:11pt"><td style="width:170pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Fourth Quarter</p></td><td style="width:132pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 2.13</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 1.55</p></td></tr><tr style="height:11pt"><td style="width:170pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Third Quarter</p></td><td style="width:132pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2.77</p></td><td style="width:75pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1.50</p></td></tr><tr style="height:11pt"><td style="width:170pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Second Quarter</p></td><td style="width:132pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">3.24</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1.15</p></td></tr><tr style="height:11pt"><td style="width:170pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">First Quarter</p></td><td style="width:132pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">3.90</p></td><td style="width:75pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1.72</p></td></tr><tr style="height:11pt"><td style="width:170pt" bgcolor="#CEEFFB"><p class="s7" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Year ended December 31, 2015</p></td><td style="width:132pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:75pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:170pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Fourth Quarter</p></td><td style="width:132pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 6.26</p></td><td style="width:75pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 3.11</p></td></tr><tr style="height:11pt"><td style="width:170pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Third Quarter</p></td><td style="width:132pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">11.99</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">3.67</p></td></tr><tr style="height:11pt"><td style="width:170pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Second Quarter</p></td><td style="width:132pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">14.39</p></td><td style="width:75pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">8.50</p></td></tr><tr style="height:11pt"><td style="width:170pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">First Quarter</p></td><td style="width:132pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">11.00</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">8.04</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">On March 29, 2017, the last reported sale price of our common stock on the NASDAQ Global Market was $1.01 per share, and there were 21 holders of record of our common stock. The actual number of holders of common stock is greater than these numbers of record holders and includes stockholders who are beneficial owners, but whose shares are held in street name by brokers and nominees. The number of holders of record also does not include stockholders whose shares may be held in trust by other entities.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 32pt;text-indent: 0pt;text-align: left;">Dividend Policy</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We have never declared or paid any cash dividends on our common stock. Neither Delaware law nor our amended and restated certificate of incorporation requires our board of directors to declare dividends on our common stock. Any future determination to declare cash dividends on our common stock will be made at the discretion of our board of directors and will depend on our financial condition, results of operations, capital requirements, general business conditions, covenants under our Credit Facility, limitations imposed by the terms of our Preferred Stock, and other factors that our board of directors may deem relevant. We do not anticipate paying cash dividends on our common stock for the foreseeable future.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 32pt;text-indent: 0pt;text-align: left;">Equity Compensation Plan Information</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Information regarding the securities authorized for issuance under our equity compensation plans will be included in our Proxy Statement relating to our 2017 annual meeting of stockholders to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2016, and is incorporated herein by reference.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 32pt;text-indent: 0pt;text-align: left;">Issuer Purchases of Equity Securities</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Under our equity incentive plan, participants may satisfy the statutory minimum federal, state and local withholding tax obligation arising in connection with plan awards by electing to have the Company withhold shares of common stock otherwise issuable under the award. The following table provides information about such withholding, which is deemed an issuer repurchase, during the quarter ended December 31, 2016:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse" cellspacing="0"><tr style="height:17pt"><td style="width:141pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="text-indent: 0pt;line-height: 7pt;text-align: left;">Period</p></td><td style="width:151pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 79pt;padding-right: 8pt;text-indent: 0pt;line-height: 8pt;text-align: center;">Total Number of</p><p class="s8" style="padding-left: 79pt;padding-right: 8pt;text-indent: 0pt;line-height: 7pt;text-align: center;">Shares Purchased <span class="s23">(1)</span></p></td><td style="width:85pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 13pt;padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: center;">Average Price Paid</p><p class="s8" style="padding-left: 13pt;padding-right: 11pt;text-indent: 0pt;line-height: 7pt;text-align: center;">per Share</p></td></tr><tr style="height:11pt"><td style="width:141pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">10/1/16–10/31/16</p></td><td style="width:151pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td><td style="width:85pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td></tr><tr style="height:11pt"><td style="width:141pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">11/1/16–11/30/16</p></td><td style="width:151pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">23,323</p></td><td style="width:85pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 1.90</p></td></tr><tr style="height:11pt"><td style="width:141pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">12/1/16–12/31/16</p></td><td style="width:151pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                        1,946</p></td><td style="width:85pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 1.73</p></td></tr><tr style="height:17pt"><td style="width:141pt"><p class="s10" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Total</p></td><td style="width:151pt"><p class="s10" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;text-align: right;">25,269</p></td><td style="width:85pt"><p class="s10" style="padding-top: 1pt;padding-right: 4pt;text-indent: 0pt;text-align: right;">$ 1.89</p></td></tr></table><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><span><img width="96" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_046.png"/></span><span style=" color: black; font-family:&quot;Times New Roman&quot;, serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 10pt;"> </span></p><p style="padding-top: 1pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">(1) Represents shares of common stock delivered to us as payment of taxes on the vesting of restricted stock units under our equity incentive plan.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">34</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_047.png"/></span></p><h4 style="padding-top: 3pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">Performance Graph</h4><p class="s15" style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Notwithstanding any statement to the contrary in any of our filings with the SEC, the following information shall not be deemed “filed” with the SEC or “soliciting material” under the Securities Exchange Act of 1934 and shall not be incorporated by reference into any such filings irrespective of any general incorporation language contained in such filing.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The following graph compares the total cumulative stockholder return on our common stock with the total cumulative return of the S&amp;P 500 Index and the S&amp;P Software and Services Index during the period commencing on December 12, 2014, the initial trading day of our common stock, and ending on December 31, 2016. The graph assumes that $100 was invested at the beginning of the period in our common stock and in each of the comparative indices, and the reinvestment of any dividends. Historical stock price performance should not be relied upon as an indication of future stock price performance.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 104pt;text-indent: 0pt;text-align: left;"><span><img width="459" height="283" alt="image" src="NASDAQ_CNXR_2016/Image_048.jpg"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">35</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_049.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark13">Item 6. Selected Financial Data</a><a name="bookmark54">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-top: 4pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">Selected Consolidated Financial and Other Data</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The tables on the following pages set forth the consolidated financial and operating data as of and for the periods indicated. The consolidated statements of operations data presented below for the years ended December 31, 2016, 2015, 2014, 2013 and 2012 and the consolidated balance sheet data as of December 31, 2016, 2015, 2014, 2013 and 2012 have been derived from our audited consolidated financial statements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The following information should be read in conjunction with our consolidated financial statements and related notes, the sections titled “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the other information included elsewhere in this Annual Report on Form 10-K. Our historical results should not be considered a reliable indicator of our future results of operations.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Consolidated Statements of Operations Data</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 263pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 257pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="377" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_050.png"/></span></p><p class="s3" style="padding-left: 262pt;text-indent: 0pt;text-align: center;">2016                       2015                       2014                       2013                     2012</p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:9pt"><td style="width:308pt" colspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 5pt;text-indent: 0pt;line-height: 7pt;text-align: left;">(in thousands, exc</p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="text-indent: 0pt;line-height: 7pt;text-align: left;">ept share and per s</p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="text-indent: 0pt;line-height: 7pt;text-align: left;">hare amounts)</p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s7" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Consolidated Statements of Operations Data:</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:54pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Revenue</p></td><td style="width:58pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 81,894</p></td><td style="width:59pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 95,847</p></td><td style="width:59pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 84,579</p></td><td style="width:58pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 58,326</p></td><td style="width:54pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 29,626</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">Cost of Revenue <span class="s24">(1)</span></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           56,895</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">            50,670</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">            52,431</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">            50,173</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">            22,886</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Gross Margin</p></td><td style="width:58pt"><p class="s21" style="padding-top: 1pt;padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           24,999</p></td><td style="width:59pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">            45,177</p></td><td style="width:59pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">            32,148</p></td><td style="width:58pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">              8,153</p></td><td style="width:54pt"><p class="s21" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">              6,740</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Operating Expenses:</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:54pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">Research and Development <span class="s24">(1)</span></p></td><td style="width:58pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">22,297</p></td><td style="width:59pt"><p class="s10" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">22,718</p></td><td style="width:59pt"><p class="s10" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">18,125</p></td><td style="width:58pt"><p class="s10" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">11,806</p></td><td style="width:54pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">7,371</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">Sales and Marketing <span class="s24">(1)</span></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">10,410</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">9,507</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">7,729</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">6,800</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">6,644</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">General and Administrative <span class="s24">(1)</span></p></td><td style="width:58pt"><p class="s21" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           13,162</p></td><td style="width:59pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">            14,439</p></td><td style="width:59pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">            10,552</p></td><td style="width:58pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">            12,187</p></td><td style="width:54pt"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">              7,492</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Total Operating Expenses</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           45,869</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">            46,664</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">            36,406</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">            30,793</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">            21,507</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">Loss from Operations</p></td><td style="width:58pt"><p class="s21" style="padding-top: 1pt;padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">          (20,870<span class="s10"> )</span></p></td><td style="width:59pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">             (1,487<span class="s10"> )</span></p></td><td style="width:59pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">             (4,258<span class="s10"> )</span></p></td><td style="width:58pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">          (22,640<span class="s10"> )</span></p></td><td style="width:54pt"><p class="s21" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           (14,767<span class="s10"> )</span></p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Other Expenses:</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:54pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Interest Expense</p></td><td style="width:58pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">3,485</p></td><td style="width:59pt"><p class="s10" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">5,665</p></td><td style="width:59pt"><p class="s10" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">5,937</p></td><td style="width:58pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">4,644</p></td><td style="width:54pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,992</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Other Expense (Income), net</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">              2,239</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                 140</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                  (68<span class="s10"> )</span></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                      -</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                       -</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Loss before Income Taxes</p></td><td style="width:58pt"><p class="s21" style="padding-top: 1pt;padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">          (26,594<span class="s10"> )</span></p></td><td style="width:59pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">             (7,292<span class="s10"> )</span></p></td><td style="width:59pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">          (10,127<span class="s10"> )</span></p></td><td style="width:58pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">          (27,284<span class="s10"> )</span></p></td><td style="width:54pt"><p class="s21" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           (16,759<span class="s10"> )</span></p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Income Tax Benefit (Provision)</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                   60</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                  (51<span class="s10"> )</span></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                  (33<span class="s10"> )</span></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                 900</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                      3</p></td></tr><tr style="height:12pt"><td style="width:250pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Net Loss</p></td><td style="width:58pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s21" style="padding-top: 1pt;padding-right: 7pt;text-indent: 0pt;text-align: right;">$ (26,534<span class="s10"> )</span></p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ (7,343 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_051.png"/></span></p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ (10,160 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_052.png"/></span></p></td><td style="width:58pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ (26,384 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_053.png"/></span></p></td><td style="width:54pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;text-align: right;">$ (16,756 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_054.png"/></span></p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Net loss per common share - basic and diluted</p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 7pt;text-indent: 0pt;text-align: right;">$ (1.31<span class="s10"> )</span></p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;text-align: left;">$ (0.34 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="62" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_055.png"/></span></p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;text-align: left;">$ (10.27 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="62" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_056.png"/></span></p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;text-align: left;">$ (163.37 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="62" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_057.png"/></span></p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;text-align: right;">$ 14.05</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="63" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_058.png"/></span></p></td></tr><tr style="height:21pt"><td style="width:250pt"><p class="s10" style="padding-left: 5pt;padding-right: 49pt;text-indent: -5pt;line-height: 10pt;text-align: left;">Weighted Average Common Shares Outstanding - basic and diluted</p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s21" style="padding-right: 11pt;text-indent: 0pt;text-align: right;">    22,275,256</p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">21,813,407</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_059.png"/></span></p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 12pt;text-indent: 0pt;text-align: left;">1,362,109</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_060.png"/></span></p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 18pt;text-indent: 0pt;text-align: left;">184,051</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_061.png"/></span></p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 5pt;text-indent: 0pt;text-align: right;">1,353,862</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_062.png"/></span></p></td></tr><tr style="height:10pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s7" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Other Financial Data:</p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">Adjusted gross margin <span class="s24">(2)</span></p></td><td style="width:58pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">29,545</p></td><td style="width:59pt"><p class="s10" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">49,945</p></td><td style="width:59pt"><p class="s10" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">36,163</p></td><td style="width:58pt"><p class="s10" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">11,984</p></td><td style="width:54pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">7,572</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">Adjusted EBITDA <span class="s24">(3)</span></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(13,607 )</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">8,268</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">1,328</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(17,291 )</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(13,054 )</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="96" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_063.png"/></span></p><ol id="l5"><li style="padding-top: 1pt;padding-left: 32pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Cost of revenue and operating expenses include stock-based compensation expense as follows:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 264pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 258pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="375" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_064.png"/></span></p><p class="s3" style="padding-left: 263pt;text-indent: 0pt;text-align: center;">2016                      2015                      2014                      2013                       2012</p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:9pt"><td style="width:303pt" colspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="text-indent: 0pt;line-height: 7pt;text-align: right;">(</p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="text-indent: 0pt;line-height: 7pt;text-align: right;">dollars in thousand</p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="text-indent: 0pt;line-height: 7pt;text-align: left;">s)</p></td><td style="width:60pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:251pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Cost of Revenue</p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 689</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 5pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 922</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 5pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 123</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 92</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 121</p></td></tr><tr style="height:11pt"><td style="width:251pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Research and Development</p></td><td style="width:52pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">422</p></td><td style="width:59pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,379</p></td><td style="width:58pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">78</p></td><td style="width:58pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">55</p></td><td style="width:60pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">48</p></td></tr><tr style="height:11pt"><td style="width:251pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Sales and Marketing</p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">243</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">518</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">32</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">34</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">61</p></td></tr><tr style="height:10pt"><td style="width:251pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">General and Administrative</p></td><td style="width:52pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,308</p></td><td style="width:59pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,893</p></td><td style="width:58pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,203</p></td><td style="width:58pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">458</p></td><td style="width:60pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">470</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 32pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">We define adjusted gross margin as gross margin before depreciation and amortization expense, as well as stock-based compensation expense. See the section titled “Adjusted Gross Margin and Adjusted EBITDA” below for more information and for a reconciliation of adjusted gross margin to gross margin, the most directly comparable financial measure calculated and presented in accordance with GAAP (Generally Accepted Accounting Principles).</p></li><li style="padding-left: 32pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">We defined adjusted EBITDA as net income (loss) before net interest, other expense, taxes, depreciation and amortization expense, adjusted to eliminate stock-based compensation and non-cash changes in fair value of contingent consideration and</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 4pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">36</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_065.png"/></span></p><p style="padding-top: 3pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">impairments of goodwill, intangible and long-lived assets, if any. See the section titled “Adjusted Gross Margin and Adjusted EBITDA” below for more information and for a reconciliation of adjusted EBITDA to EBITDA, the most directly comparable financial measure calculated and presented in accordance with GAAP.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:29pt"><td style="width:250pt"><p class="s7" style="text-indent: 0pt;line-height: 9pt;text-align: left;">Our Segments</p></td><td style="width:58pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:176pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-top: 4pt;padding-left: 43pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Year Ended December 31,</p></td><td style="width:54pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:9pt"><td style="width:250pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 15pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2016</p></td><td style="width:176pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 16pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2015 2014 2013</p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 16pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2012</p></td></tr><tr style="height:9pt"><td style="width:250pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:176pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 50pt;text-indent: 0pt;line-height: 7pt;text-align: left;">(dollars in thousands)</p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s7" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Segment Statements of Operations Data</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:176pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:54pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Revenue</p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:176pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:54pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/Commercial</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 49,081</p></td><td style="width:176pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 55,487 $ 40,369 $ 33,028</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 28,341</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/State</p></td><td style="width:58pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">3,453</p></td><td style="width:176pt"><p class="s10" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">13,372 21,632 3,177</p></td><td style="width:54pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">65</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Medicare</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">18,565</p></td><td style="width:176pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">17,973 16,175 15,941</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">-</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Private Exchange</p></td><td style="width:58pt"><p class="s21" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           10,795</p></td><td style="width:176pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">              9,015 6,403 6,180</p></td><td style="width:54pt"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">              1,220</p></td></tr><tr style="height:12pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Total Revenue</p></td><td style="width:58pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 11pt;text-indent: 0pt;text-align: right;">$ 81,894</p></td><td style="width:176pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ 95,847 $ 84,579 $ 58,326</p><p class="s25" style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_066.png"/></span>	<span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_067.png"/></span>	<span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_068.png"/></span></p></td><td style="width:54pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;text-align: right;">$ 29,626</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_069.png"/></span></p></td></tr><tr style="height:10pt"><td style="width:250pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Gross Margin</p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:176pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/Commercial</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 11,906</p></td><td style="width:176pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 23,715 $ 10,323 $ (747 )</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 7,241</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/State</p></td><td style="width:58pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,325</p></td><td style="width:176pt"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">6,300 11,038 (1,121 )</p></td><td style="width:54pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(784 )</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Medicare</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">11,460</p></td><td style="width:176pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">10,651 9,451 7,839</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">-</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Private Exchange</p></td><td style="width:58pt"><p class="s21" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                 308</p></td><td style="width:176pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">              4,511 1,336 2,182</p></td><td style="width:54pt"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                 283</p></td></tr><tr style="height:12pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Total Gross Margin</p></td><td style="width:58pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 11pt;text-indent: 0pt;text-align: right;">$ 24,999</p></td><td style="width:176pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ 45,177 $ 32,148 $ 8,153</p><p class="s25" style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_070.png"/></span>	<span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_071.png"/></span>	<span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_072.png"/></span></p></td><td style="width:54pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;text-align: right;">$ 6,740</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_073.png"/></span></p></td></tr><tr style="height:45pt"><td style="width:250pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s7" style="padding-top: 5pt;text-indent: 0pt;text-align: left;">Consolidated Balance Sheet Data</p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:176pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-left: 43pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Year Ended December 31,</p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:9pt"><td style="width:250pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 15pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2016</p></td><td style="width:176pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 16pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2015 2014 2013</p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 16pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2012</p></td></tr><tr style="height:9pt"><td style="width:250pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:176pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 50pt;text-indent: 0pt;line-height: 7pt;text-align: left;">(dollars in thousands)</p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s7" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Condensed Consolidated Balance Sheet Data</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:176pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:54pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Cash and cash equivalents</p></td><td style="width:58pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 6,208</p></td><td style="width:176pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 5,424 $ 28,252 $ 2,277</p></td><td style="width:54pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 1,476</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Accounts receivable — net of allowances</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">8,390</p></td><td style="width:176pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">10,792 12,128 20,935</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">6,183</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">Total assets<span class="s24">(1)</span></p></td><td style="width:58pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">82,488</p></td><td style="width:176pt"><p class="s10" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">82,689 111,390 93,202</p></td><td style="width:54pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">24,125</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Deferred revenue, total</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">40,916</p></td><td style="width:176pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">52,578 73,737 87,855</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">40,070</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Capital lease obligations, total</p></td><td style="width:58pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">34</p></td><td style="width:176pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">140 567 975</p></td><td style="width:54pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">-</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">Current maturities of long-term debt<span class="s24">(2)</span></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">578</p></td><td style="width:176pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,441 4,479 5,431</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">194</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">Long-term debt<span class="s24">(1) (2)</span></p></td><td style="width:58pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">31,944</p></td><td style="width:176pt"><p class="s10" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">46,964 47,627 31,787</p></td><td style="width:54pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,562</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">Total liabilities<span class="s24">(1)</span></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">87,978</p></td><td style="width:176pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 19pt;text-indent: 0pt;line-height: 8pt;text-align: left;">113,869 140,231 149,511</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">54,689</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Total redeemable preferred stock</p></td><td style="width:58pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">51,894</p></td><td style="width:176pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">- - 49,745</p></td><td style="width:54pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">46,060</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Common stock</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">23</p></td><td style="width:176pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">22 22 1</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Additional paid-in capital</p></td><td style="width:58pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">101,985</p></td><td style="width:176pt"><p class="s10" style="padding-left: 19pt;text-indent: 0pt;line-height: 8pt;text-align: left;">101,546 96,365 9,013</p></td><td style="width:54pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">12,059</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Total stockholders&#39; deficit</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(57,384 )</p></td><td style="width:176pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(31,180 ) (28,841 ) (106,054 )</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(76,624 )</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l6"><li style="padding-left: 49pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">As of December 31, 2015, we early-adopted Accounting Standard No. 2015-03, Simplifying the Presentation of Debt Issuance Costs, issued by the Financial Accounting Standards Board in April 2015. The effect of the adoption on the Company’s consolidated balance sheet is a reduction in Other Assets and Long-Term Debt of $954 and $1,031 as of December 31, 2014, and 2013, respectively. The adoption had no impact on the consolidated balance sheet as of December 31, 2012.</p></li><li style="padding-top: 1pt;padding-left: 49pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">On March 10, 2017, we amended our Credit Facility to, among other things, defer scheduled Senior Term Note principal payments until March 31, 2018, at which time quarterly repayments of approximately $1.3 million will resume. As a result of the foregoing amendment, we have classified our entire December 31, 2016 outstanding Senior Term Note as long-term, decreasing Current maturities of debt to $0.6 million and increasing Long-term debt to $31.9 million from the $3.1 million and $29.5 million, respectively, set forth in our fourth quarter and full year 2016 earnings release furnished with our Current Report on Form 8-K filed with the SEC on March 14, 2017.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">37</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_074.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Adjusted Gross Margin and Adjusted EBITDA</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Within the Annual Report on Form 10-K, we use adjusted gross margin and adjusted earnings before interest, taxes, depreciation and amortization, or adjusted EBITDA, to provide investors with additional information regarding our financial results. Adjusted gross margin and adjusted EBITDA are non- GAAP financial measures. We have provided below reconciliations of these measures to the most directly comparable GAAP financial measures, which for adjusted gross margin is gross margin, and for adjusted EBITDA is net loss.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We have included adjusted gross margin and adjusted EBITDA in this filing because they are key measures used by our management and board of directors to understand and evaluate our core operating performance and trends, to prepare and approve our annual budget, and to develop short- and long- term operational plans. We believe the exclusion of non-cash charges such as depreciation, amortization and stock-based compensation from adjusted EBITDA and adjusted gross margin allows us to have additional insight into the core operating performance of our business. The amount of such expenses in any specific period may not directly correlate with the underlying performance of our business operations during the period and such expenses can vary significantly between periods. The use of adjusted EBITDA and adjusted gross margin provides consistency and comparability with our past financial performance and facilitates period-to-period comparisons of operations that could otherwise be masked by the effect of the expenses that we exclude from these non-GAAP financial measures and facilitates comparisons with other peer companies, many of which use similar non-GAAP financial measures to supplement their GAAP results. Additionally, securities analysts use a measure similar to adjusted EBITDA and adjusted gross margin as supplemental measures to evaluate the overall operating performance and comparison of companies, and we anticipate that our investor and analyst presentations will continue to include these measures. Accordingly, we believe that adjusted gross margin and adjusted EBITDA provide useful information to investors and others in understanding and evaluating our operating results.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Our use of adjusted gross margin and adjusted EBITDA as analytical tools has limitations, and you should not consider them in isolation or as substitutes for analysis of our financial results as reported under GAAP. Some of these limitations are:</p><ul id="l7"><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">although depreciation and amortization are non-cash charges, the assets being depreciated and amortized might have to be replaced in the future, and adjusted gross margin and adjusted EBITDA do not reflect cash capital expenditure requirements for such replacements or for new capital expenditure requirements;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">adjusted gross margin and adjusted EBITDA do not reflect changes in, or cash requirements for, our working capital needs;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">adjusted gross margin and adjusted EBITDA do not reflect the potentially dilutive impact of stock-based compensation;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">adjusted gross margin and adjusted EBITDA do not reflect interest or tax payments that could reduce the cash available to us; and</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">other companies, including companies in our industry, might calculate adjusted gross margin and adjusted EBITDA or similarly titled measures differently, which reduces their usefulness as comparative measures.</p></li></ul></li></ol></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">38</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_075.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Because of these and other limitations, you should consider adjusted gross margin and adjusted EBITDA alongside other GAAP-based financial performance measures, including various cash flow metrics, gross margin, net loss and our other GAAP financial results. The following table presents a reconciliation of adjusted gross margin to gross margin and adjusted EBITDA to net loss for each of the periods indicated:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:8pt"><td style="width:250pt" rowspan="3"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:175pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 42pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Year Ended December 31,</p></td><td style="width:54pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:9pt"><td style="width:59pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 16pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2016</p></td><td style="width:175pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 16pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2015 2014 2013</p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 16pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2012</p></td></tr><tr style="height:9pt"><td style="width:59pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:175pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 49pt;text-indent: 0pt;line-height: 7pt;text-align: left;">(dollars in thousands)</p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:20pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s7" style="padding-left: 5pt;padding-right: 58pt;text-indent: -5pt;line-height: 10pt;text-align: left;">Reconciliation from Gross Margin to Adjusted Gross Margin</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:175pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:54pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Gross Margin</p></td><td style="width:59pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 24,999</p></td><td style="width:175pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 45,177 $ 32,148 $ 8,153</p></td><td style="width:54pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 6,740</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Depreciation and amortization</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">3,857</p></td><td style="width:175pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">3,846 3,892 3,739</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">711</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Stock-based compensation expense</p></td><td style="width:59pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                 689</p></td><td style="width:175pt"><p class="s21" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                 922 123 92</p></td><td style="width:54pt"><p class="s21" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                  121</p></td></tr><tr style="height:12pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Adjusted Gross Margin</p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ 29,545</p></td><td style="width:175pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 11pt;text-indent: 0pt;text-align: right;">$ 49,945 $ 36,163 $ 11,984</p><p class="s25" style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_076.png"/></span>	<span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_077.png"/></span> <span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_078.png"/></span></p></td><td style="width:54pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;text-align: right;">$ 7,572</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="66" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_079.png"/></span></p></td></tr><tr style="height:10pt"><td style="width:250pt"><p class="s7" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Reconciliation from Net Loss to Adjusted EBITDA</p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:175pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Net Loss</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ (26,534 )</p></td><td style="width:175pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (7,343 ) $ (10,160 ) $ (26,384 )</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (16,756 )</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Depreciation and amortization</p></td><td style="width:59pt"><p class="s10" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">4,601</p></td><td style="width:175pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,043 5,101 4,710</p></td><td style="width:54pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,013</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Interest expense</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">3,485</p></td><td style="width:175pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,665 5,937 4,644</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,992</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Other expense (income), net</p></td><td style="width:59pt"><p class="s10" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">2,239</p></td><td style="width:175pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">140 (68 ) —</p></td><td style="width:54pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Income tax (provision) benefit</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 36pt;text-indent: 0pt;line-height: 8pt;text-align: left;">(60 )</p></td><td style="width:175pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">51 33 (900 )</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(3 )</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Stock-based compensation expense</p></td><td style="width:59pt"><p class="s10" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">2,662</p></td><td style="width:175pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">4,712 1,436 639</p></td><td style="width:54pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">700</p></td></tr><tr style="height:11pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Change in fair value of contingent consideration</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                      -</p></td><td style="width:175pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                      - (951<span class="s10"> )</span> —</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                    —</p></td></tr><tr style="height:11pt"><td style="width:250pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Total Net Adjustments</p></td><td style="width:59pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 12,927</p></td><td style="width:175pt"><p class="s21" style="padding-top: 1pt;padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 15,611<span class="s10"> </span>$ 11,488<span class="s10"> </span>$ 9,093</p></td><td style="width:54pt"><p class="s21" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 3,702</p></td></tr><tr style="height:12pt"><td style="width:250pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Adjusted EBITDA</p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ (13,607<span class="s10"> )</span></p></td><td style="width:175pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 7pt;text-indent: 0pt;text-align: right;">$ 8,268 $ 1,328 $ (17,291 )</p><p class="s25" style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_080.png"/></span>	<span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_081.png"/></span> <span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_082.png"/></span></p></td><td style="width:54pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;text-align: right;">$ (13,054 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="66" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_083.png"/></span></p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">39</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_084.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark14">Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations</a><a name="bookmark55">&zwnj;</a><a name="bookmark56">&zwnj;</a></p><p class="s15" style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The statements included herein that are not based solely on historical facts are “forward looking statements.” Such forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties. Our actual results could differ materially from those anticipated by us in these forward-looking statements as a result of various factors, including those discussed below and elsewhere in this Annual Report on Form 10-K, particularly under the section titled “Risk Factors.”</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K. In addition to historical consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to these differences include those discussed below and elsewhere in this Annual Report on Form 10-K, particularly in the section titled “Risk Factors.”</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Overview</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We are a leading web-based consumer shopping, enrollment and retention platform for health insurance distribution. Our solutions offer a personalized health insurance shopping experience that recommends the best fit insurance plan based on an individual’s preferences, health status, preferred providers, medications and expected out-of-pocket costs. Our customers are payers, brokers, government agencies, and web-based insurance marketplace operators, who distribute health and ancillary insurance. Our solutions automate key functions in the insurance distribution process, allowing our customers to price and present plan options accurately to consumers and efficiently enroll, renew and manage plan members.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We primarily serve three separate but related market segments: Enterprise/Commercial, Medicare and Private Exchange. Our largest market segment is the Enterprise/Commercial market, in which we sell our solutions to health plans. Our Medicare segment sells web-based Medicare plan comparison and enrollment tools to a variety of different customers, including health plans, pharmacy benefit managers, or PBMs, pharmacies, field marketing organizations, or FMOs, and call centers. Lastly, our Private Exchange segment sells comprehensive defined-contribution benefit exchange solutions to benefit consultants, brokers, exchange operators and aggregators. We believe our presence in these markets and resulting access to such a broad and diverse customer base gives us a strong position at the center of the health insurance distribution marketplace. We also serve a fourth, and increasingly shrinking, market through our Enterprise/State segment. Our Enterprise/State segment, which has sold our sales automation solutions to state governments, allows our state governments to offer customized individual and small group exchanges. Due to the limited market opportunities, we have continued to reduce our focus and dependency on this segment.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We sell our web-based solutions and related services primarily through our direct sales force. We derive most of our revenue from software services fees, which primarily consist of monthly subscription fees paid to us for access to, usage and hosting of our web-based insurance distribution software solutions, and related production support services. Software services fees paid to us from our Enterprise/Commercial customers are based on the size of the health plan for a specified period of time, which usually ranges from three to five years, and the number of software modules used. Software services fees paid to us from our Medicare and Private Exchange customers are based on the volume of enrollments for which our software solutions are utilized for a contracted period, which usually ranges from one to three years.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Our Enterprise/State software service and professional services fees have been largely derived from multiple element contracts for non-hosted software solutions and related services for which we do not have vendor specific objective evidence, or VSOE, of relative fair value of the contractual elements. For purposes of presentation in management’s discussion and analysis, management classifies a portion of the overall arrangement fee as software services and professional services based on an evaluation of various available indicators of fair value, including relative contract value of the software and professional services elements to total contractual value, and applies judgment to reasonably classify the arrangement fee. Our classification of multiple element arrangement fees is for management’s discussion and analysis purposes only and does not affect the timing or amount of revenue recognized.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Software services revenue accounted for approximately 69%, 67% and 75% of our total revenue during the years ended December 31, 2016, 2015 and 2014, respectively.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Our customer contracts are generally only cancellable by the customer in an instance of our uncured breach, although some of our customers (including government customers) are able to terminate their respective contracts without cause or for convenience. Of our top 20 customers by 2016 revenue, some customers can terminate their contract for convenience upon written notice. These customers represented $28.1 million, or 32.4% of our Contracted Backlog balance as of December 31, 2016, including one Medicare segment customer representing approximately $10.6 million, or 12.2%, of our Contracted Backlog balance due to the recent renewal of a multiple year contract.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 4pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">40</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_085.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Another component of our revenue is professional services, which we primarily derive from the implementation of our customers onto our platform, typically including discovery, configuration and deployment, integration, testing and training. In general, it takes from six to fifteen months to implement a new Enterprise/Commercial customer’s insurance distribution solution and from one to four months to implement a new Medicare or Private Exchange insurance distribution solution.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Professional services revenue accounted for approximately 27%, 30% and 21% of our total revenue during the years ended December 31, 2016, 2015 and 2014, respectively.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We also derive a small portion of our revenue from commissions earned on annual employee enrollments in which our health plan network and software solutions are used in connection with each enrollment.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Management is focused on risks that could have an adverse impact on our operations and our key financial and operating performance metrics, as described below, and takes actions to mitigate those risks. In our Enterprise/Commercial segment, for example, while fluctuations in bookings are not uncommon given the sales cycle for software solution services in that segment, management routinely assesses staffing levels required to support contracted business volume and adjusts staffing levels accordingly. As part of its ongoing assessment of our software capabilities, management also considers industry trends, such as consumers’ increased reliance on mobile devices, to determine where to allocate research and development funding. One of our overall strategic initiatives is to continue to increase the percentage of software services revenue (and reduce professional services revenue as a percentage of total revenue) as we believe this will have a positive impact on overall gross margins in the future.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Key Financial and Operating Performance Metrics</p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">We regularly monitor a number of financial and operating metrics in order to measure our current performance and project our future performance.</p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">These metrics help us develop and refine our growth strategies and make strategic decisions. We discuss consolidated revenue, gross margin and the components of operating loss, as well as segment revenue and components of segment gross margin, in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Components of Operating Results.” In addition, we utilize other key metrics as described below.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Contracted Backlog</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We believe the balance of contracted future billings, or Contracted Backlog, is an important indicator of the economic health of our business, as it provides an important source of visibility into our future sources of revenue.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We have generally signed multiple-year subscription contracts for our software services. The timing of our invoices to our customer is a negotiated term and thus varies among our customers. For multiple-year agreements, it is common to invoice an initial amount at contract signing for implementation work that is deferred, followed by subsequent annual, quarterly or monthly invoices once we launch a customer, which is when our product is usable by the customer. At any point in the contract term, there may be amounts that we have not yet been contractually able to invoice. Until such time as these amounts are invoiced, they are not recorded in revenue, deferred revenue or elsewhere in our consolidated financial statements and are considered by us to be Contracted Backlog. The amount of our total Contracted Backlog for software services and professional services contracts, which we define as including both cancellable and non-cancellable portions of our customer agreements that we have not yet billed, was approximately $86.7 million and $89.7 million as of December 31, 2016 and 2015, respectively.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">The anticipated impact of the December 31, 2016 Contracted Backlog on each future year’s billings is as follows:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:115.651pt" cellspacing="0"><tr style="height:9pt"><td style="width:167pt"><p class="s8" style="text-indent: 0pt;line-height: 7pt;text-align: left;">Year ending December 31</p></td><td style="width:156pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">Millions of Dollars</p></td></tr><tr style="height:11pt"><td style="width:167pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">2017</p></td><td style="width:156pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 39.5</p></td></tr><tr style="height:11pt"><td style="width:167pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">2018</p></td><td style="width:156pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">28.5</p></td></tr><tr style="height:11pt"><td style="width:167pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">2019</p></td><td style="width:156pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">11.0</p></td></tr><tr style="height:11pt"><td style="width:167pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Thereafter</p></td><td style="width:156pt"><p class="s21" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                          7.7</p></td></tr><tr style="height:12pt"><td style="width:167pt" bgcolor="#CEEFFB"><p class="s7" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">TOTAL</p></td><td style="width:156pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 4pt;text-indent: 0pt;line-height: 9pt;text-align: right;">$ 86.7</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 101pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="66" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_086.png"/></span></p></td></tr></table><p style="padding-left: 384pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="66" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_087.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We expect that the amount of our Contracted Backlog relative to the total value of our contracts will change from period to period for several reasons, including the amount of cash collected early in the contract term, the specific timing and duration of large customer contracts, varying invoicing cycles of customer contracts, potential customer upsells dependent on our customer contracts, the specific timing of customer renewal and changes in customer financial circumstances. Accordingly, we believe that fluctuations in our Contracted Backlog may not be a reliable indicator of our future revenue beyond one year.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">41</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_088.png"/></span></p><h4 style="padding-top: 3pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Software Revenue Retention Rate</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We believe that our ability to retain our customers and expand the revenue we generate from them over time is an important component of our strategy and reflects the long-term value of our customer relationships. We measure our performance on this basis using a metric we refer to as our Software Revenue Retention Rate. We calculate this metric for a particular period by establishing the group of our customers that had active contracts for a given period (excluding our Enterprise/State customers, of which there was one, two, and three customers during the years ended December 31, 2016, 2015 and 2014, respectively). We then calculate our Software Revenue Retention Rate by taking the amount of software revenue we recognized for this group in the subsequent comparable period (for which we are reporting the rate) and dividing it by the software revenue we recognized for the group in the prior period.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">For the years ended December 31, 2016, 2015 and 2014, our Software Revenue Retention Rate was in excess of 91%.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Adjusted Gross Margin and Adjusted EBITDA</h4><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">Adjusted gross margin represents our gross margin before depreciation and amortization expense, as well as stock-based compensation expense.</p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Adjusted earnings before interest, taxes, depreciation and amortization, or adjusted EBITDA, represents net income (loss) before net interest, other expense, taxes, depreciation and amortization expense, adjusted to eliminate stock-based compensation and non-cash changes in fair value of contingent consideration and impairments of goodwill, intangible, and other long-lived assets, if any. Adjusted gross margin and adjusted EBITDA are not measures calculated in accordance with GAAP, or Generally Accepted Accounting Principles. Please refer to “Selected Consolidated Financial Data—Adjusted Gross Margin and Adjusted EBITDA” in this Annual Report on Form 10-K for a discussion of the limitations of adjusted gross margin and adjusted EBITDA and reconciliations of adjusted gross margin to gross margin and adjusted EBITDA to net loss, the most comparable GAAP measurements, respectively, for the years ended December 31, 2016, 2015, 2014, 2013 and 2012.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Components of Operating Results</p><h4 style="padding-top: 5pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Revenue</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We derive most of our revenue from software services fees, which primarily consist of subscription fees paid to us for access to, usage and hosting of our web-based software solutions, and related production support services.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Software services fees paid to us from our Enterprise/Commercial customers are contracted rates based on the size of the health plan using our solutions for a specified period of time, which usually ranges from three to five years, and the number of software modules used. Software services fees paid to us from our Enterprise/State customers have been based on contracted rates and the number of software solution modules being used for a specified period of time, which have ranged from one to three years. Software services fees paid to us from our Medicare and Private Exchange customers are based on the volume of enrollments for which our software solutions are utilized for a contracted period, which usually ranges from one to three years. Our customer contracts are generally only cancellable by the customer in an instance of our uncured breach, although some of our customers are able to terminate their respective contracts without cause or for convenience. Software services revenue accounted for approximately 69%, 67% and 75% of our total revenue during the years ended December 31, 2016, 2015 and 2014, respectively.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Another component of our revenue is professional services, which we primarily derive from the implementation of our customers onto our platform, typically including discovery, configuration and deployment, integration, testing and training. In general, it takes from six to fifteen months to implement a new enterprise customer’s solution and from one to three months to implement a new Medicare or Private Exchange solution. Professional services revenue accounted for approximately 27%, 30% and 21% of our total revenue during the years ended December 31, 2016, 2015 and 2014, respectively.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We also derive a small portion of other revenue from commissions earned on annual employee enrollments in which our health plan network and web- based software solutions are used in connection with each enrollment.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">For all contractual arrangements that include multiple elements, we allocate revenue from a customer contract to software services and professional services based on the type of multiple element arrangement. For instance, with respect to multiple-element arrangements containing hosted software, we identify each software and professional services unit of accounting based on the terms of the customer contract and allocate revenue to each unit of accounting based on the relative selling price of each deliverable. Revenue from each element is recognized as each element is delivered. Similarly, for multiple-element arrangements containing non-hosted software, during the periods reported we accounted for the entire arrangement as a single unit of accounting, because some or all of the deliverable elements did not have stand-alone value when the related contracts were executed. In these situations, all revenue has been deferred until delivery of the final element, at which time the contract value is recognized ratably over the longer of the contract or estimated period of customer benefit. For purposes of presentation in management’s discussion and analysis, management classifies a portion of the overall arrangement fee as software and professional services fees based on an evaluation of various available indicators of fair value, including relative contract value of the software and professional services elements to total contractual value,</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 4pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">42</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_089.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">and applies judgment to reasonably classify the arrangement fee. Our classification of multiple element arrangement fees does not affect the timing or amount of revenue recognized.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We generally invoice our customers for software services in advance, in monthly, quarterly or annual installments. We typically invoice our Medicare and Private Exchange customers for implementation fees at the inception of the arrangement. We generally invoice our Enterprise/Commercial and Enterprise/State customers for implementation fees at various contractually defined times throughout the implementation process. Implementation fees that have been invoiced are initially recorded as deferred revenue until recognized.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The Enterprise/State segment had one remaining state exchange customer as of December 31, 2016, whose contract expires in 2017. As a result of the customer decline, we anticipate future Enterprise/State revenue will be lower than prior periods.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Overhead Allocation</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Expenses associated with our facilities and depreciation are allocated between cost of revenue and operating expenses based on employee payroll costs determined by the nature of work performed.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Cost of Revenue</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Cost of revenue primarily consists of salaries and other personnel-related costs, including benefits, bonuses and stock-based compensation, for employees providing services to our customers and supporting our web-based software services. Additional expenses in cost of revenue include third-party contract labor, co-location facility costs for our data centers, depreciation expense for computer equipment directly associated with generating revenue, infrastructure maintenance costs, amortization expenses associated with deferred implementation costs and acquired intangible assets, allocated overhead and other direct costs.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Our cost of revenue is expensed as we incur the costs, with the exception of certain direct, incremental costs associated with new customer implementation efforts, which we defer. The related revenue from fees we receive for our implementation services performed before a customer is operating on our platform is deferred until the commencement of the usage of our software services, at which time the revenue is recognized ratably over the longer of the related contract term or the estimated period of customer benefit. Therefore, certain costs incurred in providing these services are expensed in periods prior to the recognition of the corresponding revenue. Our cost associated with providing implementation services has been significantly higher as a percentage of revenue than our cost associated with providing our on-going services due to the labor associated with providing implementation services. We took certain costs reduction actions in 2016 and expect to make further cost reductions in 2017, which we anticipate will reduce our cost of revenue in future periods in terms of dollars and as a percentage of revenue.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Operating Expenses</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Operating expenses consist of research and development, sales and marketing, and general and administrative expenses. Salaries and personnel-related costs are the most significant component of each of these expense categories. We expect our operating expenses to decrease in aggregate dollars and as a percentage of revenue over the near term as we implement changes to improve profitability.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Research and development expense. <span class="p">The nature of our research and development activities includes market requirements and definition, product design, software development, quality assurance and product release. Research and development expense consists primarily of salaries and other personnel- related costs, including benefits, bonuses and stock-based compensation for our research and development employees. Additional expenses include costs related to the development, quality assurance, and testing of new technology, and enhancement of our existing platform technology, consulting, travel and allocated overhead. We believe continuing to invest in research and development efforts is essential to maintaining our competitive position. We have continued to invest in a common software platform intended to reduce future software implementation and maintenance costs and to increase margins, but we expect our research and development expense to decrease as a percentage of revenue over the longer term to a target of under twenty percent of revenue.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Sales and marketing expense. <span class="p">Sales and marketing expense consists primarily of salaries and other personnel-related costs, including benefits, bonuses, stock-based compensation and commissions for our sales and marketing employees. We record expense for commissions at the time of contract signing. Additional expenses include advertising, lead generation, promotional event programs, corporate communications, travel and allocated overhead. We expect our sales and marketing expense to increase in both dollars and as a percentage of revenue in the foreseeable future as we expand our marketing activities in order to grow our business.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 8pt;text-indent: 24pt;text-align: left;">General and administrative expense. <span class="p">General and administrative expense consists primarily of salaries and other personnel-related costs, including benefits, bonuses and stock-based compensation for administrative, finance and accounting, legal, information technology and human resource employees. Additional expenses include consulting and professional fees, insurance and other</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 4pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">43</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_090.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">corporate expenses, travel, and expenses incurred as a result of operating as a public company, including costs associated with compliance with the Sarbanes- Oxley Act and other regulations governing public companies, costs of directors’ and officers’ liability insurance, professional services expenses and costs associated with an investor relations function.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Other Expenses</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Other expenses primarily consist of interest expense incurred on outstanding borrowings under our financing obligations, existing notes and credit facilities, along with financing related expenses to amend or extinguish existing notes and credit facilities.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Income Tax (Expense) Benefit</h4><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">Income taxes primarily consist of United States federal and state income tax net operating loss benefits, net of changes in valuation allowances.</p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Valuation allowances are recorded to reduce deferred tax assets to the amount we believe is more likely than not to be realized.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">Our income tax (expense) benefit was not meaningful in the years ended December 31, 2016, 2015, and 2014.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">As a result of cumulative net operating losses, we have net operating loss carryforwards for federal income tax purposes of approximately $121.0 million as of December 31, 2016. State net operating loss carryforwards were approximately $77.8 million as of December 31, 2016. Our net operating losses will expire at various dates beginning in 2020, if not utilized. As a result of prior equity issuances and other transactions in our stock, we have experienced “ownership changes” under Section 382 which limit the amount of net operating loss carryforwards available to us. We may also experience ownership changes in the future, which may result in further limitation of the amount of net operating losses which may be available in future years. At December 31, 2016 we had a full tax valuation allowance offsetting the recorded tax benefit of our federal and state net operating loss carryforwards.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Results of Operations</p><h4 style="padding-top: 5pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Statements of Operations Data</h4><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">The following table sets forth our consolidated statements of operations data for each of the periods indicated:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 234pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 280pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="276" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_091.png"/></span></p><p class="s3" style="padding-left: 233pt;text-indent: 0pt;text-align: center;">2016                              2015                             2014</p><p style="padding-left: 280pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="276" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_092.png"/></span></p><p class="s3" style="padding-left: 233pt;text-indent: 0pt;text-align: center;">(dollars in thousands, except share and per share amounts)</p><table style="border-collapse:collapse;margin-left:61.8254pt" cellspacing="0"><tr style="height:11pt"><td style="width:188pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Revenue</p></td><td style="width:104pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 81,894</p></td><td style="width:73pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 95,847</p></td><td style="width:66pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 84,579</p></td></tr><tr style="height:11pt"><td style="width:188pt"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">Cost of Revenue <span class="s24">(1)</span></p></td><td style="width:104pt"><p class="s21" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                   56,895</p></td><td style="width:73pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                   50,670</p></td><td style="width:66pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                   52,431</p></td></tr><tr style="height:11pt"><td style="width:188pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Gross Margin</p></td><td style="width:104pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                   24,999</p></td><td style="width:73pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                   45,177</p></td><td style="width:66pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                   32,148</p></td></tr><tr style="height:11pt"><td style="width:188pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Operating Expenses:</p></td><td style="width:104pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:73pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:66pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:188pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">Research and Development <span class="s24">(1)</span></p></td><td style="width:104pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">22,297</p></td><td style="width:73pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">22,718</p></td><td style="width:66pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">18,125</p></td></tr><tr style="height:11pt"><td style="width:188pt"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">Sales and Marketing <span class="s24">(1)</span></p></td><td style="width:104pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">10,410</p></td><td style="width:73pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">9,507</p></td><td style="width:66pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">7,729</p></td></tr><tr style="height:11pt"><td style="width:188pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">General and Administrative <span class="s24">(1)</span></p></td><td style="width:104pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                   13,162</p></td><td style="width:73pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                   14,439</p></td><td style="width:66pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                   10,552</p></td></tr><tr style="height:11pt"><td style="width:188pt"><p class="s10" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Total Operating Expenses</p></td><td style="width:104pt"><p class="s10" style="padding-top: 1pt;padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">45,869</p></td><td style="width:73pt"><p class="s10" style="padding-top: 1pt;padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">46,664</p></td><td style="width:66pt"><p class="s10" style="padding-top: 1pt;padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">36,406</p></td></tr><tr style="height:11pt"><td style="width:188pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:104pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:73pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:66pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:188pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Loss from Operations</p></td><td style="width:104pt;border-top-style:solid;border-top-width:1pt"><p class="s21" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                 (20,870<span class="s10"> )</span></p></td><td style="width:73pt;border-top-style:solid;border-top-width:1pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                    (1,487<span class="s10"> )</span></p></td><td style="width:66pt;border-top-style:solid;border-top-width:1pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                    (4,258<span class="s10"> )</span></p></td></tr><tr style="height:11pt"><td style="width:188pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Other Expenses:</p></td><td style="width:104pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:73pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:66pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:188pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Interest Expense</p></td><td style="width:104pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">3,485</p></td><td style="width:73pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,665</p></td><td style="width:66pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,937</p></td></tr><tr style="height:11pt"><td style="width:188pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Other Expense (Income), net</p></td><td style="width:104pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                     2,239</p></td><td style="width:73pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                        140</p></td><td style="width:66pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                         (68<span class="s10"> )</span></p></td></tr><tr style="height:11pt"><td style="width:188pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Loss before Income Taxes</p></td><td style="width:104pt"><p class="s21" style="padding-top: 1pt;padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                 (26,594<span class="s10"> )</span></p></td><td style="width:73pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                    (7,292<span class="s10"> )</span></p></td><td style="width:66pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                 (10,127<span class="s10"> )</span></p></td></tr><tr style="height:11pt"><td style="width:188pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Income Tax Benefit (Provision)</p></td><td style="width:104pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                          60</p></td><td style="width:73pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                         (51<span class="s10"> )</span></p></td><td style="width:66pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                         (33<span class="s10"> )</span></p></td></tr><tr style="height:12pt"><td style="width:188pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Net Loss</p></td><td style="width:104pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s21" style="padding-top: 1pt;padding-right: 7pt;text-indent: 0pt;text-align: right;">$ (26,534<span class="s10"> )</span></p></td><td style="width:73pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ (7,343 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="83" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_093.png"/></span></p></td><td style="width:66pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ (10,160 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="83" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_094.png"/></span></p></td></tr><tr style="height:11pt"><td style="width:188pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Net loss per common share - basic and diluted</p></td><td style="width:104pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 7pt;text-indent: 0pt;text-align: right;">$ (1.31<span class="s10"> )</span></p></td><td style="width:73pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;text-align: left;">$ (0.34 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="83" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_095.png"/></span></p></td><td style="width:66pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;text-align: left;">$ (10.27 )</p></td></tr><tr style="height:21pt"><td style="width:188pt"><p class="s10" style="padding-top: 1pt;padding-left: 5pt;padding-right: 65pt;text-indent: -5pt;line-height: 10pt;text-align: left;">Weighted Average Common Shares Outstanding - basic and diluted</p></td><td style="width:104pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s21" style="padding-right: 11pt;text-indent: 0pt;text-align: right;">           22,275,256</p></td><td style="width:73pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 22pt;text-indent: 0pt;text-align: left;">21,813,407</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="82" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_096.png"/></span></p></td><td style="width:66pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 4pt;text-indent: 0pt;text-align: right;">1,362,109</p></td></tr><tr style="height:10pt"><td style="width:188pt" bgcolor="#CEEFFB"><p class="s7" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Other Financial Data:</p></td><td style="width:104pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:73pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:66pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:188pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Adjusted gross margin</p></td><td style="width:104pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">29,545</p></td><td style="width:73pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">49,945</p></td><td style="width:66pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">36,163</p></td></tr><tr style="height:11pt"><td style="width:188pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Adjusted EBITDA</p></td><td style="width:104pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(13,607 )</p></td><td style="width:73pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">8,268</p></td><td style="width:66pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,328</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 4pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">44</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_097.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="119" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_098.png"/></span></p><p style="padding-top: 1pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">(1) Cost of revenue and operating expenses include stock-based compensation expense as follows:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:61.8254pt" cellspacing="0"><tr style="height:8pt"><td style="width:219pt" rowspan="3"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:62pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:83pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 1pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Year Ended December 31,</p></td><td style="width:67pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:9pt"><td style="width:62pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 22pt;padding-right: 23pt;text-indent: 0pt;line-height: 7pt;text-align: center;">2016</p></td><td style="width:83pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 33pt;padding-right: 33pt;text-indent: 0pt;line-height: 7pt;text-align: center;">2015</p></td><td style="width:67pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 23pt;padding-right: 27pt;text-indent: 0pt;line-height: 7pt;text-align: center;">2014</p></td></tr><tr style="height:9pt"><td style="width:62pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:83pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 8pt;text-indent: 0pt;line-height: 7pt;text-align: left;">(dollars in thousands)</p></td><td style="width:67pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:219pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Cost of Revenue</p></td><td style="width:62pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 1pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 689</p></td><td style="width:83pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 10pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 922</p></td><td style="width:67pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 123</p></td></tr><tr style="height:11pt"><td style="width:219pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Research and Development</p></td><td style="width:62pt"><p class="s10" style="padding-right: 1pt;text-indent: 0pt;line-height: 8pt;text-align: right;">422</p></td><td style="width:83pt"><p class="s10" style="padding-left: 52pt;text-indent: 0pt;line-height: 8pt;text-align: left;">1,379</p></td><td style="width:67pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">78</p></td></tr><tr style="height:11pt"><td style="width:219pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Sales and Marketing</p></td><td style="width:62pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 1pt;text-indent: 0pt;line-height: 8pt;text-align: right;">243</p></td><td style="width:83pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 10pt;text-indent: 0pt;line-height: 8pt;text-align: right;">518</p></td><td style="width:67pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">32</p></td></tr><tr style="height:10pt"><td style="width:219pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">General and Administrative</p></td><td style="width:62pt"><p class="s10" style="padding-right: 1pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,308</p></td><td style="width:83pt"><p class="s10" style="padding-left: 52pt;text-indent: 0pt;line-height: 8pt;text-align: left;">1,893</p></td><td style="width:67pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,203</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">The following table sets forth our consolidated statements of operations data as a percentage of revenue for each of the periods indicated:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 251pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 304pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="236" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_099.png"/></span></p><p class="s3" style="padding-left: 250pt;text-indent: 0pt;text-align: center;">2016                          2015                        2014</p><table style="border-collapse:collapse;margin-left:61.8254pt" cellspacing="0"><tr style="height:11pt"><td style="width:175pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Revenue</p></td><td style="width:129pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">100.0 %</p></td><td style="width:65pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">100.0 %</p></td><td style="width:62pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">100.0 %</p></td></tr><tr style="height:11pt"><td style="width:175pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Cost of Revenue</p></td><td style="width:129pt"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                69.5<span class="s10"> %</span></p></td><td style="width:65pt"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                52.9<span class="s10"> %</span></p></td><td style="width:62pt"><p class="s21" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                62.0<span class="s10"> %</span></p></td></tr><tr style="height:11pt"><td style="width:175pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Gross Margin</p></td><td style="width:129pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                30.5<span class="s10"> %</span></p></td><td style="width:65pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                47.1<span class="s10"> %</span></p></td><td style="width:62pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                38.0<span class="s10"> %</span></p></td></tr><tr style="height:13pt"><td style="width:175pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Operating Expenses:</p></td><td style="width:129pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:65pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:62pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:175pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Research and Development</p></td><td style="width:129pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">27.2 %</p></td><td style="width:65pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">23.7 %</p></td><td style="width:62pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">21.4 %</p></td></tr><tr style="height:11pt"><td style="width:175pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Sales and Marketing</p></td><td style="width:129pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">12.7 %</p></td><td style="width:65pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">9.9 %</p></td><td style="width:62pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">9.1 %</p></td></tr><tr style="height:11pt"><td style="width:175pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">General and Administrative</p></td><td style="width:129pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                16.1<span class="s10"> %</span></p></td><td style="width:65pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                15.1<span class="s10"> %</span></p></td><td style="width:62pt" bgcolor="#CEEFFB"><p class="s21" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                12.5<span class="s10"> %</span></p></td></tr><tr style="height:11pt"><td style="width:175pt"><p class="s10" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Total Operating Expenses</p></td><td style="width:129pt"><p class="s10" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">56.0 %</p></td><td style="width:65pt"><p class="s10" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">48.7 %</p></td><td style="width:62pt"><p class="s10" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">43.0 %</p></td></tr><tr style="height:11pt"><td style="width:175pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:129pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:65pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:62pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:175pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Loss from Operations</p></td><td style="width:129pt;border-top-style:solid;border-top-width:1pt"><p class="s21" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">               (25.5<span class="s10"> %)</span></p></td><td style="width:65pt;border-top-style:solid;border-top-width:1pt"><p class="s21" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                 (1.6<span class="s10"> %)</span></p></td><td style="width:62pt;border-top-style:solid;border-top-width:1pt"><p class="s21" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                 (5.0<span class="s10"> %)</span></p></td></tr><tr style="height:11pt"><td style="width:175pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Other Expenses:</p></td><td style="width:129pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:65pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:62pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:175pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Interest Expense</p></td><td style="width:129pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">4.3 %</p></td><td style="width:65pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5.9 %</p></td><td style="width:62pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">7.0 %</p></td></tr><tr style="height:11pt"><td style="width:175pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Other Expense (Income), net</p></td><td style="width:129pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                   2.7<span class="s10"> %</span></p></td><td style="width:65pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                   0.1<span class="s10"> %</span></p></td><td style="width:62pt" bgcolor="#CEEFFB"><p class="s21" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                 (0.1<span class="s10"> %)</span></p></td></tr><tr style="height:11pt"><td style="width:175pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Loss before Income taxes</p></td><td style="width:129pt"><p class="s21" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">               (32.5<span class="s10"> %)</span></p></td><td style="width:65pt"><p class="s21" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                 (7.6<span class="s10"> %)</span></p></td><td style="width:62pt"><p class="s21" style="padding-top: 1pt;padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">               (12.0<span class="s10"> %)</span></p></td></tr><tr style="height:11pt"><td style="width:175pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Income Tax Benefit (Provision)</p></td><td style="width:129pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                   0.1<span class="s10"> %</span></p></td><td style="width:65pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                 (0.1<span class="s10"> %)</span></p></td><td style="width:62pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                   0.0<span class="s10"> %</span></p></td></tr><tr style="height:13pt"><td style="width:175pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">Net Loss</p></td><td style="width:129pt"><p class="s21" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;text-align: right;">               (32.4<span class="s10"> %)</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 71pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="60" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_100.png"/></span></p></td><td style="width:65pt"><p class="s10" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;text-align: right;">(7.7 %)</p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_101.png"/></span></p></td><td style="width:62pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: right;">(12.0 %)</p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_102.png"/></span></p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Our Segments</h4><p style="text-indent: 0pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_103.png"/></span></p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">The following table sets forth segment results for revenue and gross margin for the periods indicated:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:61.8254pt" cellspacing="0"><tr style="height:8pt"><td style="width:254pt" colspan="2" rowspan="3"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:177pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 46pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Year Ended December 31,</p></td></tr><tr style="height:9pt"><td style="width:177pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 17pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2016 2015 2014</p></td></tr><tr style="height:9pt"><td style="width:177pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 53pt;text-indent: 0pt;line-height: 7pt;text-align: left;">(dollars in thousands)</p></td></tr><tr style="height:11pt"><td style="width:177pt" bgcolor="#CEEFFB"><p class="s7" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Segment Statements of Operations Data:</p></td><td style="width:77pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:177pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:177pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Revenue:</p></td><td style="width:77pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:177pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:177pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/Commercial</p></td><td style="width:77pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:177pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 49,081 $ 55,487 $ 40,369</p></td></tr><tr style="height:11pt"><td style="width:177pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/State</p></td><td style="width:77pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:177pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">3,453 13,372 21,632</p></td></tr><tr style="height:11pt"><td style="width:177pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Medicare</p></td><td style="width:77pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:177pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">18,565 17,973 16,175</p></td></tr><tr style="height:11pt"><td style="width:177pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Private Exchange</p></td><td style="width:77pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:177pt"><p class="s21" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">             10,795 9,015 6,403</p></td></tr><tr style="height:12pt"><td style="width:177pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Total Revenue</p></td><td style="width:77pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:177pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 4pt;text-indent: 0pt;text-align: right;">$ 81,894<span class="s10"> $ 95,847 $ 84,579</span></p><p class="s26" style="padding-left: 5pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="60" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_104.png"/></span>	<span><img width="69" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_105.png"/></span></p></td></tr><tr style="height:10pt"><td style="width:177pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Gross Margin:</p></td><td style="width:77pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:177pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:177pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/Commercial</p></td><td style="width:77pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:177pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 11,906 $ 23,715 $ 10,323</p></td></tr><tr style="height:11pt"><td style="width:177pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/State</p></td><td style="width:77pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:177pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,325 6,300 11,038</p></td></tr><tr style="height:11pt"><td style="width:177pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Medicare</p></td><td style="width:77pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:177pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">11,460 10,651 9,451</p></td></tr><tr style="height:11pt"><td style="width:177pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Private Exchange</p></td><td style="width:77pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:177pt"><p class="s21" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                   308 4,511 1,336</p></td></tr><tr style="height:12pt"><td style="width:177pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Total Gross Margin</p></td><td style="width:77pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:177pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 4pt;text-indent: 0pt;text-align: right;">$ 24,999<span class="s10"> $ 45,177 $ 32,148</span></p><p class="s26" style="padding-left: 5pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="60" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_106.png"/></span>	<span><img width="67" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_107.png"/></span><span class="s25">	</span><span><img width="67" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_108.png"/></span></p></td></tr><tr style="height:34pt"><td style="width:177pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:77pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 32pt;padding-right: 33pt;text-indent: 0pt;text-align: center;">45</p></td><td style="width:177pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr></table><p class="s14" style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Comparison of Years Ended December 31, 2016 and 2015</p><h4 style="padding-top: 5pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Revenue</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 4pt;padding-left: 118pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_109.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_110.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_111.png"/></span></p><p class="s3" style="padding-left: 265pt;text-indent: 0pt;text-align: left;">2016 2015 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_112.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="411" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_113.png"/></span></p><p class="s3" style="padding-left: 347pt;text-indent: 0pt;text-align: left;">(dollars in thousands)</p><p style="padding-top: 1pt;padding-bottom: 1pt;padding-left: 8pt;text-indent: 0pt;text-align: left;"><span class="s27" style=" background-color: #CEEFFB;">Revenue by Type:                                                                                                                                                                                                                                             </span></p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:10pt"><td style="width:144pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Software services</p></td><td style="width:121pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 56,688</p></td><td style="width:58pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">69.2 %</p></td><td style="width:49pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 64,393</p></td><td style="width:58pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">67.2 %</p></td><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ (7,705 )</p></td><td style="width:56pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">(12.0 %)</p></td></tr><tr style="height:11pt"><td style="width:144pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Professional services</p></td><td style="width:121pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">22,354</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">27.3 %</p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">28,648</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">29.9 %</p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 22pt;text-indent: 0pt;line-height: 8pt;text-align: left;">(6,294 )</p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">(22.0 %)</p></td></tr><tr style="height:11pt"><td style="width:144pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Other</p></td><td style="width:121pt"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           2,852</p></td><td style="width:58pt"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">               3.5<span class="s10"> %</span></p></td><td style="width:49pt"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           2,806</p></td><td style="width:58pt"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">               2.9<span class="s10"> %</span></p></td><td style="width:52pt"><p class="s21" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                46</p></td><td style="width:56pt"><p class="s21" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">               1.6<span class="s10"> %</span></p></td></tr><tr style="height:12pt"><td style="width:144pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Total revenue</p></td><td style="width:121pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 9pt;text-align: right;">$ 81,894</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 78pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="48" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_114.png"/></span></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;line-height: 9pt;text-align: right;">100.0 %</p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 9pt;text-align: right;">$ 95,847</p><p style="padding-left: 2pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="57" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_115.png"/></span></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;line-height: 9pt;text-align: right;">100.0 %</p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 2pt;text-indent: 0pt;line-height: 9pt;text-align: left;">$ (13,953 )</p><p style="padding-left: 2pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="57" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_116.png"/></span></p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: right;">(14.6 %)</p></td></tr></table><p style="padding-left: 230pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="48" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_117.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The decrease in software services revenue was primarily attributable to a $7.1 million year-over-year decrease from the completion of contractual relationships with two Enterprise/State customer contracts, and a $2.7 million decrease in the volume of software services delivered to Enterprise/Commercial customers due in part to transitioning customers to our upgraded software platforms, partially offset by a $2.1 million increase in software services delivered to Medicare and Private Exchange customers added during the past year and other volume and mix changes across all segments except Enterprise/State which has one remaining customer at December 31, 2016.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The decrease in professional services revenue was primarily attributable to a $2.9 million year-over-year decrease related to the previously mentioned Enterprise/State customers, and the accelerated recognition of $3.6 million of revenue from the second quarter 2015 termination of our contractual relationships with two Enterprise/Commercial customers, partially offset by other volume and mix changes across all segments except Enterprise/State which has one remaining customer at December 31, 2016.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 32pt;text-indent: 0pt;text-align: left;">Segment Revenue</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 118pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_118.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_119.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_120.png"/></span></p><p class="s3" style="padding-left: 265pt;text-indent: 0pt;text-align: left;">2016 2015 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_121.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="411" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_122.png"/></span></p><p class="s3" style="padding-left: 347pt;text-indent: 0pt;text-align: left;">(dollars in thousands)</p><p style="padding-top: 1pt;padding-bottom: 1pt;padding-left: 8pt;text-indent: 0pt;text-align: left;"><span class="s27" style=" background-color: #CEEFFB;">Revenue by Segment:                                                                                                                                                                                                                                       </span></p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:10pt"><td style="width:148pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/Commercial</p></td><td style="width:117pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 49,081</p></td><td style="width:58pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">59.9 %</p></td><td style="width:49pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 55,487</p></td><td style="width:58pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">57.9 %</p></td><td style="width:52pt"><p class="s10" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ (6,406 )</p></td><td style="width:56pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">(11.5 %)</p></td></tr><tr style="height:11pt"><td style="width:148pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/State</p></td><td style="width:117pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">3,453</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">4.2 %</p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">13,372</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">14.0 %</p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(9,919 )</p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">(74.2 %)</p></td></tr><tr style="height:11pt"><td style="width:148pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Medicare</p></td><td style="width:117pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">18,565</p></td><td style="width:58pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">22.7 %</p></td><td style="width:49pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">17,973</p></td><td style="width:58pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">18.8 %</p></td><td style="width:52pt"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">592</p></td><td style="width:56pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">3.3 %</p></td></tr><tr style="height:11pt"><td style="width:148pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Private Exchange</p></td><td style="width:117pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">         10,795</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">             13.2<span class="s10"> %</span></p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           9,015</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">               9.3<span class="s10"> %</span></p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s21" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">           1,780</p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">             19.7<span class="s10"> %</span></p></td></tr><tr style="height:13pt"><td style="width:148pt"><p class="s10" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Total Revenue</p></td><td style="width:117pt"><p class="s21" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;text-align: right;">$ 81,894</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 74pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="49" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_123.png"/></span></p></td><td style="width:58pt"><p class="s10" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;text-align: right;">100.0 %</p></td><td style="width:49pt"><p class="s10" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;text-align: right;">$ 95,847</p><p style="padding-left: 2pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="57" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_124.png"/></span></p></td><td style="width:58pt"><p class="s10" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;text-align: right;">100.0 %</p></td><td style="width:52pt"><p class="s10" style="padding-top: 1pt;padding-left: 3pt;text-indent: 0pt;text-align: left;">$ (13,953 )</p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="57" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_125.png"/></span></p></td><td style="width:56pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: right;">(14.6 %)</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The decrease in our Enterprise/Commercial revenue was primarily attributable to the accelerated recognition of $3.6 million of revenue from the second quarter 2015 termination of our contractual relationships with two customers and a $2.7 million decrease in the volume of software services delivered to Enterprise/Commercial customers due in part to transitioning customers to our upgraded software platforms. The decrease in our Enterprise/State revenue was primarily attributable to a year-over-year decrease from the completion of contractual relationships with two state exchange contracts in 2015, resulting in a reduction of subsequent software and professional services revenue. The Enterprise/State segment had one remaining state exchange customer at December 31, 2016, whose contract expires in 2017. As a result of the customer decline we anticipate future Enterprise/State revenue will be lower than prior periods.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The growth in our Medicare revenue was primarily attributable to an increase in software services and professional services as a result of an increase in customers. The growth in our Private Exchange revenue was driven primarily by an increase in the number of customers using our software services, including $0.8 million from our June 2016 acquisition of ConnectedHealth, LLC.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">46</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_126.png"/></span></p><h4 style="padding-top: 3pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Cost of Revenue</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 4pt;padding-left: 289pt;text-indent: 0pt;text-align: left;">Year Ended December 31,</p><p style="padding-left: 228pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_127.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_128.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_129.png"/></span></p><p class="s3" style="padding-left: 267pt;text-indent: 0pt;text-align: left;">2016 2015 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_130.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><p style="padding-left: 228pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="411" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_131.png"/></span></p><p class="s3" style="padding-left: 350pt;text-indent: 0pt;text-align: left;">(dollars in thousands)</p><p style="text-indent: 0pt;text-align: left;">Cost of Revenue $ 56,895 69.5 % $ 50,670 52.9 % $ 6,225 12.3 %</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 10pt;text-align: left;"/><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 4pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The increase in cost of revenue was primarily attributable to a $4.1 million increase in the amortization of previously deferred upfront direct software implementation costs as an increasing number of customers became implemented on our software solutions. Additionally, cost of revenue included a $1.8 million increase in salaries and personnel-related costs, including $0.6 million of severance, a $0.9 million increase in outside contractor costs, and a $2.2 million increase in other costs primarily related to outside call center and commissions to third-party partners in our Private Exchange segment, partially offset by a $2.8 million increase in capitalization of deferred implementation costs related to the implementation of new customer solutions including several large Private Exchange customers.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">In dollars and as a percentage of revenue, our cost of revenue increase was primarily attributed to higher than anticipated initial support costs for several Enterprise/Commercial customers, and reflects the impact of adding to Private Exchange the relatively higher fixed cost structure of ConnectedHealth, LLC since the June 7, 2016 acquisition. We took certain costs reduction actions in 2016 and expect to make further cost reductions in 2017, which we anticipate will reduce our cost of revenue in future periods in terms of dollars and as a percentage of revenue.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-top: 5pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Segment Gross Margin</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 118pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_132.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_133.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_134.png"/></span></p><p class="s3" style="padding-left: 265pt;text-indent: 0pt;text-align: left;">2016 2015 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_135.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="411" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_136.png"/></span></p><p class="s3" style="padding-left: 347pt;text-indent: 0pt;text-align: left;">(dollars in thousands)</p><p style="padding-top: 1pt;padding-bottom: 1pt;padding-left: 8pt;text-indent: 0pt;text-align: left;"><span class="s27" style=" background-color: #CEEFFB;">Segment Gross Margin:                                                                                                                                                                                                                                   </span></p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:10pt"><td style="width:148pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/Commercial</p></td><td style="width:117pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 11,906</p></td><td style="width:58pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">24.3 %</p></td><td style="width:49pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 23,715</p></td><td style="width:58pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">42.7 %</p></td><td style="width:52pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (11,809 )</p></td><td style="width:56pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">(49.8 %)</p></td></tr><tr style="height:11pt"><td style="width:148pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/State</p></td><td style="width:117pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,325</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">38.4 %</p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">6,300</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">47.1 %</p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(4,975 )</p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">(79.0 %)</p></td></tr><tr style="height:11pt"><td style="width:148pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Medicare</p></td><td style="width:117pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">11,460</p></td><td style="width:58pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">61.7 %</p></td><td style="width:49pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">10,651</p></td><td style="width:58pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">59.3 %</p></td><td style="width:52pt"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">809</p></td><td style="width:56pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">7.6 %</p></td></tr><tr style="height:11pt"><td style="width:148pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Private Exchange</p></td><td style="width:117pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">              308</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">               2.9<span class="s10"> %</span></p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           4,511</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">             50.0<span class="s10"> %</span></p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">          (4,203<span class="s10"> )</span></p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: right;">            (93.2<span class="s10"> %)</span></p></td></tr><tr style="height:13pt"><td style="width:148pt"><p class="s10" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Total Gross Margin</p></td><td style="width:117pt"><p class="s21" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;text-align: right;">$ 24,999</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 74pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="49" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_137.png"/></span></p></td><td style="width:58pt"><p class="s10" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;text-align: right;">30.5 %</p></td><td style="width:49pt"><p class="s10" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;text-align: right;">$ 45,177</p><p style="padding-left: 2pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="57" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_138.png"/></span></p></td><td style="width:58pt"><p class="s10" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;text-align: right;">47.1 %</p></td><td style="width:52pt"><p class="s10" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;text-align: right;">$ (20,178 )</p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="57" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_139.png"/></span></p></td><td style="width:56pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: right;">(44.7 %)</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The Enterprise/Commercial gross margin decrease consisted of a $6.4 million decrease in revenue and a $5.4 million increase in cost of revenue. The decrease in revenue was primarily attributable to the $3.6 million second quarter 2015 accelerated recognition of revenue from the termination of our contractual relationship with two Enterprise/Commercial customers and a $2.7 million decrease in the volume of software services delivered to Enterprise/Commercial customers due in part to transitioning customers to our upgraded software platforms. The increase in cost of revenue was primarily attributable to a $4.5 million increase in the recognition of previously deferred costs related to software implementations and a greater than anticipated $0.5 million increase in salaries and personnel-related costs and outside contractor costs to support certain installed customers. Our Enterprise/Commercial gross margin included $0.5 million and $0.4 million, respectively, of depreciation and amortization for each of the years ended December 31, 2016 and 2015.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The Enterprise/State gross margin decrease consisted of a $9.9 million decrease in revenue and a corresponding $4.9 million decrease in cost of revenue. The decrease in revenue was primarily attributable to the termination of a state exchange contract and the non-renewal of a state exchange customer, as previously disclosed, resulting in a reduction of subsequent software and professional services revenue. The reduction in costs of revenue relate to staffing realignment efforts consistent with current and expected future needs of our Enterprise/State segment. Our Enterprise/State gross margin included less than</p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">$0.1 million of depreciation and amortization for each of the years ended December 31, 2016 and 2015.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The Medicare gross margin increase consisted of a $0.6 million increase in revenue and $0.2 million decrease in cost of revenue. The increase in revenue was primarily from variable software usage fees which better leverage our semi-fixed delivery costs. The decrease in cost of revenue was primarily attributable to lower personnel-related costs. Our Medicare gross margin included $2.5 million of depreciation and amortization for each of the years ended December 31, 2016 and 2015.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">47</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_140.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The Private Exchange gross margin decrease consisted of a $1.8 million increase in revenue and $6.0 million increase in cost of revenue. The increase in cost of revenue was primarily attributable to a $4.7 million increase in delivery costs and the inclusion of a $1.3 million one-time gain on extinguishment of a vendor obligation in the fourth quarter of 2015. The higher delivery costs were partially to support some non-traditional client arrangements with variable fee compensation arrangements that were implemented in 2016. The fourth quarter 2016 transaction volumes and revenue from these arrangements did not materialize as expected, which caused these delivery costs to be underutilized and decreased our Private Exchange gross margins. Our Private Exchange gross margin included $0.9 million of depreciation and amortization for each of the years ended December 31, 2016 and 2015.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We have taken actions in the first quarter of 2017 to evaluate and reduce our delivery cost structure that we believe will help improve our future financial performance.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Research and Development</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 100pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_141.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_142.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_143.png"/></span></p><p class="s3" style="padding-left: 264pt;text-indent: 0pt;text-align: left;">2016 2015 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_144.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="412" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_145.png"/></span></p><p class="s3" style="padding-left: 347pt;text-indent: 0pt;text-align: left;">(dollars in thousands)</p><p style="text-indent: 0pt;text-align: left;">Research and Development $ 22,297 27.2 % $ 22,718 23.7 % $ (421 ) (1.9 %)</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 10pt;text-align: left;"/><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 4pt;padding-left: 8pt;text-indent: 24pt;text-align: justify;">The decrease in research and development expense was primarily attributable to a $1.0 million decrease in share-based compensation, partially offset by a $0.6 million increase in engineering consulting fees and other costs for product development efforts expected to benefit our Enterprise/Commercial and Private Exchange segments. Our 2016 research and development expense includes approximately $0.6 million of severance related to personnel reductions and leadership change actions taken in 2016.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The research and development spending during the year ended December 31, 2016 was a continuation of our efforts to invest in a common software platform intended to reduce future software implementation and maintenance costs and increase margins. While we expect to continue our research and development investment in new software solutions and functionality, we believe such expense as a percent of revenue will decline over time to our long-term target of under twenty percent of revenue.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Sales and Marketing</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 121pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 227pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_146.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_147.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_148.png"/></span></p><p class="s3" style="padding-left: 266pt;text-indent: 0pt;text-align: left;">2016 2015 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="128" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_149.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><p style="padding-left: 227pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="413" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_150.png"/></span></p><p class="s3" style="padding-left: 349pt;text-indent: 0pt;text-align: left;">(dollars in thousands)</p><p style="text-indent: 0pt;text-align: left;">Sales and Marketing $ 10,410 12.7 % $ 9,507 9.9 % $ 903 9.5 %</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 10pt;text-align: left;"/><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 4pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The increase in sales and marketing expense was primarily attributable to a $0.6 million increase in salaries and personnel-related costs related to an increase in our sales and marketing headcount and discrete costs related to the end of service by our former Executive Vice President of Sales and Marketing. In addition, there was a $0.4 million increase in commission expense associated with higher commissionable booking levels in the fourth quarter of 2016 as</p><p style="padding-top: 2pt;padding-left: 8pt;text-indent: 0pt;line-height: 110%;text-align: left;">compared to the fourth quarter of 2015, offset by a $0.1 million decrease in other expenses. The increase in commission expense was attributable to revamping of our sales organization, which led to more commissionable bookings in the fourth quarter of 2016 as compared to a year prior.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">General and Administrative</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 118pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_151.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_152.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_153.png"/></span></p><p class="s3" style="padding-left: 265pt;text-indent: 0pt;text-align: left;">2016 2015 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_154.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="411" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_155.png"/></span></p><p class="s3" style="padding-left: 347pt;text-indent: 0pt;text-align: left;">(dollars in thousands)</p><p style="text-indent: 0pt;text-align: left;">General and Administrative $ 13,162 16.1 % $ 14,439 15.1 % $ (1,277 ) (8.8 %)</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 10pt;text-align: left;"/><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 4pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The decrease in general and administrative expense was primarily attributable to a $0.6 million decrease in share-based compensation, a $0.5 million decrease in amortization resulting from the full amortization of a covenant not to compete from our January 2013 DRX acquisition, and a $0.4 million decrease in professional fees. These costs were partly offset by $0.2 million of acquisition expenditures related to the June 2016 acquisition of ConnectedHealth, LLC, and other costs. Our 2016 general and</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">48</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_156.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">administrative expense includes approximately $0.4 million of severance related to personnel reductions and leadership change actions taken in 2016.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Interest Expense</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 118pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_157.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_158.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_159.png"/></span></p><p class="s3" style="padding-left: 265pt;text-indent: 0pt;text-align: left;">2016 2015 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_160.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="411" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_161.png"/></span></p><p class="s3" style="padding-left: 347pt;text-indent: 0pt;text-align: left;">(dollars in thousands)</p><p style="text-indent: 0pt;text-align: left;">Interest Expense $ 3,485 4.3 % $ 5,665 5.9 % $ (2,180 ) (38.5 %)</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 10pt;text-align: left;"/><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 4pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The decrease in interest expense was primarily attributable to a decrease in average borrowings outstanding during the year ended December 31, 2016, as compared to the year ended December 31, 2015. The decrease in our interest expense is directly attributable to our efforts to increase our balance sheet liquidity through our May 2, 2016, $52.0 million preferred stock offering, and repayment of our $30.0 million subordinated THL Note. We anticipate our 2017 interest expense will increase due in part to our March 10, 2017 amendment of our senior credit facility.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Other Expense</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 291pt;text-indent: 0pt;text-align: left;">Year Ended December 31,</p><p style="padding-left: 230pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="267" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_162.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="125" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_163.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_164.png"/></span></p><p class="s3" style="padding-left: 269pt;text-indent: 0pt;text-align: left;">2016 2015 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 24pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="134" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_165.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><p style="padding-left: 230pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="418" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_166.png"/></span></p><p class="s3" style="padding-left: 355pt;text-indent: 0pt;text-align: left;">(dollars in thousands)</p><p style="text-indent: 0pt;text-align: left;">Other expense (income), net $ 2,239 2.7 % $ 140 0.1 % $ 2,099 *</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 10pt;text-align: left;"/><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s28" style="padding-top: 4pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">0127635<span class="p">*Not meaningful</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: justify;">The increase in other expense, net was primarily attributable to a $0.6 million breakage fee and the $0.5 million recognition of original issue discount (OID) and deferred financing costs triggered by the early extinguishment of the THL Note, in addition to $0.7 million of refinancing fees and the recognition if $0.4 million of previously deferred financing costs triggered by the amendment of our bank credit facility during the year ended December 31, 2016.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Comparison of Years Ended December 31, 2015 and 2014</p><h4 style="padding-top: 5pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Revenue</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 118pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_167.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_168.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_169.png"/></span></p><p class="s3" style="padding-left: 265pt;text-indent: 0pt;text-align: left;">2015 2014 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_170.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="411" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_171.png"/></span></p><p class="s3" style="padding-left: 347pt;text-indent: 0pt;text-align: left;">(dollars in thousands)</p><p style="padding-top: 1pt;padding-bottom: 1pt;padding-left: 8pt;text-indent: 0pt;text-align: left;"><span class="s27" style=" background-color: #CEEFFB;">Revenue by Type:                                                                                                                                                                                                                                             </span></p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:10pt"><td style="width:144pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Software services</p></td><td style="width:121pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 64,393</p></td><td style="width:58pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">67.2 %</p></td><td style="width:49pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 63,384</p></td><td style="width:58pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">74.9 %</p></td><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 1,009</p></td><td style="width:56pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1.6 %</p></td></tr><tr style="height:11pt"><td style="width:144pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Professional services</p></td><td style="width:121pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">28,648</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">29.9 %</p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">17,557</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">20.8 %</p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 20pt;text-indent: 0pt;line-height: 8pt;text-align: left;">11,091</p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">63.2 %</p></td></tr><tr style="height:11pt"><td style="width:144pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Other</p></td><td style="width:121pt"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           2,806</p></td><td style="width:58pt"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">               2.9<span class="s10"> %</span></p></td><td style="width:49pt"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           3,638</p></td><td style="width:58pt"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">               4.3<span class="s10"> %</span></p></td><td style="width:52pt"><p class="s21" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">             (832<span class="s10"> )</span></p></td><td style="width:56pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: right;">            (22.9<span class="s10"> %)</span></p></td></tr><tr style="height:11pt"><td style="width:144pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Total revenue</p></td><td style="width:121pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 95,847</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 78pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="49" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_172.png"/></span></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">100.0 %</p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 84,579</p><p style="padding-left: 2pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="57" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_173.png"/></span></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">100.0 %</p></td><td style="width:52pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 11,268</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="49" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_174.png"/></span></p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">13.3 %</p></td></tr></table><p class="s29" style="padding-left: 230pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="49" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_175.png"/></span>	<span><img width="49" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_176.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The growth in software services revenue was primarily attributable to the year-over-year growth in customers implemented on our software solutions, offset by a $4.6 million year-over-year reduction in software services resulting from the completion of contractual relationships with two state exchange customers. The increase in professional services revenue was primarily attributable to the satisfaction of several Enterprise/Commercial customer obligations, along with the accelerated recognition of $3.6 million of revenue from the second quarter 2015 termination of our contractual relationships with two Enterprise/Commercial customers, offset by a $3.7 million year-over-year decline related to the previously mentioned state exchange customers.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">49</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_177.png"/></span></p><h4 style="padding-top: 3pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Segment Revenue</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 4pt;padding-left: 118pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_178.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_179.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_180.png"/></span></p><p class="s3" style="padding-left: 265pt;text-indent: 0pt;text-align: left;">2015 2014 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_181.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:9pt"><td style="width:323pt" colspan="3"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:107pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 17pt;text-indent: 0pt;line-height: 7pt;text-align: left;">(dollars in thousands)</p></td><td style="width:108pt" colspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:218pt" bgcolor="#CEEFFB"><p class="s7" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Revenue by Segment:</p></td><td style="width:47pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:107pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:52pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:218pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/Commercial</p></td><td style="width:47pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 55,487</p></td><td style="width:58pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">57.9 %</p></td><td style="width:107pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 40,369 47.7 %</p></td><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 15,118</p></td><td style="width:56pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">37.4 %</p></td></tr><tr style="height:11pt"><td style="width:218pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/State</p></td><td style="width:47pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">13,372</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">14.0 %</p></td><td style="width:107pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">21,632 25.6 %</p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(8,260 )</p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">(38.2 %)</p></td></tr><tr style="height:11pt"><td style="width:218pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Medicare</p></td><td style="width:47pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">17,973</p></td><td style="width:58pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">18.8 %</p></td><td style="width:107pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">16,175 19.1 %</p></td><td style="width:52pt"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,798</p></td><td style="width:56pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">11.1 %</p></td></tr><tr style="height:11pt"><td style="width:218pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Private Exchange</p></td><td style="width:47pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           9,015</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">               9.3<span class="s10"> %</span></p></td><td style="width:107pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           6,403 7.6<span class="s10"> %</span></p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s21" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">           2,612</p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">             40.8<span class="s10"> %</span></p></td></tr><tr style="height:13pt"><td style="width:218pt"><p class="s10" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;text-align: left;">Total Revenue</p></td><td style="width:47pt"><p class="s21" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;text-align: right;">$ 95,847</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="49" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_182.png"/></span></p></td><td style="width:58pt"><p class="s10" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;text-align: right;">100.0 %</p></td><td style="width:107pt"><p class="s10" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;text-align: right;">$ 84,579 100.0 %</p><p style="padding-left: 2pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="57" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_183.png"/></span></p></td><td style="width:52pt"><p class="s10" style="padding-top: 1pt;padding-left: 2pt;text-indent: 0pt;text-align: left;">$ 11,268</p><p style="padding-left: 2pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="57" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_184.png"/></span></p></td><td style="width:56pt"><p class="s10" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;text-align: right;">13.3 %</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 4pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The growth in our Enterprise/Commercial revenue was primarily attributable to the year-over-year growth in customers implemented on our software solutions, the completion of more software services with existing customers, and the accelerated recognition of $3.6 million of revenue from the second quarter 2015 termination of our contractual relationships with two customers. The decrease in our Enterprise/State revenue was primarily attributable to the third quarter 2014 termination of a state exchange contract and the third quarter 2015 non-renewal of a state exchange customer, resulting in a reduction of subsequent software and professional services revenue. The growth in our Medicare revenue was primarily attributable to an increase in software services and professional services as a result of an increase in customers. The growth in our Private Exchange revenue was primarily attributable to a $2.6 million growth in software services revenue as a result of an increase in both customers and revenue per customer.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The Enterprise/State segment had one remaining state exchange customer at December 31, 2015, compared to three in the comparative year. As a result of the customer decline we anticipate future Enterprise/State revenue will be lower than prior periods.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Cost of Revenue</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 118pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_185.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_186.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_187.png"/></span></p><p class="s3" style="padding-left: 265pt;text-indent: 0pt;text-align: left;">2015 2014 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_188.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="411" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_189.png"/></span></p><p class="s3" style="padding-left: 347pt;text-indent: 0pt;text-align: left;">(dollars in thousands)</p><p style="text-indent: 0pt;text-align: left;">Cost of Revenue $ 50,670 52.9 % $ 52,431 62.0 % $ (1,761 ) (3.4 %)</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 10pt;text-align: left;"/><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 4pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The decrease in cost of revenue was primarily attributable to a $3.4 million decrease in professional fees to outside contractors, a $0.9 million decrease in salaries and personnel-related costs and a $1.8 million decrease in other costs primarily related to a decrease in outside call center, travel and facilities costs. Additionally, in the year ended December 31, 2015 we amortized an additional $5.4 million of previously deferred implementation costs, as compared to the year ended December 31, 2014, of which $2.6 million was accelerated amortization related to the two above-mentioned second quarter 2015 Enterprise/Commercial customer terminations. We also experienced a $1.0 million increase in capitalization of new customer deferred implementation costs compared to the year ended December 31, 2014.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Segment Gross Margin</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 118pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_190.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_191.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_192.png"/></span></p><p class="s3" style="padding-left: 265pt;text-indent: 0pt;text-align: left;">2015 2014 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_193.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:9pt"><td style="width:323pt" colspan="3"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:107pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 17pt;text-indent: 0pt;line-height: 7pt;text-align: left;">(dollars in thousands)</p></td><td style="width:108pt" colspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:218pt" bgcolor="#CEEFFB"><p class="s7" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Segment Gross Margin:</p></td><td style="width:47pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:107pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:52pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:218pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/Commercial</p></td><td style="width:47pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 23,715</p></td><td style="width:58pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">42.7 %</p></td><td style="width:107pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 10,323 25.6 %</p></td><td style="width:52pt"><p class="s10" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 13,392</p></td><td style="width:56pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">129.7 %</p></td></tr><tr style="height:11pt"><td style="width:218pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/State</p></td><td style="width:47pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">6,300</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">47.1 %</p></td><td style="width:107pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">11,038 51.0 %</p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(4,738 )</p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">(42.9 %)</p></td></tr><tr style="height:11pt"><td style="width:218pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Medicare</p></td><td style="width:47pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">10,651</p></td><td style="width:58pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">59.3 %</p></td><td style="width:107pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">9,451 58.4 %</p></td><td style="width:52pt"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,200</p></td><td style="width:56pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">12.7 %</p></td></tr><tr style="height:11pt"><td style="width:218pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Private Exchange</p></td><td style="width:47pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           4,511</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">             50.0<span class="s10"> %</span></p></td><td style="width:107pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           1,336 20.9<span class="s10"> %</span></p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s21" style="padding-left: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">           3,175</p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           237.6<span class="s10"> %</span></p></td></tr></table><p style="padding-top: 2pt;padding-left: 16pt;text-indent: 0pt;text-align: center;">Total Gross Margin                                                                   <u>$       45,177</u>                 47.1 %  $      32,148                 38.0 %  $      13,029            40.5 %</p><p class="s29" style="padding-left: 230pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="49" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_194.png"/></span>	<span><img width="57" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_195.png"/></span><span class="s31">	</span><span><img width="57" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_196.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">50</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_197.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The Enterprise/Commercial gross margin increase consisted of a $15.1 million increase in revenue and $1.7 million increase in cost of revenue. The increase in revenue was primarily attributable to recognition of previously deferred revenue related to software implementations and ancillary professional services upon the satisfaction of remaining contractual obligations and $3.6 million second quarter 2015 accelerated recognition of revenue from the termination of our contractual relationship with two Enterprise/Commercial customers. The increase in cost of revenue was primarily attributable to a $6.9 million increase in the recognition of previously deferred costs related to software implementations, which is inclusive of $2.6 million of accelerated amortization related to the second quarter 2015 termination of our contractual relationship with the two Enterprise/Commercial customers, partially offset by a $4.5 million reduction in direct labor, outside contractor costs, and related travel following the completion of our efforts related to the October 1, 2013 ACA rollout and a $0.7 million reduction in deferred implementation cost capitalization and other expenses compared to the year ended December 31, 2014. Our Enterprise/Commercial gross margin included $0.4 million and $0.4 million, respectively, of depreciation and amortization for each of the years ended December 31, 2015 and 2014.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The Enterprise/State gross margin decrease consisted of a $8.3 million decrease in revenue and a corresponding $3.5 million decrease in cost of revenue. The decrease in revenue was primarily attributable to the third quarter 2014 termination of a state exchange contract and the third quarter 2015 non- renewal of a state exchange customer, resulting in a reduction of subsequent software and professional services revenue. The reduction in costs of revenue relate to staffing realignment efforts consistent with current and expected future needs of our Enterprise/State segment. Our Enterprise/State gross margin included less than $0.1 million of depreciation and amortization for each of the years ended December 31, 2015 and 2014.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The Medicare gross margin increase consisted of a $1.8 million increase in revenue and $0.6 million increase in cost of revenue. The increase in cost of revenue was primarily attributable to personnel-related cost increases to support current and anticipated growth in this segment. Our Medicare gross margin included $2.5 million of depreciation and amortization for each of the years ended December 31, 2015 and 2014.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The Private Exchange gross margin increase consisted of a $2.6 million increase in revenue and $0.6 million decrease in cost of revenue. The decrease in cost of revenue was primarily attributable to a $1.3 million one-time gain on extinguishment of a vendor obligation offset by a $0.7 million increase in personnel-related and other costs to support current and anticipated customer growth in this segment. Our Private Exchange gross margin included $0.9 million and $0.8 million of depreciation and amortization in the years ended December 31, 2015 and 2014, respectively.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Research and Development</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 289pt;text-indent: 0pt;text-align: left;">Year Ended December 31,</p><p style="padding-left: 228pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_198.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_199.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_200.png"/></span></p><p class="s3" style="padding-left: 267pt;text-indent: 0pt;text-align: left;">2015 2014 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_201.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><p style="padding-left: 228pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="411" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_202.png"/></span></p><p class="s3" style="padding-left: 350pt;text-indent: 0pt;text-align: left;">(dollars in thousands)</p><p style="text-indent: 0pt;text-align: left;">Research and Development $ 22,718 23.7 % $ 18,125 21.4 % $ 4,593 25.3 %</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 10pt;text-align: left;"/><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 4pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The increase in research and development expense was primarily attributable to a $3.5 million increase in salaries and personnel-related costs, due to additional research and development efforts. Additionally, we experienced a $1.1 million increase in engineering consulting fees and other expenses for product development.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The increased research and development spending during the year ended December 31, 2015, was a continuation of our efforts to invest in a common software platform intended to reduce future software implementation and maintenance costs and increase margins. We expect these efforts will benefit our Enterprise Commercial and Private Exchange segments. Additionally, we continued development of new software solutions intended to take advantage of opportunities within our customer base and the emerging private exchange market.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Sales and Marketing</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 289pt;text-indent: 0pt;text-align: left;">Year Ended December 31,</p><p style="padding-left: 228pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_203.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_204.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_205.png"/></span></p><p class="s3" style="padding-left: 267pt;text-indent: 0pt;text-align: left;">2015 2014 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_206.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><p style="padding-left: 228pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="411" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_207.png"/></span></p><p class="s3" style="padding-left: 350pt;text-indent: 0pt;text-align: left;">(dollars in thousands)</p><p style="text-indent: 0pt;text-align: left;">Sales and Marketing $ 9,507 9.9 % $ 7,729 9.1 % $ 1,778 23.0 %</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 10pt;text-align: left;"/><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 4pt;padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">51</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_208.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The increase in sales and marketing expense was primarily attributable to a $1.2 million increase in salaries and personnel-related costs due to hiring of additional sales employees and a $0.6 million increase in other expenses, of which $0.2 million was attributed to our 2015 Client Forum event.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">General and Administrative</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 289pt;text-indent: 0pt;text-align: left;">Year Ended December 31,</p><p style="padding-left: 228pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_209.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_210.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_211.png"/></span></p><p class="s3" style="padding-left: 267pt;text-indent: 0pt;text-align: left;">2015 2014 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_212.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><p style="padding-left: 228pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="411" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_213.png"/></span></p><p class="s3" style="padding-left: 350pt;text-indent: 0pt;text-align: left;">(dollars in thousands)</p><p style="text-indent: 0pt;text-align: left;">General and Administrative $ 14,439 15.1 % $ 10,552 12.5 % $ 3,887 36.8 %</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 10pt;text-align: left;"/><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 4pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The increase in general and administrative expense was primarily attributable to $2.2 million of incremental costs associated with being a public company and $0.3 million related to the 2015 transition of chief executive officer responsibilities. Additionally, the 2014 comparative period includes a $1.0 million benefit recorded related to the decrease in fair value of the DestinationRx contingent acquisition consideration and a $0.4 million benefit from the settlement of a number of sales and use tax contingencies, which were both recorded in the fourth quarter of 2014.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Interest Expense</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 100pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="269" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_214.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_215.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="126" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_216.png"/></span></p><p class="s3" style="padding-left: 264pt;text-indent: 0pt;text-align: left;">2015 2014 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 72pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="127" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_217.png"/></span></p><p class="s3" style="padding-left: 30pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><p style="padding-left: 225pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="412" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_218.png"/></span></p><p class="s3" style="padding-left: 347pt;text-indent: 0pt;text-align: left;">(dollars in thousands)</p><p style="text-indent: 0pt;text-align: left;">Interest Expense $ 5,665 5.9 % $ 5,937 7.0 % $ (272 ) (4.6 %)</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 10pt;text-align: left;"/><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 4pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The decrease in interest expense was primarily attributable to a decrease in average borrowings outstanding and a lower weighted average cost of debt on our outstanding borrowings during the year ended December 31, 2015, as compared to the year ended December 31, 2014.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Other Expense</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 100pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 223pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="273" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_219.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="129" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_220.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="130" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_221.png"/></span></p><p class="s3" style="padding-left: 264pt;text-indent: 0pt;text-align: left;">2015 2014 Period-to-Period Change</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Amount</p><p class="s3" style="padding-top: 1pt;padding-left: 31pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 26pt;text-indent: 0pt;text-align: left;">Revenue Amount</p><p style="padding-left: 76pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="134" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_222.png"/></span></p><p class="s3" style="padding-left: 31pt;text-indent: 0pt;text-align: left;">% of</p><p class="s3" style="padding-left: 26pt;text-indent: 0pt;text-align: left;">Revenue Amount %</p><p style="padding-left: 223pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="427" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_223.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="718" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_224.png"/></span></p><p class="s3" style="padding-left: 351pt;text-indent: 0pt;text-align: left;">(dollars in thousands)</p><p style="padding-top: 1pt;padding-left: 16pt;text-indent: 0pt;text-align: center;">Other expense (income), net                                                       $           140                  0.1 %  $             (68 )                (0.1 %)  $            208                   *</p><ul id="l8"><li style="padding-top: 1pt;padding-left: 32pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Not meaningful</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">The increase in other expense, net was primarily due to refinancing fees from the amendment of our bank credit facility and the THL Note in 2015.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Critical Accounting Policies and Significant Judgments and Estimates</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our management’s discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses. In accordance with GAAP, we base our estimates on historical experience and on various other assumptions that we believe reasonable under the circumstances. Actual results might differ from these estimates under different assumptions or conditions.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">While our significant accounting policies are more fully described in Note 2 to our consolidated financial statements appearing in Part II, Item 8: “Financial Statements and Supplementary Data” of this Annual Report on Form 10-K, we believe the following accounting policies are critical to the process of making significant judgments and estimates in the preparation of our consolidated financial statements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">52</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_225.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We have elected to take advantage of the extended transition period for complying with new or revised accounting standards under Section 102(B)(1), which will allow us to delay the adoption of new or revised accounting standards that have different effective dates for public and private companies until those standards apply to private companies. As a result of this election, our financial statements may not be comparable to companies that comply with public company effective dates.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Revenue Recognition and Deferred Revenue</h4><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">We derive our revenue primarily from the following sources: (a) the sale, implementation and ongoing support of our insurance distribution solutions;</p><ol id="l9"><li style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><p style="display: inline;">fees from brokers for the right to access our multi-payer quoting platform; (c) our Medicare.gov contract, which was a cost-plus-fixed-fee contract through the fourth quarter of 2015; and (d) commissions earned on annual employee enrollments in which our health plan network and software solutions are used in connection with each enrollment. In all contractual arrangements, we determine whether persuasive evidence of an arrangement exists, services have been rendered, the fee is fixed or determinable, and collection is probable. If any of these criteria are not met, the Company does not recognize revenue until all of the criteria are met.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We have multiple sources of revenue, which fall under different sets of revenue recognition rules including accounting for revenue under hosted and non-hosted arrangements and percentage of completion accounting. The determination of whether the contract meets the definition of software and the corresponding separability of the elements and fair value assessments require judgment.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: justify;">We recognize revenue for upfront license and implementation fees over the longer of the term of the customer agreement or the estimated period of customer benefit based on various factors including, but not limited to, contract terms, contract extensions and renewals, customer attrition, the nature and pace of technology advancements and obsolescence, and the anticipated impact of demand, competition, and other regulatory and economic factors.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: justify;">Most of our deferred revenue relates to professional services performed for our Enterprise/Commercial customers, which require a more extensive and lengthy implementation. We expect to continue to evaluate the term over which our Enterprise/Commercial implementation fee revenue is recognized as we gain more experience with customer contract renewals.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">At December 31, 2016, deferred revenue related to the Enterprise/Commercial segment was $26.9 million and is being recognized in our statements of operations over a weighted average period of approximately three years. If the weighted average period had been increased by one year to four years, the Enterprise/Commercial revenue for the year ended December 31, 2016 would have decreased by approximately $1.5 million.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Deferred Implementation Costs</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We capitalize certain direct, incremental costs associated with new customer implementation efforts, and we account for those costs as deferred implementation costs, to the extent that they are deemed recoverable. We had $23.3 and $24.6 million of deferred implementation costs recorded as of December 31, 2016 and 2015, respectively. Deferred implementation costs are amortized consistent with the recognition of deferred revenue. The deferred implementation cost balance is subject to periodic impairment evaluation to determine recoverability of the asset. At every reporting period, we evaluate the recoverability of the deferred implementation costs, factoring in the remaining implementation schedule, estimated cost to complete the implementation effort and the probability of revenue in excess of deferred costs capitalized.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Goodwill and Acquired Intangible Assets</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Goodwill represents the excess of the aggregate of the fair value of consideration transferred in a business combination over the fair value of assets acquired, net of liabilities assumed. Goodwill is not amortized, but is subject to an annual impairment test. We test goodwill for impairment at the reporting unit level annually on October 31, or more frequently if events or changes in business circumstances indicate the carrying value may not be recoverable.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We test goodwill for impairment at the reporting unit level using a two-step approach. In step one, we determine if the fair value of the reporting unit exceeds the unit’s carrying value. If step one indicates that the fair value of the reporting unit is less than its carrying value, we perform step two, determining the fair value of goodwill and, if the carrying value of goodwill exceeds the implied fair value, recording an impairment charge.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">We have three reporting units with goodwill, Enterprise/Commercial, Medicare, and Private Exchange; the Enterprise/Commercial, Medicare, and Private Exchange reporting units have $7.7 million, $14.7 million, and $8.6 million of goodwill, respectively, as of December 31, 2016. To determine the fair value of our reporting units, we use a discounted cash flow analysis and market comparisons. A discounted cash flow analysis requires significant assumptions and estimates about future</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 4pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">53</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_226.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">operations. Significant judgments inherent in this discounted cash flow analysis include the expected revenue growth and operating margins and the determination of an appropriate discount rate. The excess fair value over carrying value as of our latest assessment was $38.4 million for Medicare, $13.0 million for Enterprise/Commercial, and $3.5 million for Private Exchange. The Private Exchange reporting unit has approximately 30% excess fair value over carrying value, while the other reporting units have greater than 100% excess fair value.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The Private Exchange reporting unit’s discounted cash flow analysis assumes an approximate 21% discount rate. A 1% change in the discount rate used approximates a $1.0 million change in the fair value of the reporting unit. The discounted cash flow analysis requires an approximate 14% average revenue growth rate until reaching a 3% terminal growth rate in 2026, holding all other inputs constant, to have excess cash flows. The revenue and related cash flow growth is primarily due to new and existing client software service arrangements that include variable transaction based fees. The amount of actual revenue and cash these variable fee arrangements generate is dependent on market conditions and our customers’ success in using our software services to transact insurance enrollments. Should either market conditions or our customers’ efforts to generate transaction volumes fall short of our expectations, some or all of the Private Exchange reporting unit’s goodwill may not be recoverable.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: justify;">We review acquired intangible assets for impairment whenever events or changes in circumstances indicate the carrying amount of the asset may not be recoverable. Recoverability is assessed by comparing the carrying amount of the asset to the undiscounted future cash flows expected to be generated by the asset. Measurement of any impairment loss is based on estimated fair value.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Given the significance of our goodwill and intangible assets, an adverse change in fair value could result in an impairment charge, which could be material to our financial statements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Liquidity and Capital Resources</p><h4 style="padding-top: 5pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Sources of Liquidity</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our primary need for liquidity is to fund working capital requirements, capital expenditures and for general corporate purposes, including to develop new technologies, make investments in or acquisitions of other businesses, solutions or technologies, and to repay portions of outstanding borrowings and interest on such borrowings. We have funded our operations primarily through cash from operating activities, debt borrowings, and the issuance of common and convertible preferred stock. As of December 31, 2016, we had cash and cash equivalents of $6.2 million.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 22pt;text-align: justify;">For the years ended December 31, 2016, 2015, and 2014, our net losses from continuing operations were $20.9 million, $1.5 million, and $4.3 million, respectively, and cash used in operations was $24.5 million, $16.2 million, and $20.3 million, respectively. As a result of our lower than anticipated variable fee revenue and our higher than anticipated cost of delivery, along with our continued efforts to grow our client base and invest in our software solutions, our December 31, 2016 liquidity was less than we previously expected.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 22pt;text-align: left;">In light of our financial results, we have taken a number of actions in 2016 and the first quarter of 2017 to continue to support our operations and meet our obligations including the following:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ul id="l10"><li style="padding-left: 43pt;text-indent: -17pt;text-align: left;"><p style="display: inline;">On May 2, 2016, we issued and sold the newly created Series A Preferred Stock for an aggregate purchase price of $52.0 million. Net of customary transaction costs, we received cash of approximately $49.3 million, of which we used approximately $30.6 million to subsequently repay the principal balance, accrued interest, loan termination and professional fees associated with the THL Note;</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 43pt;text-indent: -17pt;text-align: left;"><p style="display: inline;">On June 8, 2016, we amended our existing senior credit facility, resulting in the extension of the facility to June 8, 2021 from January 18, 2018 and increased the term loan funding to $35.0 million from approximately $20.0 million;</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 43pt;text-indent: -17pt;text-align: justify;"><p style="display: inline;">During the second half of 2016 we put a greater focus on our overall profitability and aligning our cost structure with revenue and customer billings. We reduced our headcount to 370 at December 31, 2016, compared to 411 at December 31, 2015. We also began consolidating the procurement of outside contract labor resources to reduce our cost of delivery;</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 43pt;text-indent: -17pt;text-align: left;"><p style="display: inline;">On January 1, 2017, we hired a new Chief Financial Officer to bring additional financial and operational experience to our company. Under our new Chief Financial Officer’s leadership, we have continued to evaluate and reduce headcount and eliminate certain other expenditures to better align resources with the 2017 operating plan. Between the cost reduction actions taken in 2016 and those planned in 2017, we expect to decrease our total cost structure and reduce the cash used in operations by at least $15.0 million from 2016 levels. In addition, we have also taken steps to evaluate and improve the pricing of our software solutions and services. We believe that, collectively, these steps are necessary to improve our future financial performance;</p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">54</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_227.png"/></span></p></li><li style="padding-top: 3pt;padding-left: 43pt;text-indent: -17pt;text-align: left;"><p style="display: inline;">On March 10, 2017, we completed the issuance of a newly created Series B Preferred Stock for an aggregate purchase price of $17.5 million. Net of customary transaction costs, we received cash of approximately $16.8 million, of which we used approximately $0.6 million to repay our outstanding revolving line of credit balance, with the remainder of the net proceeds available for general corporate purposes; and</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 43pt;text-indent: -17pt;text-align: left;"><p style="display: inline;">Finally, on March 10, 2017, we amended our senior credit facility to, among other things, (i) defer scheduled Senior Term Loan principal repayments until March 31, 2018, and (ii) revise the EBITDA and Minimum Liquidity covenants. The deferral of the principal repayments provides approximately $2.5 million of additional liquidity through December 31, 2017.</p></li></ul></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 22pt;text-align: left;">While our historical operating results indicate conditions exist that raise uncertainty related to our ability to continue as a going concern, we believe that the actions discussed above are probable of occurring and mitigating the uncertainty raised by our historical operating results. Accordingly, we expect to have sufficient liquidity to meet obligations as they come due in the 12 months from issuance of our consolidated financial statements. However, we cannot predict, with certainty, the outcome of our actions to reduce operating costs and increase the profitability of our software solutions and services.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 22pt;text-align: left;">If we continue to experience operating losses, and cannot generate sufficient liquidity through the mechanisms described above or through additional support from our investor base or some combination of other actions, while not expected, we might need to secure additional sources of funds, which may or may not be available. Additionally, if we cannot meet our senior credit facility EBITDA and Minimum Liquidity covenants, all of our approximately $32.0 million indebtedness outstanding following the March 10, 2017 amendment would become immediately payable and result in our inability to continue as a going concern without new financing.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 22pt;text-align: left;">Refer to Notes 3, 9, 10 and 15 of the Notes to Consolidated Financial Statements included in Part II, Item 8: “Financial Statements and Supplementary Data” of this Annual Report on Form 10-K for further detail.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Senior Credit Facility</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We have a bank credit facility, as amended and restated from time to time (the “Credit Facility”) that provides for short-term working capital and long- term investment needs.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">On June 8, 2016, the Credit Facility was amended and restated (the “June 2016 Amendment”), to among other things (i) extend the maturity date to June 8, 2021 from January 18, 2018, (ii) continue to provide for up to $10.0 million of revolving credit through maturity date (the “Senior Revolving Credit Facility”), and (iii) increase the term loan funding to $35.0 million (the “Senior Term Loan”).</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 26pt;text-align: left;">The June 2016 Amendment was accounted for as an extinguishment of debt resulting in the immediate recognition of $0.4 million of previous deferred financing costs, which was recorded in Other expense, net in the statements of operations for the year ended December 31, 2016.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 26pt;text-align: left;">On November 4, 2016, we amended the Credit Facility (the “November 2016 Amendment”), to, among other things, (i) remove the Net Leverage Covenant and replace it with a trailing twelve month EBITDA covenant, as defined in the November 2016 Amendment, to be measured quarterly effective as of September 30, 2016, (ii) increase the Minimum Liquidity covenant from $10.0 million to $11.5 million, effective November 4, 2016, and $15.0 million effective September 30, 2017, (iii) increase the annual principal repayments on the Senior Term Loan, and (iv) increase the interest rate on applicable borrowings effective November 4, 2016. In connection with this amendment, we repaid $2.0 million of the outstanding Senior Term Loan and incurred bank fees of approximately $0.3 million.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">On March 10, 2017, we amended the Credit Facility (the “March 2017 Amendment”), to, among other things (i) defer scheduled Senior Term Loan principal repayments until March 31, 2018, at which time quarterly principal repayments of $1.3 million will resume through March 31, 2021; (ii) replace the existing covenants with (a) a trailing twelve month EBITDA covenant of negative $12.0 million as of December 31, 2016 and a quarterly building EBITDA covenant through December 31, 2017, and a trailing twelve month EBITDA covenant from March 31, 2018 forward, as defined in the March 2017 Amendment, and (b) a minimum liquidity requirement of $1.5 million at all times from March 1, 2017 through March 31, 2018, and $15.0 million thereafter; and (iii) provide for an incremental 2.50% per annum paid-in-kind interest on all obligations from March 10, 2017 through the maturity date, which shall increase the outstanding principal balance of the Term Loan. Following the March 2017 Amendment the Credit Facility provides for up to $0.5 million of revolving credit through the maturity date of the Credit Facility.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The quarterly building EBITDA covenant, as defined in the March 2017 Amendment, requires the Company achieve at least negative $4.0 million EBITDA for the quarter ended March 31, 2017, negative $8.0 million for six months ended June 30, 2017,</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">55</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_228.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">negative $7.3 million for the nine months ended September 30, 2017 and negative $3.0 million for twelve months ended December 31, 2017 and March 31, 2018, respectively.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 26pt;text-align: justify;">As of December 31, 2016, the interest rates on our outstanding Senior Term Loan and the Senior Revolving Credit Facility were 7.34% and 9.25%, respectively. Effective with the March 10, 2017 amendment, the interest rates on then outstanding Senior Term Loan and Senior Revolving Credit Facility borrowing increased by the 2.50% per annum paid-in-kind interest.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Subordinated Loans</h4><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">Prior to May 3, 2016 we had a Senior Subordinated Term Loan Agreement with THL Corporate Finance, Inc., or the THL Note, for total proceeds of</p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">$30.0 million less $0.7 million of original issue discount. On May 3, 2016, we repaid the $30.0 million principal and accrued interest to settle the THL Note (see Note 8 of the Notes to Consolidated Financial Statements included in Part II, Item 8: “Financial Statements and Supplementary Data” of this Annual Report on Form 10-K).</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The early extinguishment of the THL Note triggered a $0.6 million breakage fee and the immediate recognition of the remaining $0.5 million of OID and deferred financing costs, which were recorded in Other expense, net in the statement of operations for the year ended December 31, 2016.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">The following table summarizes the principal balances of our outstanding borrowings as of December 31, 2016:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse" cellspacing="0"><tr style="height:9pt"><td style="width:261pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:62pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 6pt;padding-right: 10pt;text-indent: 0pt;line-height: 7pt;text-align: center;">(in thousands)</p></td></tr><tr style="height:11pt"><td style="width:261pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Credit Facility: Revolving line of credit</p></td><td style="width:62pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 6pt;padding-right: 10pt;text-indent: 0pt;line-height: 8pt;text-align: center;">$ 578</p></td></tr><tr style="height:11pt"><td style="width:261pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Credit Facility: Term loans</p></td><td style="width:62pt"><p class="s21" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: center;">                 31,944</p></td></tr><tr style="height:12pt"><td style="width:261pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:62pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-left: 6pt;padding-right: 10pt;text-indent: 0pt;line-height: 9pt;text-align: center;">$ 32,522</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"/><p class="s3" style="padding-left: 379pt;text-indent: 7pt;line-height: 142%;text-align: left;">Outstanding Principal Balance</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 384pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="67" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_229.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Preferred Stock</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">On May 2, 2016, we issued and sold a newly created Series A Preferred Stock for an aggregate purchase price of $52.0 million. Net of customary transaction costs, we received cash of approximately $49.3 million, of which we used approximately $30.6 million to subsequently repay the principal balance, accrued interest, loan termination and professional fees associated with the THL Note and the balance was available for general corporate purposes.</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The shares of Series A Preferred Stock are convertible into shares of our common stock (the “Series A Conversion Shares”) at the option of the investors at any time and they are redeemable at the option of the investors after May 2, 2023, or if there is a Fundamental Change (as that term is defined in the Certificate of Designations, Preferences and Rights of the Series A Convertible Preferred Stock). Beginning May 2, 2018, we may force conversion if the closing price of the common stock is at least 175% of the conversion price of the Series A Preferred Stock for 45 consecutive trading days, with a minimum average trading volume of at least 75,000 shares for 40 of such 45 trading days. Each share of Series A Preferred Stock is convertible into a number of Series A Conversion Shares equal to (i) the sum of (a) the stated value per share of Series A Preferred Stock, plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Series A Preferred Stock at such time (which initially is $4.50 per share, subject to customary anti-dilution adjustments). On March 10, 2017, the conversion price of the Series A Preferred Stock was adjusted to $3.96 per share as a result of the issuance of Series B Preferred Stock.</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">On March 10, 2017, we issued and sold a newly created Series B Preferred Stock for an aggregate purchase price of $17.5 million. Net of customary transaction costs, we received cash of approximately $16.8 million, of which we used approximately $0.6 million to repay our outstanding revolving line of credit balance, with the remainder of the net proceeds available for general corporate purposes.</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The shares of Series B Preferred Stock are convertible into shares of our common stock (the “Series B Conversion Shares”) at the option of the investors at any time and they are redeemable at the option of the investors after May 2, 2023, or if there is a Fundamental Change (as that term is defined in the Certificate of Designations, Preferences and Rights of Series B Convertible Preferred Stock). Beginning March 10, 2019, we may force conversion if the closing price of the common stock is at least 175% of the conversion price of the Series B Preferred Stock for 45 consecutive trading days, with a minimum average trading volume of at least 75,000 shares for 40 of such 45 trading days. Each share of Series B Preferred Stock is convertible into a number of Series B Conversion Shares equal to (i) the sum of (a) the stated value per share of Series B Preferred Stock, plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the common stock at such time (which initially is $1.91 per share, subject to certain anti-dilution adjustments).</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">56</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_230.png"/></span></p><p class="s15" style="padding-top: 3pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Preferred Stock Dividends</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">There have been no cash dividends paid in connection with the Series A Preferred Stock issued in May 2016. Holders of Series A Preferred Stock are entitled to a cumulative dividend at the rate of 7.5% per annum (subject to adjustment), payable quarterly in arrears. The dividends are to be paid in-kind, through an increase in the number of shares of common stock into which shares of Series A Preferred Stock are convertible, through at least May 2, 2018, and thereafter in cash or in-kind at our option. Upon the occurrence of certain events, the dividend rate will increase. Holders of Series B Preferred Stock are entitled to a cumulative dividend at the rate of 15% per annum (subject to adjustment), payable quarterly in arrears. The dividends are to be paid in-kind, through an increase in the number of shares of common stock into which shares of Series B Preferred Stock are convertible, through at least March 10, 2019, and thereafter in cash or in-kind at our option. Upon the occurrence of certain events, the dividend rate will increase.</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">In connection with the completion of our initial public offering in December 2014, all shares of our then-outstanding preferred stock were converted into common stock on a three-for-one basis, and $9.0 million of accrued dividends were paid in cash.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Cash Flows</h4><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">Our cash flows were as follows for the years ended December 31, 2016, 2015 and 2014:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 268pt;text-indent: 0pt;text-align: center;">Year Ended December 31,</p><p style="padding-left: 315pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="229" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_231.png"/></span></p><p class="s3" style="padding-left: 268pt;text-indent: 0pt;text-align: center;">2016                        2015                       2014</p><p class="s29" style="padding-left: 315pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="149" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_232.png"/></span>	<span><img width="68" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_233.png"/></span></p><p class="s3" style="padding-left: 349pt;text-indent: 0pt;text-align: left;">(in thousands)</p><p style="padding-top: 1pt;padding-bottom: 1pt;padding-left: 19pt;text-indent: 0pt;text-align: center;"><span class="s27" style=" background-color: #CEEFFB;">Net cash flows (used in) provided by:                                                                                                                                                       </span></p><table style="border-collapse:collapse;margin-left:61.8254pt" cellspacing="0"><tr style="height:10pt"><td style="width:227pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Operating activities</p></td><td style="width:84pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (24,469 )</p></td><td style="width:61pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (16,192 )</p></td><td style="width:59pt"><p class="s10" style="padding-right: 1pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (20,253 )</p></td></tr><tr style="height:11pt"><td style="width:227pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Investing activities</p></td><td style="width:84pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(5,682 )</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(1,317 )</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 1pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(837 )</p></td></tr><tr style="height:11pt"><td style="width:227pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Financing activities</p></td><td style="width:84pt"><p class="s21" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">             30,935</p></td><td style="width:61pt"><p class="s21" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">              (5,319<span class="s10"> )</span></p></td><td style="width:59pt"><p class="s21" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">             47,065</p></td></tr><tr style="height:12pt"><td style="width:227pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 22pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Net increase (decrease) in cash and cash equivalents</p></td><td style="width:84pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 9pt;text-align: right;">$ 784</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 31pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="60" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_234.png"/></span></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;line-height: 9pt;text-align: right;">$ (22,828 )</p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="69" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_235.png"/></span></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 3pt;text-indent: 0pt;line-height: 9pt;text-align: left;">$ 25,975</p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="69" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_236.png"/></span></p></td></tr></table><p style="padding-left: 320pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="60" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_237.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-top: 5pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Operating Activities</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">For the year ended December 31, 2016, our net cash and cash equivalents used in operating activities of $24.5 million consisted of a net loss of $26.5 million and $7.8 million of cash used by changes in working capital, partially offset by $9.8 million in adjustments for non-cash items. The cash used in working capital primarily consisted of a decrease in deferred revenue of $12.2 million, partially offset by a $2.8 million decrease in accounts receivable due to increased collection efforts, and a $1.3 million increase in deferred implementation costs for new customers. The decrease in deferred revenue was a result of recognizing previously deferred upfront fees which are recognized as revenue ratably over the longer of the estimated period of customer benefit or contract, beginning once the software services have commenced. Overall the operating cash used was primarily a result of (i) lower than expected 2016 bookings and fourth quarter variable transaction revenue, (ii) continued investment in research and development, and (iii) higher than anticipated costs of delivery during a year of executive leadership, sales organization, and go to market transitions. Between the cost reduction actions taken in 2016 and those planned in 2017, we expect to decrease our total cost structure and reduce the cash used in operations by at least $15.0 million from 2016 levels.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">For the year ended December 31, 2015, our net cash and cash equivalents used in operating activities of $16.2 million consisted of a net loss of $7.3 million and $19.4 million of cash used by changes in working capital, partially offset by $10.6 million in adjustments for non-cash items. The decrease in cash resulting from changes in working capital primarily consisted of a decrease in deferred revenue of $21.2 million. The decrease in deferred revenue was a result of recognizing previously deferred upfront fees which are recognized as revenue ratably over the longer of the estimated period of customer benefit or contract, beginning once the software services have commenced.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">For the year ended December 31, 2014, our net cash and cash equivalents used in operating activities of $20.3 million consisted of a net loss of $10.2 million and $17.7 million of cash used by changes in working capital, partially offset by $7.6 million in adjustments for non-cash items. The cash used by changes in working capital primarily consisted of a decrease in deferred revenue of $14.1 million. The decrease in deferred revenue was a result of contracts closed during prior periods with associated upfront fees, on which we began recognizing revenue ratably as implementations were completed and software services have commenced.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">A substantial amount of revenue in a period comes from the recognition of previously collected and deferred revenue, while period-end accounts receivable balances are directly influenced by the timing of contractually negotiated milestone and time-based advance billings and their subsequent collection. We generally have the contractual right to invoice and collect fees from customers ahead of delivery and revenue recognition of our software and professional services.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">57</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_238.png"/></span></p><p class="s15" style="padding-top: 3pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Investing Activities</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">For the year ended December 31, 2016, net cash used in investing activities was $5.7 million, consisting of $4.7 million for the acquisition of ConnectedHealth, net of cash acquired, and $1.0 million for the purchase of property and equipment.</p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;line-height: 158%;text-align: left;">For the year ended December 31, 2015, net cash used in investing activities was $1.3 million, for the purchase of property and equipment. For the year ended December 31, 2014, net cash used in investing activities was $0.8 million, for the purchase of property and equipment.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Financing Activities</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Net cash provided by financing activities totaled $30.9 million for 2016, consisting of $49.3 million net proceeds from our May 2, 2016 Series A Preferred Stock offering and $16.2 million of term debt borrowings under our Amended Credit Facility. The proceeds were partially offset by the $33.3 million repayment of the THL Note and term debt borrowings and payment of $1.1 million of financing and other fees.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">For the year ended December 31, 2015, net cash used in financing activities totaled $5.3 million and consisted of $4.8 million in repayments of debt and capital lease obligations and $0.7 million in payments of offering costs related to our December 2014 IPO, offset by $0.3 million in net proceeds from employee stock option transactions.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: justify;">For the year ended December 31, 2014, net cash provided by financing activities was $47.1 million, consisting of $45.9 million of proceeds from our initial public offering, net of issuance costs, and $32.8 million in proceeds from credit facility and term-debt borrowings partially offset by $19.6 million of debt and capital lease obligation payments, $9.0 million of dividends on preferred stock, $2.3 million of deferred business acquisition purchase price and</p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">$0.7 million of financing fees paid.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-top: 5pt;padding-left: 56pt;text-indent: 0pt;text-align: left;">Operating and Capital Expenditure Requirements</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We believe that our existing cash and cash equivalent balances, the cash proceeds from our March 10, 2017 issuance of our newly created Series B Preferred Stock, the permitted Senior Term Loan principal loan repayments deferrals, and our actions to reduce our operating expenses and increase pricing for our software services will provide liquidity sufficient to meet our anticipated cash requirements through at least the next 12 months, including expected capital expenditure requirements of approximately $1.0 million. If our available cash and cash equivalents balances are insufficient to satisfy our liquidity requirements, we may seek to sell additional equity or convertible debt securities or enter into an additional credit facility. The sale of equity and convertible debt securities may result in dilution to our stockholders and those securities may have rights senior to those of our common shares. If we raise additional funds through the issuance of convertible debt securities, these securities could contain covenants that would restrict our operations. We may require additional capital beyond our currently anticipated amounts. Additional capital may not be available on reasonable terms, or at all.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Quarterly Trends and Seasonality</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our overall operating results fluctuate from quarter to quarter as a result of a variety of factors, some of which are out of our control. These fluctuations are primarily driven by an increase in the third and fourth quarters in activity at our customers in preparation for and during the annual insurance enrollment cycle, which occurs annually during our fourth quarter. Our historical results should not be considered a reliable indicator of our future results of operations.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">58</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_239.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Contractual Obligations and Commitments</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Our principal commitments consist of obligations under our outstanding debt facilities, non-cancelable leases for our office space and computer equipment, purchase commitments for our co-location and other support services.</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">As noted in the Liquidity and Capital Resources section above, on March 10, 2017, we amended the Credit Facility, which among other things, (i) deferred our scheduled Senior Term Loan principal repayments until March 31, 2018, at which time quarterly principal repayments of $1.3 million will resume through March 31, 2021; (ii) provided for an incremental 2.50% per annum paid-in-kind interest on all obligations from March 10, 2017 through the maturity date, which will increase the outstanding principal balance of the Senior Term Loan; and (iii) required that we repay the Senior Revolving Credit Facility. The following table reflects our revised estimated principal and interest payments as of December 31, 2016, taking into account the effects of the</p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:20pt"><td style="width:539pt" colspan="6"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">March 10, 2017 amendment. Future events could cause actual payments to differ from these estimates.</p></td></tr><tr style="height:9pt"><td style="width:304pt" colspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s8" style="padding-left: 12pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Less than 1</p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:60pt"><p class="s8" style="padding-left: 10pt;text-indent: 0pt;line-height: 7pt;text-align: left;">More than 5</p></td></tr><tr style="height:9pt"><td style="width:304pt" colspan="2"><p class="s8" style="text-indent: 0pt;line-height: 7pt;text-align: left;">Contractual Obligations: Total</p><p style="text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="318" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_240.png"/></span></p></td><td style="width:58pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 21pt;padding-right: 21pt;text-indent: 0pt;line-height: 7pt;text-align: center;">year</p></td><td style="width:58pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 14pt;text-indent: 0pt;line-height: 7pt;text-align: left;">1-3 years</p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 14pt;text-indent: 0pt;line-height: 7pt;text-align: left;">3-5 years</p></td><td style="width:60pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 20pt;padding-right: 21pt;text-indent: 0pt;line-height: 7pt;text-align: center;">years</p></td></tr><tr style="height:19pt"><td style="width:539pt" colspan="6"><p class="s8" style="padding-right: 125pt;text-indent: 0pt;text-align: right;">(In thousands)</p><p style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;"><span class="s32" style=" background-color: #CEEFFB;">Long-term debt—Revolving line of credit                                                                                                                                                                                                     </span></p></td></tr><tr style="height:11pt"><td style="width:173pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Principal <span class="s24">(1)</span></p></td><td style="width:131pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 578</p></td><td style="width:58pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 578</p></td><td style="width:177pt" colspan="3"><p class="s10" style="padding-left: 5pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ — $ — $ —</p></td></tr><tr style="height:11pt"><td style="width:173pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Interest <span class="s24">(2)</span></p></td><td style="width:131pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">53</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">53</p></td><td style="width:177pt" colspan="3" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 44pt;text-indent: 0pt;line-height: 8pt;text-align: left;">— — —</p></td></tr><tr style="height:10pt"><td style="width:539pt" colspan="6"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Long-term debt—Other senior and subordinated</p></td></tr><tr style="height:11pt"><td style="width:173pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Principal <span class="s24">(3)</span></p></td><td style="width:131pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">34,858</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">10,500</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">24,358</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td></tr><tr style="height:11pt"><td style="width:173pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Interest <span class="s24">(2)</span></p></td><td style="width:131pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">8,761</p></td><td style="width:58pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2,367</p></td><td style="width:58pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">4,227</p></td><td style="width:59pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2,167</p></td><td style="width:60pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td></tr><tr style="height:11pt"><td style="width:173pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Operating lease obligations</p></td><td style="width:131pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">8,559</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,521</p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2,736</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,805</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2,497</p></td></tr><tr style="height:11pt"><td style="width:173pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Capital lease obligations</p></td><td style="width:131pt"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                   35</p></td><td style="width:58pt"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                   35</p></td><td style="width:58pt"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                    —</p></td><td style="width:59pt"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                    —</p></td><td style="width:60pt"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                    —</p></td></tr><tr style="height:14pt"><td style="width:173pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">Total</p></td><td style="width:131pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 3pt;padding-right: 5pt;text-indent: 0pt;line-height: 9pt;text-align: right;">$ 52,844</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 83pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="56" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_241.png"/></span></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 3pt;padding-right: 5pt;text-indent: 0pt;line-height: 9pt;text-align: right;">$ 4,554</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_242.png"/></span></p></td><td style="width:58pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 3pt;padding-right: 5pt;text-indent: 0pt;line-height: 9pt;text-align: right;">$ 17,463</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_243.png"/></span></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 3pt;padding-right: 5pt;text-indent: 0pt;line-height: 9pt;text-align: right;">$ 28,330</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_244.png"/></span></p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 3pt;padding-right: 6pt;text-indent: 0pt;line-height: 9pt;text-align: right;">$ 2,497</p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="66" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_245.png"/></span></p></td></tr></table><p style="padding-left: 263pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="56" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_246.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l11"><li style="padding-left: 32pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Repayment of the revolving line of credit is due at end of the term in June 2021. Early repayment is allowed and the revolving line of credit and interest was repaid subsequent to year end.</p></li><li style="padding-left: 32pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Includes estimated interest payments based on contractual rates as of December 31, 2016.</p></li><li style="padding-left: 32pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Principal includes the 2.50% per annum paid-in-kind interest, which increases the outstanding principal balance of the term loan and is payable at maturity.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Off-Balance Sheet Arrangements</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">As of December 31, 2016, we had standby letters of credit totaling $0.2 million as security for rented office space, which is immaterial in respect of the Company’s liquidity, capital resources, market risk support, credit risk support or other benefits.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Recent Accounting Pronouncements</p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">See Note 2 to the Consolidated Financial Statements for information on new accounting standards.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">JOBS Act</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The JOBS Act contains provisions that, among other things, reduce certain reporting requirements for qualifying public companies. As defined in the JOBS Act, a public company whose initial public offering of common equity securities occurred after December 8, 2011 and whose annual gross revenue is less than $1.0 billion will, in general, qualify as an “emerging growth company” until the earliest of:</p><ul id="l12"><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the last day of its fiscal year following the fifth anniversary of the date of its initial public offering of common equity securities;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the last day of its fiscal year in which it has annual gross revenue of $1.0 billion or more;</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">the date on which it has, during the previous three-year period, issued more than $1.0 billion in non-convertible debt; and</p></li><li style="padding-top: 5pt;padding-left: 56pt;text-indent: -24pt;line-height: 10pt;text-align: left;"><p style="display: inline;">the date on which it is deemed to be a “large accelerated filer,” which will occur at such time as the company (a) has an aggregate worldwide market value of common equity securities held by non-affiliates of $700 million or more as of the last business day of its most recently completed second fiscal quarter, and (b) has been required to file annual and quarterly reports under the Securities Exchange Act of 1934 for a period of at least 12 months and (c) has filed at least one annual report pursuant to the Securities Act of 1934.</p></li></ul></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">59</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_247.png"/></span></p><p style="padding-top: 3pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">Under this definition, we are an “emerging growth company” and could remain an emerging growth company until as late as December 31, 2019.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;"><a href="#bookmark57" class="s18" name="bookmark15">As an “emerging growth company” we have chosen to rely on such exemptions and are therefore not required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act and (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing</a> additional information about the audit and the financial statements (auditor discussion and analysis).<a name="bookmark57">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark58">Item 7A. Quantitative and Qualitative Disclosures about Market Risk.</a></p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We have operations solely in the United States and are exposed to market risks in the ordinary course of our business. Market risk is the risk of loss to future earnings, values or future cash flows that may result from changes in the price of a financial instrument. The value of a financial instrument might change as a result of changes in interest rates, exchange rates, commodity prices, equity prices and other market changes. We do not use derivative financial instruments for speculative, hedging or trading purposes, although in the future we might enter into exchange rate hedging arrangements to manage the risks described below.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Interest Rate Risk</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">We are exposed to market risk related to changes in interest rates. Borrowings under the term loan and revolving line of credit with Wells Fargo Bank, which was entered into in January 2013, as amended, bear interest at rates that are variable. Increases in the LIBOR or Prime Rate would increase the amount of interest payable under these borrowings. We had total borrowings subject to a variable interest rate of $32.5 million and $49.4 million as of December 31, 2016, and 2015, respectively. As a result, each change of one percentage point in interest rates would result in an approximately $0.3 million and approximately $0.5 million change in our annual interest expense on our outstanding borrowings as of December 31, 2016 and 2015, respectively. Any debt we incur in the future may also bear interest at variable rates.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 56pt;text-indent: 0pt;text-align: left;">Inflation Risk</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;"><a href="#bookmark59" class="s18" name="bookmark16">We do not believe that inflation has had a material effect on our business, financial condition, or results of operations. We continue to monitor the impact of inflation in order to minimize its effects through pricing strategies, productivity improvements and cost reductions. If our costs were to become subject to significant inflationary pressures, we may not be able to fully offset such higher costs through price increases. Our inability or failure to do so</a> could harm our business, financial condition, and results of operations.<a name="bookmark59">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark60">Item 8. Financial Statements and Supplementary Data</a></p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;"><a href="#bookmark62" class="s18">The information required by this item is incorporated by reference to the consolidated financial statements and accompanying notes set forth on</a> pages F-1 through F-27 of this Annual Report on Form 10-K.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark17">Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure</a><a name="bookmark61">&zwnj;</a><a name="bookmark62">&zwnj;</a></p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;"><a name="bookmark18">None.</a><a name="bookmark63">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark64">Item 9A. Controls and Procedures</a></p><h4 style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Disclosure Controls and Procedures</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act, refers to controls and procedures that are designed to ensure that information required to be disclosed by a company in the reports that it files under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that such information is accumulated and communicated to a company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2016, the end of the period covered by this Annual Report on Form 10-K. Based upon such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures were effective as of such date.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">60</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_248.png"/></span></p><h4 style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Changes in Internal Control Over Financial Reporting</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: justify;">There were no changes in our internal control over financial reporting during the quarter ended December 31, 2016, which were identified in connection with management’s evaluation required by Rules 13a-15(d) and 15d-15(d) under the Exchange Act, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Management’s Report on Internal Control Over Financial Reporting and Attestation Report of Registered Public Accounting Firm</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based on the framework in Internal Control—Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on the evaluation, our management concluded that our internal control over financial reporting was effective as of December 31, 2016.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: justify;">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation. Also, projections of any evaluation of the effectiveness of internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The JOBS Act permits “emerging growth companies” like us to take advantage of certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies. Because we are an emerging growth company, we are exempt from the requirements of auditor attestation reports on the effectiveness of our internal control over financial reporting. We will continue to be exempt until we no longer qualify as an emerging growth company.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Limitations on Controls</h4><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;"><a href="#bookmark65" class="s18" name="bookmark19">Our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving their objectives as specified above. Management does not expect, however, that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all error and fraud. Any control system, no matter how well designed and operated, is based upon certain assumptions and can provide only reasonable, not absolute, assurance that its objectives will be met. Further, no evaluation of controls can provide absolute assurance that</a> misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within our company have been detected.<a name="bookmark65">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark66">Item 9B. Other Information</a></p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">None.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">61</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_249.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;"><a name="bookmark20">PART III</a><a name="bookmark21">&zwnj;</a><a name="bookmark67">&zwnj;</a><a name="bookmark68">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark69">Item 10. Directors, Executive Officers and Corporate Governance</a></p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;"><a href="#bookmark70" class="s18" name="bookmark22">Information required by Part III, Item 10, will be included in our Proxy Statement relating to our 2017 annual meeting of stockholders to be filed with</a> the SEC within 120 days after the end of our fiscal year ended December 31, 2016, and is incorporated herein by reference.<a name="bookmark70">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark71">Item 11. Executive Compensation</a></p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;"><a href="#bookmark72" class="s18" name="bookmark23">Information required by Part III, Item 11, will be included in our Proxy Statement relating to our 2017 annual meeting of stockholders to be filed with</a> the SEC within 120 days after the end of our fiscal year ended December 31, 2016, and is incorporated herein by reference.<a name="bookmark72">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark73">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;"><a href="#bookmark74" class="s18" name="bookmark24">Information required by Part III, Item 12, will be included in our Proxy Statement relating to our 2017 annual meeting of stockholders to be filed with</a> the SEC within 120 days after the end of our fiscal year ended December 31, 2016, and is incorporated herein by reference.<a name="bookmark74">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark75">Item 13. Certain Relationships and Related Transactions, and Director Independence</a></p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;"><a href="#bookmark77" class="s18">Information required by Part III, Item 13, will be included in our Proxy Statement relating to our 2017 annual meeting of stockholders to be filed with</a> the SEC within 120 days after the end of our fiscal year ended December 31, 2016, and is incorporated herein by reference.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark25">Item 14. Principal Accounting Fees and Services</a><a name="bookmark76">&zwnj;</a><a name="bookmark77">&zwnj;</a></p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 24pt;text-align: left;">Information required by Part III, Item 14, will be included in our Proxy Statement relating to our 2017 annual meeting of stockholders to be filed with the SEC within 120 days after the end of our fiscal year ended December 31, 2016, and is incorporated herein by reference.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">62</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_250.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;"><a name="bookmark26">PART IV</a><a name="bookmark27">&zwnj;</a><a name="bookmark78">&zwnj;</a><a name="bookmark79">&zwnj;</a></p><p class="s14" style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark80">Item 15. Exhibits and Financial Statement Schedules</a></p><ol id="l13"><li style="padding-top: 5pt;padding-left: 18pt;text-indent: -10pt;text-align: left;"><p style="display: inline;">Documents Filed with Report</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l14"><li style="padding-left: 19pt;text-indent: -11pt;text-align: left;"><p class="s14" style="display: inline;">Consolidated Financial Statements</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 525pt;text-indent: 0pt;text-align: left;">Page</p><p style="padding-left: 519pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="35" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_251.png"/></span></p><p class="s33" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a href="#bookmark84" class="a">Report of Independent Registered Public Accounting </a><span style=" color: #0000ED; font-family:&quot;Times New Roman&quot;, serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt;">Firm</span> <span style=" color: #000;">F-2</span></p><p class="s33" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a href="#bookmark85" class="a">Consolidated Balance Sheets as of December 31, 2016 and </a><span style=" color: #0000ED; font-family:&quot;Times New Roman&quot;, serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt;">2015</span> <span style=" color: #000;">F-3</span></p><p class="s33" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><span style=" color: #0000ED; font-family:&quot;Times New Roman&quot;, serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt;">Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2016, 2015 and 2014</span> <a href="#bookmark87" class="s18">F-4 </a><span style=" color: #0000ED; font-family:&quot;Times New Roman&quot;, serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt;">Consolidated Statements of Stockholders’ Deficit for the years ended December 31, 2016, 2015 and 2014</span> <span style=" color: #000;">F-5</span></p><p class="s33" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a href="#bookmark88" class="a">Consolidated Statements of Cash Flows for the years ended December 31, 2016, 2015 and </a><span style=" color: #0000ED; font-family:&quot;Times New Roman&quot;, serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt;">2014</span> <span style=" color: #000;">F-6</span></p><p class="s33" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a href="#bookmark89" class="a">Notes to Consolidated Financial </a><span style=" color: #0000ED; font-family:&quot;Times New Roman&quot;, serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt;">Statements</span> <span style=" color: #000;">F-7</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-top: 5pt;padding-left: 19pt;text-indent: -11pt;text-align: left;"><p class="s14" style="display: inline;">Financial Statement Schedule</p><p class="s33" style="padding-top: 6pt;padding-left: 8pt;text-indent: 0pt;text-align: left;"><span style=" color: #0000ED; font-family:&quot;Times New Roman&quot;, serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt;">Schedule II—Valuation and Qualifying Accounts</span> <span style=" color: #000;">F-26</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li></ol></li><li style="padding-left: 19pt;text-indent: -11pt;text-align: left;"><p class="s15" style="display: inline;">Exhibits.</p></li></ol><p style="padding-top: 5pt;padding-left: 1pt;text-indent: 0pt;text-align: center;">The information required by this Item is set forth on the exhibit index that follows the signature page of this Annual Report on Form 10-K.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark81">Item 16. Form 10-K Summary</a></p><p style="padding-top: 5pt;padding-left: 30pt;text-indent: 0pt;text-align: left;">None.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 4pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">63</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_252.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;"><a name="bookmark28">SIGNATURES</a><a name="bookmark82">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Date: March 31, 2017</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 330pt;text-indent: 0pt;text-align: left;">CONNECTURE, INC.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 349pt;text-indent: -19pt;line-height: 110%;text-align: left;">By: <u>/s/ Jeffery A. Surges</u> Jeffery A. Surges</p><p style="padding-left: 349pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Chief Executive Officer</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">64</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_253.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 194pt;text-indent: 0pt;text-align: left;">SIGNATURES AND POWER OF ATTORNEY</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Each person whose individual signature appears below hereby authorizes and appoints Jeffery A. Surges and Vincent E. Estrada, and each of them, with full power of substitution and resubstitution and full power to act without the other, as his or her true and lawful attorney-in-fact and agent to act in his or her name, place and stead and to execute in the name and on behalf of each person, individually and in each capacity stated below, and to file any and all amendments to this Annual Report on Form 10-K, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing, ratifying and confirming all that said attorneys-in-fact and agents or any of them or their or his substitute or substitutes may lawfully do or cause to be done by virtue thereof.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities indicated.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 94pt;text-indent: 0pt;text-align: left;">Signature Title Date</p><p class="s34" style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="270" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_254.png"/></span> <span><img width="285" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_255.png"/></span> <span><img width="143" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_256.png"/></span></p><p class="s30" style="padding-top: 6pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">/s/ Jeffery A. Surges<span class="p"> President and Chief Executive Officer (Principal Executive March 31, 2017</span></p><p class="s15" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Jeffery A. Surges <span class="p">Officer) and Director</span></p><p class="s30" style="padding-top: 6pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">/s/ Vincent E. Estrada<span class="p"> Chief Financial Officer (Principal Financial and Accounting March 31, 2017</span></p><p class="s15" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Vincent E. Estrada <span class="p">Officer)</span></p><p class="s30" style="padding-top: 6pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">/s/ David A. Jones, Jr.<span class="p"> Chairman of the Board of Directors March 31, 2017</span></p><p class="s15" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">David A. Jones, Jr.</p><p class="s30" style="padding-top: 6pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">/s/ A. John Ansay<span class="p"> Director March 31, 2017</span></p><p class="s15" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">A. John Ansay</p><p class="s30" style="padding-top: 6pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">/s/ Vickie L. Capps<span class="p"> Director March 31, 2017</span></p><p class="s15" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Vickie L. Capps</p><p class="s30" style="padding-top: 6pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">/s/ Paul Kusserow<span class="p"> Director March 31, 2017</span></p><p class="s15" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Paul Kusserow</p><p class="s30" style="padding-top: 6pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">/s/ Ezra Perlman<span class="p"> Director March 31, 2017</span></p><p class="s15" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Ezra Perlman</p><p class="s30" style="padding-top: 6pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">/s/ Russell S. Thomas<span class="p"> Director March 31, 2017</span></p><p class="s15" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Russell S. Thomas</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 7pt;padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">65</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_257.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;"><a name="bookmark29">INDEX TO FINANCIAL STATEMENTS</a><a name="bookmark83">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="text-indent: 0pt;text-align: right;">Page</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 519pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="35" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_258.png"/></span></p><p class="s33" style="padding-left: 2pt;text-indent: 0pt;text-align: center;"><a href="#bookmark84" class="a">Report of Independent Registered Public Accounting </a><span style=" color: #0000ED; font-family:&quot;Times New Roman&quot;, serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt;">Firm</span>                                                                                                                                                           <span style=" color: #000;">F-2</span></p><p class="s33" style="padding-left: 2pt;text-indent: 0pt;text-align: center;"><a href="#bookmark85" class="a">Consolidated Balance Sheets as of December 31, 2016 and </a><span style=" color: #0000ED; font-family:&quot;Times New Roman&quot;, serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt;">2015</span>                                                                                                                                    <span style=" color: #000;">F-3</span></p><p class="s33" style="padding-left: 2pt;text-indent: 0pt;text-align: center;"><a href="#bookmark86" class="a">Consolidated Statements of Operations and Comprehensive Loss for the years ended December 31, 2016, 2015 and </a><span style=" color: #0000ED; font-family:&quot;Times New Roman&quot;, serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt;">2014</span>                                                <span style=" color: #000;">F-4</span></p><p class="s33" style="padding-left: 2pt;text-indent: 0pt;text-align: center;"><a href="#bookmark87" class="a">Consolidated Statements of Stockholders’ Deficit for the years ended December 31, 2016, 2015 and </a><span style=" color: #0000ED; font-family:&quot;Times New Roman&quot;, serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt;">2014</span>                                                                      <span style=" color: #000;">F-5</span></p><p class="s33" style="padding-left: 2pt;text-indent: 0pt;text-align: center;"><a href="#bookmark88" class="a">Consolidated Statements of Cash Flows for the years ended December 31, 2016, 2015 and </a><span style=" color: #0000ED; font-family:&quot;Times New Roman&quot;, serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt;">2014</span>                                                                                     <span style=" color: #000;">F-6</span></p><p class="s33" style="padding-left: 2pt;text-indent: 0pt;text-align: center;"><a href="#bookmark89" class="a">Notes to Consolidated Financial </a><span style=" color: #0000ED; font-family:&quot;Times New Roman&quot;, serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt;">Statements</span>                                                                                                                                                                                   <span style=" color: #000;">F-7</span></p><p class="s33" style="padding-left: 2pt;text-indent: 0pt;text-align: center;"><a href="#bookmark90" class="a">Schedule II—Valuation </a><span style=" color: #0000ED; font-family:&quot;Times New Roman&quot;, serif; font-style: normal; font-weight: normal; text-decoration: underline; font-size: 8pt;">and Qualifying Accounts</span>                                                                                                                                                                <span style=" color: #000;">F-26</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-1</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_259.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark84">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">To the Board of Directors and Stockholders of Connecture, Inc. and Subsidiaries Brookfield, Wisconsin</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">We have audited the accompanying consolidated balance sheets of Connecture, Inc. and Subsidiaries (the “Company”), as of December 31, 2016 and 2015 and the related consolidated statements of operations and comprehensive loss, stockholders’ deficit, and cash flows for each of the three years in the period ended December 31, 2016. Our audits also included the financial statement schedule listed in the Index at Item 15. These consolidated financial statements and financial statement schedule are the responsibility of the Company’s management. Our responsibility is to express an opinion on the consolidated financial statements and financial statement schedule based on our audits.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">We conducted our audits in accordance with the standards of the Public Company Accounting Oversight Board (United States). Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. Our audits included consideration of internal control over financial reporting as a basis for designing audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion. An audit also includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements, assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">In our opinion, such consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2016, and 2015, and the results of their operations and their cash flows for each of the three years in the period ended December 31, 2016, in conformity with accounting principles generally accepted in the United States of America. Also, in our opinion, such financial statement schedule, when considered in relation to the basic consolidated financial statements taken as a whole, presents fairly in all material respects the information set forth therein.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">/s/ Deloitte &amp; Touche LLP</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Milwaukee, Wisconsin March 31, 2017</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-2</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_260.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">CONNECTURE, INC. AND SUBSIDIARIES</p><p class="s14" style="padding-top: 5pt;padding-left: 19pt;text-indent: 0pt;text-align: center;"><a name="bookmark85">CONSOLIDATED BALANCE SHEETS AS OF DECEMBER 31, 2016 and 2015</a></p><p class="s14" style="padding-left: 19pt;text-indent: 0pt;text-align: center;">(In thousands, except share and per share information)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">2016 2015</p><p class="s29" style="padding-left: 378pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="99" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_261.png"/></span>	<span><img width="99" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_262.png"/></span></p><p style="padding-left: 19pt;text-indent: 0pt;text-align: center;"><span class="s27" style=" background-color: #CEEFFB;">ASSETS                                                                                                                                                                                                                                                              </span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">CURRENT ASSETS:</p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:11pt"><td style="width:331pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Cash and cash equivalents</p></td><td style="width:116pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 6,208</p></td><td style="width:11pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:80pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 5,424</p></td></tr><tr style="height:11pt"><td style="width:331pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Accounts receivable</p></td><td style="width:116pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">8,390</p></td><td style="width:11pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:80pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">10,792</p></td></tr><tr style="height:11pt"><td style="width:331pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Prepaid expenses and other current assets</p></td><td style="width:116pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                           1,153</p></td><td style="width:11pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:80pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                              652</p></td></tr><tr style="height:11pt"><td style="width:331pt"><p class="s10" style="padding-top: 1pt;padding-left: 22pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Total current assets</p></td><td style="width:116pt"><p class="s10" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">15,751</p></td><td style="width:11pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:80pt"><p class="s10" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">16,868</p></td></tr><tr style="height:11pt"><td style="width:331pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">PROPERTY AND EQUIPMENT — Net</p></td><td style="width:116pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,957</p></td><td style="width:11pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:80pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2,109</p></td></tr><tr style="height:11pt"><td style="width:331pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">GOODWILL</p></td><td style="width:116pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">31,072</p></td><td style="width:11pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:80pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">26,779</p></td></tr><tr style="height:11pt"><td style="width:331pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">OTHER INTANGIBLE ASSETS — Net</p></td><td style="width:116pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">9,188</p></td><td style="width:11pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:80pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">11,392</p></td></tr><tr style="height:11pt"><td style="width:331pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">DEFERRED IMPLEMENTATION COSTS</p></td><td style="width:116pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">23,257</p></td><td style="width:11pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:80pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">24,565</p></td></tr><tr style="height:11pt"><td style="width:331pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">OTHER ASSETS</p></td><td style="width:116pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                           1,263</p></td><td style="width:11pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:80pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                              976</p></td></tr><tr style="height:11pt"><td style="width:331pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">TOTAL ASSETS</p></td><td style="width:116pt"><p class="s21" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 82,488</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 44pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="89" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_263.png"/></span></p></td><td style="width:11pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:80pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 82,689</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 4pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="90" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_264.png"/></span></p></td></tr><tr style="height:1pt"><td style="width:331pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:116pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:11pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:80pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:20pt"><td style="width:331pt" bgcolor="#CEEFFB"><p class="s7" style="text-indent: 0pt;text-align: left;">LIABILITIES, REDEEMABLE PREFERRED STOCK AND STOCKHOLDERS’</p><p class="s7" style="padding-left: 5pt;text-indent: 0pt;line-height: 8pt;text-align: left;">DEFICIT</p></td><td style="width:116pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:11pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:80pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:12pt"><td style="width:331pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">CURRENT LIABILITIES:</p></td><td style="width:116pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:91pt" colspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:331pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Accounts payable</p></td><td style="width:116pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 7,387</p></td><td style="width:91pt" colspan="2" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 10pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 6,853</p></td></tr><tr style="height:11pt"><td style="width:331pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Accrued payroll and related liabilities</p></td><td style="width:116pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">4,945</p></td><td style="width:91pt" colspan="2"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">3,560</p></td></tr><tr style="height:11pt"><td style="width:331pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Other liabilities</p></td><td style="width:116pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,950</p></td><td style="width:91pt" colspan="2" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2,188</p></td></tr><tr style="height:11pt"><td style="width:331pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Current maturities of debt</p></td><td style="width:116pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">578</p></td><td style="width:91pt" colspan="2"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,441</p></td></tr><tr style="height:11pt"><td style="width:331pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Deferred revenue</p></td><td style="width:116pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                         31,606</p></td><td style="width:91pt" colspan="2" bgcolor="#CEEFFB"><p class="s21" style="padding-left: 10pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                         34,049</p></td></tr><tr style="height:11pt"><td style="width:331pt"><p class="s10" style="padding-top: 1pt;padding-left: 22pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Total current liabilities</p></td><td style="width:116pt"><p class="s10" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">46,466</p></td><td style="width:91pt" colspan="2"><p class="s10" style="padding-top: 1pt;padding-left: 60pt;text-indent: 0pt;line-height: 8pt;text-align: left;">48,091</p></td></tr><tr style="height:11pt"><td style="width:331pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">DEFERRED REVENUE</p></td><td style="width:116pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">9,310</p></td><td style="width:91pt" colspan="2" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 60pt;text-indent: 0pt;line-height: 8pt;text-align: left;">18,529</p></td></tr><tr style="height:11pt"><td style="width:331pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">DEFERRED TAX LIABILITY</p></td><td style="width:116pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">23</p></td><td style="width:91pt" colspan="2"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">23</p></td></tr><tr style="height:11pt"><td style="width:331pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">LONG-TERM DEBT</p></td><td style="width:116pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">31,944</p></td><td style="width:91pt" colspan="2" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 60pt;text-indent: 0pt;line-height: 8pt;text-align: left;">46,964</p></td></tr><tr style="height:11pt"><td style="width:331pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">OTHER LONG-TERM LIABILITIES</p></td><td style="width:116pt"><p class="s21" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                              235</p></td><td style="width:91pt" colspan="2"><p class="s21" style="padding-left: 10pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                              262</p></td></tr><tr style="height:11pt"><td style="width:331pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 22pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Total liabilities</p></td><td style="width:116pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                         87,978</p></td><td style="width:91pt" colspan="2" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-left: 10pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                       113,869</p></td></tr><tr style="height:13pt"><td style="width:331pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">COMMITMENTS AND CONTINGENCIES (Note 8)</p></td><td style="width:116pt"><p class="s21" style="padding-top: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                                      </p></td><td style="width:91pt" colspan="2"><p class="s21" style="padding-top: 3pt;padding-left: 10pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                                      </p></td></tr><tr style="height:11pt"><td style="width:331pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">REDEEMABLE PREFERRED STOCK - SERIES A</p></td><td style="width:116pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                         51,894</p></td><td style="width:91pt" colspan="2" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-left: 10pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                                 —</p></td></tr><tr style="height:24pt"><td style="width:331pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">STOCKHOLDERS’ DEFICIT:</p><p class="s10" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">Common stock, $0.001 par value, 75,000,000 shares authorized as of December 31,</p></td><td style="width:116pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:91pt" colspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:20pt"><td style="width:331pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 17pt;text-indent: 0pt;line-height: 9pt;text-align: left;">2016 and December 31, 2015, and 22,524,655 and 22,063,357 shares issued and</p><p class="s10" style="padding-left: 17pt;text-indent: 0pt;line-height: 9pt;text-align: left;">outstanding as of December 31, 2016 and December 31, 2015, respectively</p></td><td style="width:116pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 9pt;text-align: right;">23</p></td><td style="width:91pt" colspan="2" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 9pt;text-align: right;">22</p></td></tr><tr style="height:10pt"><td style="width:331pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Additional paid-in capital</p></td><td style="width:116pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">101,985</p></td><td style="width:91pt" colspan="2"><p class="s10" style="padding-left: 56pt;text-indent: 0pt;line-height: 8pt;text-align: left;">101,546</p></td></tr><tr style="height:11pt"><td style="width:331pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Accumulated deficit</p></td><td style="width:116pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">(159,105 )</p></td><td style="width:91pt" colspan="2" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 53pt;text-indent: 0pt;line-height: 8pt;text-align: left;">(132,571 )</p></td></tr><tr style="height:11pt"><td style="width:331pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Treasury stock, at cost</p></td><td style="width:116pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: right;">                             (287<span class="s10"> )</span></p></td><td style="width:91pt" colspan="2"><p class="s21" style="padding-left: 10pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                             (177<span class="s10"> )</span></p></td></tr><tr style="height:11pt"><td style="width:331pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 22pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Total stockholders’ deficit</p></td><td style="width:116pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                       (57,384<span class="s10"> )</span></p></td><td style="width:91pt" colspan="2" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-left: 10pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                        (31,180<span class="s10"> )</span></p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><span><img width="718" height="41" alt="image" src="NASDAQ_CNXR_2016/Image_265.png"/></span></p><p style="padding-top: 1pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">TOTAL LIABILITIES, REDEEMABLE PREFERRED STOCK AND</p><p style="padding-left: 1pt;text-indent: 0pt;text-align: center;">STOCKHOLDERS’ DEFICIT                                                                                                                              <u>$                     82,488</u>      $                   82,689</p><p class="s29" style="padding-left: 383pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="92" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_266.png"/></span>	<span><img width="101" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_267.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The accompanying notes to the consolidated financial statements are an integral part of the statements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-3</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_268.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">CONNECTURE, INC. AND SUBSIDIARIES</p><p class="s14" style="padding-top: 5pt;padding-left: 114pt;text-indent: 0pt;text-align: center;"><a name="bookmark86">CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS FOR THE YEARS ENDED DECEMBER 31, 2016, 2015 and 2014</a></p><p class="s14" style="padding-left: 19pt;text-indent: 0pt;text-align: center;">(In thousands, except share and per share information)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:11pt"><td style="width:319pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:76pt"><p class="s8" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">2016</p><p style="text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="84" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_269.png"/></span></p></td><td style="width:75pt"><p class="s8" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">2015</p><p style="text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="84" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_270.png"/></span></p></td><td style="width:68pt"><p class="s8" style="padding-left: 23pt;padding-right: 29pt;text-indent: 0pt;line-height: 8pt;text-align: center;">2014</p><p style="text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="84" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_271.png"/></span></p></td></tr><tr style="height:11pt"><td style="width:319pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">REVENUE</p></td><td style="width:76pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 81,894</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 95,847</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 84,579</p></td></tr><tr style="height:15pt"><td style="width:319pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">COST OF REVENUE</p></td><td style="width:76pt"><p class="s21" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">                   56,895</p></td><td style="width:75pt"><p class="s21" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">                   50,670</p></td><td style="width:68pt"><p class="s21" style="padding-top: 2pt;padding-right: 5pt;text-indent: 0pt;text-align: right;">                   52,431</p></td></tr><tr style="height:11pt"><td style="width:319pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">GROSS MARGIN</p></td><td style="width:76pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                   24,999</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                   45,177</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                   32,148</p></td></tr><tr style="height:13pt"><td style="width:319pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">OPERATING EXPENSES:</p></td><td style="width:76pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:75pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:68pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:319pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Research and development</p></td><td style="width:76pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">22,297</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">22,718</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">18,125</p></td></tr><tr style="height:11pt"><td style="width:319pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Sales and marketing</p></td><td style="width:76pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">10,410</p></td><td style="width:75pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">9,507</p></td><td style="width:68pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">7,729</p></td></tr><tr style="height:11pt"><td style="width:319pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">General and administrative</p></td><td style="width:76pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                   13,162</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                   14,439</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                   10,552</p></td></tr><tr style="height:14pt"><td style="width:319pt"><p class="s10" style="padding-top: 1pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">Total operating expenses</p></td><td style="width:76pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">                   45,869</p></td><td style="width:75pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">                   46,664</p></td><td style="width:68pt"><p class="s21" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;text-align: right;">                   36,406</p></td></tr><tr style="height:11pt"><td style="width:319pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">LOSS FROM OPERATIONS</p></td><td style="width:76pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(20,870 )</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(1,487 )</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(4,258 )</p></td></tr><tr style="height:12pt"><td style="width:319pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">OTHER EXPENSES:</p></td><td style="width:76pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:75pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:68pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:319pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Interest expense</p></td><td style="width:76pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">3,485</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,665</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,937</p></td></tr><tr style="height:11pt"><td style="width:319pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Other expense (income), net</p></td><td style="width:76pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                      2,239</p></td><td style="width:75pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                         140</p></td><td style="width:68pt"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                          (68<span class="s10"> )</span></p></td></tr><tr style="height:11pt"><td style="width:319pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 22pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Total other expenses</p></td><td style="width:76pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                      5,724</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                      5,805</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                      5,869</p></td></tr><tr style="height:15pt"><td style="width:319pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">LOSS BEFORE PROVISION FOR INCOME TAXES</p></td><td style="width:76pt"><p class="s10" style="padding-top: 3pt;padding-right: 9pt;text-indent: 0pt;text-align: right;">(26,594 )</p></td><td style="width:75pt"><p class="s10" style="padding-top: 3pt;padding-right: 9pt;text-indent: 0pt;text-align: right;">(7,292 )</p></td><td style="width:68pt"><p class="s10" style="padding-top: 3pt;padding-right: 2pt;text-indent: 0pt;text-align: right;">(10,127 )</p></td></tr><tr style="height:11pt"><td style="width:319pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">BENEFIT (PROVISION) FOR INCOME TAXES</p></td><td style="width:76pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                           60</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                          (51<span class="s10"> )</span></p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                          (33<span class="s10"> )</span></p></td></tr><tr style="height:13pt"><td style="width:319pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">NET LOSS</p></td><td style="width:76pt"><p class="s21" style="padding-top: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ (26,534<span class="s10"> )</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="76" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_272.png"/></span></p></td><td style="width:75pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ (7,343 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="85" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_273.png"/></span></p></td><td style="width:68pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 3pt;padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (10,160 )</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="75" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_274.png"/></span></p></td></tr><tr style="height:1pt"><td style="width:319pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:76pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:75pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:68pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:319pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">COMPREHENSIVE LOSS</p></td><td style="width:76pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;text-align: left;">$ (26,534<span class="s10"> )</span></p></td><td style="width:75pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;text-align: left;">$ (7,343 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="85" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_275.png"/></span></p></td><td style="width:68pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;text-align: right;">$ (10,160 )</p></td></tr><tr style="height:12pt"><td style="width:319pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">NET LOSS PER COMMON SHARE:</p></td><td style="width:76pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:75pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:68pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:12pt"><td style="width:319pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Basic and diluted</p></td><td style="width:76pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;text-align: left;">$ (1.31<span class="s10"> )</span></p></td><td style="width:75pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;text-align: left;">$ (0.34 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="85" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_276.png"/></span></p></td><td style="width:68pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;text-align: right;">$ (10.27 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="85" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_277.png"/></span></p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><span><img width="718" height="16" alt="image" src="NASDAQ_CNXR_2016/Image_278.png"/></span></p><p style="padding-top: 2pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING:</p><p style="padding-left: 16pt;text-indent: 0pt;text-align: center;">Basic and diluted                                                                                                              <u>           22,275,256</u>               21,813,407                 1,362,109</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The accompanying notes to the consolidated financial statements are an integral part of the statements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-4</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_279.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">CONNECTURE, INC. AND SUBSIDIARIES</p><p class="s14" style="padding-top: 5pt;padding-left: 114pt;text-indent: 0pt;text-align: center;"><a name="bookmark87">CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT FOR THE YEARS ENDED DECEMBER 31, 2016, 2015 and 2014</a></p><table style="border-collapse:collapse" cellspacing="0"><tr style="height:17pt"><td style="width:182pt" rowspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:110pt;border-bottom-style:solid;border-bottom-width:1pt" colspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-left: 31pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Common Stock</p></td><td style="width:70pt" colspan="2"><p class="s8" style="padding-left: 17pt;padding-right: 17pt;text-indent: 0pt;line-height: 8pt;text-align: center;">Additional</p><p class="s8" style="padding-left: 17pt;padding-right: 17pt;text-indent: 0pt;line-height: 7pt;text-align: center;">Paid-In</p></td><td style="width:61pt"><p class="s8" style="padding-left: 10pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Treasury</p><p class="s8" style="padding-left: 11pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Stock, at</p></td><td style="width:59pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-right: 10pt;text-indent: 0pt;line-height: 7pt;text-align: center;">Accumulated</p></td><td style="width:56pt"><p class="s8" style="padding-left: 3pt;padding-right: 8pt;text-indent: 0pt;line-height: 8pt;text-align: center;">Total</p><p class="s8" style="padding-left: 3pt;padding-right: 9pt;text-indent: 0pt;line-height: 7pt;text-align: center;">Stockholders’</p></td></tr><tr style="height:9pt"><td style="width:110pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt" colspan="2"><p class="s8" style="padding-left: 13pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Shares Amount</p></td><td style="width:70pt" colspan="2"><p class="s8" style="padding-left: 17pt;padding-right: 17pt;text-indent: 0pt;line-height: 7pt;text-align: center;">Capital</p></td><td style="width:61pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 17pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Cost</p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-right: 10pt;text-indent: 0pt;line-height: 7pt;text-align: center;">Deficit</p></td><td style="width:56pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 14pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Deficit</p></td></tr><tr style="height:11pt"><td style="width:182pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">BALANCES — December 31, 2013</p></td><td style="width:110pt;border-top-style:solid;border-top-width:1pt" colspan="2" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 19pt;text-indent: 0pt;line-height: 8pt;text-align: left;">184,051 $ 1</p></td><td style="width:70pt" colspan="2" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 10pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 9,013</p></td><td style="width:61pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ -</p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: center;">$ (115,068 )</p></td><td style="width:56pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (106,054 )</p></td></tr><tr style="height:11pt"><td style="width:182pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Preferred stock dividends,</p></td><td style="width:110pt" colspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:70pt" colspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:10pt"><td style="width:182pt"><p class="s10" style="padding-left: 17pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Series A and Series B</p></td><td style="width:110pt" colspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:70pt" colspan="2"><p class="s10" style="padding-left: 36pt;text-indent: 0pt;line-height: 8pt;text-align: left;">(3,830 )</p></td><td style="width:61pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(3,830 )</p></td></tr><tr style="height:11pt"><td style="width:182pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Stock-based compensation expense</p></td><td style="width:110pt" colspan="2" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:70pt" colspan="2" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 38pt;text-indent: 0pt;line-height: 8pt;text-align: left;">1,436</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,436</p></td></tr><tr style="height:11pt"><td style="width:182pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Exercise of stock options</p></td><td style="width:110pt" colspan="2"><p class="s10" style="padding-left: 27pt;text-indent: 0pt;line-height: 8pt;text-align: left;">8,633</p></td><td style="width:70pt" colspan="2"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">16</p></td><td style="width:61pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">16</p></td></tr><tr style="height:11pt"><td style="width:182pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 39pt;text-indent: 0pt;line-height: 8pt;text-align: right;">Conversion of redeemable convertible</p></td><td style="width:110pt" colspan="2" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:70pt" colspan="2" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:10pt"><td style="width:182pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 17pt;text-indent: 0pt;line-height: 8pt;text-align: left;">preferred stock</p></td><td style="width:110pt" colspan="2" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 8pt;text-indent: 0pt;line-height: 8pt;text-align: left;">14,861,539 15</p></td><td style="width:70pt" colspan="2" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 34pt;text-indent: 0pt;line-height: 8pt;text-align: left;">44,569</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">44,584</p></td></tr><tr style="height:10pt"><td style="width:182pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Initial public offering, net of issuance</p></td><td style="width:110pt" colspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:70pt" colspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:10pt"><td style="width:182pt"><p class="s10" style="padding-left: 17pt;text-indent: 0pt;line-height: 8pt;text-align: left;">costs</p></td><td style="width:59pt"><p class="s10" style="padding-left: 12pt;text-indent: 0pt;line-height: 8pt;text-align: left;">6,635,000</p></td><td style="width:51pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">6</p></td><td style="width:11pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">45,161</p></td><td style="width:61pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">45,167</p></td></tr><tr style="height:11pt"><td style="width:182pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Net loss</p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:51pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:11pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                          </p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: center;">           (10,160<span class="s10"> )</span></p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           (10,160<span class="s10"> )</span></p></td></tr><tr style="height:12pt"><td style="width:182pt"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">BALANCES — December 31, 2014</p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s21" style="text-indent: 0pt;text-align: left;">    21,689,223</p></td><td style="width:51pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="text-indent: 0pt;text-align: right;">$ 22</p></td><td style="width:11pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;text-align: right;">$ 96,365</p></td><td style="width:61pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="text-indent: 0pt;text-align: left;">$ -</p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;text-align: center;">$ (125,228 )</p></td><td style="width:56pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;text-align: right;">$ (28,841 )</p></td></tr><tr style="height:11pt"><td style="width:182pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Stock-based compensation expense</p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:51pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:11pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">4,712</p></td><td style="width:61pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">4,712</p></td></tr><tr style="height:11pt"><td style="width:182pt"><p class="s10" style="padding-right: 39pt;text-indent: 0pt;line-height: 8pt;text-align: right;">Exercise of stock options and issuance</p></td><td style="width:59pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:51pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:11pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:10pt"><td style="width:182pt"><p class="s10" style="padding-left: 17pt;text-indent: 0pt;line-height: 8pt;text-align: left;">of other stock awards</p></td><td style="width:59pt"><p class="s10" style="padding-left: 19pt;text-indent: 0pt;line-height: 8pt;text-align: left;">424,283</p></td><td style="width:51pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:11pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">469</p></td><td style="width:61pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">469</p></td></tr><tr style="height:11pt"><td style="width:182pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Treasury stock acquired</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(50,149 )</p></td><td style="width:51pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:11pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(177 )</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(177 )</p></td></tr><tr style="height:11pt"><td style="width:182pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Net loss</p></td><td style="width:59pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                         </p></td><td style="width:51pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:11pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p class="s21" style="padding-right: 8pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                         </p></td><td style="width:61pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                          </p></td><td style="width:59pt"><p class="s21" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: center;">             (7,343<span class="s10"> )</span></p></td><td style="width:56pt"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">              (7,343<span class="s10"> )</span></p></td></tr><tr style="height:12pt"><td style="width:182pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">BALANCES — December 31, 2015</p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">    22,063,357</p></td><td style="width:51pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: right;">$ 22</p></td><td style="width:11pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 11pt;text-indent: 0pt;text-align: right;">$ 101,546</p></td><td style="width:61pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ (177 )</p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">$ (132,571 )</p></td><td style="width:56pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;text-align: right;">$ (31,180 )</p></td></tr><tr style="height:11pt"><td style="width:182pt"><p class="s10" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Preferred stock dividends, Series A</p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:51pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:11pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(2,643 )</p></td><td style="width:61pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(2,643 )</p></td></tr><tr style="height:11pt"><td style="width:182pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Stock-based compensation expense</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:51pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:11pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2,662</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2,662</p></td></tr><tr style="height:11pt"><td style="width:182pt"><p class="s10" style="padding-right: 39pt;text-indent: 0pt;line-height: 8pt;text-align: right;">Exercise of stock options and issuance</p></td><td style="width:59pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:51pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:11pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:10pt"><td style="width:182pt"><p class="s10" style="padding-left: 17pt;text-indent: 0pt;line-height: 8pt;text-align: left;">of other stock awards</p></td><td style="width:59pt"><p class="s10" style="padding-left: 19pt;text-indent: 0pt;line-height: 8pt;text-align: left;">512,489</p></td><td style="width:51pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">1</p></td><td style="width:11pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p class="s10" style="padding-right: 11pt;text-indent: 0pt;line-height: 8pt;text-align: right;">420</p></td><td style="width:61pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">421</p></td></tr><tr style="height:11pt"><td style="width:182pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Treasury stock acquired</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(51,191 )</p></td><td style="width:51pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:11pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(110 )</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:56pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(110 )</p></td></tr><tr style="height:11pt"><td style="width:182pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Net loss</p></td><td style="width:59pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                         </p></td><td style="width:51pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:11pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt"><p class="s21" style="padding-right: 8pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                         </p></td><td style="width:61pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                          </p></td><td style="width:59pt"><p class="s21" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: center;">           (26,534<span class="s10"> )</span></p></td><td style="width:56pt"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           (26,534<span class="s10"> )</span></p></td></tr><tr style="height:12pt"><td style="width:182pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">BALANCES — December 31, 2016</p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">    22,524,655</p></td><td style="width:51pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: right;">$ 23</p></td><td style="width:11pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 11pt;text-indent: 0pt;text-align: right;">$ 101,985</p></td><td style="width:61pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ (287 )</p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">$ (159,105 )</p></td><td style="width:56pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;text-align: right;">$ (57,384 )</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"/><p class="s14" style="padding-left: 19pt;text-indent: 0pt;text-align: center;">(In thousands, except share and per share information)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s31" style="padding-left: 249pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="69" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_280.png"/></span>	<span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_281.png"/></span>	<span><img width="67" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_282.png"/></span>	<span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_283.png"/></span>	<span><img width="67" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_284.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s30" style="text-indent: 0pt;text-align: center;">                           </p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s31" style="padding-left: 249pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="68" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_285.png"/></span>	<span><img width="64" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_286.png"/></span>	<span><img width="67" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_287.png"/></span>	<span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_288.png"/></span>	<span><img width="67" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_289.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s30" style="text-indent: 0pt;text-align: center;">                           </p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s31" style="padding-left: 249pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="69" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_290.png"/></span>	<span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_291.png"/></span>	<span><img width="67" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_292.png"/></span>	<span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_293.png"/></span>	<span><img width="67" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_294.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The accompanying notes to the consolidated financial statements are an integral part of the statements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-5</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_295.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">CONNECTURE, INC. AND SUBSIDIARIES</p><p class="s14" style="padding-top: 5pt;padding-left: 141pt;text-indent: 0pt;text-align: center;"><a name="bookmark88">CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2016, 2015 and 2014</a></p><p class="s14" style="padding-left: 19pt;text-indent: 0pt;text-align: center;">(Dollars in thousands)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:8pt"><td style="width:289pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:106pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 53pt;padding-right: 36pt;text-indent: 0pt;line-height: 7pt;text-align: center;">2016</p></td><td style="width:75pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 23pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2015</p></td><td style="width:68pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 23pt;padding-right: 29pt;text-indent: 0pt;line-height: 7pt;text-align: center;">2014</p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">CASH FLOWS FROM OPERATING ACTIVITIES:</p></td><td style="width:106pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:75pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:68pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:289pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Net loss</p></td><td style="width:106pt"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (26,534 )</p></td><td style="width:75pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ (7,343 )</p></td><td style="width:68pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (10,160 )</p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Adjustments to reconcile net loss to net cash used in operating activities</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:75pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:68pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:289pt"><p class="s10" style="padding-left: 22pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Depreciation and amortization</p></td><td style="width:106pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">4,601</p></td><td style="width:75pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,043</p></td><td style="width:68pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,101</p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 22pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Stock-based compensation expense</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2,662</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">4,712</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,436</p></td></tr><tr style="height:11pt"><td style="width:289pt"><p class="s10" style="padding-left: 22pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Interest accretion on financing obligations</p></td><td style="width:106pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">489</p></td><td style="width:75pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">921</p></td><td style="width:68pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,983</p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 22pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Change in fair value of contingent consideration</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(951 )</p></td></tr><tr style="height:11pt"><td style="width:289pt"><p class="s10" style="padding-left: 22pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Other financing fees and non-cash adjustments</p></td><td style="width:106pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2,063</p></td><td style="width:75pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">49</p></td><td style="width:68pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">29</p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 22pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Change in operating assets and liabilities, net of acquisition:</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:75pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:68pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:289pt"><p class="s10" style="padding-left: 34pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Accounts receivable</p></td><td style="width:106pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2,831</p></td><td style="width:75pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,291</p></td><td style="width:68pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">8,782</p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 34pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Prepaid expenses and other assets</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(546 )</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">757</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(495 )</p></td></tr><tr style="height:11pt"><td style="width:289pt"><p class="s10" style="padding-left: 34pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Deferred implementation costs</p></td><td style="width:106pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,308</p></td><td style="width:75pt"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(13 )</p></td><td style="width:68pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(4,653 )</p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 34pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Accounts payable</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">263</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,856</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(3,463 )</p></td></tr><tr style="height:11pt"><td style="width:289pt"><p class="s10" style="padding-left: 34pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Accrued expenses and other liabilities</p></td><td style="width:106pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">623</p></td><td style="width:75pt"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(2,306 )</p></td><td style="width:68pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(3,744 )</p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 34pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Deferred revenue</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                  (12,229<span class="s10"> )</span></p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                  (21,159<span class="s10"> )</span></p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                  (14,118<span class="s10"> )</span></p></td></tr><tr style="height:14pt"><td style="width:289pt"><p class="s10" style="padding-top: 1pt;padding-left: 45pt;text-indent: 0pt;text-align: left;">Net cash used in operating activities</p></td><td style="width:106pt"><p class="s21" style="padding-top: 1pt;padding-right: 9pt;text-indent: 0pt;text-align: right;">                  (24,469<span class="s10"> )</span></p></td><td style="width:75pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">                  (16,192<span class="s10"> )</span></p></td><td style="width:68pt"><p class="s21" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;text-align: right;">                  (20,253<span class="s10"> )</span></p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">CASH FLOWS FROM INVESTING ACTIVITIES:</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:75pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:68pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:289pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Purchases of property and equipment</p></td><td style="width:106pt"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(999 )</p></td><td style="width:75pt"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(1,317 )</p></td><td style="width:68pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(837 )</p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Business acquisition, net of cash acquired</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                    (4,683<span class="s10"> )</span></p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                           —</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                           —</p></td></tr><tr style="height:14pt"><td style="width:289pt"><p class="s10" style="padding-top: 1pt;padding-left: 45pt;text-indent: 0pt;text-align: left;">Net cash used in investing activities</p></td><td style="width:106pt"><p class="s21" style="padding-top: 1pt;padding-right: 9pt;text-indent: 0pt;text-align: right;">                    (5,682<span class="s10"> )</span></p></td><td style="width:75pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">                    (1,317<span class="s10"> )</span></p></td><td style="width:68pt"><p class="s21" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;text-align: right;">                       (837<span class="s10"> )</span></p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">CASH FLOWS FROM FINANCING ACTIVITIES:</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:75pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:68pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:289pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Borrowings under revolving line of credit</p></td><td style="width:106pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">3,550</p></td><td style="width:75pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td><td style="width:68pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">12,030</p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Repayments under revolving line of credit</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(3,550 )</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(340 )</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(16,791 )</p></td></tr><tr style="height:11pt"><td style="width:289pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Borrowings of term debt</p></td><td style="width:106pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">16,156</p></td><td style="width:75pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td><td style="width:68pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">20,767</p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Repayments of term debt</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(33,337 )</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(4,025 )</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(2,375 )</p></td></tr><tr style="height:11pt"><td style="width:289pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Payment of financing fees</p></td><td style="width:106pt"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(1,372 )</p></td><td style="width:75pt"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(103 )</p></td><td style="width:68pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(715 )</p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Payment of capital lease obligations</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(74 )</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(418 )</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(489 )</p></td></tr><tr style="height:11pt"><td style="width:289pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Payment of deferred business acquisition purchase price</p></td><td style="width:106pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td><td style="width:75pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td><td style="width:68pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(2,294 )</p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Proceeds from initial public offering, net of issuance costs</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(725 )</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">45,907</p></td></tr><tr style="height:11pt"><td style="width:289pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Dividends paid</p></td><td style="width:106pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td><td style="width:75pt"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td><td style="width:68pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(8,991 )</p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Proceeds from preferred stock, net</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">49,251</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td></tr><tr style="height:11pt"><td style="width:289pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Other</p></td><td style="width:106pt"><p class="s21" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                         311</p></td><td style="width:75pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                         292</p></td><td style="width:68pt"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                           16</p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 45pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Net cash provided by (used in) financing activities</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                   30,935</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                    (5,319<span class="s10"> )</span></p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                   47,065</p></td></tr><tr style="height:11pt"><td style="width:289pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS</p></td><td style="width:106pt"><p class="s10" style="padding-top: 1pt;padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">784</p></td><td style="width:75pt"><p class="s10" style="padding-top: 1pt;padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(22,828 )</p></td><td style="width:68pt"><p class="s10" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">25,975</p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">CASH AND CASH EQUIVALENTS — Beginning of period</p></td><td style="width:106pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 12pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                      5,424</p></td><td style="width:75pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                   28,252</p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                      2,277</p></td></tr><tr style="height:12pt"><td style="width:289pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">CASH AND CASH EQUIVALENTS — End of period</p></td><td style="width:106pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s21" style="padding-top: 1pt;padding-right: 12pt;text-indent: 0pt;text-align: right;">$ 6,208</p></td><td style="width:75pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ 5,424</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="85" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_296.png"/></span></p></td><td style="width:68pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;text-align: right;">$ 28,252</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="85" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_297.png"/></span></p></td></tr><tr style="height:10pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">SUPPLEMENTAL CASH FLOW INFORMATION:</p></td><td style="width:106pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:75pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:68pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:12pt"><td style="width:289pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Cash paid for interest</p></td><td style="width:106pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s21" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">$ 3,363</p></td><td style="width:75pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="text-indent: 0pt;text-align: left;">$ 5,721</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="85" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_298.png"/></span></p></td><td style="width:68pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;text-align: right;">$ 5,627</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="85" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_299.png"/></span></p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Cash (received) paid for income taxes</p></td><td style="width:106pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 9pt;text-indent: 0pt;text-align: right;">$ (15<span class="s10"> )</span></p></td><td style="width:75pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;text-align: left;">$ 15</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="85" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_300.png"/></span></p></td><td style="width:68pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;text-align: right;">$ 245</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="85" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_301.png"/></span></p></td></tr><tr style="height:10pt"><td style="width:289pt"><p class="s10" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Non-cash investing and financing activities:</p></td><td style="width:106pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:75pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:68pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:12pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 22pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Purchase of property and equipment in accounts payable</p></td><td style="width:106pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">$ 4</p></td><td style="width:75pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;text-align: left;">$ —</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="83" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_302.png"/></span></p></td><td style="width:68pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;text-align: right;">$ 15</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="83" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_303.png"/></span></p></td></tr><tr style="height:11pt"><td style="width:289pt"><p class="s10" style="padding-top: 1pt;padding-left: 22pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Direct issuance costs in accounts payable</p></td><td style="width:106pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s21" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">$ —</p></td><td style="width:75pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="text-indent: 0pt;text-align: left;">$ —</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="83" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_304.png"/></span></p></td><td style="width:68pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;text-align: right;">$ 740</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="83" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_305.png"/></span></p></td></tr><tr style="height:11pt"><td style="width:289pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 22pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Accrued preferred stock dividends</p></td><td style="width:106pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">$ 2,643</p></td><td style="width:75pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;text-align: left;">$ —</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="83" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_306.png"/></span></p></td><td style="width:68pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;text-align: right;">$ —</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="83" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_307.png"/></span></p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The accompanying notes to the consolidated financial statements are an integral part of the statements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-6</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_308.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">CONNECTURE, INC. AND SUBSIDIARIES</p><p class="s14" style="padding-top: 5pt;padding-left: 19pt;text-indent: 0pt;text-align: center;"><a name="bookmark89">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</a></p><p class="s14" style="padding-left: 19pt;text-indent: 0pt;text-align: center;">AS OF AND FOR THE YEARS ENDED DECEMBER 31, 2016, 2015 and 2014</p><p class="s14" style="padding-left: 19pt;text-indent: 0pt;text-align: center;">(Dollars in thousands, except share and per share information)</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l15"><li style="padding-left: 16pt;text-indent: -8pt;text-align: left;"><p class="s14" style="display: inline;">DESCRIPTION OF BUSINESS</p><p class="s14" style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Description of Business<span class="p">—Connecture, Inc. and its subsidiaries, including DestinationRx, Inc., or DRX, RxHealth Insurance Agency, Inc., ConnectedHealth, LLC, and Insurix, Inc. (collectively, the “Company”), is a Delaware corporation. The Company is a web-based consumer shopping, enrollment and retention platform for health insurance distribution in the United States. The Company’s solutions offer a personalized health insurance shopping experience that recommends the best fit insurance plan based on an individual’s preferences, health status, preferred providers, medications and expected out-of-pocket costs. The Company’s customers are payers, brokers, government agencies, and web-based insurance marketplace operators, who distribute health and ancillary insurance. The Company’s solutions automate key functions in the insurance distribution process, allowing customers to price and present plan options accurately to consumers and efficiently enroll, renew and manage plan members.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">On June 7, 2016, the Company acquired ConnectedHealth, LLC, a benefits technology company with a software and services platform that makes it easier for consumers and employees to shop for personalized insurance benefits online.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 16pt;text-indent: -8pt;text-align: left;"><p class="s14" style="display: inline;">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</p><p class="s14" style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Basis of Presentation<span class="p">—The consolidated financial statements include the accounts of Connecture, Inc. and its wholly owned subsidiaries. All inter-company transactions and balances have been eliminated.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Use of Estimates<span class="p">—The preparation of financial statements in conformity with generally accepted accounting principles requires management to make extensive estimates and assumptions that affect the amounts reported in the financial statements and the accompanying notes. Actual results could differ from those estimates.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Cash and Cash Equivalents<span class="p">—The Company considers all highly liquid investments with maturities of three months or less when purchased to be cash equivalents. Cash and cash equivalents are maintained at financial institutions and, at times, balances may exceed federally insured limits. The Company has never experienced any losses related to these balances. Amounts on deposit in excess of federally insured limits as of December 31, 2016 were $5,958.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Accounts Receivable and Allowance for Doubtful Accounts<span class="p">—The Company’s normal and customary terms for customer payment is 30 days. The outstanding accounts receivable can vary significantly based on timing of billing milestones, renewals and other factors. When necessary, the Company maintains an allowance for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. The estimates are based on the composition of the accounts receivable aging, historical bad debts, changes in payment patterns, customer creditworthiness, and current economic trends. The Company writes off uncollectible receivables after all reasonable efforts are made to collect payment.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Property and Equipment<span class="p">—Property and equipment are stated at historical cost and depreciated using the straight-line method over the estimated useful lives of the assets, generally three to five years. Repairs and maintenance are charged to expense as incurred and major leasehold improvements are capitalized and amortized over the remaining term of the lease or their estimated useful lives, whichever is shorter. The Company records a gain or loss on the disposal of property and equipment based on the difference between the proceeds received, if any, and the net book value of the assets disposed on the date of disposal.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Impairment of Long-Lived Assets<span class="p">—The Company evaluates its long-lived assets for potential impairment when impairment indicators exist. Potential impairment is assessed when there is evidence that events or changes in circumstances have occurred that indicate that the carrying amount of an asset may not be recovered. The Company had no impairments during the years ended December 31, 2016, 2015 and 2014.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Intangible Assets<span class="p">—Intangible assets with definite lives are amortized using the straight-line method over their estimated useful lives, ranging from three to ten years. The carrying amount of intangible assets are reviewed whenever circumstances arise that indicate the carrying amount of an asset may not be recoverable. Recoverability of intangible assets is compared to the undiscounted future cash flows the assets are expected to generate. If the asset is considered to be impaired, the carrying value is compared to the fair value and this difference is recognized as an impairment loss. The Company had no impairments of intangible assets during the years ended December 31, 2016, 2015 and 2014.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 4pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-7</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_309.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Goodwill<span class="p">—Goodwill represents the excess of purchase price over the fair value of identifiable net assets acquired and liabilities assumed in a business combination. Goodwill is tested annually, as of October 31, for impairment at a reporting unit level.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company evaluates goodwill for impairment on an annual basis, or more frequently if an event or circumstance changes that would indicate that goodwill might be impaired. These events or circumstances would include a significant change in the business climate, legal factors, operating performance indicators, competition, sale or disposition of a significant portion of the business, or other factors.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company had no impairments of goodwill since inception.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Financial Instruments and Concentration of Credit Risk<span class="p">—The estimated fair values of the Company’s financial instruments, which include cash equivalents, accounts receivable and accounts payable, approximate their carrying values due to the short-term nature of these instruments.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Financial instruments that potentially subject the Company to concentrations of credit risk are principally cash and cash equivalents and accounts receivable. The Company’s credit risk is managed by investing its cash and cash equivalents in high quality money market instruments with established financial institutions. Concentrations of credit risk related to accounts receivable are limited to several customers to whom the Company makes substantial sales.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company has not experienced any material losses related to receivables from individual customers, geographic regions or groups of customers. As of and for the year ended December 31, 2016, the Company had the following customers that accounted for 10% or more of total revenue and/or total accounts receivable:</p><p class="s3" style="padding-left: 449pt;text-indent: 0pt;text-align: left;">2016</p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:9pt"><td style="width:368pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="text-indent: 0pt;line-height: 7pt;text-align: left;">Customers</p></td><td style="width:51pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 23pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Revenue</p></td><td style="width:36pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:83pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 6pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Accounts Receivable</p></td></tr><tr style="height:11pt"><td style="width:368pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">A</p></td><td style="width:51pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:36pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 6pt;text-indent: 0pt;line-height: 8pt;text-align: left;">13.4 %</p></td><td style="width:83pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 54pt;text-indent: 0pt;line-height: 8pt;text-align: left;">&lt;10%</p></td></tr><tr style="height:10pt"><td style="width:368pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">B</p></td><td style="width:51pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:36pt"><p class="s10" style="padding-left: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">&lt;10%</p></td><td style="width:83pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">12.3 %</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">No customers accounted for 10% or more of total revenue and/or total accounts receivable as of and for the year ended December 31, 2015. One customer accounted for 11.8% of total revenue for the year ended December 31, 2014.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Advertising Costs<span class="p">—Advertising costs are expensed as incurred. Advertising costs for the years ended December 31, 2016, 2015 and 2014, were $486, $502 and $560, respectively.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Fair Value Measurements<span class="p">—Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) 820, “Fair Value Measurements”, establishes a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that inputs that are most observable be used when available. Observable inputs are inputs that market participants operating within the same marketplace as the Company would use in pricing the Company’s asset or liability based on independently derived and objectively determinable market data. Unobservable inputs are inputs that cannot be sourced from a broad active market in which assets or liabilities identical or similar to those of the Company are traded. The input hierarchy is broken down into three levels based on the degree to which the exit price is independently observable or determinable as follows:</span></p><p class="s15" style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Level 1<span class="p">—Valuation based on quoted market prices in active markets for identical assets or liabilities. Since valuations are based on quoted prices that are readily and regularly available in an active market, they do not entail a significant degree of judgment. The Company has no Level 1 financial instrument assets or liabilities.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Level 2<span class="p">—Valuation based on quoted market prices of investments that are not actively traded or for which certain significant inputs are not observable, either directly or indirectly, such as municipal bonds. The Company has no Level 2 financial instrument assets or liabilities.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Level 3<span class="p">—Valuation based on inputs that are unobservable and reflect management’s best estimate of what market participants would use as fair value. The Company’s only Level 3 financial instrument was the DRX acquisition contingent consideration settled in the year ended December 31, 2015 (See Note 4).</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Revenue Recognition<span class="p">—The Company’s revenue is derived from four sources: (a) the sales of implementation and ongoing support of the Company’s software automation solutions; (b) fees from brokers for the right to access our multi-payer quoting platform; (c) a government cost-plus-fixed-fee contract; and (d) commissions. In all contractual arrangements, the Company determines whether persuasive evidence of an arrangement exists, services have been rendered, the fee is fixed or determinable and collection is probable. If any of these criteria are not met, the Company does not recognize revenue until all of the criteria are met.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-8</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_310.png"/></span></p><ol id="l16"><li style="padding-top: 3pt;padding-left: 40pt;text-indent: -8pt;text-align: left;"><h4 style="display: inline;">Software Automation Solutions Fees</h4><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">Contractual terms for the delivery and ongoing support of the Company’s software automation solutions generally consist of multiple components including: (a) software license fees (non-hosted arrangements), (b) software usage fees, (c) software maintenance fees, (d) professional services fees, (e) hosting fees and (f) production support fees.</p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">Software license fees represent amounts paid for the right to use the solution. Software usage fees represent amounts paid to cover only a specific period of time, after which usage and access rights expire. Software maintenance fees typically accompany software license fees and represent amounts paid for the right to receive commercially available updates and upgrades to the solution. Professional services fees represent amounts charged for services performed in connection with the configuration, integration and implementation of the solutions in accordance with customer specifications. Hosting fees represent fees related to post implementation hosting and monitoring of the solution. Production support fees are charged for the ongoing rate, benefits and related content management of the platform.</p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">The Company’s contracts with its customers typically bundle multiple services and are generally priced on a fixed fee basis. The term over which the Company is committed to deliver these services can range from several months to several years.</p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">The majority of the Company’s software automation solution services sold in the Enterprise/Commercial and Medicare segments and a portion of the Private Exchange segment are arrangements in which the Company hosts the web-based software automation solution and the customer pays a fee for access to and usage of the web-based software. The ownership of the technology and rights to the related code of such hosted web-based software remain with the Company and a customer has no contractual right to take possession of the software and run it on its own hardware platform. These arrangements are referred to as hosted arrangements and are accounted for as software-as-a-service under ASC 605, Revenue Recognition. A small percentage of the Company’s software automation solutions, sold primarily in the Enterprise/State segment, are arrangements in which the software is not hosted on the Company’s infrastructure. These arrangements include the licensed use of the software and are subject to accounting under ASC 985, Software Revenue Recognition.</p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">For all arrangements (whether hosted or non-hosted) that include multiple elements, the Company evaluates each element in an arrangement to determine whether it represents a separate unit of accounting. An element constitutes a separate unit of accounting when the delivered item has standalone value and delivery of the undelivered element is probable. Elements generally include implementation services, software licensing or usage fees and maintenance or other services.</p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">Accounting guidance for multiple element arrangements containing hosted software provide a hierarchy to use when determining the relative selling price for each unit of accounting. Vendor-specific objective evidence (VSOE) of selling price, based on the price at which the item is regularly sold by the vendor on a standalone basis, should be used if it exists. If VSOE of selling price is not available, third-party evidence of selling price is used to establish the selling price if it exists. If VSOE and third-party evidence do not exist, the Company allocates the arrangement fee to the separate units of accounting based on its best estimate of selling price.</p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">For hosted arrangements with multiple elements that are separate units of accounting, VSOE and third- party evidence do not currently exist and accordingly, the Company allocates the arrangement fee to the separate units of accounting based on management’s best estimate of selling price, when available. The Company determines its best estimate of selling price for services based on its overall pricing objectives, taking into consideration market conditions and customer-specific factors and by reviewing historical data related to sales of the Company’s services.</p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">Hosted arrangement revenue is recognized as follows by revenue element:</p><ul id="l17"><li style="padding-top: 5pt;padding-left: 80pt;text-indent: -24pt;text-align: left;"><p class="s14" style="display: inline;">Software usage fees and hosting fees<span class="p">—Recognized ratably over the longer of the customer contract or estimated period of customer benefit based on facts and circumstances of each relationship.</span></p></li><li style="padding-top: 5pt;padding-left: 80pt;text-indent: -24pt;text-align: justify;"><p class="s14" style="display: inline;">Professional services for new customer software solution implementation<span class="p">—Initially deferred and recognized ratably from completion of implementation through the longer of the customer contract or estimated period of customer benefit based on facts and circumstances of each relationship.</span></p></li><li style="padding-top: 5pt;padding-left: 80pt;text-indent: -24pt;text-align: left;"><p class="s14" style="display: inline;">Professional services for modifications to existing customer software solutions<span class="p">—Initially deferred and then recognized in the period services are completed.</span></p></li><li style="padding-top: 5pt;padding-left: 80pt;text-indent: -24pt;text-align: left;"><p class="s14" style="display: inline;">Production support fees<span class="p">—Recognized as the work is performed consistent with the contractual terms of the production support.</span></p><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">Multiple deliverable arrangements accounting guidance for non-hosted arrangements provide an allocation of revenue to the separate elements based upon VSOE. To date, the elements of the Company’s non-hosted arrangements, whereby the customers take possession of the software, have not been sold separately. Therefore, the contractual consideration for a delivered element for the non-hosted arrangements does not qualify as a separate unit of accounting as VSOE does not currently exist for any element of the Company’s non-hosted arrangements. Accordingly, the delivered elements are combined with the other</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-9</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_311.png"/></span></p><p style="padding-top: 3pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">consideration for the remaining undelivered elements as a single unit of accounting. Revenue for non-hosted arrangements is recognized once all elements are delivered over the longer of the customer contract or estimated period of customer benefit. As of December 31, 2016 the Company has a non-hosted arrangement with one remaining Enterprise/State customer.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li></ul></li><li style="padding-left: 40pt;text-indent: -8pt;text-align: left;"><h4 style="display: inline;">Broker Multi-Payer Quoting Platform Fees</h4><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">The Company provides an online quoting platform service to insurance brokers through its Private Exchange segment. The Company charges the brokers a monthly fee for access to the service. Revenue from the access fees is recognized in the period that the service is provided.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 40pt;text-indent: -8pt;text-align: left;"><h4 style="display: inline;">Government Cost-Plus-Fixed-Fee</h4><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">The Company used a percentage-of-completion method of accounting for its federal government contract in its Medicare segment prior to the fourth quarter of 2015. Under percentage-of-completion, the costs incurred to date had been compared to total estimated project costs and revenue was recognized in proportion to costs incurred. In the fourth quarter of 2015, the contract was renewed as a fixed fee contract and is accounted for as a multiple element arrangement.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 40pt;text-indent: -8pt;text-align: left;"><h4 style="display: inline;">Commissions</h4><p style="padding-top: 5pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">Within the Private Exchange segment, the Company earns commissions on annual employee enrollments in which the Company’s health plan network and software solutions are used in connection with each enrollment. Commissions are recorded in the period the enrollment is completed.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Cost of Revenue<span class="p">—Cost of revenue primarily consists of employee compensation and benefits, professional services costs and depreciation and amortization of assets directly associated with generating revenue. In addition, the Company allocates a portion of overhead, such as rent, facility depreciation and utilities, to cost of revenue based on employee salary.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Deferred Implementation Costs<span class="p">—The Company’s accounting policy is to capitalize direct, incremental employee labor and fringe benefits along with third- party independent contractor costs related to implementing new customer software solutions, to the extent that they are deemed recoverable. Deferred implementation costs as of December 31, 2016, and 2015 are $23,257 and $24,565, respectively, with the increases for new customer implementations, offset by current period amortization on installed customer solutions. Deferred implementation costs are amortized over the respective term of the customer arrangement consistent with the recognition of deferred revenue.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Stock-Based Compensation<span class="p">—The Company applies a fair-value based measurement method in accounting for stock-based payment transactions. Compensation cost is determined based on the grant-date fair value for stock options and performance-based restricted stock units and the grant-date closing market value for time-vested restricted stock units. Compensation cost is amortized on a straight-line basis over the vesting period for time-based awards and over the derived service period for performance-based restricted stock units.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Preferred Stock Dividends<span class="p">—Given the Company’s accumulated deficit, the Company’s accounting policy is to record the mandatorily payable dividends as a reduction of additional paid-in capital (APIC) with the offset as an increase to redeemable preferred stock on the consolidated balance sheets.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Comprehensive Loss<span class="p">—The Company’s net loss equals comprehensive loss for the years ending December 31, 2016, 2015 and 2014.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Income Taxes<span class="p">—Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that the change becomes enacted. Valuation allowances are established when necessary to reduce deferred tax assets to the amounts expected to be realized. The Company’s policy for recording interest and penalties associated with uncertain tax positions is to record such items in income tax expense.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;line-height: 106%;text-align: left;">Basic and Diluted Net Loss Per Common Share<span class="p">— The Company uses the two-class method to compute net earnings per common share because the Company has issued securities, other than common stock, that contractually entitle the holders to participate in dividends and earnings of the Company. The two-class method requires earnings for the period to be allocated between common stock and participating securities based upon their respective rights to receive distributed and undistributed earnings. Holders of the</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-10</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_312.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Company’s redeemable convertible preferred stock are entitled to participate in distributions, when and if declared by the Board of Directors that are made to common stockholders, and as a result are considered participating securities.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Under the two-class method, for periods with net income, basic net income per common share is computed by dividing the net income attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Net income attributable to common stockholders is computed by subtracting from net income the portion of current year earnings that the participating securities would have been entitled to receive pursuant to their dividend rights had all of the year’s earnings been distributed. No such adjustment to earnings is made during periods with a net loss, as the holders of the participating securities have no obligation to fund losses.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Due to net losses for the years ended December 31, 2016, 2015 and 2014, basic and diluted loss per share were the same, as the effect of potentially dilutive securities would have been anti-dilutive.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><b>New Accounting Standards</b>—In May 2014, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, No. 2014-09, <i>Revenue from Contracts with Customers (Topic 606)</i>, that outlines a single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most current revenue recognition guidance, including industry-specific guidance. The ASU is based on the principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The ASU also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to fulfill a contract. Entities have the option of using either a full retrospective or a modified retrospective approach for the adoption of the new standard. Assuming the Company remains an emerging growth company (EGC), the ASU becomes effective for the Company in the fiscal year ended December 31, 2019; early adoption is permitted. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: justify;">In August 2014, the FASB issued ASU No. 2014-15, <i>Disclosure of Uncertainties About an Entity’s Ability to Continue as a Going Concern</i>, which requires interim and annual assessments of an entity’s ability to continue as a going concern within one year of the date the financial statements are issued, and also requires certain disclosures if conditions or events raise substantial doubt about the entity’s ability to continue as a going concern. The ASU is effective for annual periods ending after December 15, 2016. The Company has adopted the provisions of the statement (see Note 3).</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">In February 2016, the FASB issued ASU 2016-02, <i>Leases, </i>which amends the existing accounting standards for lease accounting, including requiring lessees to recognize most leases on their balance sheet. Assuming the Company remains an EGC through December 31, 2019, the provisions of this update are expected to be effective for the Company beginning in the first quarter of 2020. Early adoption of ASU 2016-02 is permitted. The new leases standard requires a modified retrospective transition approach for all leases existing at, or entered into after, the date of initial application, with an option to use certain transition relief. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">In March 2016, the FASB issued ASU No. 2016-09, <i>Compensation – Stock Compensation</i>, which simplifies several aspects of the accounting for stock compensation, including the accounting for income tax effects, forfeitures, statutory tax withholdings, and cash flow classifications. Assuming the Company remains an EGC through December 31, 2019, the provisions of this update are effective for the fiscal year ended December 31, 2018. Early adoption is permitted in any interim or annual period. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">In August 2016, the FASB issued ASU No. 2016-15, <i>Statement of Cash Flows – Classification of Certain Cash Receipts and Cash Payments</i>, which clarifies cash flow statement classifications to be used for debt prepayment and debt extinguishment costs, settlement of debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing, contingent consideration payments made after a business acquisition, proceeds from the settlement of insurance claims, and other cash flow transactions. Assuming the Company remains an EGC through December 31, 2019, the provisions of this update are effective for the fiscal year ended December 31, 2019 and interim periods thereafter. Early adoption is permitted in any interim or annual period. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">In January 2017, the FASB issued ASU No. 2017-05, <i>Simplifying the Test for Goodwill Impairment</i>, which eliminates Step 2 of the goodwill impairment test requiring a hypothetical purchase price allocation. A goodwill impairment will now be the amount by which a reporting unit’s carrying value exceeds its fair value, not to exceed the carrying amount of goodwill. Additionally, the one-step impairment test will be applied to goodwill at all reporting units, even those with zero or negative carrying amounts. The provisions of this update are effective for annual and any interim impairment tests for periods beginning after December 15, 2019. Early adoption is permitted for any impairment tests performed after January 1, 2017. The Company is currently assessing the impact that this standard will have on its consolidated financial statements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-11</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_313.png"/></span></p></li></ol></li><li style="padding-top: 3pt;padding-left: 16pt;text-indent: -8pt;text-align: left;"><p class="s14" style="display: inline;">GOING CONCERN AND MANAGEMENT’S PLAN</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company’s primary need for liquidity is to fund working capital requirements, capital expenditures and for general corporate purposes, including debt repayment. For the years ended December 31, 2016, 2015, and 2014, net losses from continuing operations were $20,870, $1,487, and $4,258, respectively, and cash used in operations was $24,469, $16,192, and $20,253, respectively. The Company has taken a number of actions in 2016 and the first quarter of 2017 to continue to support its operations and meet its obligations.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">As discussed in Note 10, the Company completed the issuance of a newly created Series A Convertible Preferred Stock (the “Series A Preferred Stock”) for an aggregate purchase price of $52,000 in May 2016. In addition, as discussed in Note 9, the Company completed a June 2016 amendment and extension of its existing senior credit facility resulting in the extension of the facility to June 8, 2021 from January 18, 2018 and increased the term loan funding to $35,000 from approximately $20,000. The funds received from these actions were used to repay $30,000 of outstanding subordinated term loans, to fund working capital and for other general corporate purposes.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">In the second half of 2016 the Company put a greater focus on overall profitability and aligning its cost structure with revenue and customer billings. The Company reduced its headcount to 370 at December 31, 2016, compared to 411 at December 31, 2015. The Company also began consolidating the procurement of outside contract labor resources.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">On January 1, 2017, the Company hired a new Chief Financial Officer to bring additional financial and operational experience to the Company. Under the new Chief Financial Officer’s leadership the Company has continued to evaluate and reduce headcount and eliminate certain other expenditures to better align resources with the 2017 operating plan. Based on cost reduction actions taken in 2016 and those taken or planned to be taken in 2017, as well as steps taken to evaluate and improve pricing of the Company’s software solutions and services, the Company projects cash used in operations to decrease in 2017, compared to 2016.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">In addition, in March 2017, the Company completed the issuance of a newly created Series B Convertible Preferred Stock (the “Series B Preferred Stock”) for an aggregate purchase price of $17,500 less approximately $675 of transaction fees (See Note 10). The Company used $624 of the proceeds to repay the outstanding balance on the Company&#39;s senior revolving credit facility, with the remainder of the net proceeds available for general corporate purposes.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Finally, in March 2017, the Company amended its senior credit facility to, among other things, (i) defer scheduled Senior Term Loan principal repayments until March 31, 2018, and (ii) revise the EBITDA and Minimum Liquidity covenants (See Note 9). The deferral of the principal repayments provides approximately $2,500 of additional liquidity through December 31, 2017.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">While the Company’s historical operating results indicate conditions exist that raise uncertainty related to the Company&#39;s ability to continue as a going concern, the Company believes that the actions discussed above are probable of occurring and mitigating the uncertainty raised by the Company’s historical operating results. Accordingly, the Company expects it will have sufficient liquidity to meet obligations as they come due in the 12 months from the issuance of the consolidated financial statements.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 16pt;text-indent: -8pt;text-align: left;"><p class="s14" style="display: inline;">NET LOSS PER COMMON SHARE</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Diluted loss per common share is the same as basic loss per common share for all periods presented because the effects of potentially dilutive items were anti- dilutive given the Company’s net loss. The following common share equivalent securities have been excluded from the calculation of weighted-average common shares outstanding because the effect is anti-dilutive for the periods presented:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 270pt;text-indent: 0pt;text-align: center;">Year Ended December 31</p><p style="padding-left: 317pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="227" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_314.png"/></span></p><p class="s3" style="padding-left: 270pt;text-indent: 0pt;text-align: center;">2016                       2015                       2014</p><p class="s34" style="padding-left: 317pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="67" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_315.png"/></span> <span><img width="67" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_316.png"/></span> <span><img width="67" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_317.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_318.png"/></span></p><p style="padding-bottom: 1pt;padding-left: 61pt;text-indent: 0pt;text-align: left;"><span class="s35" style=" background-color: #CEEFFB;">Anti-Dilutive Common Share Equivalents                                                                                                                                             </span></p><table style="border-collapse:collapse;margin-left:61.8254pt" cellspacing="0"><tr style="height:10pt"><td style="width:182pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Redeemable convertible preferred stock</p></td><td style="width:57pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:68pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">7,888,440</p></td><td style="width:9pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:51pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td><td style="width:9pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:55pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">14,047,208</p></td></tr><tr style="height:11pt"><td style="width:182pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Restricted Stock Units</p></td><td style="width:57pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:68pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">1,047</p></td><td style="width:9pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:51pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">53,454</p></td><td style="width:9pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td></tr><tr style="height:11pt"><td style="width:182pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Stock options</p></td><td style="width:57pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:68pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: right;">           177,010</p></td><td style="width:9pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:51pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: right;">        1,069,243</p></td><td style="width:9pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:55pt"><p class="s21" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">        1,373,895</p></td></tr><tr style="height:12pt"><td style="width:182pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Total anti-dilutive common share equivalents</p></td><td style="width:57pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:68pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;text-align: right;">        8,066,497</p></td><td style="width:9pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:51pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: right;">1,122,697</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="68" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_319.png"/></span></p></td><td style="width:9pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:55pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 4pt;text-indent: 0pt;text-align: right;">15,421,103</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="68" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_320.png"/></span></p></td></tr><tr style="height:33pt"><td style="width:182pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:57pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 25pt;text-indent: 0pt;text-align: left;">F-12</p></td><td style="width:68pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:9pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:51pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:9pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:55pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr></table><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Basic and diluted net loss per common share is calculated as follows:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 268pt;text-indent: 0pt;text-align: center;">Year Ended December 31</p><p style="padding-left: 315pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="229" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_321.png"/></span></p><p class="s3" style="padding-left: 268pt;text-indent: 0pt;text-align: center;">2016                        2015                       2014</p><p class="s34" style="padding-left: 315pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="68" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_322.png"/></span> <span><img width="68" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_323.png"/></span> <span><img width="68" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_324.png"/></span></p><p style="padding-bottom: 1pt;padding-left: 61pt;text-indent: 0pt;text-align: left;"><span class="s36" style=" background-color: #CEEFFB;">Numerator:                                                                                                                                                                                                    </span></p><table style="border-collapse:collapse;margin-left:61.8254pt" cellspacing="0"><tr style="height:10pt"><td style="width:197pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Net loss</p></td><td style="width:114pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (26,534 )</p></td><td style="width:61pt"><p class="s10" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ (7,343 )</p></td><td style="width:59pt"><p class="s10" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ (10,160 )</p></td></tr><tr style="height:11pt"><td style="width:197pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Less: Preferred stock dividends</p></td><td style="width:114pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">               2,643</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s21" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                     —</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s21" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">               3,830</p></td></tr><tr style="height:11pt"><td style="width:197pt"><p class="s10" style="padding-top: 1pt;padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Net loss attributable to common stock</p></td><td style="width:114pt"><p class="s10" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (29,177 )</p></td><td style="width:61pt"><p class="s10" style="padding-top: 1pt;padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ (7,343 )</p></td><td style="width:59pt"><p class="s10" style="padding-top: 1pt;padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ (13,990 )</p></td></tr></table><p style="padding-left: 73pt;text-indent: -11pt;line-height: 110%;text-align: left;"><span class="s36" style=" background-color: #CEEFFB;">Denominator:</span><span class="s37"> Weighted-average common shares outstanding,</span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="574" height="17" alt="image" src="NASDAQ_CNXR_2016/Image_325.png"/></span></p><p style="padding-left: 78pt;text-indent: 0pt;line-height: 9pt;text-align: left;">basic and diluted<u> 22,275,256 21,813,407 1,362,109</u></p><p style="padding-top: 1pt;padding-left: 61pt;text-indent: 0pt;text-align: left;">Net loss per common share, basic and diluted <u>$ (1.31</u> ) $ (0.34 ) $ (10.27 )</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-top: 7pt;padding-left: 16pt;text-indent: -8pt;text-align: left;"><p class="s14" style="display: inline;">CONNECTEDHEALTH ACQUISITION</p></li></ol><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">On June 7, 2016, the Company completed the acquisition of all equity units of ConnectedHealth, LLC (“ConnectedHealth”) for a cash purchase price of</p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">$4,601, net of cash acquired and a working capital adjustment, using available excess cash. ConnectedHealth is a benefits technology company with a software and services platform that makes it easier for consumers and employees to shop for personalized insurance benefits online. The Company completed the acquisition to acquire ConnectedHealth’s software technology.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The acquisition of ConnectedHealth was accounted for as a business combination in accordance with FASB ASC Topic 805, Business Combinations. Assets acquired and liabilities assumed were recorded at their fair value as of the acquisition date based on valuations using the income approach. The excess of purchase price over the estimated fair values of tangible assets, intangible assets and assumed liabilities was recorded as goodwill.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The allocation of the purchase price for ConnectedHealth as of December 31, 2016, is as follows:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:115.651pt" cellspacing="0"><tr style="height:11pt"><td style="width:210pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Cash and cash equivalents</p></td><td style="width:113pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 25</p></td></tr><tr style="height:11pt"><td style="width:210pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Trade accounts receivable</p></td><td style="width:113pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">428</p></td></tr><tr style="height:11pt"><td style="width:210pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Prepaid expenses and other current assets</p></td><td style="width:113pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">31</p></td></tr><tr style="height:11pt"><td style="width:210pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Intangible assets</p></td><td style="width:113pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,200</p></td></tr><tr style="height:11pt"><td style="width:210pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Goodwill</p></td><td style="width:113pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">4,293</p></td></tr><tr style="height:11pt"><td style="width:210pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Other long-term assets</p></td><td style="width:113pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">54</p></td></tr><tr style="height:11pt"><td style="width:210pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Accounts payable and other current liabilities</p></td><td style="width:113pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">(1,225 )</p></td></tr><tr style="height:11pt"><td style="width:210pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Other long-term liabilities</p></td><td style="width:113pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: right;">                    (180<span class="s10"> )</span></p></td></tr><tr style="height:12pt"><td style="width:210pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Total purchase price</p></td><td style="width:113pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 4pt;text-indent: 0pt;line-height: 9pt;text-align: right;">$ 4,626</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 58pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="65" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_326.png"/></span></p></td></tr></table><p style="padding-left: 384pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="65" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_327.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The goodwill is primarily attributable to synergies with the software and services that ConnectedHealth provides and the anticipated value of selling the Company’s software and services to ConnectedHealth’s existing client base. The goodwill and intangible assets have been assigned to the Private Exchange segment. The goodwill and intangible assets are deductible for income tax purposes.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Revenue attributable to ConnectedHealth from the acquisition date through December 31, 2016 was approximately $832. The following unaudited supplemental pro forma information presents the Company’s results of operations as though the acquisition of ConnectedHealth had occurred on January 1, 2015. The information is not indicative of the Company’s operating results which would have occurred had the acquisition been consummated as of that date. The pro forma information below does not include anticipated synergies, the impact of purchase accounting adjustments, or certain other expected benefits of the acquisition and should not be used as a predictive measure of the Company’s future results of operations.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="text-indent: 0pt;text-align: right;">Year Ended December 31,</p><table style="border-collapse:collapse;margin-left:70.6907pt" cellspacing="0"><tr style="height:9pt"><td style="width:293pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:60pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 18pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2016</p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 21pt;padding-right: 22pt;text-indent: 0pt;line-height: 7pt;text-align: center;">2015</p></td></tr><tr style="height:11pt"><td style="width:293pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Total revenue</p></td><td style="width:60pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 82,864</p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 98,448</p></td></tr><tr style="height:11pt"><td style="width:293pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Net (loss)</p></td><td style="width:60pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(27,157 )</p></td><td style="width:59pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">(13,879 )</p></td></tr><tr style="height:11pt"><td style="width:293pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Weighted average common shares outstanding - basic and diluted</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">22,275,256</p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">21,813,407</p></td></tr><tr style="height:10pt"><td style="width:293pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Net (loss) per share - basic and diluted</p></td><td style="width:60pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (1.34 )</p></td><td style="width:59pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">$ (0.64 )</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 4pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-13</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_328.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">The pro forma financial information has been adjusted, where applicable, for: (i) amortization of acquired intangible assets, (ii) additional interest expense on presumed acquisition financing, (iii) the income tax effect of the pro forma adjustments, and (iv) to exclude acquisition related expenses.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><span><img width="500" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_329.png"/></span></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The acquisition related expenses were approximately $200 and have been recorded in General and Administrative expenses in the Condensed Consolidated Statements of Operations and Comprehensive Loss.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:5.5pt" cellspacing="0"><tr style="height:12pt"><td style="width:292pt"><p class="s7" style="padding-left: 2pt;text-indent: 0pt;line-height: 9pt;text-align: left;">6. PROPERTY AND EQUIPMENT</p></td><td style="width:168pt" colspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:31pt"><td style="width:292pt"><p class="s10" style="padding-top: 2pt;padding-left: 2pt;text-indent: 0pt;text-align: left;">Property and equipment consisted of the following as of December 31:</p></td><td style="width:108pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-top: 5pt;padding-left: 67pt;text-indent: 0pt;line-height: 8pt;text-align: left;">2016</p></td><td style="width:60pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-top: 5pt;padding-left: 21pt;padding-right: 22pt;text-indent: 0pt;line-height: 8pt;text-align: center;">2015</p></td></tr><tr style="height:11pt"><td style="width:292pt"><p class="s10" style="padding-top: 1pt;padding-left: 82pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Furniture and fixtures</p></td><td style="width:108pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 818</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 729</p></td></tr><tr style="height:11pt"><td style="width:292pt"><p class="s10" style="padding-left: 82pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Computer equipment</p></td><td style="width:108pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,136</p></td><td style="width:60pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">4,224</p></td></tr><tr style="height:11pt"><td style="width:292pt"><p class="s10" style="padding-left: 82pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Leasehold improvements</p></td><td style="width:108pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                    628</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s21" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                    590</p></td></tr><tr style="height:11pt"><td style="width:292pt"><p class="s10" style="padding-top: 1pt;padding-left: 94pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Property and equipment—gross</p></td><td style="width:108pt"><p class="s10" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">6,582</p></td><td style="width:60pt"><p class="s10" style="padding-top: 1pt;padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,543</p></td></tr><tr style="height:11pt"><td style="width:292pt"><p class="s10" style="padding-left: 82pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Accumulated depreciation</p></td><td style="width:108pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">               (4,625<span class="s10"> )</span></p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: right;">               (3,434<span class="s10"> )</span></p></td></tr><tr style="height:13pt"><td style="width:292pt"><p class="s10" style="padding-top: 1pt;padding-left: 82pt;text-indent: 0pt;text-align: left;">Property and equipment—net</p></td><td style="width:108pt"><p class="s21" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;text-align: right;">$ 1,957</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 54pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="64" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_330.png"/></span></p></td><td style="width:60pt"><p class="s10" style="padding-top: 1pt;padding-left: 3pt;text-indent: 0pt;text-align: left;">$ 2,109</p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="71" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_331.png"/></span></p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><span><img width="503" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_332.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="503" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_333.png"/></span></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Depreciation expense for the years ended December 31, 2016, 2015 and 2014 was $1,191, $1,020 and $964, respectively.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l18"><li style="padding-left: 16pt;text-indent: -8pt;text-align: left;"><p class="s14" style="display: inline;">GOODWILL AND OTHER INTANGIBLE ASSETS</p><p class="s14" style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Goodwill<span class="p">—The Company has no accumulated goodwill impairments as of December 31, 2016.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:17pt"><td style="width:154pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:144pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-right: 13pt;text-indent: 0pt;line-height: 8pt;text-align: right;">Enterprise/</p><p class="s8" style="padding-right: 11pt;text-indent: 0pt;line-height: 7pt;text-align: right;">Commercial</p></td><td style="width:77pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 14pt;padding-right: 26pt;text-indent: 0pt;line-height: 8pt;text-align: center;">Enterprise/</p><p class="s8" style="padding-left: 14pt;padding-right: 26pt;text-indent: 0pt;line-height: 7pt;text-align: center;">State</p></td><td style="width:46pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-left: 2pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Medicare</p></td><td style="width:59pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 18pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Private</p><p class="s8" style="padding-left: 14pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Exchange</p></td><td style="width:58pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="text-indent: 0pt;line-height: 7pt;text-align: center;">Total</p></td></tr><tr style="height:11pt"><td style="width:154pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">December 31, 2015</p></td><td style="width:144pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 7,732</p></td><td style="width:77pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 5pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ — $</p></td><td style="width:46pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 16pt;text-indent: 0pt;line-height: 8pt;text-align: left;">14,711</p></td><td style="width:59pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: center;">$ 4,336</p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: center;">$ 26,779</p></td></tr><tr style="height:11pt"><td style="width:154pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Acquisition</p></td><td style="width:144pt"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                     —</p></td><td style="width:123pt" colspan="2"><p class="s21" style="padding-left: 5pt;text-indent: 0pt;line-height: 8pt;text-align: left;">                       — —</p></td><td style="width:59pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: center;">              4,293</p></td><td style="width:58pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: center;">              4,293</p></td></tr><tr style="height:11pt"><td style="width:154pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">December 31, 2016</p></td><td style="width:144pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 7,732</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 95pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="55" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_334.png"/></span></p></td><td style="width:123pt" colspan="2" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 5pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ — $ 14,711</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s26" style="padding-left: 5pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="71" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_335.png"/></span>	<span><img width="61" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_336.png"/></span></p></td><td style="width:59pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: center;">$ 8,629</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="62" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_337.png"/></span></p></td><td style="width:58pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: center;">$ 31,072</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 11pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="55" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_338.png"/></span></p></td></tr></table><p class="s29" style="padding-left: 258pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="55" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_339.png"/></span>	<span><img width="71" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_340.png"/></span>	<span><img width="61" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_341.png"/></span>	<span><img width="62" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_342.png"/></span>	<span><img width="55" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_343.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><span><img width="639" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_344.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="646" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_345.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="646" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_346.png"/></span></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Other Intangible Assets<span class="p">—Other intangible assets consist of the following as of December 31, 2016:</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:5.5pt" cellspacing="0"><tr style="height:25pt"><td style="width:273pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:60pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-left: 20pt;text-indent: -7pt;line-height: 9pt;text-align: left;">Useful Lives - In Years</p></td><td style="width:55pt"><p class="s8" style="padding-left: 16pt;padding-right: 10pt;text-indent: 5pt;text-align: left;">Gross Carrying</p><p class="s8" style="padding-left: 21pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Value</p></td><td style="width:10pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-left: 4pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Accumulated Amortization</p></td><td style="width:54pt"><p class="s8" style="padding-left: 10pt;padding-right: 15pt;text-indent: 8pt;text-align: left;">Net Carrying</p><p class="s8" style="padding-left: 15pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Value</p></td></tr><tr style="height:11pt"><td style="width:273pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 29pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Customer Relationship</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 10pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: center;">3-10</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 1pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 7,398</p></td><td style="width:10pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (3,077 )</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 4,321</p></td></tr><tr style="height:11pt"><td style="width:273pt"><p class="s10" style="padding-left: 29pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Covenants Not to Compete</p></td><td style="width:60pt"><p class="s10" style="padding-left: 10pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: center;">2.5-5</p></td><td style="width:55pt"><p class="s10" style="padding-right: 1pt;text-indent: 0pt;line-height: 8pt;text-align: right;">800</p></td><td style="width:10pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(800 )</p></td><td style="width:54pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td></tr><tr style="height:11pt"><td style="width:273pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 29pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Acquired Technology</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 10pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: center;">3-5</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 1pt;text-indent: 0pt;line-height: 8pt;text-align: right;">12,892</p></td><td style="width:10pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(9,770 )</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">3,122</p></td></tr><tr style="height:11pt"><td style="width:273pt"><p class="s10" style="padding-left: 29pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Trademarks</p></td><td style="width:60pt"><p class="s10" style="padding-left: 10pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: center;">10</p></td><td style="width:55pt"><p class="s10" style="padding-right: 1pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2,800</p></td><td style="width:10pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(1,108 )</p></td><td style="width:54pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,692</p></td></tr><tr style="height:11pt"><td style="width:273pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 29pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Software</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 5pt;text-indent: 0pt;line-height: 8pt;text-align: center;">3</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 1pt;text-indent: 0pt;line-height: 8pt;text-align: right;">               1,770</p></td><td style="width:10pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">              (1,717<span class="s10"> )</span></p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                    53</p></td></tr><tr style="height:12pt"><td style="width:273pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:60pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:55pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s21" style="padding-top: 1pt;padding-right: 1pt;text-indent: 0pt;text-align: right;">$ 25,660</p></td><td style="width:10pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt"><p class="s10" style="padding-top: 1pt;padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (16,472 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_347.png"/></span></p></td><td style="width:54pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;text-align: right;">$ 9,188</p></td></tr><tr style="height:25pt"><td style="width:273pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 2pt;text-indent: 0pt;text-align: left;">Other intangible assets consisted of the following as of December 31, 2015:</p></td><td style="width:60pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:55pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:10pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:54pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:22pt"><td style="width:273pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:60pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-top: 5pt;padding-left: 12pt;padding-right: 5pt;text-indent: 0pt;line-height: 7pt;text-align: center;">Useful Lives -</p></td><td style="width:55pt"><p class="s8" style="padding-top: 4pt;padding-left: 16pt;padding-right: 10pt;text-indent: 5pt;line-height: 8pt;text-align: left;">Gross Carrying</p></td><td style="width:10pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-top: 5pt;padding-left: 5pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Accumulated</p></td><td style="width:54pt"><p class="s8" style="padding-top: 4pt;padding-left: 10pt;padding-right: 15pt;text-indent: 8pt;line-height: 8pt;text-align: left;">Net Carrying</p></td></tr><tr style="height:9pt"><td style="width:273pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:60pt"><p class="s8" style="padding-left: 12pt;padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: center;">In Years</p></td><td style="width:55pt"><p class="s8" style="padding-left: 22pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Value</p></td><td style="width:10pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt"><p class="s8" style="padding-left: 5pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Amortization</p></td><td style="width:54pt"><p class="s8" style="padding-left: 15pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Value</p></td></tr><tr style="height:11pt"><td style="width:273pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 29pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Customer Relationship</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 12pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: center;">3-10</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 7,298</p></td><td style="width:10pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (2,346 )</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 4,952</p></td></tr><tr style="height:11pt"><td style="width:273pt"><p class="s10" style="padding-left: 29pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Covenants Not to Compete</p></td><td style="width:60pt"><p class="s10" style="padding-left: 12pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: center;">2.5-5</p></td><td style="width:55pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">800</p></td><td style="width:10pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(798 )</p></td><td style="width:54pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2</p></td></tr><tr style="height:11pt"><td style="width:273pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 29pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Acquired Technology</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 12pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: center;">3-5</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">11,792</p></td><td style="width:10pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(7,566 )</p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">4,226</p></td></tr><tr style="height:11pt"><td style="width:273pt"><p class="s10" style="padding-left: 29pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Trademarks</p></td><td style="width:60pt"><p class="s10" style="padding-left: 12pt;padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: center;">10</p></td><td style="width:55pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">2,800</p></td><td style="width:10pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(828 )</p></td><td style="width:54pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,972</p></td></tr><tr style="height:11pt"><td style="width:273pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 29pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Software</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 7pt;text-indent: 0pt;line-height: 8pt;text-align: center;">3</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: right;">               1,764</p></td><td style="width:10pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">              (1,524<span class="s10"> )</span></p></td><td style="width:54pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                  240</p></td></tr><tr style="height:12pt"><td style="width:273pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:60pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:55pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;text-align: right;">$ 24,454</p></td><td style="width:10pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;text-align: right;">$ (13,062 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="67" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_348.png"/></span></p></td><td style="width:54pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;text-align: right;">$ 11,392</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_349.png"/></span></p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><span><img width="639" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_350.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="646" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_351.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="646" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_352.png"/></span></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Amortization expense for the years ended December 31, 2016, 2015 and 2014, was $3,410, $4,023 and $4,137, respectively, and has been recorded in cost of revenue and general and administrative expenses.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 4pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-14</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_353.png"/></span></p><table style="border-collapse:collapse;margin-left:5.5pt" cellspacing="0"><tr style="height:28pt"><td style="width:339pt"><p class="s10" style="padding-left: 3pt;padding-right: 35pt;text-indent: 0pt;line-height: 9pt;text-align: center;">Estimated future amortization expense for the Company’s intangible assets is as follows:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-left: 3pt;padding-right: 41pt;text-indent: 0pt;line-height: 8pt;text-align: center;">Year Ending December 31</p></td><td style="width:94pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-left: 50pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Amount</p></td></tr><tr style="height:11pt"><td style="width:339pt"><p class="s10" style="padding-left: 121pt;text-indent: 0pt;line-height: 8pt;text-align: left;">2017</p></td><td style="width:94pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 3,337</p></td></tr><tr style="height:11pt"><td style="width:339pt"><p class="s10" style="padding-left: 121pt;text-indent: 0pt;line-height: 8pt;text-align: left;">2018</p></td><td style="width:94pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,337</p></td></tr><tr style="height:11pt"><td style="width:339pt"><p class="s10" style="padding-left: 121pt;text-indent: 0pt;line-height: 8pt;text-align: left;">2019</p></td><td style="width:94pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,242</p></td></tr><tr style="height:11pt"><td style="width:339pt"><p class="s10" style="padding-left: 121pt;text-indent: 0pt;line-height: 8pt;text-align: left;">2020</p></td><td style="width:94pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,240</p></td></tr><tr style="height:11pt"><td style="width:339pt"><p class="s10" style="padding-left: 121pt;text-indent: 0pt;line-height: 8pt;text-align: left;">2021</p></td><td style="width:94pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,050</p></td></tr><tr style="height:11pt"><td style="width:339pt"><p class="s10" style="padding-left: 121pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Thereafter</p></td><td style="width:94pt"><p class="s21" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                     982</p></td></tr><tr style="height:12pt"><td style="width:339pt"><p class="s10" style="padding-top: 1pt;padding-left: 121pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Total future amortization expense</p></td><td style="width:94pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 4pt;text-indent: 0pt;line-height: 9pt;text-align: right;">$ 9,188</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><span><img width="428" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_354.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="431" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_355.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="431" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_356.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="433" height="17" alt="image" src="NASDAQ_CNXR_2016/Image_357.png"/></span></p></li><li style="padding-top: 4pt;padding-left: 16pt;text-indent: -8pt;text-align: left;"><p class="s14" style="display: inline;">COMMITMENTS AND CONTINGENCIES</p></li></ol><p class="s14" style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Operating Leases<span class="p">—The Company leases office space under operating leases that expire at various dates through 2025. Rent expense for the years ended December 31, 2016, 2015 and 2014, was approximately $1,775, $1,746 and $1,587, respectively.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Future minimum lease payments under non-cancelable operating leases with initial or remaining terms equal to or exceeding one year are as follows:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:115.651pt" cellspacing="0"><tr style="height:8pt"><td style="width:186pt"><p class="s8" style="text-indent: 0pt;line-height: 7pt;text-align: left;">Years Ended December 31</p></td><td style="width:137pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-right: 19pt;text-indent: 0pt;line-height: 7pt;text-align: right;">Amount</p></td></tr><tr style="height:11pt"><td style="width:186pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">2017</p></td><td style="width:137pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 1,521</p></td></tr><tr style="height:11pt"><td style="width:186pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">2018</p></td><td style="width:137pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,380</p></td></tr><tr style="height:11pt"><td style="width:186pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">2019</p></td><td style="width:137pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,356</p></td></tr><tr style="height:11pt"><td style="width:186pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">2020</p></td><td style="width:137pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">899</p></td></tr><tr style="height:11pt"><td style="width:186pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">2021</p></td><td style="width:137pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">906</p></td></tr><tr style="height:11pt"><td style="width:186pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Thereafter</p></td><td style="width:137pt"><p class="s21" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                  2,497</p></td></tr><tr style="height:12pt"><td style="width:186pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Total minimum lease payments</p></td><td style="width:137pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 4pt;text-indent: 0pt;line-height: 9pt;text-align: right;">$ 8,559</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 83pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="65" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_358.png"/></span></p></td></tr></table><p style="padding-left: 384pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="65" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_359.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The leases provide for escalating rent over the term of the leases. The rent costs associated with such leases are aggregated and recognized on a straight-line basis over the lease term. The difference between the monthly rent payment and the straight-line rent requires an accrual of rent to be recognized and then amortized over the term of the lease. Accrued straight-line rent as of December 31, 2016 and 2015 amounted to approximately $199 and $256, respectively, and is included in other liabilities and other long-term liabilities in the accompanying consolidated balance sheets.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Letter of Credit<span class="p">—As security for certain leased property, the Company was required to provide a lessor an unconditional and irrevocable letter of credit in the amount $200 as of December 31, 2016 and 2015.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Deposits<span class="p">—From time to time the Company has been required to remit security deposits as a condition of certain of its office leases. The deposits are included in other assets on the balance sheet and amount to $856 and $710 as of December 31, 2016 and 2015, respectively.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Indemnifications<span class="p">—The Company provides certain indemnifications from time to time in the normal course of business to its customers in its professional services and software license agreements and to strategic partners through certain insurance industry association marketing agreements that contain certain indemnifications for claims that may arise from acts or omissions, patent or trademark infringement, breach of contractual representations and warranties or intentional or grossly negligent acts. These indemnifications may require the Company to reimburse the indemnified party for losses suffered or incurred by the indemnified party. The Company has not had an indemnification claim, and does not expect to have a material claim in the future. As such, the Company has not recorded any liability for these indemnifications in the consolidated financial statements.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Litigation<span class="p">—In the normal course of business, the Company and its subsidiaries are named as defendants in lawsuits and are party to contract terminations and settlements in which claims are or may be asserted against the Company. In the opinion of management, the liabilities, if any, which may ultimately result from such lawsuits and contract terminations are not expected to have a material effect on the Company’s consolidated financial statements.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-15</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_360.png"/></span></p><table style="border-collapse:collapse;margin-left:5.5pt" cellspacing="0"><tr style="height:12pt"><td style="width:311pt"><p class="s7" style="padding-left: 2pt;text-indent: 0pt;line-height: 9pt;text-align: left;">9. DEBT</p></td><td style="width:149pt" colspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:31pt"><td style="width:311pt"><p class="s10" style="padding-top: 2pt;padding-left: 2pt;text-indent: 0pt;text-align: left;">Debt consisted of the following as of December 31:</p></td><td style="width:89pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-top: 5pt;padding-left: 48pt;text-indent: 0pt;line-height: 8pt;text-align: left;">2016</p></td><td style="width:60pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-top: 5pt;padding-left: 21pt;padding-right: 22pt;text-indent: 0pt;line-height: 8pt;text-align: center;">2015</p></td></tr><tr style="height:11pt"><td style="width:311pt"><p class="s10" style="padding-top: 1pt;padding-left: 82pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Senior term loans</p></td><td style="width:89pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 31,944</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 19,125</p></td></tr><tr style="height:11pt"><td style="width:311pt"><p class="s10" style="padding-left: 82pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Senior revolving credit facility</p></td><td style="width:89pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">578</p></td><td style="width:60pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">316</p></td></tr><tr style="height:11pt"><td style="width:311pt"><p class="s10" style="padding-left: 82pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Subordinated loans</p></td><td style="width:89pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                      —</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s21" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">              30,000</p></td></tr><tr style="height:11pt"><td style="width:311pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:89pt"><p class="s10" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">32,522</p></td><td style="width:60pt"><p class="s10" style="padding-top: 1pt;padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">49,441</p></td></tr><tr style="height:11pt"><td style="width:311pt"><p class="s10" style="padding-left: 82pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Less: original issue discounts and deferred financing costs</p></td><td style="width:89pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">(1,036 )</p></td></tr><tr style="height:11pt"><td style="width:311pt"><p class="s10" style="padding-left: 82pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Less: current maturities of debt</p></td><td style="width:89pt"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                  (578<span class="s10"> )</span></p></td><td style="width:60pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: right;">               (1,441<span class="s10"> )</span></p></td></tr><tr style="height:12pt"><td style="width:311pt"><p class="s10" style="padding-top: 1pt;padding-left: 82pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Long-term debt</p></td><td style="width:89pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 9pt;text-align: right;">$ 31,944</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 3pt;text-indent: 0pt;line-height: 9pt;text-align: left;">$ 46,964</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><span><img width="497" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_361.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="503" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_362.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="503" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_363.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="505" height="17" alt="image" src="NASDAQ_CNXR_2016/Image_364.png"/></span></p><p class="s14" style="padding-top: 4pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Senior Debt<span class="p">— The Company has a bank credit facility, as amended and restated from time to time that provides for short-term working capital and long-term investment needs (the “Credit Facility”). The Credit Facility is collateralized by all of the Company’s assets.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">On June 8, 2016, the Credit Facility was amended and restated (the “June 2016 Amendment”), to among other things (i) extend the maturity date to June 8, 2021 from January 18, 2018, (ii) continue to provide for up to $10,000 of revolving credit through the maturity date (the “Senior Revolving Credit Facility”), and (iii) increase the term loan funding to $35,000 from approximately $20,000 at June 8, 2016 (the “Senior Term Loan”).</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The June 2016 Amendment was accounted for as an extinguishment of debt resulting in the immediate recognition of $381 of previously deferred financing costs, which was recorded in Other expense, net in the statements of operations for the year ended December 31, 2016.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">On November 4, 2016, the Company amended the Credit Facility (the “November 2016 Amendment”), to, among other things, (i) remove the Net Leverage Covenant and replace it with a trailing twelve month EBITDA covenant, as defined in the November 2016 Amendment, to be measured quarterly effective as of September 30, 2016, (ii) increase the Minimum Liquidity covenant from $10,000 to $11,500, effective November 4, 2016, and $15,000 effective September 30, 2017, (iii) increase the annual principal repayments on the Senior Term Loan, and (iv) increase the interest rate on applicable borrowings effective November 4, 2016. In connection with this amendment, the Company repaid $2,000 of the outstanding Senior Term Loan and incurred bank fees of approximately $300, which were recorded in Other expense, net in the consolidated statements of operations for the year ended December 31, 2016.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">On March 10, 2017, the Company amended the Credit Facility (the “March 2017 Amendment”), to among other things (i) defer scheduled Senior Term Loan principal repayments until March 31, 2018, at which time quarterly principal repayments of $1,313 will resume through March 31, 2021; (ii) replace the EBITDA and Minimum Liquidity covenants with (a) a trailing twelve month EBITDA covenant of negative $12,000 as of December 31, 2016, a quarterly building EBITDA covenant through December 31, 2017, and a trailing twelve month EBITDA from March 31, 2018 forward, as defined in the March 2017 Amendment, and (b) a minimum liquidity requirement of $1,500 at all times from March 1, 2017 through March 31, 2018, and $15,000 thereafter; and (iii) provide for an incremental 2.50% per annum paid-in-kind interest on all obligations from March 10, 2017 through the maturity date, which shall increase the outstanding principal balance of the Senior Term Loan. The quarterly building EBITDA, as defined in the March 2017 Amendment, requires the Company achieve at least negative $4,000 for the quarter ended March 31, 2017, negative $8,000 for six months ended June 30, 2017, negative $7,250 for the nine months ended September 30, 2017 and negative $3,000 for twelve months ended December 31, 2017 and March 31, 2018.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Following the March 2017 Amendment the Credit Facility provides for up to $0.5 million of revolving credit through the maturity date of the Credit Facility.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The Credit Facility contains covenants and customary representations and warranties of the Company, as well as various limitations on the activities of the Company as they relate to additional indebtedness, junior liens, investments, capital expenditures, paying dividends, and mergers and acquisitions. As of December 31, 2016, the Company was in compliance with the financial covenants under the Credit Facility, as amended on March 10, 2017, and expects to be in compliance for the foreseeable future.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">As of December 31, 2016, the interest rates on our outstanding Senior Term Loan and the Senior Revolving Credit Facility were 7.34% and 9.25%, respectively. Effective with the March 10, 2017 amendment, the interest rates on then outstanding Senior Term Loan and Senior Revolving Credit Facility borrowing increased by 2.50% per annum paid-in-kind interest.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-16</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_365.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">THL Promissory Note<span class="p">—The Company had a Senior Subordinated Term Loan Agreement with THL Corporate Finance, Inc., (the “THL Note”) for total proceeds of $30,000 less $683 of original issue discount, or OID. On May 3, 2016, the Company repaid the $30,000 principal and accrued interest to settle the THL Note. The early extinguishment of the THL Note triggered a $560 breakage fee and the immediate recognition of the remaining $480 of OID and deferred financing costs, which were recorded in Other expense, net in the statement of operations for the year ended December 31, 2016.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Future principal payments on debt as of December 31, 2016, are as follows:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s38" style="padding-left: 115pt;text-indent: 0pt;text-align: left;">Years Ending December 31</p><table style="border-collapse:collapse;margin-left:115.651pt" cellspacing="0"><tr style="height:11pt"><td style="width:171pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">2017</p></td><td style="width:152pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 578</p></td></tr><tr style="height:11pt"><td style="width:171pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">2018</p></td><td style="width:152pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,250</p></td></tr><tr style="height:11pt"><td style="width:171pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">2019</p></td><td style="width:152pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,250</p></td></tr><tr style="height:10pt"><td style="width:171pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">2020 and thereafter</p></td><td style="width:152pt"><p class="s21" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">               21,444</p></td></tr></table><p style="padding-top: 1pt;text-indent: 0pt;text-align: center;"><span class="s36" style=" background-color: #CEEFFB;">                                                                                                                                                    32,522</span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="431" height="17" alt="image" src="NASDAQ_CNXR_2016/Image_366.png"/></span></p><p style="padding-left: 15pt;text-indent: 0pt;text-align: center;">Less original issue discount and deferred financing costs                               <u>                      —</u></p><p style="padding-top: 1pt;padding-left: 15pt;text-indent: 0pt;text-align: center;">Total                                                                                                                <u>$            32,522</u></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The March 2017 Amendment has deferred all 2017 principal payments and increased the principal payments in 2018 and thereafter.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Based on rates for instruments with comparable maturities and credit quality, which are classified as Level 2 inputs (defined in Note 2), the estimated fair value of the Company’s total debt approximated $29,000 as of December 31, 2016, and equal to its carrying value as of December 31, 2015.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l19"><li style="padding-left: 20pt;text-indent: -12pt;text-align: left;"><p class="s14" style="display: inline;">STOCKHOLDERS’ DEFICIT</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Common Stock<span class="p">—As of December 31, 2016 and 2015, the Company has authorized the issuance of 75,000,000 shares of common stock, respectively, par value of $0.001 per share.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Preferred Stock<span class="p">— On May 2, 2016, the Company issued and sold newly created Series A Preferred Stock for an aggregate purchase price of $52,000. The shares of Series A Preferred Stock are convertible into shares of the Company’s common stock (the “Series A Conversion Shares”) at the option of the investors at any time and they are redeemable at the option of the investors after May 2, 2023, or if there is a Fundamental Change (as that term is defined in the Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock). Beginning May 2, 2018, the Company may force conversion if the closing price of the common stock is at least 175% of the conversion price of the Series A Preferred Stock for 45 consecutive trading days, with a minimum average trading volume of at least 75,000 shares for 40 of such 45 trading days. Each share of Series A Preferred Stock is convertible into a number of Series A Conversion Shares equal to (i) the sum of (a) the stated value per share of Series A Preferred Stock, plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the Series A Preferred Stock at such time (which initially is $4.50 per share, subject to customary anti-dilution adjustments).</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The number of Conversion Shares underlying the Series A Preferred Stock will be increased annually by the accrual of 7.5% cumulative dividends payable in-kind (which will increase in certain circumstances, but in no event will be more than 16.5% annually). Following the second anniversary of the May 2, 2016 closing, the Company may elect to pay such cumulative dividends in cash. The conversion price for the Series A Preferred Stock is also subject to adjustment in the event of a stock split, reverse stock split, stock dividend, rights issuance, recapitalization, tender offer or similar transaction and to weighted-average price-based anti-dilution adjustments. On March 10, 2017, the conversion price of the Series A Preferred Stock was adjusted to $3.96 per share as a result of the issuance of Series B Preferred Stock.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">On March 10, 2017, the Company issued and sold newly created Series B Preferred Stock for an aggregate purchase price of $17,500. The shares of Series B Preferred Stock are convertible into shares of the Company’s common stock (the “Series B Conversion Shares”) at the option of the investors at any time and they are redeemable at the option of the investors after May 2, 2023, or if there is a Fundamental Change (as that term is defined in the Certificate of Designations, Preferences and Rights of Series B Convertible Preferred Stock). Beginning March 10, 2019, the Company may force conversion if the closing price of the common stock is at least 175% of the conversion price of the Series B Preferred Stock for 45 consecutive trading days, with a minimum average trading volume of at least 75,000 shares for 40 of such 45 trading days. Each share of Series B Preferred Stock is convertible into a number of Series B Conversion Shares equal to (i) the sum of (a) the stated value per share of Series B Preferred Stock, plus (b) all accrued and unpaid dividends thereon up to but not including the conversion date, divided by (ii) the conversion price of the common stock at such time (which initially is $1.91 per share, subject to customary anti-dilution adjustments).</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-17</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_367.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">The number of Conversion Shares underlying the Series B Preferred Stock will be increased annually by the accrual of 15.0% cumulative dividends payable in-kind (which will increase in certain circumstances, but in no event will be more than 20.0% annually). Following the second anniversary of the March 10, 2017 issuance, the Company may elect to pay such cumulative dividends in cash. The conversion price for the Series B Preferred is also subject to adjustment in the event of a stock split, reverse stock split, stock dividend, rights issuance, recapitalization, tender offer or similar transaction and to weighted-average price-based anti-dilution adjustments.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The Series A Preferred Stock and Series B Preferred Stock are entitled to vote with common stock on an as-converted basis.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Treasury Stock<span class="p">—As of December 31, 2016, the Company held 101,340 shares of common stock, which were acquired in the normal course of employees surrendering vested shares to settle withholding tax obligations triggered by stock-based compensation transactions.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Reserved Shares<span class="p">—As of December 31, 2016, the Company has 1,649,718 shares of common stock reserved for issuance in connection with the Company’s stock incentive plans.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 20pt;text-indent: -12pt;text-align: left;"><p class="s14" style="display: inline;">STOCK-BASED COMPENSATION</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company’s equity incentive plans provide for the awarding of various equity awards including stock options and restricted stock units.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company recognized stock-based compensation expense of $2,662, $4,712 and $1,436 for the years ended December 31, 2016, 2015 and 2014, respectively.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">As of December 31, 2016, approximately $3,080 of total unrecognized compensation expense related to unvested stock option and restricted stock unit awards is expected to be recognized over the remaining vesting periods, approximately 3 years. The maximum contractual term of equity awards is 10 years.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Equity Incentive Plans<span class="p">—In connection with the Company’s December 2014 initial public offering, the Board of Directors approved the 2014 Equity Incentive Plan (the 2014 “Plan”) as a replacement to the 2010 Plan. The Company will not grant any additional awards under the 2010 Plan; however, the 2010 Plan will continue to govern the terms and conditions of all outstanding equity awards previously granted under the 2010 Plan. The 2014 Plan provides for the awarding of stock options, stock appreciation rights, restricted stock, restricted stock units, performance shares and performance units, and other stock- based or cash settled equity awards as deemed appropriate by the compensation committee of the Company’s board of directors.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The 2014 Plan provides that on the first day of January each year through 2024, the available shares of common stock shall generally be increased by the smaller of (a) 2.00% of the number of issued and outstanding shares of common stock on the immediately preceding December 31, or (b) an amount determined by the Company’s Board.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">On August 3, 2016, the Company’s Board of Directors approved an amendment to the 2014 Plan to increase the number of shares available for issuance under the 2014 Plan by 1,500,000 shares, subject to stockholder approval at a special meeting of stockholders. On September 26, 2016, a special meeting of stockholders was held and the amendment to the 2014 Plan to increase the shares reserved for issuance by 1,500,000 was approved and made effective as of such date.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-18</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_368.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Stock Options—<span class="p">A summary of stock option activity for the years ended December 31, 2016 and 2015 is presented below:</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 4pt;padding-left: 299pt;text-indent: -6pt;text-align: left;">Number of Shares</p><p class="s3" style="padding-top: 4pt;padding-left: 28pt;text-indent: 0pt;text-align: justify;">Average Exercise Price<span class="s39">(a)</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 4pt;padding-left: 29pt;text-indent: -5pt;text-align: left;">Average Life (Years)<span class="s39">(b)</span></p><p class="s3" style="padding-top: 4pt;padding-left: 100pt;text-indent: 0pt;text-align: center;">Aggregate Intrinsic Value</p><p style="text-indent: 0pt;text-align: left;"><span><img width="646" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_369.png"/></span></p><p style="padding-top: 1pt;padding-left: 34pt;text-indent: 0pt;text-align: left;">Outstanding — January 1, 2015 1,838,082 $ 1.93 7.39</p><p style="text-indent: 0pt;text-align: left;"><span><img width="646" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_370.png"/></span></p><p style="padding-left: 34pt;text-indent: 0pt;text-align: left;">Granted 699,600 $ 9.72</p><p style="text-indent: 0pt;text-align: left;"><span><img width="646" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_371.png"/></span></p><p style="padding-left: 34pt;text-indent: 0pt;line-height: 110%;text-align: left;">Exercised (195,177 ) $ 1.82 $ 1,456 Forfeited<u> (35,779</u> ) $ 11.08</p><p style="padding-left: 34pt;text-indent: 0pt;text-align: left;">Outstanding — December 31, 2015  2,306,726 $ 4.16 7.59 $ 2,735</p><p style="text-indent: 0pt;text-align: left;"><span><img width="646" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_372.png"/></span></p><p style="padding-left: 34pt;text-indent: 0pt;text-align: left;">Granted 572,200 $ 2.53</p><p style="padding-left: 34pt;text-indent: 0pt;text-align: left;">Exercised (101,953 ) $ 1.85 $ 100</p><p style="text-indent: 0pt;text-align: left;"><span><img width="646" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_373.png"/></span></p><p style="padding-left: 34pt;text-indent: 0pt;text-align: left;">Forfeited (486,274 ) $ 7.81</p><p style="padding-left: 34pt;text-indent: 0pt;text-align: left;">Expired<u> (19,998</u> ) $ 11.37</p><p style="text-indent: 0pt;text-align: left;"><span><img width="646" height="18" alt="image" src="NASDAQ_CNXR_2016/Image_374.png"/></span></p><p style="padding-top: 1pt;padding-left: 34pt;text-indent: 0pt;text-align: left;">Outstanding — December 31, 2016 <u> 2,270,701</u> $ 3.01 5.04 $ —</p><p style="text-indent: 0pt;text-align: left;"><span><img width="59" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_375.png"/></span></p><p style="padding-top: 2pt;padding-left: 34pt;text-indent: 0pt;line-height: 131%;text-align: left;">Exercisable — December 31, 2016<u> 1,530,817</u> $ 2.62 2.95 $ — Vested and expected to vest — December 31, 2016<u> 2,205,410</u> $ 3.01 4.91 $ —</p><p style="text-indent: 0pt;text-align: left;"><br/></p><ol id="l20"><li style="padding-left: 32pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Weighted-average exercise price</p></li><li style="padding-left: 32pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Weighted-average contractual life remaining</p></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: justify;">The weighted average fair value per option granted during the years ended December 31, 2016, 2015 and 2014 was $1.00, $4.30 and $16.20, respectively. The weighted average fair value of stock options is estimated at the date of grant using a Black-Scholes option-pricing model. The following are weighted average assumptions used for estimating the fair value of options granted for the years ended December 31:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:88.4214pt" cellspacing="0"><tr style="height:8pt"><td style="width:210pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:57pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 14pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2016</p></td><td style="width:57pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 14pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2015</p></td><td style="width:53pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 14pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2014</p></td></tr><tr style="height:11pt"><td style="width:210pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Common stock share value</p></td><td style="width:57pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 2.53</p></td><td style="width:57pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 10.31</p></td><td style="width:53pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 18.12</p></td></tr><tr style="height:11pt"><td style="width:210pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Expected life (years)</p></td><td style="width:57pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 29pt;text-indent: 0pt;line-height: 8pt;text-align: left;">4.00</p></td><td style="width:57pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 29pt;text-indent: 0pt;line-height: 8pt;text-align: left;">5.01</p></td><td style="width:53pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 29pt;text-indent: 0pt;line-height: 8pt;text-align: left;">5.75</p></td></tr><tr style="height:11pt"><td style="width:210pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Volatility</p></td><td style="width:57pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">50.00 %</p></td><td style="width:57pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">50.00 %</p></td><td style="width:53pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">50.33 %</p></td></tr><tr style="height:11pt"><td style="width:210pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Interest rate</p></td><td style="width:57pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1.01 %</p></td><td style="width:57pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1.45 %</p></td><td style="width:53pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">2.03 %</p></td></tr><tr style="height:10pt"><td style="width:210pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Dividend yield</p></td><td style="width:57pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">0.00 %</p></td><td style="width:57pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">0.00 %</p></td><td style="width:53pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">0.00 %</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company currently estimates volatility by using the weighted average historical volatility of comparable public companies. The risk-free interest rate is the rate available as of the option date on zero-coupon U.S. government issues with a remaining term equal to the expected term of the option. The Company has not paid dividends in the past and does not plan to pay any dividends in the foreseeable future. The Company has estimated forfeitures in determining the weighted average fair value calculation. The forfeiture rate used for the years ended December 31, 2016, 2015 and 2014 was 0% for executive employees and 10% for all other employees. The Company’s estimate of forfeitures will be adjusted over the requisite service period based on the extent to which actual forfeitures differ, or are expected to differ, from the estimate.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company recognizes the grant date fair value of stock options that are expected to vest on a straight-line basis over the vesting period, which is generally three years from the date of grant.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-19</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_376.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Restricted Stock Units (RSUs)—<span class="p">A summary of RSU activity for the years ended December 31, 2016 and 2015 is presented below:</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 5pt;text-indent: 0pt;text-align: right;">Shares</p><p class="s3" style="padding-top: 4pt;padding-left: 45pt;text-indent: -11pt;text-align: left;">Average Fair Value</p><p class="s3" style="padding-left: 36pt;text-indent: 0pt;text-align: left;">per Share<span class="s39">(a)</span></p><p class="s3" style="padding-top: 4pt;padding-left: 100pt;text-indent: 0pt;text-align: center;">Aggregate Intrinsic Value</p><p style="text-indent: 0pt;text-align: left;"><span><img width="628" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_377.png"/></span></p><p style="padding-top: 1pt;padding-left: 38pt;text-indent: 0pt;text-align: left;">Outstanding — January 1, 2015 — $ —</p><p style="padding-left: 38pt;text-indent: 0pt;text-align: left;">Granted 801,270 $ 8.84</p><table style="border-collapse:collapse;margin-left:38.3955pt" cellspacing="0"><tr style="height:11pt"><td style="width:197pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Vested</p></td><td style="width:138pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(199,180 )</p></td><td style="width:136pt" colspan="2" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 4pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 9.84 $ 857</p></td></tr><tr style="height:11pt"><td style="width:197pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Forfeited</p></td><td style="width:138pt"><p class="s21" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">              (31,300<span class="s10"> )</span></p></td><td style="width:136pt" colspan="2"><p class="s10" style="padding-left: 4pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 11.37</p></td></tr><tr style="height:11pt"><td style="width:197pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Outstanding — December 31, 2015</p></td><td style="width:138pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">570,790</p></td><td style="width:98pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 4pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 8.35</p></td><td style="width:38pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:197pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Granted</p></td><td style="width:138pt"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">503,440</p></td><td style="width:98pt"><p class="s10" style="padding-left: 4pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 2.45</p></td><td style="width:38pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:197pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Vested</p></td><td style="width:138pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(260,523 )</p></td><td style="width:98pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 4pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 6.90 $</p></td><td style="width:38pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 20pt;text-indent: 0pt;line-height: 8pt;text-align: left;">567</p></td></tr><tr style="height:11pt"><td style="width:197pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Forfeited</p></td><td style="width:138pt"><p class="s21" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">           (148,211<span class="s10"> )</span></p></td><td style="width:98pt"><p class="s10" style="padding-left: 4pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 9.31</p></td><td style="width:38pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:12pt"><td style="width:197pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Outstanding — December 31, 2016</p></td><td style="width:138pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 7pt;text-indent: 0pt;line-height: 9pt;text-align: right;">             665,496</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 81pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="65" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_378.png"/></span></p></td><td style="width:98pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 4pt;text-indent: 0pt;line-height: 9pt;text-align: left;">$ 4.24</p></td><td style="width:38pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr></table><p style="padding-left: 317pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="65" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_379.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">(a) Weighted-average grant date fair value</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company recognizes the grant date fair value of the RSUs that are expected to vest on a straight-line basis over the period of vesting. The Company recognizes the income tax benefits resulting from vesting of RSUs in the period they vest; to the extent the compensation expense has been recognized.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Employee Stock Purchase Plan<span class="p">—In November 2014, the Company’s Board of Directors approved the 2014 Employee Stock Purchase Plan (the “ESPP”), which is a broadly-based stock purchase plan in which any eligible employee may elect to participate by authorizing the Company to make payroll deductions in a specific amount or designated percentage to purchase shares of the Company’s common stock at 90% of the lower of the fair market value on the first day of trading of the offering period or on the purchase date. In no event will an employee be granted ability under the ESPP that would permit the purchase of common stock with a fair market value in excess of $25 in any calendar year. The ESPP is designed to comply with Section 423 of the Code, and thus is eligible for the favorable tax treatment afforded by Section 423.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">At December 31, 2016, a total of 169,441 shares of common stock have been reserved for issuance under the ESPP. The ESPP provides that on the first day of January each year through 2024, the available shares of common stock shall generally be increased by (a) 100,000 shares or (b) 0.25% of issued and outstanding shares of common stock on the immediately preceding December 31.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">During the years ended December 31, 2016 and 2015, shares purchased under the ESPP were 150,013 and 29,927, respectively.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 20pt;text-indent: -12pt;text-align: left;"><p class="s14" style="display: inline;">INCOME TAXES</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">The (provision) benefit for income taxes for the years ended December 31 consists of:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 333pt;text-indent: 0pt;text-align: left;">2016 2015 2014</p><p class="s34" style="padding-left: 315pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="68" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_380.png"/></span> <span><img width="68" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_381.png"/></span> <span><img width="68" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_382.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><span><img width="574" height="14" alt="image" src="NASDAQ_CNXR_2016/Image_383.png"/></span></p><p style="padding-left: 73pt;text-indent: -11pt;line-height: 110%;text-align: left;"><span class="s36" style=" background-color: #CEEFFB;">Current tax expense:</span><span class="s37"> Federal $ — $ — $ —</span></p><p style="padding-left: 73pt;text-indent: 0pt;text-align: left;">State <u> 60 (47</u> )<u> (29</u> )</p><p style="text-indent: 0pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_384.png"/></span></p><p style="padding-top: 1pt;padding-left: 61pt;text-indent: 22pt;line-height: 117%;text-align: left;"><span class="p">Total current tax (provision) benefit</span><span class="s30"> 60 (47</span><span class="p"> )</span><span class="s30"> (29</span><span class="p"> ) </span><span class="s36" style=" background-color: #CEEFFB;">Deferred tax expense:                                                                                                                                                                                  </span></p><table style="border-collapse:collapse;margin-left:61.8254pt" cellspacing="0"><tr style="height:10pt"><td style="width:178pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Federal</p></td><td style="width:60pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:67pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td><td style="width:10pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(3 )</p></td><td style="width:55pt"><p class="s10" style="padding-right: 1pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(3 )</p></td></tr><tr style="height:11pt"><td style="width:178pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 9pt;text-align: left;">State</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:67pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 9pt;text-align: right;">                     —</p></td><td style="width:10pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 6pt;text-indent: 0pt;line-height: 9pt;text-align: right;">                      (1<span class="s10"> )</span></p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 1pt;text-indent: 0pt;line-height: 9pt;text-align: right;">                      (1<span class="s10"> )</span></p></td></tr><tr style="height:11pt"><td style="width:178pt"><p class="s10" style="padding-left: 22pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Total deferred tax (provision) benefit</p></td><td style="width:60pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:67pt"><p class="s21" style="text-indent: 0pt;line-height: 9pt;text-align: right;">                     —</p></td><td style="width:10pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt"><p class="s21" style="padding-right: 6pt;text-indent: 0pt;line-height: 9pt;text-align: right;">                      (4<span class="s10"> )</span></p></td><td style="width:55pt"><p class="s21" style="padding-right: 1pt;text-indent: 0pt;line-height: 9pt;text-align: right;">                      (4<span class="s10"> )</span></p></td></tr><tr style="height:12pt"><td style="width:178pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 9pt;text-align: left;">Total (provision) benefit for income taxes</p></td><td style="width:60pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:67pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;text-align: right;">$ 60</p></td><td style="width:10pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;text-align: right;">$ (51 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="69" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_385.png"/></span></p></td><td style="width:55pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 1pt;text-indent: 0pt;text-align: right;">$ (33 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="69" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_386.png"/></span></p></td></tr><tr style="height:34pt"><td style="width:178pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:60pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 29pt;text-indent: 0pt;text-align: left;">F-20</p></td><td style="width:67pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:10pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:55pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr></table><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">The (provision) benefit for income taxes for the years ended December 31, 2016, 2015 and 2014 differs from the amount of income tax determined by applying the applicable U.S. statutory federal income tax rate to the loss before (provision) benefit for income taxes as a result of the following:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:61.8254pt" cellspacing="0"><tr style="height:8pt"><td style="width:196pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:108pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 62pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2016</p></td><td style="width:65pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 19pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2015</p></td><td style="width:62pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 19pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2014</p></td></tr><tr style="height:11pt"><td style="width:196pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Federal statutory rate</p></td><td style="width:108pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">34.0 %</p></td><td style="width:65pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">34.0 %</p></td><td style="width:62pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">34.0 %</p></td></tr><tr style="height:11pt"><td style="width:196pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Effect of:</p></td><td style="width:108pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:65pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:62pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:196pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">State income taxes, net of federal benefit</p></td><td style="width:108pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">0.1 %</p></td><td style="width:65pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(0.5 )%</p></td><td style="width:62pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">(0.2 )%</p></td></tr><tr style="height:11pt"><td style="width:196pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Valuation allowance</p></td><td style="width:108pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(35.3 )%</p></td><td style="width:65pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(32.9 )%</p></td><td style="width:62pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: right;">(33.7 )%</p></td></tr><tr style="height:11pt"><td style="width:196pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Other, net</p></td><td style="width:108pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                   1.4<span class="s10"> %</span></p></td><td style="width:65pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">                 (1.3<span class="s10"> )%</span></p></td><td style="width:62pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: right;">                 (0.4<span class="s10"> )%</span></p></td></tr><tr style="height:13pt"><td style="width:196pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">Overall income tax rate</p></td><td style="width:108pt"><p class="s21" style="padding-top: 1pt;padding-right: 5pt;text-indent: 0pt;text-align: right;">                   0.2<span class="s10"> %</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 50pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="60" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_387.png"/></span></p></td><td style="width:65pt"><p class="s10" style="padding-top: 1pt;padding-right: 3pt;text-indent: 0pt;text-align: right;">(0.7 )%</p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_388.png"/></span></p></td><td style="width:62pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: right;">(0.3 )%</p><p style="padding-left: 3pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="65" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_389.png"/></span></p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Other, net primarily includes the impact of stock-based compensation and changes in net operating loss carry forward deferred tax assets as a result of change in state rates.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Deferred income taxes reflect the net effect of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the Company’s deferred tax assets are comprised of the following as of December 31:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 364pt;text-indent: 0pt;text-align: left;">2016 2015</p><table style="border-collapse:collapse;margin-left:88.4214pt" cellspacing="0"><tr style="height:11pt"><td style="width:200pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Deferred tax assets:</p></td><td style="width:177pt" colspan="2" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:200pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Net operating loss carryforward</p></td><td style="width:120pt"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 45,205</p></td><td style="width:57pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 32,844</p></td></tr><tr style="height:11pt"><td style="width:200pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Deferred revenue</p></td><td style="width:120pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">12,199</p></td><td style="width:57pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">17,576</p></td></tr><tr style="height:11pt"><td style="width:200pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Research and development credit</p></td><td style="width:120pt"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">45</p></td><td style="width:57pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">45</p></td></tr><tr style="height:11pt"><td style="width:200pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Accrued payroll and related liabilities</p></td><td style="width:120pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2,070</p></td><td style="width:57pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">1,919</p></td></tr><tr style="height:11pt"><td style="width:200pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Other</p></td><td style="width:120pt"><p class="s10" style="padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">821</p></td><td style="width:57pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">331</p></td></tr><tr style="height:11pt"><td style="width:200pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 22pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Valuation allowance</p></td><td style="width:120pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">             (48,192<span class="s10"> )</span></p></td><td style="width:57pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">             (38,817<span class="s10"> )</span></p></td></tr><tr style="height:11pt"><td style="width:200pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Net deferred tax assets</p></td><td style="width:120pt"><p class="s21" style="padding-top: 1pt;padding-right: 9pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 12,148</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 63pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="62" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_390.png"/></span></p></td><td style="width:57pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 13,898</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="62" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_391.png"/></span></p></td></tr><tr style="height:1pt"><td style="width:200pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:120pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:57pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:10pt"><td style="width:200pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Deferred tax liabilities:</p></td><td style="width:120pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:57pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:200pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Intangible assets</p></td><td style="width:120pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (3,100 )</p></td><td style="width:57pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ (4,339 )</p></td></tr><tr style="height:11pt"><td style="width:200pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Deferred implementation costs</p></td><td style="width:120pt" bgcolor="#CEEFFB"><p class="s21" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">               (9,070<span class="s10"> )</span></p></td><td style="width:57pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">               (9,581<span class="s10"> )</span></p></td></tr><tr style="height:11pt"><td style="width:200pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Total deferred tax liabilities</p></td><td style="width:120pt"><p class="s21" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">             (12,170<span class="s10"> )</span></p></td><td style="width:57pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">             (13,920<span class="s10"> )</span></p></td></tr><tr style="height:12pt"><td style="width:200pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Net deferred tax liability</p></td><td style="width:120pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;text-align: right;">$ (22<span class="s10"> )</span></p></td><td style="width:57pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ (22 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="71" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_392.png"/></span></p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Based on the uncertainties associated with future realization of the deferred tax asset, the Company established a valuation allowance, which reduces the deferred tax assets to an amount whose realization is more likely than not. The net change in the valuation allowance for the deferred tax asset was $9,375,</p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">$2,397 and $(1,476) for the years ended December 31, 2016, 2015 and 2014, respectively. Differences between effective and statutory tax rates are caused substantially by the change in the valuation allowance.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">As of December 31, 2016 and 2015, the Company has federal net operating loss carryforwards of approximately $121,000 and $87,920, respectively, available to offset future earnings and federal research and development credits of approximately $45, also available to offset future federal income tax. The net operating loss carryforwards and research and development tax credit carryforwards expire at various dates from 2020 through 2036. As of December 31, 2016 and 2015, state net operating loss carryforwards were approximately $77,800 and $56,451, respectively. As of December 31, 2016 and 2015, management has recorded a full valuation allowance against net operating losses because management believes it is more likely than not that some portion or all of these deferred tax assets will not be realized.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Under the provisions of the Internal Revenue Code (IRC), certain substantial changes in the Company’s ownership may result in a limitation of the amount of net operating loss and tax credit carryforwards which can be used in future years.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company has recorded no liability for unrecognized tax benefits and related interest and penalties as of December 31, 2016 and 2015.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company files income tax returns in the US federal tax jurisdiction and various state jurisdictions. The federal tax years for 2014 through 2016 remain open for examination. State tax years open for examination are generally 2013 through 2016, depending on the state.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-21</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_393.png"/></span></p></li><li style="padding-top: 3pt;padding-left: 20pt;text-indent: -12pt;text-align: left;"><p class="s14" style="display: inline;">EMPLOYEE RETIREMENT PLAN</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company sponsors a 401(k) profit sharing plan. All eligible employees of the Company who have reached the age of eighteen may participate in the plan. Each plan year, the Company’s Board of Directors will determine the amount, if any, that the Company will contribute to the plan as a Company matching contribution for that year. The Company recognized expense of approximately $729, $679 and $373 for the years ended December 31, 2016, 2015 and 2014, respectively, to fund Company contributions to the plan.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 20pt;text-indent: -12pt;text-align: left;"><p class="s14" style="display: inline;">SEGMENTS OF BUSINESS</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Operating segments are defined as components of an enterprise for which discrete financial information is available that is evaluated regularly by the chief operating decision maker, or CODM, for purposes of allocating resources and evaluating financial performance. The Company’s CODM is the Chief Executive Officer and the CODM reviews financial information presented on a consolidated basis and for each operating segment, for purposes of allocating resources and evaluating financial performance.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company is organized into four reportable segments, which are based on software and service offerings. The Company’s reportable segments are consistent with its operating segments and are as follows:</p><h4 style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Enterprise/Commercial <span class="p">—Offers the Company’s insurance distribution solutions to health plans.</span></h4><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Enterprise/State <span class="p">—Offers the Company’s sales automation solutions to state governments, which allows the Company’s state customers to offer customized individual and small group exchanges. The Enterprise/State segment had one remaining state exchange customer at December 31, 2016 and 2015, compared to three as of December 31, 2014.</span></h4><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Medicare<span class="p">—Offers web-based Medicare plan comparison, prescription drug comparison and enrollment tools for health plans, pharmacy benefit managers, pharmacies, field marketing organizations, and call centers.</span></h4><p style="text-indent: 0pt;text-align: left;"><br/></p><h4 style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Private Exchange<span class="p">—Offers defined-contribution benefit exchange solutions to benefit consultants, brokers, exchange operators and aggregators.</span></h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The accounting policies of the segments are the same as those described in the summary of significant accounting policies. The Company does not allocate cash, prepaid expenses, and property and equipment assets or capital expenditures to reportable segments.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company evaluates the performance of its segments based on gross margin, which is regularly reviewed by the CODM and provides insight into our individual segments and their ability to contribute to future debt service and working capital requirements of the Company.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-22</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_394.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">Unallocated corporate expenses, and assets that are not considered when the Company’s CODM evaluates segment performance are grouped within Corporate in the following segment information:</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 268pt;text-indent: 0pt;text-align: center;">Year Ended December 31</p><p style="padding-left: 315pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="229" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_395.png"/></span></p><p class="s3" style="padding-left: 268pt;text-indent: 0pt;text-align: center;">2016                        2015                       2014</p><table style="border-collapse:collapse;margin-left:61.8254pt" cellspacing="0"><tr style="height:11pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Revenue from external customers by segment:</p></td><td style="width:177pt;border-top-style:solid;border-top-width:1pt" colspan="3" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:254pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/Commercial</p></td><td style="width:61pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 49,081</p></td><td style="width:61pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 55,487</p></td><td style="width:55pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 40,369</p></td></tr><tr style="height:11pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/State</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 31pt;text-indent: 0pt;line-height: 8pt;text-align: left;">3,453</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 10pt;text-indent: 0pt;line-height: 8pt;text-align: right;">13,372</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">21,632</p></td></tr><tr style="height:11pt"><td style="width:254pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Medicare</p></td><td style="width:61pt"><p class="s10" style="padding-left: 26pt;text-indent: 0pt;line-height: 8pt;text-align: left;">18,565</p></td><td style="width:61pt"><p class="s10" style="padding-right: 10pt;text-indent: 0pt;line-height: 8pt;text-align: right;">17,973</p></td><td style="width:55pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">16,175</p></td></tr><tr style="height:11pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Private Exchange</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">             10,795</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">               9,015</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">               6,403</p></td></tr><tr style="height:11pt"><td style="width:254pt"><p class="s10" style="padding-top: 1pt;padding-left: 22pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Consolidated revenue</p></td><td style="width:61pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 81,894</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="60" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_396.png"/></span></p></td><td style="width:61pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 95,847</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="69" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_397.png"/></span></p></td><td style="width:55pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 84,579</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="60" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_398.png"/></span></p></td></tr><tr style="height:1pt"><td style="width:254pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:55pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:10pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Gross margin by segment:</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:55pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:254pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/Commercial</p></td><td style="width:61pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 11,906</p></td><td style="width:61pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 23,715</p></td><td style="width:55pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 10,323</p></td></tr><tr style="height:11pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/State</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 31pt;text-indent: 0pt;line-height: 8pt;text-align: left;">1,325</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 10pt;text-indent: 0pt;line-height: 8pt;text-align: right;">6,300</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">11,038</p></td></tr><tr style="height:11pt"><td style="width:254pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Medicare</p></td><td style="width:61pt"><p class="s10" style="padding-left: 26pt;text-indent: 0pt;line-height: 8pt;text-align: left;">11,460</p></td><td style="width:61pt"><p class="s10" style="padding-right: 10pt;text-indent: 0pt;line-height: 8pt;text-align: right;">10,651</p></td><td style="width:55pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">9,451</p></td></tr><tr style="height:11pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Private Exchange</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                   308</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">               4,511</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">               1,336</p></td></tr><tr style="height:11pt"><td style="width:254pt"><p class="s10" style="padding-top: 1pt;padding-left: 22pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Consolidated gross margin</p></td><td style="width:61pt"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 24,999</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="60" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_399.png"/></span></p></td><td style="width:61pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 45,177</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="69" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_400.png"/></span></p></td><td style="width:55pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 32,148</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="60" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_401.png"/></span></p></td></tr><tr style="height:1pt"><td style="width:254pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:55pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:10pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Consolidated operating expenses:</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:55pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:254pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Research and development</p></td><td style="width:61pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 22,297</p></td><td style="width:61pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 22,718</p></td><td style="width:55pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 18,125</p></td></tr><tr style="height:11pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Sales and marketing</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 26pt;text-indent: 0pt;line-height: 8pt;text-align: left;">10,410</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 10pt;text-indent: 0pt;line-height: 8pt;text-align: right;">9,507</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">7,729</p></td></tr><tr style="height:11pt"><td style="width:254pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">General and administrative</p></td><td style="width:61pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">             13,162</p></td><td style="width:61pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">             14,439</p></td><td style="width:55pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">             10,552</p></td></tr><tr style="height:12pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 22pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Total consolidated operating expenses</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ 45,869</p></td><td style="width:61pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ 46,664</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="69" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_402.png"/></span></p></td><td style="width:55pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ 36,406</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="69" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_403.png"/></span></p></td></tr><tr style="height:12pt"><td style="width:254pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Consolidated loss from operations</p></td><td style="width:61pt"><p class="s21" style="padding-top: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ (20,870<span class="s10"> )</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="60" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_404.png"/></span></p></td><td style="width:61pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ (1,487 )</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="69" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_405.png"/></span></p></td><td style="width:55pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ (4,258 )</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="60" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_406.png"/></span></p></td></tr><tr style="height:1pt"><td style="width:254pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:55pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:10pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Depreciation and amortization by segment:</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:61pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:55pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:254pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/Commercial</p></td><td style="width:61pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 642</p></td><td style="width:61pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 543</p></td><td style="width:55pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 584</p></td></tr><tr style="height:11pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/State</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 10pt;text-indent: 0pt;line-height: 8pt;text-align: right;">19</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 10pt;text-indent: 0pt;line-height: 8pt;text-align: right;">80</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">121</p></td></tr><tr style="height:11pt"><td style="width:254pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Medicare</p></td><td style="width:61pt"><p class="s10" style="padding-left: 31pt;text-indent: 0pt;line-height: 8pt;text-align: left;">2,576</p></td><td style="width:61pt"><p class="s10" style="padding-right: 10pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2,588</p></td><td style="width:55pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2,569</p></td></tr><tr style="height:11pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Private Exchange</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 31pt;text-indent: 0pt;line-height: 8pt;text-align: left;">1,034</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 10pt;text-indent: 0pt;line-height: 8pt;text-align: right;">992</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">896</p></td></tr><tr style="height:11pt"><td style="width:254pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Corporate</p></td><td style="width:61pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                   330</p></td><td style="width:61pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                   840</p></td><td style="width:55pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">                   931</p></td></tr><tr style="height:12pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 22pt;text-indent: 0pt;text-align: left;">Consolidated depreciation and amortization</p></td><td style="width:61pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ 4,601</p></td><td style="width:61pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ 5,043</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="69" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_407.png"/></span></p></td><td style="width:55pt;border-bottom-style:solid;border-bottom-width:1pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;text-align: left;">$ 5,101</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="69" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_408.png"/></span></p></td></tr><tr style="height:22pt"><td style="width:254pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:53pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:69pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s8" style="padding-top: 5pt;padding-left: 2pt;text-indent: 0pt;line-height: 7pt;text-align: left;">As of December 31,</p></td><td style="width:55pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:9pt"><td style="width:254pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:53pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 17pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2016</p></td><td style="width:69pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 24pt;padding-right: 27pt;text-indent: 0pt;line-height: 7pt;text-align: center;">2015</p></td><td style="width:55pt;border-top-style:solid;border-top-width:1pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 17pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2014</p></td></tr><tr style="height:11pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Identifiable assets by segment:</p></td><td style="width:53pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:69pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:55pt;border-top-style:solid;border-top-width:1pt" bgcolor="#CEEFFB"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:254pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/Commercial</p></td><td style="width:53pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 29,728</p></td><td style="width:69pt"><p class="s10" style="padding-left: 7pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 33,857</p></td><td style="width:55pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">$ 32,749</p></td></tr><tr style="height:11pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Enterprise/State</p></td><td style="width:53pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">627</p></td><td style="width:69pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 38pt;text-indent: 0pt;line-height: 8pt;text-align: left;">1,975</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">6,349</p></td></tr><tr style="height:11pt"><td style="width:254pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Medicare</p></td><td style="width:53pt"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">23,248</p></td><td style="width:69pt"><p class="s10" style="padding-left: 34pt;text-indent: 0pt;line-height: 8pt;text-align: left;">26,198</p></td><td style="width:55pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">28,314</p></td></tr><tr style="height:11pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Private Exchange</p></td><td style="width:53pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">18,247</p></td><td style="width:69pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 34pt;text-indent: 0pt;line-height: 8pt;text-align: left;">11,255</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">10,107</p></td></tr><tr style="height:11pt"><td style="width:254pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Corporate</p></td><td style="width:53pt"><p class="s21" style="padding-right: 2pt;text-indent: 0pt;line-height: 8pt;text-align: right;">             10,638</p></td><td style="width:69pt"><p class="s21" style="padding-left: 7pt;text-indent: 0pt;line-height: 8pt;text-align: left;">               9,404</p></td><td style="width:55pt"><p class="s21" style="text-indent: 0pt;line-height: 8pt;text-align: left;">             33,871</p></td></tr><tr style="height:12pt"><td style="width:254pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 22pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Consolidated assets</p></td><td style="width:53pt" bgcolor="#CEEFFB"><p class="s21" style="padding-top: 1pt;padding-right: 2pt;text-indent: 0pt;line-height: 9pt;text-align: right;">$ 82,488</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 5pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="60" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_409.png"/></span></p></td><td style="width:69pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;padding-left: 7pt;text-indent: 0pt;line-height: 9pt;text-align: left;">$ 82,689</p><p style="padding-left: 7pt;text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="69" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_410.png"/></span></p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s10" style="padding-top: 1pt;text-indent: 0pt;line-height: 9pt;text-align: left;">$ 111,390</p><p style="text-indent: 0pt;line-height: 2pt;text-align: left;"><span><img width="69" height="3" alt="image" src="NASDAQ_CNXR_2016/Image_411.png"/></span></p></td></tr></table><p style="padding-left: 320pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="60" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_412.png"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">All Company assets were held and all revenue was generated in the United States during the years ended December 31, 2016, 2015 and 2014.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-top: 5pt;padding-left: 20pt;text-indent: -12pt;text-align: left;"><p class="s14" style="display: inline;">RELATED PARTIES</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">On May 2, 2016, Chrysalis Ventures II, L.P. (“Chrysalis”), a holder of more than 5% of the Company’s outstanding common stock as of March 31, 2016, purchased $2,000 of the Series A Preferred Stock offered in the transaction discussed in Note 10.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">On March 10, 2017, Francisco Partners IV, L.P., Francisco Partners IV-A, L.P. (collectively, “Francisco Partners”) and Chrysalis, all holders of more than 5% of the Company’s outstanding common stock equivalents as of March 10, 2017, purchased $17,500 of the Series B Preferred Stock offered in the transaction discussed in Note 10. A member of the Company’s board of directors, is a Co-President of the managing companies of Francisco Partners and another member of the Company’s board of directors is a member of the general partner of Chrysalis.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-23</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_413.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company paid approximately $650 of administrative fees to Humana, Inc. in connection with the administration of the Company’s employee health benefits plan for each of the years ended December 31, 2016 and 2015. The Company’s chairman of the board of directors is a member of the Humana, Inc. board of directors.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company paid $2,900 of principal and $480 of interest to settle the subordinated promissory note with the sellers of DRX (the “DRX Seller Note”) during the year ended December 31, 2015. Then-current employees of the Company, including the Company’s current Chief Innovation Officer, New Markets, were employees and stockholders of DRX at the time of its acquisition, and as previous stockholders of DRX they received an interest in the DRX Seller Note. The $480 interest was paid to two related party stockholders, or entities controlled by the stockholders of the Company, pursuant to a note guarantee agreement the DRX sellers had with such related parties.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 20pt;text-indent: -12pt;text-align: left;"><p class="s14" style="display: inline;">CONSOLIDATED SELECTED QUARTERLY FINANCIAL DATA (unaudited)</p><p style="padding-top: 5pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">The following sets forth selected quarterly financial data for each of the eight quarters in the years ended December 31, 2016 and 2015.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:8pt"><td style="width:538pt" colspan="10"><p class="s8" style="padding-left: 318pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Quarter Ended</p></td></tr><tr style="height:9pt"><td style="width:195pt" colspan="2"><p class="s8" style="padding-right: 15pt;text-indent: 0pt;line-height: 7pt;text-align: right;">Dec 31,</p></td><td style="width:49pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 10pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Sept 30,</p></td><td style="width:50pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 11pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Jun 30,</p></td><td style="width:49pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 10pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Mar 30,</p></td><td style="width:47pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 11pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Dec 31,</p></td><td style="width:52pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 12pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Sept 30,</p></td><td style="width:50pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 11pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Jun 30,</p></td><td style="width:43pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 10pt;padding-right: 7pt;text-indent: 0pt;line-height: 7pt;text-align: center;">Mar 30,</p></td><td style="width:3pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:9pt"><td style="width:195pt" colspan="2"><p class="s8" style="padding-right: 18pt;text-indent: 0pt;line-height: 7pt;text-align: right;">2016</p></td><td style="width:49pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 11pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2016<span class="s23">(1)</span></p></td><td style="width:50pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 15pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2016</p></td><td style="width:49pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 15pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2016</p></td><td style="width:47pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 11pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2015<span class="s23">(2)</span></p></td><td style="width:52pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 16pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2015</p></td><td style="width:50pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 12pt;text-indent: 0pt;line-height: 7pt;text-align: left;">2015<span class="s23">(3)</span></p></td><td style="width:43pt;border-bottom-style:solid;border-bottom-width:1pt"><p class="s8" style="padding-left: 10pt;padding-right: 7pt;text-indent: 0pt;line-height: 7pt;text-align: center;">2015<span class="s23">(4)</span></p></td><td style="width:3pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:9pt"><td style="width:535pt" colspan="9"><p class="s8" style="padding-left: 285pt;text-indent: 0pt;line-height: 7pt;text-align: left;">(in thousands, except share amounts)</p></td><td style="width:3pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:149pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Revenue</p></td><td style="width:46pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 20,879</p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 24,729</p></td><td style="width:50pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 18,729</p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 17,557</p></td><td style="width:47pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 29,139</p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 22,667</p></td><td style="width:50pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 23,393</p></td><td style="width:46pt" colspan="2" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ 20,648</p></td></tr><tr style="height:11pt"><td style="width:149pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Gross margin</p></td><td style="width:46pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,891</p></td><td style="width:49pt"><p class="s10" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">8,838</p></td><td style="width:50pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,066</p></td><td style="width:49pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,204</p></td><td style="width:47pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">16,407</p></td><td style="width:52pt"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">10,069</p></td><td style="width:50pt"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">9,374</p></td><td style="width:46pt" colspan="2"><p class="s10" style="padding-left: 23pt;text-indent: 0pt;line-height: 8pt;text-align: left;">9,327</p></td></tr><tr style="height:11pt"><td style="width:149pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Total operating expenses</p></td><td style="width:46pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">11,189</p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 18pt;text-indent: 0pt;line-height: 8pt;text-align: left;">11,349</p></td><td style="width:50pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">12,225</p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">11,106</p></td><td style="width:47pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">10,469</p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">10,963</p></td><td style="width:50pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">12,216</p></td><td style="width:46pt" colspan="2" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 18pt;text-indent: 0pt;line-height: 8pt;text-align: left;">13,016</p></td></tr><tr style="height:11pt"><td style="width:149pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Income (loss) from operations</p></td><td style="width:46pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(5,298 )</p></td><td style="width:49pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(2,511 )</p></td><td style="width:50pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(7,159 )</p></td><td style="width:49pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(5,902 )</p></td><td style="width:47pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">5,938</p></td><td style="width:52pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(894 )</p></td><td style="width:50pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(2,842 )</p></td><td style="width:46pt" colspan="2"><p class="s10" style="padding-left: 20pt;text-indent: 0pt;line-height: 8pt;text-align: left;">(3,689 )</p></td></tr><tr style="height:11pt"><td style="width:149pt" bgcolor="#CEEFFB"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Net income (loss)</p></td><td style="width:46pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (6,232 )</p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ (3,066 )</p></td><td style="width:50pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (9,900 )</p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (7,336 )</p></td><td style="width:47pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 4,323</p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (2,308 )</p></td><td style="width:50pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ (4,259 )</p></td><td style="width:46pt" colspan="2" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 3pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ (5,099 )</p></td></tr><tr style="height:10pt"><td style="width:149pt"><p class="s10" style="text-indent: 0pt;line-height: 8pt;text-align: left;">Net income (loss) per common</p></td><td style="width:46pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:49pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:50pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:49pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:47pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:52pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:50pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:46pt" colspan="2"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:10pt"><td style="width:149pt"><p class="s10" style="padding-left: 5pt;text-indent: 0pt;line-height: 8pt;text-align: left;">share:</p></td><td style="width:46pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:49pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:50pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:49pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:47pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:52pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:50pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:43pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:3pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:11pt"><td style="width:149pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Basic</p></td><td style="width:46pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(0.32 )</p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(0.18 )</p></td><td style="width:50pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(0.47 )</p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(0.33 )</p></td><td style="width:47pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">0.20</p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(0.11 )</p></td><td style="width:50pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(0.20 )</p></td><td style="width:46pt" colspan="2" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 25pt;text-indent: 0pt;line-height: 8pt;text-align: left;">(0.24 )</p></td></tr><tr style="height:10pt"><td style="width:149pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Diluted</p></td><td style="width:46pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(0.32 )</p></td><td style="width:49pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(0.18 )</p></td><td style="width:50pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(0.47 )</p></td><td style="width:49pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(0.33 )</p></td><td style="width:47pt"><p class="s10" style="padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">0.19</p></td><td style="width:52pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(0.11 )</p></td><td style="width:50pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(0.20 )</p></td><td style="width:46pt" colspan="2"><p class="s10" style="padding-left: 25pt;text-indent: 0pt;line-height: 8pt;text-align: left;">(0.24 )</p></td></tr><tr style="height:20pt"><td style="width:538pt" colspan="10" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 5pt;padding-right: 425pt;text-indent: -5pt;line-height: 10pt;text-align: left;">Weighted-average common shares outstanding:</p></td></tr><tr style="height:11pt"><td style="width:149pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Basic</p></td><td style="width:46pt"><p class="s40" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">22,425,517</p></td><td style="width:49pt"><p class="s40" style="padding-top: 1pt;padding-left: 8pt;text-indent: 0pt;line-height: 8pt;text-align: left;">22,343,142</p></td><td style="width:50pt"><p class="s40" style="padding-top: 1pt;padding-left: 8pt;text-indent: 0pt;line-height: 8pt;text-align: left;">22,217,696</p></td><td style="width:49pt"><p class="s40" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">22,112,273</p></td><td style="width:47pt"><p class="s40" style="padding-top: 1pt;padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">21,960,077</p></td><td style="width:52pt"><p class="s40" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">21,879,414</p></td><td style="width:50pt"><p class="s40" style="padding-top: 1pt;padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">21,710,951</p></td><td style="width:46pt" colspan="2"><p class="s40" style="padding-top: 1pt;padding-left: 8pt;text-indent: 0pt;line-height: 8pt;text-align: left;">21,695,932</p></td></tr><tr style="height:11pt"><td style="width:149pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Diluted</p></td><td style="width:46pt" bgcolor="#CEEFFB"><p class="s40" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">22,425,517</p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s40" style="padding-top: 1pt;padding-left: 8pt;text-indent: 0pt;line-height: 8pt;text-align: left;">22,343,142</p></td><td style="width:50pt" bgcolor="#CEEFFB"><p class="s40" style="padding-top: 1pt;padding-left: 8pt;text-indent: 0pt;line-height: 8pt;text-align: left;">22,217,696</p></td><td style="width:49pt" bgcolor="#CEEFFB"><p class="s40" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">22,112,273</p></td><td style="width:47pt" bgcolor="#CEEFFB"><p class="s40" style="padding-top: 1pt;padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: right;">22,784,888</p></td><td style="width:52pt" bgcolor="#CEEFFB"><p class="s40" style="padding-top: 1pt;padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">21,879,414</p></td><td style="width:50pt" bgcolor="#CEEFFB"><p class="s40" style="padding-top: 1pt;padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: right;">21,710,951</p></td><td style="width:46pt" colspan="2" bgcolor="#CEEFFB"><p class="s40" style="padding-top: 1pt;padding-left: 8pt;text-indent: 0pt;line-height: 8pt;text-align: left;">21,695,932</p></td></tr></table><ol id="l21"><li style="padding-top: 1pt;padding-left: 32pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">During the three months ended September 30, 2016, the Company recognized approximately $4,600 of previously deferred revenue and approximately $2,000 of gross margin resulting from the satisfaction of a customer obligation.</p></li><li style="padding-top: 1pt;padding-left: 32pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">During the three months ended December 31, 2015, the Company recognized a $951 benefit related to the change in fair value of contingent acquisition consideration obligation.</p></li><li style="padding-top: 1pt;padding-left: 32pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">During the three months ended June 30, 2015, the Company recognized approximately $3,600 of previously deferred revenue and approximately</p><p style="padding-left: 32pt;text-indent: 0pt;text-align: left;">$1,000 of gross margin resulting from the termination of a two Enterprise/Commercial contracts.</p></li><li style="padding-top: 1pt;padding-left: 32pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">During the three months ended March 30, 2015, the Company recognized approximately $4,000 of previously deferred revenue and approximately</p></li></ol><p style="padding-top: 2pt;padding-left: 32pt;text-indent: 0pt;text-align: left;">$4,000 of gross margin resulting from the satisfaction of several customer obligations.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">The sum of 2016 quarterly net income (loss) per common share does not equal the net loss per common share for the entire year due to the impact on weighted-average shares outstanding of the conversions of the Series A Preferred Stock. The sum of 2015 quarterly net income (loss) per common share does not equal the net loss per common share for the entire year due to the impact of rounding.</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 20pt;text-indent: -12pt;text-align: left;"><p class="s14" style="display: inline;">SUBSEQUENT EVENTS</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Series B Preferred Stock - <span class="p">On March 10, 2017, the Company entered into an Investment Agreement (the “Investment Agreement”) with Francisco Partners and Chrysalis (Chrysalis and Francisco Partners, collectively, the “Investors”), pursuant to which the Company issued and sold as of such date (the “Closing”) to the Investors an aggregate of 17,500 shares of the Company’s newly created Series B Preferred Stock, par value $0.001 per share, at a purchase price of $1,000 per share, for an aggregate purchase price of $17,500. See Note 10 for terms of the Series B Preferred Stock.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">A member of the Company’s board of directors, is a Co-President of the managing companies of Francisco Partners and another member of the Company’s board of directors is a member of the general partner of Chrysalis. Both Francisco Partners and Chrysalis were holders of more than 5% of the Company’s outstanding common stock equivalents as of March 10, 2017.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-24</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_414.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">The Company expects to use the proceeds from the sale to support operations and for general corporate purposes.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Credit Facility Amendment <span class="p">- On March 10, 2017, the Company amended the Credit Facility, to, among other things, reset certain financial covenants, defer the Senior Term Loan principal repayments until March 31, 2018, and increase the interest rates on applicable borrowings as described in Note 9.</span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 19pt;text-indent: 0pt;text-align: center;">* * * * * *</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-25</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_415.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">FINANCIAL STATEMENT SCHEDULE</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a name="bookmark90">Schedule II—Valuation and Qualifying Accounts (in thousands)</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 4pt;padding-left: 239pt;text-indent: 0pt;text-align: center;">Balance at Beginning of Period</p><p style="padding-left: 222pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="58" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_416.png"/></span></p><p class="s3" style="padding-top: 4pt;padding-left: 12pt;text-indent: 0pt;text-align: center;">Additions (Reversals) Charged to Expense</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="59" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_417.png"/></span></p><p class="s3" style="padding-top: 4pt;padding-left: 13pt;text-indent: 2pt;text-align: left;">Additions (Reversals) Charged to</p><p class="s3" style="padding-left: 17pt;text-indent: 0pt;text-align: left;">Revenue Acquired Deductions</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-top: 5pt;padding-left: 8pt;text-indent: 5pt;text-align: left;">Balance at End of Period</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="59" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_418.png"/></span></p><p class="s29" style="padding-left: 330pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="61" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_419.png"/></span>	<span><img width="63" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_420.png"/></span>	<span><img width="57" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_421.png"/></span></p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:11pt"><td style="width:538pt" colspan="6"><p style="text-indent: 0pt;line-height: 9pt;text-align: left;"><span class="s32" style=" background-color: #CEEFFB;">Trade receivable allowances:                                                                                                                                                                                                                            </span></p></td></tr><tr style="height:10pt"><td style="width:166pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Year ended December 31, 2016</p></td><td style="width:96pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ —</p></td><td style="width:55pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ —</p></td><td style="width:57pt"><p class="s10" style="padding-left: 5pt;text-indent: 0pt;line-height: 8pt;text-align: left;">$ —</p></td><td style="width:111pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ — $ —</p></td><td style="width:53pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ —</p></td></tr><tr style="height:11pt"><td style="width:166pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Year ended December 31, 2015</p></td><td style="width:96pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">246</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">45</p></td><td style="width:57pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">(137 )</p></td><td style="width:111pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">— (154 )</p></td><td style="width:53pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td></tr><tr style="height:10pt"><td style="width:166pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Year ended December 31, 2014</p></td><td style="width:96pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">266</p></td><td style="width:55pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">25</p></td><td style="width:57pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">—</p></td><td style="width:111pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">— (45 )</p></td><td style="width:53pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">246</p></td></tr><tr style="height:11pt"><td style="width:538pt" colspan="6"><p style="text-indent: 0pt;line-height: 9pt;text-align: left;"><span class="s32" style=" background-color: #CEEFFB;">Deferred tax asset valuation allowance:                                                                                                                                                                                                          </span></p></td></tr><tr style="height:10pt"><td style="width:166pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Year ended December 31, 2016</p></td><td style="width:96pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 38,817</p></td><td style="width:55pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 9,375</p></td><td style="width:57pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">N/A</p></td><td style="width:111pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ — $ —</p></td><td style="width:53pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">$ 48,192</p></td></tr><tr style="height:11pt"><td style="width:166pt" bgcolor="#CEEFFB"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Year ended December 31, 2015</p></td><td style="width:96pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">36,420</p></td><td style="width:55pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">2,397</p></td><td style="width:57pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">N/A</p></td><td style="width:111pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">— —</p></td><td style="width:53pt" bgcolor="#CEEFFB"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">38,817</p></td></tr><tr style="height:10pt"><td style="width:166pt"><p class="s10" style="padding-left: 11pt;text-indent: 0pt;line-height: 8pt;text-align: left;">Year ended December 31, 2014</p></td><td style="width:96pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">37,896</p></td><td style="width:55pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">3,421</p></td><td style="width:57pt"><p class="s10" style="padding-right: 6pt;text-indent: 0pt;line-height: 8pt;text-align: right;">N/A</p></td><td style="width:111pt"><p class="s10" style="padding-right: 3pt;text-indent: 0pt;line-height: 8pt;text-align: right;">— (4,897 )</p></td><td style="width:53pt"><p class="s10" style="padding-right: 5pt;text-indent: 0pt;line-height: 8pt;text-align: right;">36,420</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-top: 4pt;padding-bottom: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;">F-26</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_422.png"/></span></p><p class="s14" style="padding-top: 3pt;padding-left: 19pt;text-indent: 0pt;text-align: center;"><a name="bookmark30">EXHIBIT INDEX</a><a name="bookmark91">&zwnj;</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s3" style="padding-left: 22pt;text-indent: 0pt;text-align: left;">Exhibit Incorporated by Reference</p><p style="padding-left: 311pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="310" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_423.png"/></span></p><p class="s3" style="padding-left: 21pt;text-indent: 0pt;text-align: left;">Number Description Form File No. Exhibit Filing Date</p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:38pt"><td style="width:52pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-top: 6pt;text-indent: 0pt;text-align: left;">2.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-top: 6pt;text-indent: 0pt;text-align: left;">Agreement and Plan of Merger, dated January 14, 2013, by and among the Registrant, DRX Acquisition Co., DestinationRx, Inc. and the principal stockholders named therein</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">2.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">2.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 3pt;padding-right: 5pt;text-indent: 0pt;text-align: left;">Stock Purchase Agreement, dated February 16, 2011, by and among the Registrant, Patrick Downend and Aaron Downend</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">2.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">2.3</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">Exchange Agreement, dated August 3, 2012, by and among the Registrant and the stockholders party thereto.</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">2.3</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">October 20, 2014</p></td></tr><tr style="height:45pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">2.4</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 3pt;padding-right: 5pt;text-indent: 0pt;text-align: left;">Agreement and Plan of Merger, dated June 7, 2016, by and among ConnectedHealth, LLC, Connecture, Inc., Speed Merger Sub, Inc., the Principal Equityholders, and Shareholder Representative Services, LLC</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">2.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">June 9, 2016</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">3.1.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">Sixth Amended and Restated Certificate of Incorporation, dated December 16, 2014</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">10-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">3.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">March 25, 2015</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">3.1.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 3pt;padding-right: 30pt;text-indent: 0pt;text-align: left;">Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">3.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">May 4, 2016</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">3.1.3</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 3pt;padding-right: 30pt;text-indent: 0pt;text-align: left;">Certificate of Designations, Preferences and Rights of Series B Convertible Preferred Stock</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">3.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">March 14, 2017</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">3.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">Amended and Restated Bylaws of the Registrant</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 3pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1/A</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 3pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 3pt;padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">3.4</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 3pt;padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">November 10, 2014</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">4.1.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">Investor Rights Agreement, dated August 3, 2012</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 3pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 3pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 3pt;padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">4.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 3pt;padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">4.1.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">First Amendment to Investor Rights Agreement, dated November 6, 2014</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1/A</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">4.1.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">November 10, 2014</p></td></tr><tr style="height:35pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">4.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: justify;">Investor Rights Agreement, dated as of May 2, 2016, by and among the Registrant and Francisco Partners IV, L.P., Francisco Partners IV-A, L.P. and Chrysalis Ventures II, L.P.</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">4.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">May 4, 2016</p></td></tr><tr style="height:35pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">4.3</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">Investor Rights Agreement dated March 10, 2017, by and among the Registrant and Francisco Partners IV, L.P., Francisco Partners IV-A, L.P. and Chrysalis Ventures II, L.P.</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">4.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">March 14, 2017</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">10.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">Form of Indemnification Agreement for directors and officers</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 3pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1/A</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 3pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 3pt;padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">10.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 3pt;padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">November 26, 2014</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">10.2†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">2010 Stock Plan, as amended, and form of agreement thereunder</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 3pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 3pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 3pt;padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">10.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 3pt;padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">10.3.1†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">2014 Equity Incentive Plan, as amended and forms of agreement thereunder</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">10.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">September 26, 2016</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">10.3.2†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 3pt;padding-right: 18pt;text-indent: 0pt;text-align: left;">Form of Restricted Stock Units Agreements under the Registrant’s 2014 Equity Incentive Plan</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">10-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">10.3.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">March 25, 2015</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">10.4†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">2014 Employee Stock Purchase Plan</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 3pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1/A</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 3pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 3pt;padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">10.14</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 3pt;padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;text-align: center;">November 26, 2014</p></td></tr><tr style="height:32pt"><td style="width:52pt"><p class="s10" style="padding-top: 3pt;text-indent: 0pt;text-align: left;">10.5.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;line-height: 10pt;text-align: left;">Investment Agreement, dated as of March 11, 2016, by and among the Registrant and Francisco Partners IV, L.P., Francisco Partners IV-A, L.P. and Chrysalis Ventures II, L.P.</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;line-height: 8pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;line-height: 8pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;line-height: 8pt;text-align: center;">10.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 8pt;padding-right: 8pt;text-indent: 0pt;line-height: 8pt;text-align: center;">March 14, 2016</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_424.png"/></span></p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:8pt"><td style="width:52pt"><p class="s8" style="padding-right: 15pt;text-indent: 0pt;line-height: 7pt;text-align: right;">Exhibit</p></td><td style="width:252pt" colspan="3"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:129pt;border-bottom-style:solid;border-bottom-width:1pt" colspan="6"><p class="s8" style="padding-left: 39pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Incorporated by Reference</p></td><td style="width:68pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:9pt"><td style="width:52pt"><p class="s8" style="padding-right: 13pt;text-indent: 0pt;line-height: 7pt;text-align: right;">Number</p></td><td style="width:252pt" colspan="3"><p class="s8" style="padding-left: 107pt;padding-right: 107pt;text-indent: 0pt;line-height: 7pt;text-align: center;">Description</p></td><td style="width:37pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;line-height: 7pt;text-align: center;">Form</p></td><td style="width:129pt;border-top-style:solid;border-top-width:1pt" colspan="6"><p class="s8" style="padding-left: 21pt;text-indent: 0pt;line-height: 7pt;text-align: left;">File No. Exhibit</p></td><td style="width:68pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 7pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Filing Date</p></td></tr><tr style="height:38pt"><td style="width:52pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-top: 6pt;text-indent: 0pt;text-align: left;">10.5.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-top: 6pt;text-indent: 0pt;text-align: left;">Amendment No. 1 to Investment Agreement, dated as of May 2, 2016, by and among the Registrant and Francisco Partners IV, L.P., Francisco Partners IV-A, L.P. and Chrysalis Ventures II, L.P.</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 12pt;text-indent: 0pt;text-align: left;">10.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 21pt;text-indent: 0pt;text-align: left;">May 4, 2016</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.6.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Voting Agreement, dated as of March 11, 2016, between Chrysalis Ventures II, L.P. and Francisco Partners IV, L.P.</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 12pt;text-indent: 0pt;text-align: left;">10.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 15pt;text-indent: 0pt;text-align: left;">March 14, 2016</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.6.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 27pt;text-indent: 0pt;text-align: left;">Voting Agreement, dated as of March 11, 2016, between GPP – Connecture, LLC and Francisco Partners IV, L.P.</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 12pt;text-indent: 0pt;text-align: left;">10.3</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 15pt;text-indent: 0pt;text-align: left;">March 14, 2016</p></td></tr><tr style="height:35pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.7</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Investment Agreement, dated as of March 11, 2016, by and among the Registrant and Francisco Partners IV, L.P., Francisco Partners IV-A, L.P. and Chrysalis Ventures II, L.P.</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 12pt;text-indent: 0pt;text-align: left;">10.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 15pt;text-indent: 0pt;text-align: left;">March 14, 2017</p></td></tr><tr style="height:45pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.8.1**</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 3pt;text-indent: 0pt;text-align: left;">Amended and Restated Credit Agreement, dated June 8, 2016, by and among Wells Fargo Bank, National Association, as administrative agent for the lenders named therein, the Registrant and DestinationRx, Inc.</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">10-Q</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 12pt;text-indent: 0pt;text-align: left;">10.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 16pt;text-indent: 0pt;text-align: left;">August 9, 2016</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.8.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Amendment No. 1 to Amended and Restated Credit Agreement, dated November 4, 2016</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">10-Q</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 12pt;text-indent: 0pt;text-align: left;">10.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 11pt;text-indent: 0pt;text-align: left;">November 9, 2016</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.8.3</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Amendment No. 2 to Amended and Restated Credit Agreement, dated March 10, 2017</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 12pt;text-indent: 0pt;text-align: left;">10.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 15pt;text-indent: 0pt;text-align: left;">March 14, 2017</p></td></tr><tr style="height:35pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.9.1**</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Credit Agreement, dated January 15, 2013, by and among Wells Fargo Bank, National Association, as administrative agent for the lenders named therein, the Registrant and DestinationRx, Inc.</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1/A</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">10.3.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">November 26, 2014</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.9.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">First Amendment to Credit Agreement, dated March 18, 2013</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">10.3.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.9.3</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Second Amendment to Credit Agreement, dated December 10, 2013</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">10.3.3</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.9.4</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Third Amendment to Credit Agreement, dated March 12, 2014</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">10.3.4</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.9.5</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Fourth Amendment to Credit Agreement, dated May 29, 2014</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">10.3.5</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.9.6</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Fifth Amendment to Credit Agreement, dated June 12, 2014</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">10.3.6</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.9.7</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Sixth Amendment to Credit Agreement, dated December 5, 2014</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1/A</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">10.3.7</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">December 8, 2014</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.9.8</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Seventh Amendment to Credit Agreement, dated December 11, 2014</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">10-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">10.5.8</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 15pt;text-indent: 0pt;text-align: left;">March 25, 2015</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.9.9</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Limited Waiver to Credit Agreement, dated December 29, 2014</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">10-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">10.5.9</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 15pt;text-indent: 0pt;text-align: left;">March 25, 2015</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.9.10</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Eighth Amendment to Credit Agreement, dated March 10, 2015</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">10.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 15pt;text-indent: 0pt;text-align: left;">March 13, 2015</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.9.11</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Ninth Amendment to Credit Agreement, dated September 30, 2015</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">10.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 15pt;text-indent: 0pt;text-align: left;">October 2, 2015</p></td></tr><tr style="height:13pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;line-height: 9pt;text-align: left;">10.9.12</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;line-height: 9pt;text-align: left;">Tenth Amendment to Credit Agreement, dated November 10, 2015</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;line-height: 9pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;line-height: 9pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 12pt;text-indent: 0pt;line-height: 9pt;text-align: left;">10.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;line-height: 9pt;text-align: left;">November 10, 2015</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_425.png"/></span></p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:8pt"><td style="width:52pt"><p class="s8" style="padding-right: 15pt;text-indent: 0pt;line-height: 7pt;text-align: right;">Exhibit</p></td><td style="width:252pt" colspan="3"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:129pt;border-bottom-style:solid;border-bottom-width:1pt" colspan="6"><p class="s8" style="padding-left: 39pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Incorporated by Reference</p></td><td style="width:68pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:9pt"><td style="width:52pt"><p class="s8" style="padding-right: 13pt;text-indent: 0pt;line-height: 7pt;text-align: right;">Number</p></td><td style="width:252pt" colspan="3"><p class="s8" style="padding-left: 107pt;padding-right: 107pt;text-indent: 0pt;line-height: 7pt;text-align: center;">Description</p></td><td style="width:37pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;line-height: 7pt;text-align: center;">Form</p></td><td style="width:129pt;border-top-style:solid;border-top-width:1pt" colspan="6"><p class="s8" style="padding-left: 21pt;text-indent: 0pt;line-height: 7pt;text-align: left;">File No. Exhibit</p></td><td style="width:68pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 7pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Filing Date</p></td></tr><tr style="height:19pt"><td style="width:52pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-top: 6pt;text-indent: 0pt;text-align: left;">10.9.13</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-top: 6pt;text-indent: 0pt;text-align: left;">Eleventh Amendment to Credit Agreement, dated December 31, 2015</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-top: 6pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-top: 6pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-top: 6pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">10.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-top: 6pt;padding-left: 15pt;text-indent: 0pt;text-align: left;">January 7, 2016</p></td></tr><tr style="height:45pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.9.14</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 3pt;text-indent: 0pt;text-align: left;">Guaranty and Security Agreement, dated January 15, 2013, by and among Wells Fargo Bank, National Association, as administrative agent for the lenders named therein, the Registrant and DestinationRx, Inc.</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">10.3.7</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:35pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.9.15</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Trademark Security Agreement, dated January 15, 2013, by and among Wells Fargo Bank, National Association, as administrative agent for the lenders named therein, the Registrant and DestinationRx, Inc.</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">10.3.8</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:35pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.9.16</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 5pt;text-indent: 0pt;text-align: left;">Patent Security Agreement, dated January 15, 2013, by and among Wells Fargo Bank, National Association, as administrative agent for the lenders named therein, the Registrant and DestinationRx, Inc.</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">10.3.9</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:35pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.9.17</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 3pt;text-indent: 0pt;text-align: left;">Copyright Security Agreement, dated January 15, 2013, by and among Wells Fargo Bank, National Association, as administrative agent for the lenders named therein, the Registrant and DestinationRx, Inc.</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">10.3.10</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:35pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.10.1**</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 13pt;text-indent: 0pt;text-align: justify;">Second Lien Term Loan Agreement, dated March 18, 2013, by and among THL Corporate Finance, Inc., as administrative agent for the lenders named therein, the Registrant and DestinationRx, Inc.</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1/A</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">10.4.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">November 26, 2014</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.10.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">First Amendment to Term Loan Agreement, dated December 4, 2013</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">10.4.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.10.3</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Second Amendment to Term Loan Agreement, dated March 20, 2014</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">10.4.3</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.10.4</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Third Amendment to Term Loan Agreement, dated May 29, 2014</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">10.4.4</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.10.5</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Fourth Amendment to Term Loan Agreement, dated June 12, 2014</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">10.4.5</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.10.6</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Fifth Amendment to Term Loan Agreement, dated December 5, 2014</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">S-1/A</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">10.4.6</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">December 8, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.10.7</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Sixth Amendment to Second Lien Term Loan Agreement, dated December 11, 2014</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">10-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">10.6.7</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 15pt;text-indent: 0pt;text-align: left;">March 25, 2015</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.10.8</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 34pt;text-indent: 0pt;text-align: left;">Limited Waiver to Second Lien Term Loan Agreement, dated December 29, 2014</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">10-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">10.6.8</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 15pt;text-indent: 0pt;text-align: left;">March 25, 2015</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.10.9</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Seventh Amendment to Term Loan Agreement, dated March 10, 2015</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">10.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 15pt;text-indent: 0pt;text-align: left;">March 13, 2015</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.10.10</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Eighth Amendment to Term Loan Agreement, dated November 5, 2015</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">10.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">November 10, 2015</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.10.11</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Ninth Amendment to Term Loan Agreement, dated December 31, 2015</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 12pt;text-indent: 0pt;text-align: left;">10.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 15pt;text-indent: 0pt;text-align: left;">January 7, 2016</p></td></tr><tr style="height:32pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.11.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 2pt;text-indent: 0pt;line-height: 10pt;text-align: justify;">Subordinated Promissory Note, dated January 15, 2013, by and among the Registrant and Randall P. Herman, on behalf of the stockholders of DestinationRx, Inc.</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;line-height: 9pt;text-align: center;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;line-height: 9pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;line-height: 9pt;text-align: left;">10.6.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;line-height: 9pt;text-align: left;">October 20, 2014</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_426.png"/></span></p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:8pt"><td style="width:52pt"><p class="s8" style="padding-right: 15pt;text-indent: 0pt;line-height: 7pt;text-align: right;">Exhibit</p></td><td style="width:252pt" colspan="3"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:129pt;border-bottom-style:solid;border-bottom-width:1pt" colspan="6"><p class="s8" style="padding-left: 39pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Incorporated by Reference</p></td><td style="width:68pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:9pt"><td style="width:52pt"><p class="s8" style="padding-right: 13pt;text-indent: 0pt;line-height: 7pt;text-align: right;">Number</p></td><td style="width:252pt" colspan="3"><p class="s8" style="padding-left: 107pt;padding-right: 107pt;text-indent: 0pt;line-height: 7pt;text-align: center;">Description</p></td><td style="width:37pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-right: 9pt;text-indent: 0pt;line-height: 7pt;text-align: right;">Form</p></td><td style="width:129pt;border-top-style:solid;border-top-width:1pt" colspan="6"><p class="s8" style="padding-left: 21pt;text-indent: 0pt;line-height: 7pt;text-align: left;">File No. Exhibit</p></td><td style="width:68pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 7pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Filing Date</p></td></tr><tr style="height:38pt"><td style="width:52pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-top: 6pt;text-indent: 0pt;text-align: left;">10.11.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-top: 6pt;text-indent: 0pt;text-align: left;">Subordinated Note Guaranty, dated January 15, 2013, by and among GPP—Connecture, LLC and Chrysalis Ventures II, L.P. and Randall P. Herman</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">10.6.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.12.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Lease Agreement, dated May 10, 2012, by and among CORE Realty Holdings Management, Inc. and the Registrant</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">10.7.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.12.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">First Amendment to Lease Agreement, dated January 31, 2013, by and among CORE Realty Holdings Management, Inc. and the Registrant</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">10.7.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:35pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.12.3</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 5pt;text-indent: 0pt;text-align: left;">Second Amendment to Lease Agreement, dated February 4, 2014, by and among CORE Realty Holdings Management, Inc. and the Registrant</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">10.7.3</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.13.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Lease Agreement, dated September 30, 2013, by and among TR 55 Allen Plaza LLC and the Registrant</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">10.8.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.13.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 10pt;text-indent: 0pt;text-align: left;">First Amendment to Lease Agreement, dated December 31, 2013, by and among TR 55 Allen Plaza LLC and the Registrant</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">10.8.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.14</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 5pt;text-indent: 0pt;text-align: left;">Lease Agreement, dated November 1, 2011, by and among 600 Wilshire Property LLC and the Registrant</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 12pt;text-indent: 0pt;text-align: left;">10.9</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.15†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 5pt;text-indent: 0pt;text-align: left;">Employment Agreement, dated November 12, 2015, by and between the Registrant and Jeffery A. Surges</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 11pt;text-indent: 0pt;text-align: right;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 12pt;text-indent: 0pt;text-align: left;">10.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">November 12, 2015</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.16†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Employment Agreement, dated January 1, 2017, by and between the Registrant and Vincent E. Estrada</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 11pt;text-indent: 0pt;text-align: right;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 12pt;text-indent: 0pt;text-align: left;">10.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 15pt;text-indent: 0pt;text-align: left;">January 3, 2017</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.17.1†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Bonus Agreement, dated December 31, 2014, by and among the Registrant and David A. Sockel</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">10.11.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.17.2†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Separation Pay Agreement, dated July 23, 2012, by and among the Registrant and David A. Sockel</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">10.11.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.18.1†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Bonus Agreement, dated December 31, 2014, by and among the Registrant and Mark E. Granville</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">10.12.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.18.2†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 5pt;text-indent: 0pt;text-align: left;">Separation Pay Agreement, dated September 10, 2012, by and among the Registrant and Mark E. Granville</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">10.12.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.18.3*†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 5pt;text-indent: 0pt;text-align: left;">Letter Agreement, dated March 30, 2017, by and between the Registrant and Mark E. Granville</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.19.1†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 12pt;text-indent: 0pt;text-align: left;">Employment Agreement, effective as of December 31, 2011, by and among the Registrant and Robert Douglas Schneider</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">10.10.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.19.2†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 5pt;text-indent: 0pt;text-align: left;">Letter Agreement, dated October 18, 2014, by and among the Registrant and Robert Douglas Schneider</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">10.10.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.19.3†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Transaction Bonus Agreement, dated October 26, 2012, by and among the Registrant and Robert Douglas Schneider</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">10.10.3</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.19.4†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Bonus Agreement, dated December 31, 2014, by and among the Registrant and Robert Douglas Schneider</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 12pt;text-indent: 0pt;text-align: right;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;text-align: left;">10.10.4</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;text-align: left;">October 20, 2014</p></td></tr><tr style="height:22pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.19.5†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;line-height: 10pt;text-align: left;">Separation Pay Agreement, dated December 31, 2011, as amended, by and among the Registrant and Robert Douglas Schneider</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-right: 12pt;text-indent: 0pt;line-height: 9pt;text-align: right;">S-1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;line-height: 9pt;text-align: left;">333-199484</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 7pt;text-indent: 0pt;line-height: 9pt;text-align: left;">10.10.5</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 13pt;text-indent: 0pt;line-height: 9pt;text-align: left;">October 20, 2014</p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_427.png"/></span></p><table style="border-collapse:collapse;margin-left:8pt" cellspacing="0"><tr style="height:8pt"><td style="width:52pt"><p class="s8" style="padding-right: 15pt;text-indent: 0pt;line-height: 7pt;text-align: right;">Exhibit</p></td><td style="width:252pt" colspan="3"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:129pt;border-bottom-style:solid;border-bottom-width:1pt" colspan="6"><p class="s8" style="padding-left: 39pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Incorporated by Reference</p></td><td style="width:68pt;border-bottom-style:solid;border-bottom-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:9pt"><td style="width:52pt"><p class="s8" style="padding-right: 13pt;text-indent: 0pt;line-height: 7pt;text-align: right;">Number</p></td><td style="width:252pt" colspan="3"><p class="s8" style="padding-left: 107pt;padding-right: 107pt;text-indent: 0pt;line-height: 7pt;text-align: center;">Description</p></td><td style="width:37pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;line-height: 7pt;text-align: center;">Form</p></td><td style="width:129pt;border-top-style:solid;border-top-width:1pt" colspan="6"><p class="s8" style="padding-left: 21pt;text-indent: 0pt;line-height: 7pt;text-align: left;">File No. Exhibit</p></td><td style="width:68pt;border-top-style:solid;border-top-width:1pt"><p class="s8" style="padding-left: 7pt;text-indent: 0pt;line-height: 7pt;text-align: left;">Filing Date</p></td></tr><tr style="height:29pt"><td style="width:52pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-top: 6pt;text-indent: 0pt;text-align: left;">10.19.6†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt;border-top-style:solid;border-top-width:1pt"><p class="s10" style="padding-top: 6pt;text-indent: 0pt;text-align: left;">Letter Agreement, dated November 12, 2015, by and between the Registrant and Robert Douglas Schneider</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-top: 5pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-top: 5pt;padding-left: 9pt;padding-right: 9pt;text-indent: 0pt;text-align: center;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-top: 5pt;padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">10.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt;border-top-style:solid;border-top-width:1pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-top: 5pt;padding-left: 9pt;text-indent: 0pt;text-align: left;">November 12, 2015</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.20.1†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Bonus Agreement, dated December 31, 2014, by and among the Registrant and James P. Purko</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">10-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;padding-right: 9pt;text-indent: 0pt;text-align: center;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">10.14.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 15pt;text-indent: 0pt;text-align: left;">March 25, 2015</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.20.2†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Separation Pay Agreement, dated July 23, 2012, by and among the Registrant and James P. Purko</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">10-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;padding-right: 9pt;text-indent: 0pt;text-align: center;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">10.14.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 15pt;text-indent: 0pt;text-align: left;">March 25, 2015</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.20.3†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Amendment No. 1 to Separation Pay Agreement, dated April 29, 2015, by and between the Registrant and James P. Purko</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">10-K/A</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;padding-right: 9pt;text-indent: 0pt;text-align: center;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">10.14.3</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 18pt;text-indent: 0pt;text-align: left;">April 29, 2015</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.20.4†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 7pt;text-indent: 0pt;text-align: left;">Amendment No. 2 to Separation Pay Agreement, dated December 14, 2016, by and between the Registrant and James P. Purko</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;padding-right: 9pt;text-indent: 0pt;text-align: center;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">10.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;text-indent: 0pt;text-align: left;">December 15, 2016</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.21†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Separation Pay Agreement, dated effective April 13, 2015, by and among the Registrant and William A. Spehr</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 9pt;padding-right: 9pt;text-indent: 0pt;text-align: center;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">10.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s10" style="padding-left: 21pt;text-indent: 0pt;text-align: left;">May 9, 2016</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">10.22†</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">2016 Bonus Plan</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">8-K</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;padding-right: 9pt;text-indent: 0pt;text-align: center;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">10.2</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 21pt;text-indent: 0pt;text-align: left;">May 4, 2016</p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">21.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">List of Subsidiaries of the Registrant</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p class="s10" style="padding-top: 2pt;padding-left: 4pt;padding-right: 4pt;text-indent: 0pt;text-align: center;">10-Q</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p class="s10" style="padding-top: 2pt;padding-left: 9pt;padding-right: 9pt;text-indent: 0pt;text-align: center;">001-36778</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p class="s10" style="padding-top: 2pt;padding-left: 6pt;padding-right: 7pt;text-indent: 0pt;text-align: center;">21.1</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p class="s10" style="padding-top: 2pt;padding-left: 16pt;text-indent: 0pt;text-align: left;">August 9, 2016</p></td></tr><tr style="height:26pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">23.1*</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Consent of Deloitte &amp; Touche LLP, Independent Registered Public Accounting Firm relating to the Registrant</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">24.1*</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Power of Attorney (see page 65 to this Annual Report on Form 10-K)</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:35pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">31.1*</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 3pt;text-indent: 0pt;text-align: left;">Certification of Principal Executive Officer Required Under Rule 13a- 14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:35pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">31.2*</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 5pt;text-indent: 0pt;text-align: left;">Certification of Principal Financial Officer Required Under Rule 13a- 14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:45pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">32.1#</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;padding-right: 5pt;text-indent: 0pt;text-align: left;">Certification of Chief Executive Officer Required Under Rule 13a- 14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:45pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">32.2#</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">Certification of Chief Financial Officer Required Under Rule 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended, and 18 U.S.C. §1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">101.INS</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">XBRL Taxonomy Document</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">101.SCH</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">XBRL Taxonomy Extension Schema</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">101.CAL</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">XBRL Taxonomy Extension Calculation Linkbase</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">101.LAB</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">XBRL Taxonomy Extension Label Linkbase</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:16pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">101.PRE</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">XBRL Taxonomy Extension Presentation Linkbase</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr><tr style="height:19pt"><td style="width:52pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">101.DEF</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:244pt"><p class="s10" style="padding-top: 2pt;text-indent: 0pt;text-align: left;">XBRL Taxonomy Extension Definition Linkbase</p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:37pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:58pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:41pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:4pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td><td style="width:86pt"><p style="text-indent: 0pt;text-align: left;"><br/></p></td></tr></table><p style="text-indent: 0pt;text-align: left;"><span><img width="96" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_428.png"/></span></p><p style="padding-top: 3pt;padding-left: 8pt;text-indent: 0pt;text-align: left;">† Management contract, compensatory plan or arrangement.</p></li></ol></li><li style="padding-left: 32pt;text-indent: -24pt;text-align: left;"><p style="display: inline;">Filed herewith</p></li></ul><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;"># Furnished herewith</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_429.png"/></span></p><p style="padding-top: 3pt;padding-left: 32pt;text-indent: -24pt;text-align: left;">** Portions of this agreement have been redacted pursuant to a request for confidential treatment that was granted by the Securities and Exchange Commission.</p><p class="s14" style="padding-top: 4pt;text-indent: 0pt;text-align: right;"><a name="bookmark31">Ex. 10.18.3</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><span><img width="115" height="23" alt="image" src="NASDAQ_CNXR_2016/Image_430.jpg"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 206%;text-align: left;">March 30, 2017 Mark Granville</p><p class="s41" style="padding-left: 8pt;text-indent: 0pt;line-height: 206%;text-align: left;">Re: Bonus Agreement <span style=" color: #000;">Dear Mark:</span></p><p style="padding-left: 8pt;text-indent: 41pt;text-align: left;">In consideration of your work for Connecture, Inc., a Delaware corporation (the “Company”) and provided that you remain continuously employed by the Company (or any controlled affiliate of the Company or its successor in interest) from the date of this Agreement through December 31, 2017 (the “Payment Event Date”), the Company will pay you a $30,000 cash bonus (less applicable withholdings and deductions) (the “Bonus”), subject to the conditions described herein. You and the Company are also parties to that certain Separation Pay Agreement dated September 10, 2012, as amended by that certain Amendment No. 1 to Separation Pay Agreement dated April 29, 2015, (together, the “Separation Pay Agreement”), which agreement shall remain in full force and effect.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 41pt;text-align: left;">If you remain continuously employed by the Company (or any controlled affiliate of the Company or its successor in interest) through the Payment Event Date, the Bonus will be paid to you on the next administratively possible payroll cycle following the Payment Event Date. If your continuous employment with the Company (or any controlled affiliate of the Company or its successor in interest) is terminated by the Company Without Cause (as defined in the Separation Pay Agreement) prior to the Payment Event Date, you will be entitled to receive the Bonus on the next administratively possible payroll cycle following your separation date, conditioned upon your compliance with all terms of the Separation Pay Agreement required for you to receive separation payments thereunder. If your employment is terminated for any other reason prior to the Payment Event Date, you will forfeit any and all rights to the Bonus.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 41pt;text-align: left;">All payments under this Agreement are subject to all applicable tax withholdings. The payments under this Agreement are intended to by exempt from application of Section 409A of the Tax Code, but the Company cannot guarantee any particular type of treatment under the Code.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 41pt;text-align: left;">By signing this Agreement, you acknowledge that. other than as provided in the Separation Pay Agreement, this Agreement contains the entire understanding of the Company and you with respect to the subject matter hereof and supersedes any and all prior understandings with respect thereto, whether written or oral, including, for the avoidance of doubt, that certain letter agreement, dated August 17, 2016, between you and the Company (the “Prior Agreement”). You also acknowledge that other than the Bonus, you have previously been paid all bonus payments provided for in the Prior Agreement and that you are not entitled to any other payment pursuant thereto other than as set forth in this Agreement.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 49pt;text-indent: 0pt;text-align: left;">This Agreement may be amended or otherwise modified only by a written instrument signed by both the Company and you</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 41pt;text-align: left;">You acknowledge that you are an employee “at-will” and the Company may terminate your employment at any time for any reason, with or without cause.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s15" style="padding-left: 19pt;text-indent: 0pt;text-align: center;">[Signature page to follow]</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s42" style="padding-top: 7pt;padding-bottom: 4pt;text-indent: 0pt;text-align: right;">CONNECTURE.COM</p><p style="padding-left: 8pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="716" height="2" alt="image" src="NASDAQ_CNXR_2016/Image_431.png"/></span></p><p class="s14" style="padding-top: 4pt;text-indent: 0pt;text-align: right;">Ex. 10.18.3</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><span><img width="115" height="23" alt="image" src="NASDAQ_CNXR_2016/Image_432.jpg"/></span></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;"><a href="#bookmark42" class="s18">Please acknowledg</a>e your agreement to the foregoing by countersigning this Agreement in the space provided below.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 100pt;text-indent: 0pt;text-align: center;">Connecture, Inc.</p><p style="padding-left: 202pt;text-indent: 0pt;text-align: left;">By: /s/Vincent Estrada</p><p style="padding-left: 374pt;text-indent: 0pt;line-height: 1pt;text-align: left;"><span><img width="228" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_433.png"/></span></p><p style="padding-left: 202pt;text-indent: 0pt;text-align: left;">Name: Vincent Estrada</p><p style="padding-left: 202pt;text-indent: 0pt;text-align: left;">Title Chief Financial Officer</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="text-indent: 0pt;text-align: left;"><span><img width="230" height="1" alt="image" src="NASDAQ_CNXR_2016/Image_434.png"/></span></p><p style="padding-left: 374pt;text-indent: -171pt;line-height: 117%;text-align: left;">Acknowledged and agreed: /s/ Mark Granville Mark Granville</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s42" style="padding-top: 3pt;text-indent: 0pt;text-align: right;">CONNECTURE.COM</p><p class="s14" style="padding-top: 3pt;text-indent: 0pt;text-align: right;"><a name="bookmark32">Exhibit 23.1</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-top: 4pt;padding-left: 135pt;text-indent: 0pt;text-align: left;">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">We consent to the incorporation by reference in Registration Statement No. 333-208921 and 333-213384 on Form S-3 and Nos. 333-208858, 333-201166, 333-207930, and 333-214453 on Form S-8 of our report dated March 31, 2017, relating to the consolidated financial statements and financial statement schedule of Connecture, Inc. and Subsidiaries (the “Company”), appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2016.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">/s/ Deloitte &amp; Touche LLP</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Milwaukee, Wisconsin March 31, 2017</p><p class="s14" style="padding-top: 3pt;text-indent: 0pt;text-align: right;"><a name="bookmark33">Exhibit 31.1</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-top: 4pt;padding-left: 151pt;text-indent: 0pt;text-align: center;">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">I, Jeffery A. Surges, certify that:</p><ol id="l22"><ol id="l23"><li style="padding-top: 5pt;padding-left: 40pt;text-indent: -8pt;text-align: left;"><p style="display: inline;">I have reviewed this annual report on Form 10-K of Connecture, Inc. (the “Company”) for the year ended December 31, 2016;</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 8pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 8pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 8pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:</p><ol id="l24"><li style="padding-top: 5pt;padding-left: 32pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></li><li style="padding-top: 5pt;padding-left: 32pt;text-indent: 24pt;text-align: justify;"><p style="display: inline;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></li><li style="padding-top: 5pt;padding-left: 32pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></li><li style="padding-top: 5pt;padding-left: 32pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li></ol></li><li style="padding-left: 8pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):</p><ol id="l25"><li style="padding-top: 5pt;padding-left: 32pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and</p></li><li style="padding-top: 5pt;padding-left: 32pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.</p></li></ol></li></ol></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Date: March 31, 2017<u> /s/ Jeffery A. Surges                                     </u></p><p class="s14" style="padding-left: 397pt;text-indent: 11pt;text-align: left;">Jeffery A. Surges Chief Executive Officer</p><h4 style="text-indent: 0pt;text-align: right;">(Principal Executive Officer)</h4><p class="s14" style="padding-top: 3pt;text-indent: 0pt;text-align: right;"><a name="bookmark34">Exhibit 31.2</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-top: 4pt;padding-left: 151pt;text-indent: 0pt;text-align: center;">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302(a) OF THE SARBANES-OXLEY ACT OF 2002</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">I, Vincent E. Estrada, certify that:</p><ol id="l26"><li style="padding-top: 5pt;padding-left: 40pt;text-indent: -8pt;text-align: left;"><p style="display: inline;">I have reviewed this annual report on Form 10-K of Connecture, Inc. (the “Company”) for the year ended December 31, 2016;</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 8pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 8pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li><li style="padding-left: 8pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">The registrant’s other certifying and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:</p><ol id="l27"><li style="padding-top: 5pt;padding-left: 32pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</p></li><li style="padding-top: 5pt;padding-left: 32pt;text-indent: 24pt;text-align: justify;"><p style="display: inline;">Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</p></li><li style="padding-top: 5pt;padding-left: 32pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</p></li><li style="padding-top: 5pt;padding-left: 32pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and</p><p style="text-indent: 0pt;text-align: left;"><br/></p></li></ol></li><li style="padding-left: 8pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):</p><ol id="l28"><li style="padding-top: 5pt;padding-left: 32pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and</p></li><li style="padding-top: 5pt;padding-left: 32pt;text-indent: 24pt;text-align: left;"><p style="display: inline;">Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.</p></li></ol></li></ol><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Date: March 31, 2017<u> /s/ Vincent E. Estrada                                    </u></p><p class="s14" style="padding-left: 398pt;text-indent: 0pt;text-align: center;">Vincent E. Estrada Chief Financial Officer</p><h4 style="padding-left: 344pt;text-indent: 0pt;text-align: center;">(Principal Financial and Accounting Officer)</h4><p class="s14" style="padding-top: 3pt;text-indent: 0pt;text-align: right;"><a name="bookmark35">Exhibit 32.1</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-top: 4pt;padding-left: 179pt;text-indent: 0pt;text-align: center;">CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350</p><p class="s14" style="padding-left: 20pt;text-indent: 0pt;text-align: center;">AS ADOPTED PURSUANT TO</p><p class="s14" style="padding-left: 170pt;text-indent: 0pt;text-align: left;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The undersigned, the Chief Executive Officer of Connecture, Inc. (the “Company”), does hereby certify under the standards set forth and solely for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Annual Report on Form 10-K of the Company for the year ended December 31, 2016 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Date: March 31, 2017<u> /s/ Jeffery A. Surges                                     </u></p><p class="s14" style="padding-left: 398pt;text-indent: 11pt;text-align: left;">Jeffery A. Surges Chief Executive Officer</p><h4 style="padding-left: 389pt;text-indent: 0pt;text-align: left;">(Principal Executive Officer)</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</p><p class="s14" style="padding-top: 3pt;text-indent: 0pt;text-align: right;"><a name="bookmark36">Exhibit 32.2</a></p><p style="text-indent: 0pt;text-align: left;"><br/></p><p class="s14" style="padding-top: 4pt;padding-left: 179pt;text-indent: 0pt;text-align: center;">CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350</p><p class="s14" style="padding-left: 20pt;text-indent: 0pt;text-align: center;">AS ADOPTED PURSUANT TO</p><p class="s14" style="padding-left: 170pt;text-indent: 0pt;text-align: left;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">The undersigned, the Chief Financial Officer of Connecture, Inc. (the “Company”), does hereby certify under the standards set forth and solely for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge, the Annual Report on Form 10-K of the Company for the year ended December 31, 2016 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in that Form 10-K fairly presents, in all material respects, the financial condition and results of operations of the Company.</p><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 0pt;text-align: left;">Date: March 31, 2017<u> /s/ Vincent E. Estrada                                   </u></p><p class="s14" style="padding-left: 398pt;text-indent: 0pt;text-align: center;">Vincent E. Estrada Chief Financial Officer</p><h4 style="padding-left: 360pt;text-indent: 0pt;text-align: left;">(Principal Financial and Accounting Officer)</h4><p style="text-indent: 0pt;text-align: left;"><br/></p><p style="padding-left: 8pt;text-indent: 24pt;text-align: left;">A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.</p></body></html>
